TW201012812A - Insecticidal sulphur-derivatized 1-azinylpyrazoles - Google Patents
Insecticidal sulphur-derivatized 1-azinylpyrazoles Download PDFInfo
- Publication number
- TW201012812A TW201012812A TW98121287A TW98121287A TW201012812A TW 201012812 A TW201012812 A TW 201012812A TW 98121287 A TW98121287 A TW 98121287A TW 98121287 A TW98121287 A TW 98121287A TW 201012812 A TW201012812 A TW 201012812A
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- alkyl
- alkoxy
- formula
- compound
- Prior art date
Links
- 230000000749 insecticidal effect Effects 0.000 title description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 52
- 238000000034 method Methods 0.000 claims abstract description 47
- 239000000203 mixture Substances 0.000 claims abstract description 41
- -1 dentyl Chemical group 0.000 claims description 199
- 150000001875 compounds Chemical class 0.000 claims description 179
- 125000000217 alkyl group Chemical group 0.000 claims description 178
- 125000003545 alkoxy group Chemical group 0.000 claims description 119
- 125000001424 substituent group Chemical class 0.000 claims description 96
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 76
- 125000005843 halogen group Chemical group 0.000 claims description 68
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 62
- 125000001188 haloalkyl group Chemical group 0.000 claims description 60
- 239000002585 base Substances 0.000 claims description 57
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 51
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 38
- 125000003396 thiol group Chemical class [H]S* 0.000 claims description 34
- 239000002904 solvent Substances 0.000 claims description 31
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 30
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 29
- 125000004122 cyclic group Chemical group 0.000 claims description 29
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 26
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 25
- 125000003118 aryl group Chemical group 0.000 claims description 25
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 23
- 125000003282 alkyl amino group Chemical group 0.000 claims description 22
- 125000004414 alkyl thio group Chemical group 0.000 claims description 22
- 229910052799 carbon Inorganic materials 0.000 claims description 22
- 125000000623 heterocyclic group Chemical group 0.000 claims description 22
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 20
- 125000001153 fluoro group Chemical group F* 0.000 claims description 20
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 19
- 125000001072 heteroaryl group Chemical group 0.000 claims description 18
- 241001465754 Metazoa Species 0.000 claims description 17
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 17
- 125000003342 alkenyl group Chemical group 0.000 claims description 17
- 125000005083 alkoxyalkoxy group Chemical group 0.000 claims description 17
- 241000238631 Hexapoda Species 0.000 claims description 16
- 125000003277 amino group Chemical group 0.000 claims description 16
- 241000607479 Yersinia pestis Species 0.000 claims description 15
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 15
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 15
- 150000001335 aliphatic alkanes Chemical group 0.000 claims description 14
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 14
- 239000001257 hydrogen Substances 0.000 claims description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims description 14
- 229910052717 sulfur Inorganic materials 0.000 claims description 14
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 13
- 125000005133 alkynyloxy group Chemical group 0.000 claims description 13
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 13
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 claims description 12
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 11
- 125000000304 alkynyl group Chemical group 0.000 claims description 11
- 150000001412 amines Chemical class 0.000 claims description 11
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 11
- SFDJOSRHYKHMOK-UHFFFAOYSA-N nitramide Chemical compound N[N+]([O-])=O SFDJOSRHYKHMOK-UHFFFAOYSA-N 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 239000011593 sulfur Substances 0.000 claims description 10
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 claims description 9
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 claims description 9
- 239000011737 fluorine Substances 0.000 claims description 9
- 229910052731 fluorine Inorganic materials 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 241000894007 species Species 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 125000006350 alkyl thio alkyl group Chemical group 0.000 claims description 8
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 8
- 238000007254 oxidation reaction Methods 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- 206010036790 Productive cough Diseases 0.000 claims description 7
- 239000005864 Sulphur Substances 0.000 claims description 7
- 125000004429 atom Chemical group 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- 210000003802 sputum Anatomy 0.000 claims description 7
- 208000024794 sputum Diseases 0.000 claims description 7
- 125000005265 dialkylamine group Chemical group 0.000 claims description 6
- 230000003647 oxidation Effects 0.000 claims description 6
- 239000004606 Fillers/Extenders Substances 0.000 claims description 5
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 5
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 5
- 125000003884 phenylalkyl group Chemical group 0.000 claims description 5
- 125000004688 alkyl sulfonyl alkyl group Chemical group 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 4
- 125000004966 cyanoalkyl group Chemical group 0.000 claims description 4
- 125000004994 halo alkoxy alkyl group Chemical group 0.000 claims description 4
- 125000004441 haloalkylsulfonyl group Chemical group 0.000 claims description 4
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 4
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 4
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 3
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 claims description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 3
- 125000005093 alkyl carbonyl alkyl group Chemical group 0.000 claims description 3
- 125000004687 alkyl sulfinyl alkyl group Chemical group 0.000 claims description 3
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- 150000003217 pyrazoles Chemical class 0.000 claims description 3
- 125000002730 succinyl group Chemical group C(CCC(=O)*)(=O)* 0.000 claims description 3
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 claims description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 2
- 239000004327 boric acid Substances 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 125000004354 sulfur functional group Chemical group 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 235000019000 fluorine Nutrition 0.000 claims 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 claims 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 1
- 229910002651 NO3 Inorganic materials 0.000 claims 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical group O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- 125000005055 alkyl alkoxy group Chemical group 0.000 claims 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 claims 1
- JEVCWSUVFOYBFI-UHFFFAOYSA-N cyanyl Chemical group N#[C] JEVCWSUVFOYBFI-UHFFFAOYSA-N 0.000 claims 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 claims 1
- 125000004439 haloalkylsulfanyl group Chemical group 0.000 claims 1
- 125000004440 haloalkylsulfinyl group Chemical group 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 claims 1
- JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical group N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 229910052763 palladium Inorganic materials 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical group C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 claims 1
- 239000004575 stone Substances 0.000 claims 1
- 125000006296 sulfonyl amino group Chemical group [H]N(*)S(*)(=O)=O 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
- 230000009466 transformation Effects 0.000 claims 1
- 239000000543 intermediate Substances 0.000 abstract description 18
- 239000002917 insecticide Substances 0.000 abstract description 13
- 230000008569 process Effects 0.000 abstract description 9
- 230000000590 parasiticidal effect Effects 0.000 abstract description 4
- 239000002297 parasiticide Substances 0.000 abstract description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 335
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 71
- 241000196324 Embryophyta Species 0.000 description 59
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 40
- WEVYAHXRMPXWCK-FIBGUPNXSA-N acetonitrile-d3 Chemical compound [2H]C([2H])([2H])C#N WEVYAHXRMPXWCK-FIBGUPNXSA-N 0.000 description 37
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 33
- 230000000694 effects Effects 0.000 description 29
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 28
- 238000005481 NMR spectroscopy Methods 0.000 description 27
- 241000244206 Nematoda Species 0.000 description 26
- 241000239226 Scorpiones Species 0.000 description 26
- 239000003112 inhibitor Substances 0.000 description 24
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- 239000003795 chemical substances by application Substances 0.000 description 21
- 238000012360 testing method Methods 0.000 description 20
- 239000002253 acid Substances 0.000 description 19
- 230000015572 biosynthetic process Effects 0.000 description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 241000238876 Acari Species 0.000 description 17
- 241001674044 Blattodea Species 0.000 description 17
- 241000237858 Gastropoda Species 0.000 description 16
- 150000001721 carbon Chemical group 0.000 description 16
- 150000003839 salts Chemical class 0.000 description 16
- 238000003786 synthesis reaction Methods 0.000 description 16
- 238000005160 1H NMR spectroscopy Methods 0.000 description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 15
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 14
- 239000003995 emulsifying agent Substances 0.000 description 14
- 241000256602 Isoptera Species 0.000 description 13
- 239000000460 chlorine Substances 0.000 description 13
- 239000007789 gas Substances 0.000 description 13
- 239000007921 spray Substances 0.000 description 13
- IAKOZHOLGAGEJT-UHFFFAOYSA-N 1,1,1-trichloro-2,2-bis(p-methoxyphenyl)-Ethane Chemical compound C1=CC(OC)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(OC)C=C1 IAKOZHOLGAGEJT-UHFFFAOYSA-N 0.000 description 12
- 229920000742 Cotton Polymers 0.000 description 12
- 241000219146 Gossypium Species 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 11
- 241000283690 Bos taurus Species 0.000 description 11
- 240000008042 Zea mays Species 0.000 description 11
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 10
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 10
- 239000012141 concentrate Substances 0.000 description 10
- 235000005822 corn Nutrition 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 241000255925 Diptera Species 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 9
- 229910052794 bromium Inorganic materials 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 8
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical group [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- 244000045947 parasite Species 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 241000256844 Apis mellifera Species 0.000 description 7
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 7
- 235000010469 Glycine max Nutrition 0.000 description 7
- 244000068988 Glycine max Species 0.000 description 7
- 240000007594 Oryza sativa Species 0.000 description 7
- 235000007164 Oryza sativa Nutrition 0.000 description 7
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 7
- 229910052801 chlorine Inorganic materials 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 239000008187 granular material Substances 0.000 description 7
- 230000002363 herbicidal effect Effects 0.000 description 7
- 239000004009 herbicide Substances 0.000 description 7
- 235000009566 rice Nutrition 0.000 description 7
- 229920006395 saturated elastomer Polymers 0.000 description 7
- 239000002689 soil Substances 0.000 description 7
- 241001124076 Aphididae Species 0.000 description 6
- 241000283073 Equus caballus Species 0.000 description 6
- JNCMHMUGTWEVOZ-UHFFFAOYSA-N F[CH]F Chemical compound F[CH]F JNCMHMUGTWEVOZ-UHFFFAOYSA-N 0.000 description 6
- 108010081348 HRT1 protein Hairy Proteins 0.000 description 6
- 102100021881 Hairy/enhancer-of-split related with YRPW motif protein 1 Human genes 0.000 description 6
- 241000258937 Hemiptera Species 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 6
- 241000257303 Hymenoptera Species 0.000 description 6
- 241001494479 Pecora Species 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 239000000417 fungicide Substances 0.000 description 6
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 6
- 150000002430 hydrocarbons Chemical group 0.000 description 6
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 6
- 229910052707 ruthenium Inorganic materials 0.000 description 6
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- 235000021419 vinegar Nutrition 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 241000193388 Bacillus thuringiensis Species 0.000 description 5
- 241000282465 Canis Species 0.000 description 5
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 5
- 241000255777 Lepidoptera Species 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 235000013330 chicken meat Nutrition 0.000 description 5
- 235000019253 formic acid Nutrition 0.000 description 5
- 125000001041 indolyl group Chemical group 0.000 description 5
- 230000002452 interceptive effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000003071 parasitic effect Effects 0.000 description 5
- 229920005862 polyol Polymers 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 5
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 5
- 239000000052 vinegar Substances 0.000 description 5
- JVVRJMXHNUAPHW-UHFFFAOYSA-N 1h-pyrazol-5-amine Chemical class NC=1C=CNN=1 JVVRJMXHNUAPHW-UHFFFAOYSA-N 0.000 description 4
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 4
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 4
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 4
- 241001465677 Ancylostomatoidea Species 0.000 description 4
- 241000271566 Aves Species 0.000 description 4
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 241000257159 Musca domestica Species 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- MWMQNVGAHVXSPE-UHFFFAOYSA-N Pyriprole Chemical compound ClC=1C=C(C(F)(F)F)C=C(Cl)C=1N1N=C(C#N)C(SC(F)F)=C1NCC1=CC=CC=N1 MWMQNVGAHVXSPE-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 description 4
- 244000061456 Solanum tuberosum Species 0.000 description 4
- 241000243774 Trichinella Species 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 125000001931 aliphatic group Chemical group 0.000 description 4
- 125000002877 alkyl aryl group Chemical group 0.000 description 4
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 4
- 229940097012 bacillus thuringiensis Drugs 0.000 description 4
- 239000004305 biphenyl Substances 0.000 description 4
- 235000010290 biphenyl Nutrition 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 4
- 210000000744 eyelid Anatomy 0.000 description 4
- 239000003630 growth substance Substances 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 125000005842 heteroatom Chemical group 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 125000000468 ketone group Chemical group 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 239000007800 oxidant agent Substances 0.000 description 4
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 230000035806 respiratory chain Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 239000002023 wood Substances 0.000 description 4
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 3
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 3
- 241000256111 Aedes <genus> Species 0.000 description 3
- 241000256186 Anopheles <genus> Species 0.000 description 3
- 241000239223 Arachnida Species 0.000 description 3
- 240000005528 Arctium lappa Species 0.000 description 3
- 235000003130 Arctium lappa Nutrition 0.000 description 3
- 235000008078 Arctium minus Nutrition 0.000 description 3
- 241000238421 Arthropoda Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 240000002791 Brassica napus Species 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241001466007 Heteroptera Species 0.000 description 3
- 240000008415 Lactuca sativa Species 0.000 description 3
- 235000003228 Lactuca sativa Nutrition 0.000 description 3
- 244000061176 Nicotiana tabacum Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 241000286209 Phasianidae Species 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 241001267621 Tylenchulus semipenetrans Species 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 240000006365 Vitis vinifera Species 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 230000000895 acaricidal effect Effects 0.000 description 3
- 239000000642 acaricide Substances 0.000 description 3
- 239000000556 agonist Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 125000006612 decyloxy group Chemical group 0.000 description 3
- 230000007123 defense Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- NYPJDWWKZLNGGM-UHFFFAOYSA-N fenvalerate Aalpha Natural products C=1C=C(Cl)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-UHFFFAOYSA-N 0.000 description 3
- 239000003337 fertilizer Substances 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 3
- 125000001841 imino group Chemical group [H]N=* 0.000 description 3
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000010985 leather Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000004576 sand Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 150000003568 thioethers Chemical class 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- CXBMCYHAMVGWJQ-CABCVRRESA-N (1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)methyl (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCN1C(=O)C(CCCC2)=C2C1=O CXBMCYHAMVGWJQ-CABCVRRESA-N 0.000 description 2
- SBNFWQZLDJGRLK-RTWAWAEBSA-N (1R)-trans-phenothrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-RTWAWAEBSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- LUBJCRLGQSPQNN-UHFFFAOYSA-N 1-Phenylurea Chemical compound NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 description 2
- PZBPKYOVPCNPJY-UHFFFAOYSA-N 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=C)CN1C=NC=C1 PZBPKYOVPCNPJY-UHFFFAOYSA-N 0.000 description 2
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 description 2
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 description 2
- WNZQDUSMALZDQF-UHFFFAOYSA-N 2-benzofuran-1(3H)-one Chemical compound C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 description 2
- FSCWZHGZWWDELK-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione Chemical compound O=C1C(C)(C=C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 FSCWZHGZWWDELK-UHFFFAOYSA-N 0.000 description 2
- 102000012440 Acetylcholinesterase Human genes 0.000 description 2
- 108010022752 Acetylcholinesterase Proteins 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000256118 Aedes aegypti Species 0.000 description 2
- 241000256173 Aedes albopictus Species 0.000 description 2
- 241000272517 Anseriformes Species 0.000 description 2
- 241001600408 Aphis gossypii Species 0.000 description 2
- 241000239290 Araneae Species 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 206010004194 Bed bug infestation Diseases 0.000 description 2
- 241001573716 Blaniulus guttulatus Species 0.000 description 2
- 241000238657 Blattella germanica Species 0.000 description 2
- 241000256593 Brachycaudus schwartzi Species 0.000 description 2
- 235000011331 Brassica Nutrition 0.000 description 2
- 241000219198 Brassica Species 0.000 description 2
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 2
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 2
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 2
- 241000243771 Bursaphelenchus xylophilus Species 0.000 description 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 2
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 2
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000252506 Characiformes Species 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000005944 Chlorpyrifos Substances 0.000 description 2
- 241001414835 Cimicidae Species 0.000 description 2
- 241000254173 Coleoptera Species 0.000 description 2
- 241000256059 Culex pipiens Species 0.000 description 2
- 241000254171 Curculionidae Species 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- 244000008991 Curcuma longa Species 0.000 description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 2
- 239000005947 Dimethoate Substances 0.000 description 2
- 241000399949 Ditylenchus dipsaci Species 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241000239183 Filaria Species 0.000 description 2
- 241000222336 Ganoderma Species 0.000 description 2
- 241000248126 Geophilus Species 0.000 description 2
- 241000482313 Globodera ellingtonae Species 0.000 description 2
- 241001442497 Globodera rostochiensis Species 0.000 description 2
- 239000005562 Glyphosate Substances 0.000 description 2
- 244000060234 Gmelina philippensis Species 0.000 description 2
- 241001480796 Haemaphysalis Species 0.000 description 2
- 241000775881 Haematopota pluvialis Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 241001149911 Isopoda Species 0.000 description 2
- 241001177134 Lyctus Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000237852 Mollusca Species 0.000 description 2
- 241000257226 Muscidae Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NQRFDNJEBWAUBL-UHFFFAOYSA-N N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NCC)=NC(CC)=C1C(=O)NC(C#N)C1=CC=CS1 NQRFDNJEBWAUBL-UHFFFAOYSA-N 0.000 description 2
- 241001491877 Operophtera brumata Species 0.000 description 2
- 241000238887 Ornithodoros Species 0.000 description 2
- 241000283898 Ovis Species 0.000 description 2
- 241001130173 Paralongidorus maximus Species 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- 241000255969 Pieris brassicae Species 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 235000014443 Pyrus communis Nutrition 0.000 description 2
- 241000500703 Python regius Species 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- 241000208422 Rhododendron Species 0.000 description 2
- 241001132771 Rotylenchus buxophilus Species 0.000 description 2
- 240000000111 Saccharum officinarum Species 0.000 description 2
- 235000007201 Saccharum officinarum Nutrition 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 240000003829 Sorghum propinquum Species 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- 241000256251 Spodoptera frugiperda Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 241001501942 Suricata suricatta Species 0.000 description 2
- 241000270708 Testudinidae Species 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 241000223259 Trichoderma Species 0.000 description 2
- 239000005942 Triflumuron Substances 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- YXWCBRDRVXHABN-JCMHNJIXSA-N [cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-[(z)-2-chloro-2-(4-chlorophenyl)ethenyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound C=1C=C(F)C(OC=2C=CC=CC=2)=CC=1C(C#N)OC(=O)C1C(C)(C)C1\C=C(/Cl)C1=CC=C(Cl)C=C1 YXWCBRDRVXHABN-JCMHNJIXSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 229940022698 acetylcholinesterase Drugs 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 150000008052 alkyl sulfonates Chemical class 0.000 description 2
- 125000005109 alkynylthio group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- RMRFFCXPLWYOOY-UHFFFAOYSA-N allyl radical Chemical compound [CH2]C=C RMRFFCXPLWYOOY-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000009120 camo Nutrition 0.000 description 2
- 125000002837 carbocyclic group Chemical group 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000005607 chanvre indien Nutrition 0.000 description 2
- PSOVNZZNOMJUBI-UHFFFAOYSA-N chlorantraniliprole Chemical compound CNC(=O)C1=CC(Cl)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl PSOVNZZNOMJUBI-UHFFFAOYSA-N 0.000 description 2
- 125000000068 chlorophenyl group Chemical group 0.000 description 2
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 229910001610 cryolite Inorganic materials 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000003373 curcuma longa Nutrition 0.000 description 2
- DVBUIBGJRQBEDP-UHFFFAOYSA-N cyantraniliprole Chemical compound CNC(=O)C1=CC(C#N)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl DVBUIBGJRQBEDP-UHFFFAOYSA-N 0.000 description 2
- 150000001924 cycloalkanes Chemical class 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 229960003887 dichlorophen Drugs 0.000 description 2
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- FBOUIAKEJMZPQG-BLXFFLACSA-N diniconazole-M Chemical compound C1=NC=NN1/C([C@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-BLXFFLACSA-N 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 244000078703 ectoparasite Species 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 2
- XQUXKZZNEFRCAW-UHFFFAOYSA-N fenpropathrin Chemical compound CC1(C)C(C)(C)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 XQUXKZZNEFRCAW-UHFFFAOYSA-N 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 238000002309 gasification Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229940097068 glyphosate Drugs 0.000 description 2
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 2
- 210000004013 groin Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000011487 hemp Substances 0.000 description 2
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 150000002466 imines Chemical group 0.000 description 2
- RONFGUROBZGJKP-UHFFFAOYSA-N iminoctadine Chemical compound NC(N)=NCCCCCCCCNCCCCCCCCN=C(N)N RONFGUROBZGJKP-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 125000001261 isocyanato group Chemical group *N=C=O 0.000 description 2
- 239000010977 jade Substances 0.000 description 2
- PVTHJAPFENJVNC-MHRBZPPQSA-N kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000011785 micronutrient Substances 0.000 description 2
- 235000013369 micronutrients Nutrition 0.000 description 2
- ZLBGSRMUSVULIE-GSMJGMFJSA-N milbemycin A3 Chemical class O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 ZLBGSRMUSVULIE-GSMJGMFJSA-N 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- BLCKKNLGFULNRC-UHFFFAOYSA-L n,n-dimethylcarbamodithioate;nickel(2+) Chemical compound [Ni+2].CN(C)C([S-])=S.CN(C)C([S-])=S BLCKKNLGFULNRC-UHFFFAOYSA-L 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000004311 natamycin Substances 0.000 description 2
- 235000010298 natamycin Nutrition 0.000 description 2
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 2
- 229960003255 natamycin Drugs 0.000 description 2
- 239000005645 nematicide Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 229940116315 oxalic acid Drugs 0.000 description 2
- 230000010627 oxidative phosphorylation Effects 0.000 description 2
- 150000002923 oximes Chemical class 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachlorophenol Chemical compound OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- JGCSKOVQDXEQHI-UHFFFAOYSA-N phenazine-1-carboxylic acid Chemical compound C1=CC=C2N=C3C(C(=O)O)=CC=CC3=NC2=C1 JGCSKOVQDXEQHI-UHFFFAOYSA-N 0.000 description 2
- 229960003536 phenothrin Drugs 0.000 description 2
- CTYRPMDGLDAWRQ-UHFFFAOYSA-N phenyl hydrogen sulfate Chemical compound OS(=O)(=O)OC1=CC=CC=C1 CTYRPMDGLDAWRQ-UHFFFAOYSA-N 0.000 description 2
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 2
- 229940067157 phenylhydrazine Drugs 0.000 description 2
- 230000008635 plant growth Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 description 2
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 2
- QJBZDBLBQWFTPZ-UHFFFAOYSA-N pyrrolnitrin Chemical compound [O-][N+](=O)C1=C(Cl)C=CC=C1C1=CNC=C1Cl QJBZDBLBQWFTPZ-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 2
- FBQQHUGEACOBDN-UHFFFAOYSA-N quinomethionate Chemical compound N1=C2SC(=O)SC2=NC2=CC(C)=CC=C21 FBQQHUGEACOBDN-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 description 2
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000003195 sodium channel blocking agent Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 238000009331 sowing Methods 0.000 description 2
- 125000003003 spiro group Chemical group 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- 125000003107 substituted aryl group Chemical group 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- ROZUQUDEWZIBHV-UHFFFAOYSA-N tecloftalam Chemical compound OC(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C(=O)NC1=CC=CC(Cl)=C1Cl ROZUQUDEWZIBHV-UHFFFAOYSA-N 0.000 description 2
- XLNZEKHULJKQBA-UHFFFAOYSA-N terbufos Chemical compound CCOP(=S)(OCC)SCSC(C)(C)C XLNZEKHULJKQBA-UHFFFAOYSA-N 0.000 description 2
- 229960005199 tetramethrin Drugs 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- NKNFWVNSBIXGLL-UHFFFAOYSA-N triazamate Chemical compound CCOC(=O)CSC1=NC(C(C)(C)C)=NN1C(=O)N(C)C NKNFWVNSBIXGLL-UHFFFAOYSA-N 0.000 description 2
- XAIPTRIXGHTTNT-UHFFFAOYSA-N triflumuron Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)NC(=O)C1=CC=CC=C1Cl XAIPTRIXGHTTNT-UHFFFAOYSA-N 0.000 description 2
- HIZCIEIDIFGZSS-UHFFFAOYSA-L trithiocarbonate Chemical compound [S-]C([S-])=S HIZCIEIDIFGZSS-UHFFFAOYSA-L 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- BCEHBSKCWLPMDN-MGPLVRAMSA-N voriconazole Chemical compound C1([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)=NC=NC=C1F BCEHBSKCWLPMDN-MGPLVRAMSA-N 0.000 description 2
- 229960004740 voriconazole Drugs 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- 229910052727 yttrium Inorganic materials 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- ZCVAOQKBXKSDMS-PVAVHDDUSA-N (+)-trans-(S)-allethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)O[C@@H]1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-PVAVHDDUSA-N 0.000 description 1
- ZCVAOQKBXKSDMS-AQYZNVCMSA-N (+)-trans-allethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-AQYZNVCMSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- NNJPGOLRFBJNIW-HNNXBMFYSA-N (-)-demecolcine Chemical compound C1=C(OC)C(=O)C=C2[C@@H](NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-HNNXBMFYSA-N 0.000 description 1
- YNWVFADWVLCOPU-MDWZMJQESA-N (1E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1 YNWVFADWVLCOPU-MDWZMJQESA-N 0.000 description 1
- FJDPATXIBIBRIM-QFMSAKRMSA-N (1R)-trans-cyphenothrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 FJDPATXIBIBRIM-QFMSAKRMSA-N 0.000 description 1
- XERJKGMBORTKEO-VZUCSPMQSA-N (1e)-2-(ethylcarbamoylamino)-n-methoxy-2-oxoethanimidoyl cyanide Chemical compound CCNC(=O)NC(=O)C(\C#N)=N\OC XERJKGMBORTKEO-VZUCSPMQSA-N 0.000 description 1
- AGMMRUPNXPWLGF-AATRIKPKSA-N (2,3,5,6-tetrafluoro-4-methylphenyl)methyl 2,2-dimethyl-3-[(e)-prop-1-enyl]cyclopropane-1-carboxylate Chemical compound CC1(C)C(/C=C/C)C1C(=O)OCC1=C(F)C(F)=C(C)C(F)=C1F AGMMRUPNXPWLGF-AATRIKPKSA-N 0.000 description 1
- NHOWDZOIZKMVAI-UHFFFAOYSA-N (2-chlorophenyl)(4-chlorophenyl)pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(Cl)C=C1 NHOWDZOIZKMVAI-UHFFFAOYSA-N 0.000 description 1
- SAPGTCDSBGMXCD-UHFFFAOYSA-N (2-chlorophenyl)-(4-fluorophenyl)-pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(F)C=C1 SAPGTCDSBGMXCD-UHFFFAOYSA-N 0.000 description 1
- ZMYFCFLJBGAQRS-IRXDYDNUSA-N (2R,3S)-epoxiconazole Chemical compound C1=CC(F)=CC=C1[C@@]1(CN2N=CN=C2)[C@H](C=2C(=CC=CC=2)Cl)O1 ZMYFCFLJBGAQRS-IRXDYDNUSA-N 0.000 description 1
- RYAUSSKQMZRMAI-ALOPSCKCSA-N (2S,6R)-4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1C[C@H](C)O[C@H](C)C1 RYAUSSKQMZRMAI-ALOPSCKCSA-N 0.000 description 1
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 1
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 1
- XUNYDVLIZWUPAW-UHFFFAOYSA-N (4-chlorophenyl) n-(4-methylphenyl)sulfonylcarbamate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)OC1=CC=C(Cl)C=C1 XUNYDVLIZWUPAW-UHFFFAOYSA-N 0.000 description 1
- PPDBOQMNKNNODG-NTEUORMPSA-N (5E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentanol Chemical compound C1=NC=NN1CC1(O)C(C)(C)CC\C1=C/C1=CC=C(Cl)C=C1 PPDBOQMNKNNODG-NTEUORMPSA-N 0.000 description 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 1
- WCXDHFDTOYPNIE-RIYZIHGNSA-N (E)-acetamiprid Chemical compound N#C/N=C(\C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-RIYZIHGNSA-N 0.000 description 1
- PGOOBECODWQEAB-UHFFFAOYSA-N (E)-clothianidin Chemical compound [O-][N+](=O)\N=C(/NC)NCC1=CN=C(Cl)S1 PGOOBECODWQEAB-UHFFFAOYSA-N 0.000 description 1
- CFRPSFYHXJZSBI-DHZHZOJOSA-N (E)-nitenpyram Chemical compound [O-][N+](=O)/C=C(\NC)N(CC)CC1=CC=C(Cl)N=C1 CFRPSFYHXJZSBI-DHZHZOJOSA-N 0.000 description 1
- FZRBKIRIBLNOAM-UHFFFAOYSA-N (E,E)-2-propynyl 3,7,11-trimethyl-2,4-dodecadienoate Chemical compound CC(C)CCCC(C)CC=CC(C)=CC(=O)OCC#C FZRBKIRIBLNOAM-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- XGWIJUOSCAQSSV-XHDPSFHLSA-N (S,S)-hexythiazox Chemical compound S([C@H]([C@@H]1C)C=2C=CC(Cl)=CC=2)C(=O)N1C(=O)NC1CCCCC1 XGWIJUOSCAQSSV-XHDPSFHLSA-N 0.000 description 1
- RMOGWMIKYWRTKW-UONOGXRCSA-N (S,S)-paclobutrazol Chemical compound C([C@@H]([C@@H](O)C(C)(C)C)N1N=CN=C1)C1=CC=C(Cl)C=C1 RMOGWMIKYWRTKW-UONOGXRCSA-N 0.000 description 1
- ZFHGXWPMULPQSE-SZGBIDFHSA-N (Z)-(1S)-cis-tefluthrin Chemical compound FC1=C(F)C(C)=C(F)C(F)=C1COC(=O)[C@@H]1C(C)(C)[C@@H]1\C=C(/Cl)C(F)(F)F ZFHGXWPMULPQSE-SZGBIDFHSA-N 0.000 description 1
- QNBTYORWCCMPQP-JXAWBTAJSA-N (Z)-dimethomorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(Cl)=CC=1)=C/C(=O)N1CCOCC1 QNBTYORWCCMPQP-JXAWBTAJSA-N 0.000 description 1
- HOKKPVIRMVDYPB-UVTDQMKNSA-N (Z)-thiacloprid Chemical compound C1=NC(Cl)=CC=C1CN1C(=N/C#N)/SCC1 HOKKPVIRMVDYPB-UVTDQMKNSA-N 0.000 description 1
- CKPCAYZTYMHQEX-NBVRZTHBSA-N (e)-1-(2,4-dichlorophenyl)-n-methoxy-2-pyridin-3-ylethanimine Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=N/OC)/CC1=CC=CN=C1 CKPCAYZTYMHQEX-NBVRZTHBSA-N 0.000 description 1
- QMMOXUPEWRXHJS-HYXAFXHYSA-N (z)-pent-2-ene Chemical compound CC\C=C/C QMMOXUPEWRXHJS-HYXAFXHYSA-N 0.000 description 1
- SVNOXIYXCLVHLV-UHFFFAOYSA-N 1,2,3,4,5,6-hexachlorobenzene Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl.ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl SVNOXIYXCLVHLV-UHFFFAOYSA-N 0.000 description 1
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical compound C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- JWUCHKBSVLQQCO-UHFFFAOYSA-N 1-(2-fluorophenyl)-1-(4-fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol Chemical compound C=1C=C(F)C=CC=1C(C=1C(=CC=CC=1)F)(O)CN1C=NC=N1 JWUCHKBSVLQQCO-UHFFFAOYSA-N 0.000 description 1
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 description 1
- VGPIBGGRCVEHQZ-UHFFFAOYSA-N 1-(biphenyl-4-yloxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC(C=C1)=CC=C1C1=CC=CC=C1 VGPIBGGRCVEHQZ-UHFFFAOYSA-N 0.000 description 1
- LQDARGUHUSPFNL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(COC(F)(F)C(F)F)CN1C=NC=N1 LQDARGUHUSPFNL-UHFFFAOYSA-N 0.000 description 1
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 1
- MGNFYQILYYYUBS-UHFFFAOYSA-N 1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1CCCCC1 MGNFYQILYYYUBS-UHFFFAOYSA-N 0.000 description 1
- ULCWZQJLFZEXCS-UHFFFAOYSA-N 1-[[2-(2,4-dichlorophenyl)-5-(2,2,2-trifluoroethoxy)oxolan-2-yl]methyl]-1,2,4-triazole Chemical compound O1C(OCC(F)(F)F)CCC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 ULCWZQJLFZEXCS-UHFFFAOYSA-N 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- YIKWKLYQRFRGPM-UHFFFAOYSA-N 1-dodecylguanidine acetate Chemical compound CC(O)=O.CCCCCCCCCCCCN=C(N)N YIKWKLYQRFRGPM-UHFFFAOYSA-N 0.000 description 1
- ZFSFKYIBIOKXKI-UHFFFAOYSA-N 1-ethyl-1-methylhydrazine Chemical compound CCN(C)N ZFSFKYIBIOKXKI-UHFFFAOYSA-N 0.000 description 1
- HFWWGJSMDPUEFD-UHFFFAOYSA-N 1-isothiocyanatodecane Chemical compound CCCCCCCCCCN=C=S HFWWGJSMDPUEFD-UHFFFAOYSA-N 0.000 description 1
- PFFIDZXUXFLSSR-UHFFFAOYSA-N 1-methyl-N-[2-(4-methylpentan-2-yl)-3-thienyl]-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound S1C=CC(NC(=O)C=2C(=NN(C)C=2)C(F)(F)F)=C1C(C)CC(C)C PFFIDZXUXFLSSR-UHFFFAOYSA-N 0.000 description 1
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 description 1
- FMTFEIJHMMQUJI-NJAFHUGGSA-N 102130-98-3 Natural products CC=CCC1=C(C)[C@H](CC1=O)OC(=O)[C@@H]1[C@@H](C=C(C)C)C1(C)C FMTFEIJHMMQUJI-NJAFHUGGSA-N 0.000 description 1
- IHWDSEPNZDYMNF-UHFFFAOYSA-N 1H-indol-2-amine Chemical class C1=CC=C2NC(N)=CC2=C1 IHWDSEPNZDYMNF-UHFFFAOYSA-N 0.000 description 1
- NFTOEHBFQROATQ-UHFFFAOYSA-N 2,3-dihydrofuran-5-carboxylic acid Chemical compound OC(=O)C1=CCCO1 NFTOEHBFQROATQ-UHFFFAOYSA-N 0.000 description 1
- NIOPZPCMRQGZCE-WEVVVXLNSA-N 2,4-dinitro-6-(octan-2-yl)phenyl (E)-but-2-enoate Chemical compound CCCCCCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)\C=C\C NIOPZPCMRQGZCE-WEVVVXLNSA-N 0.000 description 1
- YTOPFCCWCSOHFV-UHFFFAOYSA-N 2,6-dimethyl-4-tridecylmorpholine Chemical compound CCCCCCCCCCCCCN1CC(C)OC(C)C1 YTOPFCCWCSOHFV-UHFFFAOYSA-N 0.000 description 1
- STMIIPIFODONDC-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(O)(CCCC)CN1C=NC=N1 STMIIPIFODONDC-UHFFFAOYSA-N 0.000 description 1
- DNBMPXLFKQCOBV-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl n-(1h-benzimidazol-2-yl)carbamate Chemical compound C1=CC=C2NC(NC(=O)OCCOCCOCC)=NC2=C1 DNBMPXLFKQCOBV-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- HZJKXKUJVSEEFU-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile Chemical compound C=1C=C(Cl)C=CC=1C(CCCC)(C#N)CN1C=NC=N1 HZJKXKUJVSEEFU-UHFFFAOYSA-N 0.000 description 1
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 description 1
- KWLVWJPJKJMCSH-UHFFFAOYSA-N 2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide Chemical compound C1=C(OCC#C)C(OC)=CC(CCNC(=O)C(OCC#C)C=2C=CC(Cl)=CC=2)=C1 KWLVWJPJKJMCSH-UHFFFAOYSA-N 0.000 description 1
- YABFPHSQTSFWQB-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-(1,2,4-triazol-1-yl)-3-(trimethylsilyl)propan-2-ol Chemical compound C=1C=C(F)C=CC=1C(O)(C[Si](C)(C)C)CN1C=NC=N1 YABFPHSQTSFWQB-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- QKJJCZYFXJCKRX-HZHKWBLPSA-N 2-[(2s,3s,6r)-6-[4-amino-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]-3-[[(2s)-2-amino-3-hydroxypropanoyl]amino]-3,6-dihydro-2h-pyran-2-yl]-5-(diaminomethylideneamino)-2,4-dihydroxypentanoic acid Chemical compound O1[C@H](C(O)(CC(O)CN=C(N)N)C(O)=O)[C@@H](NC(=O)[C@H](CO)N)C=C[C@@H]1N1C(=O)N=C(N)C(CO)=C1 QKJJCZYFXJCKRX-HZHKWBLPSA-N 0.000 description 1
- MNHVNIJQQRJYDH-UHFFFAOYSA-N 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2-dihydro-1,2,4-triazole-3-thione Chemical compound N1=CNC(=S)N1CC(C1(Cl)CC1)(O)CC1=CC=CC=C1Cl MNHVNIJQQRJYDH-UHFFFAOYSA-N 0.000 description 1
- YNNUSGIPVFPVBX-UHFFFAOYSA-N 2-[2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine Chemical compound CN1CCCC1CCOC(C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 YNNUSGIPVFPVBX-UHFFFAOYSA-N 0.000 description 1
- BOTNFCTYKJBUMU-UHFFFAOYSA-N 2-[4-(2-methylpropyl)piperazin-4-ium-1-yl]-2-oxoacetate Chemical compound CC(C)C[NH+]1CCN(C(=O)C([O-])=O)CC1 BOTNFCTYKJBUMU-UHFFFAOYSA-N 0.000 description 1
- NCDBYAPSWOPDRN-UHFFFAOYSA-N 2-[dichloro(fluoro)methyl]sulfanylisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(SC(Cl)(Cl)F)C(=O)C2=C1 NCDBYAPSWOPDRN-UHFFFAOYSA-N 0.000 description 1
- PVTHJAPFENJVNC-UHFFFAOYSA-N 2-amino-2-[5-amino-2-methyl-6-(2,3,4,5,6-pentahydroxycyclohexyl)oxyoxan-3-yl]iminoacetic acid Chemical compound NC1CC(N=C(N)C(O)=O)C(C)OC1OC1C(O)C(O)C(O)C(O)C1O PVTHJAPFENJVNC-UHFFFAOYSA-N 0.000 description 1
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 1
- UPGATMBHQQONPH-UHFFFAOYSA-N 2-aminooxycarbonylbenzoic acid Chemical class NOC(=O)C1=CC=CC=C1C(O)=O UPGATMBHQQONPH-UHFFFAOYSA-N 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- UNCQVRBWJWWJBF-UHFFFAOYSA-N 2-chloropyrimidine Chemical compound ClC1=NC=CC=N1 UNCQVRBWJWWJBF-UHFFFAOYSA-N 0.000 description 1
- AWSZRJQNBMEZOI-UHFFFAOYSA-N 2-methoxyethyl 2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-[2-(trifluoromethyl)phenyl]propanoate Chemical compound C=1C=C(C(C)(C)C)C=CC=1C(C#N)(C(=O)OCCOC)C(=O)C1=CC=CC=C1C(F)(F)F AWSZRJQNBMEZOI-UHFFFAOYSA-N 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- WVKPYYLOFMTDHB-UHFFFAOYSA-N 2-norbornyl radical Chemical group C1CC2[CH]CC1C2 WVKPYYLOFMTDHB-UHFFFAOYSA-N 0.000 description 1
- 229940061334 2-phenylphenol Drugs 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- ZRDUSMYWDRPZRM-UHFFFAOYSA-N 2-sec-butyl-4,6-dinitrophenyl 3-methylbut-2-enoate Chemical compound CCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)C=C(C)C ZRDUSMYWDRPZRM-UHFFFAOYSA-N 0.000 description 1
- AUQAUAIUNJIIEP-UHFFFAOYSA-N 3,4,5-trimethylphenyl methylcarbamate Chemical compound CNC(=O)OC1=CC(C)=C(C)C(C)=C1 AUQAUAIUNJIIEP-UHFFFAOYSA-N 0.000 description 1
- SOUGWDPPRBKJEX-UHFFFAOYSA-N 3,5-dichloro-N-(1-chloro-3-methyl-2-oxopentan-3-yl)-4-methylbenzamide Chemical compound ClCC(=O)C(C)(CC)NC(=O)C1=CC(Cl)=C(C)C(Cl)=C1 SOUGWDPPRBKJEX-UHFFFAOYSA-N 0.000 description 1
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical class O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 1
- OVFHHJZHXHZIHT-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)quinazolin-4-one Chemical compound ClC1=CC(Cl)=CC=C1N1C(=O)C2=CC=CC=C2N=C1N1N=CN=C1 OVFHHJZHXHZIHT-UHFFFAOYSA-N 0.000 description 1
- SWBHWUYHHJCADA-UHFFFAOYSA-N 3-(2-chlorophenyl)-6-(2,6-difluorophenyl)-1,2,4,5-tetrazine Chemical compound FC1=CC=CC(F)=C1C1=NN=C(C=2C(=CC=CC=2)Cl)N=N1 SWBHWUYHHJCADA-UHFFFAOYSA-N 0.000 description 1
- BZGLBXYQOMFXAU-UHFFFAOYSA-N 3-(2-methylpiperidin-1-yl)propyl 3,4-dichlorobenzoate Chemical compound CC1CCCCN1CCCOC(=O)C1=CC=C(Cl)C(Cl)=C1 BZGLBXYQOMFXAU-UHFFFAOYSA-N 0.000 description 1
- XTDZGXBTXBEZDN-UHFFFAOYSA-N 3-(difluoromethyl)-N-(9-isopropyl-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl)-1-methylpyrazole-4-carboxamide Chemical compound CC(C)C1C2CCC1C1=C2C=CC=C1NC(=O)C1=CN(C)N=C1C(F)F XTDZGXBTXBEZDN-UHFFFAOYSA-N 0.000 description 1
- ZJRSKTXMSIVNAU-UHFFFAOYSA-N 3-amino-4-iodopyridine Chemical compound NC1=CN=CC=C1I ZJRSKTXMSIVNAU-UHFFFAOYSA-N 0.000 description 1
- GHCKERHPOQWERJ-UHFFFAOYSA-N 3-aminoacridine Chemical compound C1=CC=CC2=NC3=CC(N)=CC=C3C=C21 GHCKERHPOQWERJ-UHFFFAOYSA-N 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- RLHYYDKFOQSWIB-UHFFFAOYSA-N 3-chloro-5-(trifluoromethyl)benzonitrile Chemical compound FC(F)(F)C1=CC(Cl)=CC(C#N)=C1 RLHYYDKFOQSWIB-UHFFFAOYSA-N 0.000 description 1
- RUXHWBMJNBBYNL-UHFFFAOYSA-N 3-hydroxy-1,2-dihydropyrrol-5-one Chemical compound OC1=CC(=O)NC1 RUXHWBMJNBBYNL-UHFFFAOYSA-N 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- ZXVONLUNISGICL-UHFFFAOYSA-N 4,6-dinitro-o-cresol Chemical compound CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O ZXVONLUNISGICL-UHFFFAOYSA-N 0.000 description 1
- RQDJADAKIFFEKQ-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-phenyl-2-(1,2,4-triazol-1-ylmethyl)butanenitrile Chemical compound C1=CC(Cl)=CC=C1CCC(C=1C=CC=CC=1)(C#N)CN1N=CN=C1 RQDJADAKIFFEKQ-UHFFFAOYSA-N 0.000 description 1
- NNPRCLUGHFXSOU-UHFFFAOYSA-N 4-chloro-n-[cyano(ethoxy)methyl]benzamide Chemical compound CCOC(C#N)NC(=O)C1=CC=C(Cl)C=C1 NNPRCLUGHFXSOU-UHFFFAOYSA-N 0.000 description 1
- PGYDGBCATBINCB-UHFFFAOYSA-N 4-diethoxyphosphoryl-n,n-dimethylaniline Chemical compound CCOP(=O)(OCC)C1=CC=C(N(C)C)C=C1 PGYDGBCATBINCB-UHFFFAOYSA-N 0.000 description 1
- SBUKOHLFHYSZNG-UHFFFAOYSA-N 4-dodecyl-2,6-dimethylmorpholine Chemical compound CCCCCCCCCCCCN1CC(C)OC(C)C1 SBUKOHLFHYSZNG-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 description 1
- NRTLIYOWLVMQBO-UHFFFAOYSA-N 5-chloro-1,3-dimethyl-N-(1,1,3-trimethyl-1,3-dihydro-2-benzofuran-4-yl)pyrazole-4-carboxamide Chemical compound C=12C(C)OC(C)(C)C2=CC=CC=1NC(=O)C=1C(C)=NN(C)C=1Cl NRTLIYOWLVMQBO-UHFFFAOYSA-N 0.000 description 1
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 description 1
- GOFJDXZZHFNFLV-UHFFFAOYSA-N 5-fluoro-1,3-dimethyl-N-[2-(4-methylpentan-2-yl)phenyl]pyrazole-4-carboxamide Chemical compound CC(C)CC(C)C1=CC=CC=C1NC(=O)C1=C(F)N(C)N=C1C GOFJDXZZHFNFLV-UHFFFAOYSA-N 0.000 description 1
- PCCSBWNGDMYFCW-UHFFFAOYSA-N 5-methyl-5-(4-phenoxyphenyl)-3-(phenylamino)-1,3-oxazolidine-2,4-dione Chemical compound O=C1C(C)(C=2C=CC(OC=3C=CC=CC=3)=CC=2)OC(=O)N1NC1=CC=CC=C1 PCCSBWNGDMYFCW-UHFFFAOYSA-N 0.000 description 1
- QSOQMBDNBYAXTG-UHFFFAOYSA-N 5-methyl-6-octyl-1,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine Chemical compound NC1C(CCCCCCCC)=C(C)N=C2NC=NN21 QSOQMBDNBYAXTG-UHFFFAOYSA-N 0.000 description 1
- GABNAHQQEVWYNS-UHFFFAOYSA-N 5-phenyl-2,3-dihydro-1,4-dithiine 1,1,4,4-tetraoxide Chemical compound O=S1(=O)CCS(=O)(=O)C(C=2C=CC=CC=2)=C1 GABNAHQQEVWYNS-UHFFFAOYSA-N 0.000 description 1
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 description 1
- MPTIVJYPACEMTA-UHFFFAOYSA-N 6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine Chemical compound FC1=CC(F)=CC(F)=C1C1=CN2N=CN=C2N=C1 MPTIVJYPACEMTA-UHFFFAOYSA-N 0.000 description 1
- VAZNJOLLULMJGT-UHFFFAOYSA-N 6-bromopyridine Chemical compound BrC1=C=CC=C[N]1 VAZNJOLLULMJGT-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005660 Abamectin Substances 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 240000005020 Acaciella glauca Species 0.000 description 1
- 241001580860 Acarapis Species 0.000 description 1
- 239000005651 Acequinocyl Substances 0.000 description 1
- 239000005875 Acetamiprid Substances 0.000 description 1
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 description 1
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 description 1
- 229940121683 Acetylcholine receptor antagonist Drugs 0.000 description 1
- 239000005964 Acibenzolar-S-methyl Substances 0.000 description 1
- 241000254032 Acrididae Species 0.000 description 1
- 239000005652 Acrinathrin Substances 0.000 description 1
- 241000819811 Acronicta major Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 240000005007 Actinomucor elegans Species 0.000 description 1
- 241001506414 Aculus Species 0.000 description 1
- 241000902874 Agelastica alni Species 0.000 description 1
- 241001621841 Alopecurus myosuroides Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000238679 Amblyomma Species 0.000 description 1
- 241001480736 Amblyomma hebraeum Species 0.000 description 1
- 239000005726 Ametoctradin Substances 0.000 description 1
- 241001398046 Amphimallon solstitiale Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000532200 Androctonus crassicauda Species 0.000 description 1
- 241000411449 Anobium punctatum Species 0.000 description 1
- 241001279740 Anopheles sinensis Species 0.000 description 1
- 241000693245 Antestiopsis Species 0.000 description 1
- 241001640910 Anthrenus Species 0.000 description 1
- 241000625753 Anticarsia Species 0.000 description 1
- 241000625764 Anticarsia gemmatalis Species 0.000 description 1
- 241001600407 Aphis <genus> Species 0.000 description 1
- 241001162025 Archips podana Species 0.000 description 1
- 241000237518 Arion Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 241001437124 Atanus Species 0.000 description 1
- 241000219307 Atriplex rosea Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 239000005878 Azadirachtin Substances 0.000 description 1
- 239000005730 Azoxystrobin Substances 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241001490249 Bactrocera oleae Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000254123 Bemisia Species 0.000 description 1
- 239000005736 Benthiavalicarb Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 241001142392 Bibio Species 0.000 description 1
- 239000005653 Bifenazate Substances 0.000 description 1
- 239000005874 Bifenthrin Substances 0.000 description 1
- 108010018763 Biotin carboxylase Proteins 0.000 description 1
- 239000005738 Bixafen Substances 0.000 description 1
- 241000238662 Blatta orientalis Species 0.000 description 1
- 241000238660 Blattidae Species 0.000 description 1
- 241000929635 Blissus Species 0.000 description 1
- 241000238678 Boophilus Species 0.000 description 1
- 241000216129 Boophthora Species 0.000 description 1
- 239000005739 Bordeaux mixture Substances 0.000 description 1
- 239000005740 Boscalid Substances 0.000 description 1
- 241001669698 Bostrychus Species 0.000 description 1
- 241000322475 Bovicola Species 0.000 description 1
- 241000463528 Bovicola limbata Species 0.000 description 1
- 241000273316 Brachycaudus Species 0.000 description 1
- 241000273318 Brachycaudus cardui Species 0.000 description 1
- 241000743774 Brachypodium Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 244000188595 Brassica sinapistrum Species 0.000 description 1
- 241000941072 Braula Species 0.000 description 1
- 239000005741 Bromuconazole Substances 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- 241001517925 Bucculatrix Species 0.000 description 1
- 241000041029 Bulinus Species 0.000 description 1
- 239000005742 Bupirimate Substances 0.000 description 1
- 239000005885 Buprofezin Substances 0.000 description 1
- XOIWLVAFXBUUAV-UHFFFAOYSA-K C(C)(=O)[O-].C(CCCCCCC)(=O)O.[Bi+3].C(C)(=O)[O-].C(C)(=O)[O-] Chemical compound C(C)(=O)[O-].C(CCCCCCC)(=O)O.[Bi+3].C(C)(=O)[O-].C(C)(=O)[O-] XOIWLVAFXBUUAV-UHFFFAOYSA-K 0.000 description 1
- JFLRKDZMHNBDQS-UCQUSYKYSA-N CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C Chemical compound CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C JFLRKDZMHNBDQS-UCQUSYKYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000006009 Calcium phosphide Substances 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 241000906761 Calocoris Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005745 Captan Substances 0.000 description 1
- 241001350371 Capua Species 0.000 description 1
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 239000005746 Carboxin Substances 0.000 description 1
- NYSZJNUIVUBQMM-BQYQJAHWSA-N Cardamonin Chemical compound COC1=CC(O)=CC(O)=C1C(=O)\C=C\C1=CC=CC=C1 NYSZJNUIVUBQMM-BQYQJAHWSA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 229940123982 Cell wall synthesis inhibitor Drugs 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000255579 Ceratitis capitata Species 0.000 description 1
- 241001094931 Chaetosiphon fragaefolii Species 0.000 description 1
- GXGJIOMUZAGVEH-UHFFFAOYSA-N Chamazulene Chemical group CCC1=CC=C(C)C2=CC=C(C)C2=C1 GXGJIOMUZAGVEH-UHFFFAOYSA-N 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 241001436125 Cheiridium Species 0.000 description 1
- 241000426499 Chilo Species 0.000 description 1
- 241000668556 Chionaspis Species 0.000 description 1
- 239000005886 Chlorantraniliprole Substances 0.000 description 1
- 229940127437 Chloride Channel Antagonists Drugs 0.000 description 1
- 108010009685 Cholinergic Receptors Proteins 0.000 description 1
- 239000005887 Chromafenozide Substances 0.000 description 1
- 241001262789 Chrysomya chloropyga Species 0.000 description 1
- 241001574870 Chrysops caecutiens Species 0.000 description 1
- 241001097338 Cicadulina Species 0.000 description 1
- 241001124216 Cicindelinae Species 0.000 description 1
- 241001414836 Cimex Species 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001152840 Cleonus Species 0.000 description 1
- 239000005888 Clothianidin Substances 0.000 description 1
- 241000098277 Cnaphalocrocis Species 0.000 description 1
- 241000224483 Coccidia Species 0.000 description 1
- 241000255749 Coccinellidae Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- 241000683561 Conoderus Species 0.000 description 1
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 239000005752 Copper oxychloride Substances 0.000 description 1
- 244000071736 Corypha sylvestris Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241001094916 Cryptomyzus ribis Species 0.000 description 1
- 241001124552 Ctenolepisma Species 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000256054 Culex <genus> Species 0.000 description 1
- 241000144210 Culex pipiens pallens Species 0.000 description 1
- 241000256057 Culex quinquefasciatus Species 0.000 description 1
- 241000256061 Culex tarsalis Species 0.000 description 1
- 239000005889 Cyantraniliprole Substances 0.000 description 1
- 239000005754 Cyazofamid Substances 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 241001635274 Cydia pomonella Species 0.000 description 1
- 239000005655 Cyflumetofen Substances 0.000 description 1
- 239000005756 Cymoxanil Substances 0.000 description 1
- 239000005946 Cypermethrin Substances 0.000 description 1
- 239000005757 Cyproconazole Substances 0.000 description 1
- 239000005758 Cyprodinil Substances 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 235000018783 Dacrycarpus dacrydioides Nutrition 0.000 description 1
- 239000005644 Dazomet Substances 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 239000005892 Deltamethrin Substances 0.000 description 1
- 241001128004 Demodex Species 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 241000865080 Dermacentor albipictus Species 0.000 description 1
- 241001480819 Dermacentor andersoni Species 0.000 description 1
- 241000577477 Dermacentor reticulatus Species 0.000 description 1
- 241001480793 Dermacentor variabilis Species 0.000 description 1
- 241001300085 Deroceras Species 0.000 description 1
- 244000147058 Derris elliptica Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000489975 Diabrotica Species 0.000 description 1
- 239000005759 Diethofencarb Substances 0.000 description 1
- 239000005760 Difenoconazole Substances 0.000 description 1
- LBGPXIPGGRQBJW-UHFFFAOYSA-N Difenzoquat Chemical compound C[N+]=1N(C)C(C=2C=CC=CC=2)=CC=1C1=CC=CC=C1 LBGPXIPGGRQBJW-UHFFFAOYSA-N 0.000 description 1
- 239000005893 Diflubenzuron Substances 0.000 description 1
- 239000005761 Dimethomorph Substances 0.000 description 1
- 239000005762 Dimoxystrobin Substances 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 239000005764 Dithianon Substances 0.000 description 1
- 239000005765 Dodemorph Substances 0.000 description 1
- 239000005766 Dodine Substances 0.000 description 1
- 241001581005 Dysaphis Species 0.000 description 1
- 241001425477 Dysdercus Species 0.000 description 1
- AIGRXSNSLVJMEA-UHFFFAOYSA-N EPN Chemical compound C=1C=CC=CC=1P(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 AIGRXSNSLVJMEA-UHFFFAOYSA-N 0.000 description 1
- 241000353522 Earias insulana Species 0.000 description 1
- UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 description 1
- 206010014096 Echinococciasis Diseases 0.000 description 1
- 208000009366 Echinococcosis Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000243686 Eisenia fetida Species 0.000 description 1
- 102000015782 Electron Transport Complex III Human genes 0.000 description 1
- 108010024882 Electron Transport Complex III Proteins 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 241001222563 Empoasca onukii Species 0.000 description 1
- 241000488563 Eotetranychus carpini Species 0.000 description 1
- 241001301805 Epilachna Species 0.000 description 1
- 239000005767 Epoxiconazole Substances 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 241001125671 Eretmochelys imbricata Species 0.000 description 1
- 241001515686 Erythroneura Species 0.000 description 1
- 239000005895 Esfenvalerate Substances 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- FNELVJVBIYMIMC-UHFFFAOYSA-N Ethiprole Chemical compound N1=C(C#N)C(S(=O)CC)=C(N)N1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl FNELVJVBIYMIMC-UHFFFAOYSA-N 0.000 description 1
- 239000005961 Ethoprophos Substances 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000005896 Etofenprox Substances 0.000 description 1
- 239000005897 Etoxazole Substances 0.000 description 1
- 239000005769 Etridiazole Substances 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 241000239245 Euscelis Species 0.000 description 1
- 241000098297 Euschistus Species 0.000 description 1
- 241001585293 Euxoa Species 0.000 description 1
- 239000005772 Famoxadone Substances 0.000 description 1
- 241000371383 Fannia Species 0.000 description 1
- 241000233488 Feltia Species 0.000 description 1
- 239000005774 Fenamidone Substances 0.000 description 1
- 239000005958 Fenamiphos (aka phenamiphos) Substances 0.000 description 1
- 239000005656 Fenazaquin Substances 0.000 description 1
- 239000005775 Fenbuconazole Substances 0.000 description 1
- 239000005776 Fenhexamid Substances 0.000 description 1
- 239000005898 Fenoxycarb Substances 0.000 description 1
- 239000005777 Fenpropidin Substances 0.000 description 1
- 239000005778 Fenpropimorph Substances 0.000 description 1
- 239000005657 Fenpyroximate Substances 0.000 description 1
- PNVJTZOFSHSLTO-UHFFFAOYSA-N Fenthion Chemical compound COP(=S)(OC)OC1=CC=C(SC)C(C)=C1 PNVJTZOFSHSLTO-UHFFFAOYSA-N 0.000 description 1
- 239000005899 Fipronil Substances 0.000 description 1
- 239000005900 Flonicamid Substances 0.000 description 1
- 239000005780 Fluazinam Substances 0.000 description 1
- 239000005901 Flubendiamide Substances 0.000 description 1
- 239000005781 Fludioxonil Substances 0.000 description 1
- 239000005782 Fluopicolide Substances 0.000 description 1
- 239000005785 Fluquinconazole Substances 0.000 description 1
- VEVZCONIUDBCDC-UHFFFAOYSA-N Flurprimidol Chemical compound C=1N=CN=CC=1C(O)(C(C)C)C1=CC=C(OC(F)(F)F)C=C1 VEVZCONIUDBCDC-UHFFFAOYSA-N 0.000 description 1
- 239000005786 Flutolanil Substances 0.000 description 1
- 239000005787 Flutriafol Substances 0.000 description 1
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 description 1
- 239000005948 Formetanate Substances 0.000 description 1
- 239000005790 Fosetyl Substances 0.000 description 1
- 239000005959 Fosthiazate Substances 0.000 description 1
- 239000005791 Fuberidazole Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- ULCWZQJLFZEXCS-KGLIPLIRSA-N Furconazole-cis Chemical compound O1[C@@H](OCC(F)(F)F)CC[C@@]1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 ULCWZQJLFZEXCS-KGLIPLIRSA-N 0.000 description 1
- QTDRLOKFLJJHTG-UHFFFAOYSA-N Furmecyclox Chemical compound C1=C(C)OC(C)=C1C(=O)N(OC)C1CCCCC1 QTDRLOKFLJJHTG-UHFFFAOYSA-N 0.000 description 1
- 241000585112 Galba Species 0.000 description 1
- 208000001613 Gambling Diseases 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241001276563 Haematobia irritans irritans Species 0.000 description 1
- 241000562487 Haematobosca stimulans Species 0.000 description 1
- 241000562576 Haematopota Species 0.000 description 1
- 241000243976 Haemonchus Species 0.000 description 1
- 241001147381 Helicoverpa armigera Species 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- 241001176496 Heteronychus arator Species 0.000 description 1
- 239000005661 Hexythiazox Substances 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 241000771999 Hippobosca Species 0.000 description 1
- 241000771993 Hippobosca equina Species 0.000 description 1
- 241001288674 Holotrichia consanguinea Species 0.000 description 1
- 241001480803 Hyalomma Species 0.000 description 1
- 241000561960 Hybomitra Species 0.000 description 1
- 241000115042 Hylamorpha elegans Species 0.000 description 1
- 239000005794 Hymexazol Substances 0.000 description 1
- 241000577499 Hypothenemus Species 0.000 description 1
- 241001058149 Icerya Species 0.000 description 1
- 241001595209 Idiocerus Species 0.000 description 1
- 239000005795 Imazalil Substances 0.000 description 1
- 239000005906 Imidacloprid Substances 0.000 description 1
- FKWDSATZSMJRLC-UHFFFAOYSA-N Iminoctadine acetate Chemical compound CC([O-])=O.CC([O-])=O.CC([O-])=O.NC([NH3+])=NCCCCCCCC[NH2+]CCCCCCCCN=C(N)[NH3+] FKWDSATZSMJRLC-UHFFFAOYSA-N 0.000 description 1
- 239000005907 Indoxacarb Substances 0.000 description 1
- 239000005796 Ipconazole Substances 0.000 description 1
- 239000005867 Iprodione Substances 0.000 description 1
- 239000005797 Iprovalicarb Substances 0.000 description 1
- VROYMKJUVCKXBU-UHFFFAOYSA-N Irumamycin Natural products CCC(=O)C1(C)OC1C(C)CC(C)C1C(C)C(O)C(C)C=CC(OC2OC(C)C(O)C(OC(N)=O)C2)CCCC=C(C)C(O2)C(C)=CCC2(O)CC(=O)O1 VROYMKJUVCKXBU-UHFFFAOYSA-N 0.000 description 1
- AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 1
- 239000005799 Isopyrazam Substances 0.000 description 1
- 241000397365 Javesella pellucida Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 239000005800 Kresoxim-methyl Substances 0.000 description 1
- NWUWYYSKZYIQAE-ZBFHGGJFSA-N L-(R)-iprovalicarb Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C1=CC=C(C)C=C1 NWUWYYSKZYIQAE-ZBFHGGJFSA-N 0.000 description 1
- 241000256686 Lasius <genus> Species 0.000 description 1
- 241000948337 Lasius niger Species 0.000 description 1
- 241000051764 Lasius umbratus Species 0.000 description 1
- 241000801118 Lepidium Species 0.000 description 1
- 241000669027 Lepidosaphes Species 0.000 description 1
- 241000560153 Leptoglossus phyllopus Species 0.000 description 1
- 241000786150 Lipoptena capreoli Species 0.000 description 1
- 241000692235 Lipoptena cervi Species 0.000 description 1
- 241000218300 Liriodendron Species 0.000 description 1
- 241000532753 Lixus Species 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 241000656865 Lyctus linearis Species 0.000 description 1
- 241000721703 Lymantria dispar Species 0.000 description 1
- 241000237354 Lymnaea Species 0.000 description 1
- 241000721701 Lynx Species 0.000 description 1
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 1
- 241000721715 Macrosiphum Species 0.000 description 1
- 241000927670 Mahanarva fimbriolata Species 0.000 description 1
- 239000005949 Malathion Substances 0.000 description 1
- 239000005802 Mancozeb Substances 0.000 description 1
- 239000005804 Mandipropamid Substances 0.000 description 1
- 241000940612 Medina Species 0.000 description 1
- 244000217433 Melampodium divaricatum Species 0.000 description 1
- 239000005805 Mepanipyrim Substances 0.000 description 1
- 239000005806 Meptyldinocap Substances 0.000 description 1
- 240000002624 Mespilus germanica Species 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 239000005914 Metaflumizone Substances 0.000 description 1
- MIFOMMKAVSCNKQ-HWIUFGAZSA-N Metaflumizone Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)N\N=C(C=1C=C(C=CC=1)C(F)(F)F)\CC1=CC=C(C#N)C=C1 MIFOMMKAVSCNKQ-HWIUFGAZSA-N 0.000 description 1
- 239000005807 Metalaxyl Substances 0.000 description 1
- 239000005808 Metalaxyl-M Substances 0.000 description 1
- 241000131592 Metcalfiella Species 0.000 description 1
- 239000005868 Metconazole Substances 0.000 description 1
- 239000005916 Methomyl Substances 0.000 description 1
- 239000005917 Methoxyfenozide Substances 0.000 description 1
- 239000005809 Metiram Substances 0.000 description 1
- 239000005810 Metrafenone Substances 0.000 description 1
- 241001497122 Migdolus Species 0.000 description 1
- 239000005918 Milbemectin Substances 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241001147402 Monachus Species 0.000 description 1
- 241001094463 Monellia Species 0.000 description 1
- 241001094800 Monelliopsis Species 0.000 description 1
- 241001442208 Monochamus Species 0.000 description 1
- 241000699729 Muridae Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000005811 Myclobutanil Substances 0.000 description 1
- 241001477928 Mythimna Species 0.000 description 1
- 241000721623 Myzus Species 0.000 description 1
- IUOKJNROJISWRO-UHFFFAOYSA-N N-(2-cyano-3-methylbutan-2-yl)-2-(2,4-dichlorophenoxy)propanamide Chemical compound CC(C)C(C)(C#N)NC(=O)C(C)OC1=CC=C(Cl)C=C1Cl IUOKJNROJISWRO-UHFFFAOYSA-N 0.000 description 1
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Substances IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- XQJQCBDIXRIYRP-UHFFFAOYSA-N N-{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1C(C2CC2)C1 XQJQCBDIXRIYRP-UHFFFAOYSA-N 0.000 description 1
- 229910019093 NaOCl Inorganic materials 0.000 description 1
- 241000196499 Naupactus xanthographus Species 0.000 description 1
- 241001084186 Neotrombicula Species 0.000 description 1
- 241001671714 Nezara Species 0.000 description 1
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 1
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- VJAWBEFMCIINFU-UHFFFAOYSA-N Nitrothal-isopropyl Chemical compound CC(C)OC(=O)C1=CC(C(=O)OC(C)C)=CC([N+]([O-])=O)=C1 VJAWBEFMCIINFU-UHFFFAOYSA-N 0.000 description 1
- 241000256259 Noctuidae Species 0.000 description 1
- 241000916006 Nomadacris septemfasciata Species 0.000 description 1
- OBDMBTJDUDYSBS-UHFFFAOYSA-N O.O.O.O.[C] Chemical compound O.O.O.O.[C] OBDMBTJDUDYSBS-UHFFFAOYSA-N 0.000 description 1
- 241000036147 Ochlerotatus taeniorhynchus Species 0.000 description 1
- 241001102020 Oebalus Species 0.000 description 1
- 241000153952 Oligotricha striata Species 0.000 description 1
- 241000777573 Oncometopia Species 0.000 description 1
- 241001611401 Opistophthalmus boehmi Species 0.000 description 1
- 241001446191 Orthezia Species 0.000 description 1
- 241000238814 Orthoptera Species 0.000 description 1
- 241001250072 Oryctes rhinoceros Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000238590 Ostracoda Species 0.000 description 1
- 241000790252 Otodectes cynotis Species 0.000 description 1
- YXLXNENXOJSQEI-UHFFFAOYSA-L Oxine-copper Chemical compound [Cu+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 YXLXNENXOJSQEI-UHFFFAOYSA-L 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000005985 Paclobutrazol Substances 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241001480233 Paragonimus Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241001516563 Paratrioza Species 0.000 description 1
- 241001523676 Parcoblatta Species 0.000 description 1
- 241000562493 Pegomya Species 0.000 description 1
- 241000721454 Pemphigus Species 0.000 description 1
- 239000005813 Penconazole Substances 0.000 description 1
- 239000005814 Pencycuron Substances 0.000 description 1
- 239000005815 Penflufen Substances 0.000 description 1
- 241000374367 Peniocereus striatus Species 0.000 description 1
- 239000005816 Penthiopyrad Substances 0.000 description 1
- 241000238675 Periplaneta americana Species 0.000 description 1
- 241001608567 Phaedon cochleariae Species 0.000 description 1
- 241000250508 Phalangium Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241001058119 Phenacoccus Species 0.000 description 1
- 241001432757 Philipomyia Species 0.000 description 1
- 241000932963 Philopteridae Species 0.000 description 1
- 241000722350 Phlebotomus <genus> Species 0.000 description 1
- 241000916808 Phloeomyzus passerinii Species 0.000 description 1
- 241000283216 Phocidae Species 0.000 description 1
- 239000005921 Phosmet Substances 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 241001525654 Phyllocnistis citrella Species 0.000 description 1
- 241001640279 Phyllophaga Species 0.000 description 1
- 241000745988 Phyllostachys Species 0.000 description 1
- 244000302661 Phyllostachys pubescens Species 0.000 description 1
- 235000003570 Phyllostachys pubescens Nutrition 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 241001516577 Phylloxera Species 0.000 description 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 1
- 239000005818 Picoxystrobin Substances 0.000 description 1
- 241000255972 Pieris <butterfly> Species 0.000 description 1
- 241000940371 Piezodorus Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 240000007320 Pinus strobus Species 0.000 description 1
- 235000008578 Pinus strobus Nutrition 0.000 description 1
- 239000005923 Pirimicarb Substances 0.000 description 1
- 239000005924 Pirimiphos-methyl Substances 0.000 description 1
- 241000193804 Planococcus <bacterium> Species 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 235000006751 Platycodon Nutrition 0.000 description 1
- 244000274050 Platycodon grandiflorum Species 0.000 description 1
- 241000222350 Pleurotus Species 0.000 description 1
- 235000007685 Pleurotus columbinus Nutrition 0.000 description 1
- 240000001462 Pleurotus ostreatus Species 0.000 description 1
- 235000001603 Pleurotus ostreatus Nutrition 0.000 description 1
- 241000500437 Plutella xylostella Species 0.000 description 1
- 241000883286 Polydesmus Species 0.000 description 1
- 229930182764 Polyoxin Natural products 0.000 description 1
- 241000243142 Porifera Species 0.000 description 1
- 239000005820 Prochloraz Substances 0.000 description 1
- 239000005821 Propamocarb Substances 0.000 description 1
- MKIMSXGUTQTKJU-UHFFFAOYSA-N Propamocarb hydrochloride Chemical compound [Cl-].CCCOC(=O)NCCC[NH+](C)C MKIMSXGUTQTKJU-UHFFFAOYSA-N 0.000 description 1
- 239000005822 Propiconazole Substances 0.000 description 1
- 239000005823 Propineb Substances 0.000 description 1
- 239000005824 Proquinazid Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 239000005825 Prothioconazole Substances 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 241000543705 Przhevalskiana silenus Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241001454908 Pteromalus Species 0.000 description 1
- 241001105129 Ptinus Species 0.000 description 1
- 239000005869 Pyraclostrobin Substances 0.000 description 1
- 239000005828 Pyrimethanil Substances 0.000 description 1
- 239000005927 Pyriproxyfen Substances 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 241000944747 Quesada gigas Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241001481703 Rhipicephalus <genus> Species 0.000 description 1
- 241000949016 Rhipicephalus bursa Species 0.000 description 1
- 241000864202 Rhipicephalus evertsi Species 0.000 description 1
- 241001481697 Rhipicephalus turanicus Species 0.000 description 1
- 241000864200 Rhipicephalus zambeziensis Species 0.000 description 1
- ISRUGXGCCGIOQO-UHFFFAOYSA-N Rhoden Chemical compound CNC(=O)OC1=CC=CC=C1OC(C)C ISRUGXGCCGIOQO-UHFFFAOYSA-N 0.000 description 1
- 240000008199 Rhododendron molle Species 0.000 description 1
- 241000318997 Rhyzopertha dominica Species 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000304160 Sarcophaga carnaria Species 0.000 description 1
- 241000509416 Sarcoptes Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241001339782 Scapharca broughtonii Species 0.000 description 1
- 241000253973 Schistocerca gregaria Species 0.000 description 1
- 241000242678 Schistosoma Species 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 241001529553 Scoparia <angiosperm> Species 0.000 description 1
- 239000005834 Sedaxane Substances 0.000 description 1
- 239000004113 Sepiolite Substances 0.000 description 1
- 241000422846 Sequoiadendron giganteum Species 0.000 description 1
- 239000005835 Silthiofam Substances 0.000 description 1
- 241000256108 Simulium <genus> Species 0.000 description 1
- 241000925083 Simulium ornatum Species 0.000 description 1
- 241001177138 Sinoxylon Species 0.000 description 1
- 241000258242 Siphonaptera Species 0.000 description 1
- 241000254152 Sitophilus oryzae Species 0.000 description 1
- 108010052164 Sodium Channels Proteins 0.000 description 1
- 102000018674 Sodium Channels Human genes 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 241000532885 Sphenophorus Species 0.000 description 1
- 239000005929 Spinetoram Substances 0.000 description 1
- GOENIMGKWNZVDA-OAMCMWGQSA-N Spinetoram Chemical compound CO[C@@H]1[C@H](OCC)[C@@H](OC)[C@H](C)O[C@H]1OC1C[C@H]2[C@@H]3C=C4C(=O)[C@H](C)[C@@H](O[C@@H]5O[C@H](C)[C@H](CC5)N(C)C)CCC[C@H](CC)OC(=O)CC4[C@@H]3CC[C@@H]2C1 GOENIMGKWNZVDA-OAMCMWGQSA-N 0.000 description 1
- 239000005930 Spinosad Substances 0.000 description 1
- 239000005664 Spirodiclofen Substances 0.000 description 1
- 239000005665 Spiromesifen Substances 0.000 description 1
- 239000005931 Spirotetramat Substances 0.000 description 1
- 239000005837 Spiroxamine Substances 0.000 description 1
- 241001414853 Spissistilus festinus Species 0.000 description 1
- 241000256248 Spodoptera Species 0.000 description 1
- 241000256247 Spodoptera exigua Species 0.000 description 1
- 241001147695 Staphylococcus caprae Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000950030 Sternechus Species 0.000 description 1
- 241001513492 Sternostoma Species 0.000 description 1
- 235000001231 Streptopus amplexifolius Nutrition 0.000 description 1
- 244000305550 Streptopus amplexifolius Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 244000045067 Suillus grevillei Species 0.000 description 1
- 239000005934 Sulfoxaflor Substances 0.000 description 1
- 241001280974 Synanthedon myopaeformis Species 0.000 description 1
- 241000779819 Syncarpia glomulifera Species 0.000 description 1
- 241000255626 Tabanus <genus> Species 0.000 description 1
- 241000255632 Tabanus atratus Species 0.000 description 1
- 241000925066 Tabanus bromius Species 0.000 description 1
- 241000511648 Tabanus sudeticus Species 0.000 description 1
- 241000189578 Taeniothrips Species 0.000 description 1
- 240000000785 Tagetes erecta Species 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000005839 Tebuconazole Substances 0.000 description 1
- 239000005937 Tebufenozide Substances 0.000 description 1
- 239000005658 Tebufenpyrad Substances 0.000 description 1
- 239000005938 Teflubenzuron Substances 0.000 description 1
- 239000005939 Tefluthrin Substances 0.000 description 1
- 241000254109 Tenebrio molitor Species 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- 239000005840 Tetraconazole Substances 0.000 description 1
- 241001454295 Tetranychidae Species 0.000 description 1
- 241001454294 Tetranychus Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 241000239292 Theraphosidae Species 0.000 description 1
- 239000005940 Thiacloprid Substances 0.000 description 1
- 239000005941 Thiamethoxam Substances 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000333690 Tineola bisselliella Species 0.000 description 1
- 241001519477 Tinocallis Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 241001161507 Titanus Species 0.000 description 1
- 239000005845 Tolclofos-methyl Substances 0.000 description 1
- 241001432111 Tomaspis Species 0.000 description 1
- 241001238451 Tortrix viridana Species 0.000 description 1
- 241000869417 Trematodes Species 0.000 description 1
- 239000005846 Triadimenol Substances 0.000 description 1
- 239000005847 Triazoxide Substances 0.000 description 1
- 241000254086 Tribolium <beetle> Species 0.000 description 1
- 241001533104 Tribulus terrestris Species 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 239000005857 Trifloxystrobin Substances 0.000 description 1
- 239000005858 Triflumizole Substances 0.000 description 1
- 241000790999 Trinoton Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000005859 Triticonazole Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 241000215579 Trogoxylon Species 0.000 description 1
- 241001168740 Tychius Species 0.000 description 1
- 241000122724 Urocerus augur Species 0.000 description 1
- 241000254198 Urocerus gigas Species 0.000 description 1
- MUCRYNWJQNHDJH-OADIDDRXSA-N Ursonic acid Chemical compound C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C MUCRYNWJQNHDJH-OADIDDRXSA-N 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- JARYYMUOCXVXNK-UHFFFAOYSA-N Validamycin A Natural products OC1C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)CC1NC1C=C(CO)C(O)C(O)C1O JARYYMUOCXVXNK-UHFFFAOYSA-N 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 241000895647 Varroa Species 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 241000282485 Vulpes vulpes Species 0.000 description 1
- 241000061220 Werneckiella equi Species 0.000 description 1
- 241000216750 Wilhelmia Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- CVQODEWAPZVVBU-UHFFFAOYSA-N XMC Chemical compound CNC(=O)OC1=CC(C)=CC(C)=C1 CVQODEWAPZVVBU-UHFFFAOYSA-N 0.000 description 1
- BUHNCQOJJZAOMJ-UHFFFAOYSA-N ZXI 8901 Chemical compound C=1C=C(OC(F)F)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=C(Br)C=C1 BUHNCQOJJZAOMJ-UHFFFAOYSA-N 0.000 description 1
- 241001035865 Zabrus Species 0.000 description 1
- 241000209149 Zea Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 239000006011 Zinc phosphide Substances 0.000 description 1
- 239000005870 Ziram Substances 0.000 description 1
- 239000005863 Zoxamide Substances 0.000 description 1
- GBAWQJNHVWMTLU-RQJHMYQMSA-N [(1R,5S)-7-chloro-6-bicyclo[3.2.0]hepta-2,6-dienyl] dimethyl phosphate Chemical compound C1=CC[C@@H]2C(OP(=O)(OC)OC)=C(Cl)[C@@H]21 GBAWQJNHVWMTLU-RQJHMYQMSA-N 0.000 description 1
- VXSIXFKKSNGRRO-MXOVTSAMSA-N [(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate;[(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-3-[(e)-3-methoxy-2-methyl-3-oxoprop-1-enyl Chemical class CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1.CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VXSIXFKKSNGRRO-MXOVTSAMSA-N 0.000 description 1
- FZSVSABTBYGOQH-XFFZJAGNSA-N [(e)-(3,3-dimethyl-1-methylsulfanylbutan-2-ylidene)amino] n-methylcarbamate Chemical compound CNC(=O)O\N=C(C(C)(C)C)\CSC FZSVSABTBYGOQH-XFFZJAGNSA-N 0.000 description 1
- BZMIHNKNQJJVRO-LVZFUZTISA-N [(e)-c-(3-chloro-2,6-dimethoxyphenyl)-n-ethoxycarbonimidoyl] benzoate Chemical compound COC=1C=CC(Cl)=C(OC)C=1C(=N/OCC)\OC(=O)C1=CC=CC=C1 BZMIHNKNQJJVRO-LVZFUZTISA-N 0.000 description 1
- FSAVDKDHPDSCTO-WQLSENKSSA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] diethyl phosphate Chemical compound CCOP(=O)(OCC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl FSAVDKDHPDSCTO-WQLSENKSSA-N 0.000 description 1
- QSGNQELHULIMSJ-POHAHGRESA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] dimethyl phosphate Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl QSGNQELHULIMSJ-POHAHGRESA-N 0.000 description 1
- KVIZNNVXXNFLMU-AIIUZBJTSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl (1r,3r)-2,2-dimethyl-3-[(e)-prop-1-enyl]cyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)[C@H]1C(C)(C)[C@@H]1\C=C\C KVIZNNVXXNFLMU-AIIUZBJTSA-N 0.000 description 1
- OOWCJRMYMAMSOH-UHFFFAOYSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)C1C(C)(C)C1C=C(C)C OOWCJRMYMAMSOH-UHFFFAOYSA-N 0.000 description 1
- ROVGZAWFACYCSP-MQBLHHJJSA-N [2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-MQBLHHJJSA-N 0.000 description 1
- AKEPZOFDLMZKDT-UHFFFAOYSA-N [SH2]=NC#N Chemical class [SH2]=NC#N AKEPZOFDLMZKDT-UHFFFAOYSA-N 0.000 description 1
- INISTDXBRIBGOC-CGAIIQECSA-N [cyano-(3-phenoxyphenyl)methyl] (2s)-2-[2-chloro-4-(trifluoromethyl)anilino]-3-methylbutanoate Chemical compound N([C@@H](C(C)C)C(=O)OC(C#N)C=1C=C(OC=2C=CC=CC=2)C=CC=1)C1=CC=C(C(F)(F)F)C=C1Cl INISTDXBRIBGOC-CGAIIQECSA-N 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- 229950008167 abamectin Drugs 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 description 1
- QDRXWCAVUNHOGA-UHFFFAOYSA-N acequinocyl Chemical group C1=CC=C2C(=O)C(CCCCCCCCCCCC)=C(OC(C)=O)C(=O)C2=C1 QDRXWCAVUNHOGA-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- YLJLLELGHSWIDU-OKZTUQRJSA-N acetic acid;(2s,6r)-4-cyclododecyl-2,6-dimethylmorpholine Chemical compound CC(O)=O.C1[C@@H](C)O[C@@H](C)CN1C1CCCCCCCCCCC1 YLJLLELGHSWIDU-OKZTUQRJSA-N 0.000 description 1
- 102000034337 acetylcholine receptors Human genes 0.000 description 1
- UELITFHSCLAHKR-UHFFFAOYSA-N acibenzolar-S-methyl Chemical group CSC(=O)C1=CC=CC2=C1SN=N2 UELITFHSCLAHKR-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- YLFSVIMMRPNPFK-WEQBUNFVSA-N acrinathrin Chemical compound CC1(C)[C@@H](\C=C/C(=O)OC(C(F)(F)F)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YLFSVIMMRPNPFK-WEQBUNFVSA-N 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- GMAUQNJOSOMMHI-JXAWBTAJSA-N alanycarb Chemical compound CSC(\C)=N/OC(=O)N(C)SN(CCC(=O)OCC)CC1=CC=CC=C1 GMAUQNJOSOMMHI-JXAWBTAJSA-N 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- JROURLWMOZCGJV-UHFFFAOYSA-N alizarin blue Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C1=CC=CN=C1C(O)=C2O JROURLWMOZCGJV-UHFFFAOYSA-N 0.000 description 1
- 125000005108 alkenylthio group Chemical group 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 125000005087 alkynylcarbonyl group Chemical group 0.000 description 1
- 125000005225 alkynyloxycarbonyl group Chemical group 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 229940024113 allethrin Drugs 0.000 description 1
- UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- GGKQIOFASHYUJZ-UHFFFAOYSA-N ametoctradin Chemical compound NC1=C(CCCCCCCC)C(CC)=NC2=NC=NN21 GGKQIOFASHYUJZ-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 229960002587 amitraz Drugs 0.000 description 1
- QXAITBQSYVNQDR-ZIOPAAQOSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1/N=C/N(C)\C=N\C1=CC=C(C)C=C1C QXAITBQSYVNQDR-ZIOPAAQOSA-N 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 244000000054 animal parasite Species 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 239000000921 anthelmintic agent Substances 0.000 description 1
- 229940124339 anthelmintic agent Drugs 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001887 anti-feedant effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000009341 apiculture Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000005264 aryl amine group Chemical group 0.000 description 1
- 125000005129 aryl carbonyl group Chemical group 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 239000002956 ash Substances 0.000 description 1
- 239000005667 attractant Substances 0.000 description 1
- AKNQMEBLVAMSNZ-UHFFFAOYSA-N azaconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCCO1 AKNQMEBLVAMSNZ-UHFFFAOYSA-N 0.000 description 1
- 229950000294 azaconazole Drugs 0.000 description 1
- VEHPJKVTJQSSKL-UHFFFAOYSA-N azadirachtin Natural products O1C2(C)C(C3(C=COC3O3)O)CC3C21C1(C)C(O)C(OCC2(OC(C)=O)C(CC3OC(=O)C(C)=CC)OC(C)=O)C2C32COC(C(=O)OC)(O)C12 VEHPJKVTJQSSKL-UHFFFAOYSA-N 0.000 description 1
- FTNJWQUOZFUQQJ-NDAWSKJSSA-N azadirachtin A Chemical compound C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C\C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-NDAWSKJSSA-N 0.000 description 1
- FTNJWQUOZFUQQJ-IRYYUVNJSA-N azadirachtin A Natural products C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C/C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-IRYYUVNJSA-N 0.000 description 1
- VNKBTWQZTQIWDV-UHFFFAOYSA-N azamethiphos Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=O)(OC)OC)C2=N1 VNKBTWQZTQIWDV-UHFFFAOYSA-N 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- CJJOSEISRRTUQB-UHFFFAOYSA-N azinphos-methyl Chemical compound C1=CC=C2C(=O)N(CSP(=S)(OC)OC)N=NC2=C1 CJJOSEISRRTUQB-UHFFFAOYSA-N 0.000 description 1
- ONHBDDJJTDTLIR-UHFFFAOYSA-N azocyclotin Chemical compound C1CCCCC1[Sn](N1N=CN=C1)(C1CCCCC1)C1CCCCC1 ONHBDDJJTDTLIR-UHFFFAOYSA-N 0.000 description 1
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- XEGGRYVFLWGFHI-UHFFFAOYSA-N bendiocarb Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)O2 XEGGRYVFLWGFHI-UHFFFAOYSA-N 0.000 description 1
- FYZBOYWSHKHDMT-UHFFFAOYSA-N benfuracarb Chemical compound CCOC(=O)CCN(C(C)C)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 FYZBOYWSHKHDMT-UHFFFAOYSA-N 0.000 description 1
- YFXPPSKYMBTNAV-UHFFFAOYSA-N bensultap Chemical compound C=1C=CC=CC=1S(=O)(=O)SCC(N(C)C)CSS(=O)(=O)C1=CC=CC=C1 YFXPPSKYMBTNAV-UHFFFAOYSA-N 0.000 description 1
- VVSLYIKSEBPRSN-PELKAZGASA-N benthiavalicarb Chemical compound C1=C(F)C=C2SC([C@@H](C)NC(=O)[C@@H](NC(O)=O)C(C)C)=NC2=C1 VVSLYIKSEBPRSN-PELKAZGASA-N 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- VHLKTXFWDRXILV-UHFFFAOYSA-N bifenazate Chemical compound C1=C(NNC(=O)OC(C)C)C(OC)=CC=C1C1=CC=CC=C1 VHLKTXFWDRXILV-UHFFFAOYSA-N 0.000 description 1
- OMFRMAHOUUJSGP-IRHGGOMRSA-N bifenthrin Chemical compound C1=CC=C(C=2C=CC=CC=2)C(C)=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C OMFRMAHOUUJSGP-IRHGGOMRSA-N 0.000 description 1
- 229960001901 bioallethrin Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229950002373 bioresmethrin Drugs 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- OIPMQULDKWSNGX-UHFFFAOYSA-N bis[[ethoxy(oxo)phosphaniumyl]oxy]alumanyloxy-ethoxy-oxophosphanium Chemical compound [Al+3].CCO[P+]([O-])=O.CCO[P+]([O-])=O.CCO[P+]([O-])=O OIPMQULDKWSNGX-UHFFFAOYSA-N 0.000 description 1
- BPBOBPIKWGUSQG-UHFFFAOYSA-N bismuthane Chemical compound [BiH3] BPBOBPIKWGUSQG-UHFFFAOYSA-N 0.000 description 1
- LDLMOOXUCMHBMZ-UHFFFAOYSA-N bixafen Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=C(F)C=C1C1=CC=C(Cl)C(Cl)=C1 LDLMOOXUCMHBMZ-UHFFFAOYSA-N 0.000 description 1
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 229940118790 boscalid Drugs 0.000 description 1
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- HJJVPARKXDDIQD-UHFFFAOYSA-N bromuconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCC(Br)C1 HJJVPARKXDDIQD-UHFFFAOYSA-N 0.000 description 1
- 229960003168 bronopol Drugs 0.000 description 1
- DSKJPMWIHSOYEA-UHFFFAOYSA-N bupirimate Chemical compound CCCCC1=C(C)N=C(NCC)N=C1OS(=O)(=O)N(C)C DSKJPMWIHSOYEA-UHFFFAOYSA-N 0.000 description 1
- PRLVTUNWOQKEAI-VKAVYKQESA-N buprofezin Chemical compound O=C1N(C(C)C)\C(=N\C(C)(C)C)SCN1C1=CC=CC=C1 PRLVTUNWOQKEAI-VKAVYKQESA-N 0.000 description 1
- MGIWDIMSTXWOCO-UHFFFAOYSA-N butanedioic acid;copper Chemical compound [Cu].OC(=O)CCC(O)=O MGIWDIMSTXWOCO-UHFFFAOYSA-N 0.000 description 1
- KXRPCFINVWWFHQ-UHFFFAOYSA-N cadusafos Chemical compound CCC(C)SP(=O)(OCC)SC(C)CC KXRPCFINVWWFHQ-UHFFFAOYSA-N 0.000 description 1
- 229940105847 calamine Drugs 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940095758 cantharidin Drugs 0.000 description 1
- DHZBEENLJMYSHQ-XCVPVQRUSA-N cantharidin Chemical compound C([C@@H]1O2)C[C@@H]2[C@]2(C)[C@@]1(C)C(=O)OC2=O DHZBEENLJMYSHQ-XCVPVQRUSA-N 0.000 description 1
- 229930008397 cantharidin Natural products 0.000 description 1
- DHZBEENLJMYSHQ-UHFFFAOYSA-N cantharidine Natural products O1C2CCC1C1(C)C2(C)C(=O)OC1=O DHZBEENLJMYSHQ-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940117949 captan Drugs 0.000 description 1
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 description 1
- 229960005286 carbaryl Drugs 0.000 description 1
- CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical compound C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 1
- 239000006013 carbendazim Substances 0.000 description 1
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 description 1
- DUEPRVBVGDRKAG-UHFFFAOYSA-N carbofuran Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-UHFFFAOYSA-N 0.000 description 1
- 125000005243 carbonyl alkyl group Chemical group 0.000 description 1
- JLQUFIHWVLZVTJ-UHFFFAOYSA-N carbosulfan Chemical compound CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 JLQUFIHWVLZVTJ-UHFFFAOYSA-N 0.000 description 1
- GYSSRZJIHXQEHQ-UHFFFAOYSA-N carboxin Chemical compound S1CCOC(C)=C1C(=O)NC1=CC=CC=C1 GYSSRZJIHXQEHQ-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- RXDMAYSSBPYBFW-UHFFFAOYSA-N carpropamid Chemical compound C=1C=C(Cl)C=CC=1C(C)NC(=O)C1(CC)C(C)C1(Cl)Cl RXDMAYSSBPYBFW-UHFFFAOYSA-N 0.000 description 1
- IRUJZVNXZWPBMU-UHFFFAOYSA-N cartap Chemical compound NC(=O)SCC(N(C)C)CSC(N)=O IRUJZVNXZWPBMU-UHFFFAOYSA-N 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- BIWJNBZANLAXMG-YQELWRJZSA-N chloordaan Chemical compound ClC1=C(Cl)[C@@]2(Cl)C3CC(Cl)C(Cl)C3[C@]1(Cl)C2(Cl)Cl BIWJNBZANLAXMG-YQELWRJZSA-N 0.000 description 1
- XFDJMIHUAHSGKG-UHFFFAOYSA-N chlorethoxyfos Chemical compound CCOP(=S)(OCC)OC(Cl)C(Cl)(Cl)Cl XFDJMIHUAHSGKG-UHFFFAOYSA-N 0.000 description 1
- CWFOCCVIPCEQCK-UHFFFAOYSA-N chlorfenapyr Chemical compound BrC1=C(C(F)(F)F)N(COCC)C(C=2C=CC(Cl)=CC=2)=C1C#N CWFOCCVIPCEQCK-UHFFFAOYSA-N 0.000 description 1
- 239000003467 chloride channel stimulating agent Substances 0.000 description 1
- QGTYWWGEWOBMAK-UHFFFAOYSA-N chlormephos Chemical compound CCOP(=S)(OCC)SCCl QGTYWWGEWOBMAK-UHFFFAOYSA-N 0.000 description 1
- HKMOPYJWSFRURD-UHFFFAOYSA-N chloro hypochlorite;copper Chemical compound [Cu].ClOCl HKMOPYJWSFRURD-UHFFFAOYSA-N 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical compound OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- PFIADAMVCJPXSF-UHFFFAOYSA-N chloroneb Chemical compound COC1=CC(Cl)=C(OC)C=C1Cl PFIADAMVCJPXSF-UHFFFAOYSA-N 0.000 description 1
- LFHISGNCFUNFFM-UHFFFAOYSA-N chloropicrin Chemical compound [O-][N+](=O)C(Cl)(Cl)Cl LFHISGNCFUNFFM-UHFFFAOYSA-N 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- HPNSNYBUADCFDR-UHFFFAOYSA-N chromafenozide Chemical compound CC1=CC(C)=CC(C(=O)N(NC(=O)C=2C(=C3CCCOC3=CC=2)C)C(C)(C)C)=C1 HPNSNYBUADCFDR-UHFFFAOYSA-N 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 description 1
- KMPWYEUPVWOPIM-LSOMNZGLSA-N cinchonine Chemical compound C1=CC=C2C([C@@H]([C@H]3N4CC[C@H]([C@H](C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-LSOMNZGLSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- JOXAXMBQVHFGQT-UHFFFAOYSA-J copper;manganese(2+);n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[Cu+2].[S-]C(=S)NCCNC([S-])=S.[S-]C(=S)NCCNC([S-])=S JOXAXMBQVHFGQT-UHFFFAOYSA-J 0.000 description 1
- BXNANOICGRISHX-UHFFFAOYSA-N coumaphos Chemical compound CC1=C(Cl)C(=O)OC2=CC(OP(=S)(OCC)OCC)=CC=C21 BXNANOICGRISHX-UHFFFAOYSA-N 0.000 description 1
- 230000009193 crawling Effects 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- SCKHCCSZFPSHGR-UHFFFAOYSA-N cyanophos Chemical compound COP(=S)(OC)OC1=CC=C(C#N)C=C1 SCKHCCSZFPSHGR-UHFFFAOYSA-N 0.000 description 1
- YXKMMRDKEKCERS-UHFFFAOYSA-N cyazofamid Chemical compound CN(C)S(=O)(=O)N1C(C#N)=NC(Cl)=C1C1=CC=C(C)C=C1 YXKMMRDKEKCERS-UHFFFAOYSA-N 0.000 description 1
- 125000004465 cycloalkenyloxy group Chemical group 0.000 description 1
- 125000000000 cycloalkoxy group Chemical group 0.000 description 1
- 125000005366 cycloalkylthio group Chemical group 0.000 description 1
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- LSFUGNKKPMBOMG-UHFFFAOYSA-N cycloprothrin Chemical compound ClC1(Cl)CC1(C=1C=CC=CC=1)C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 LSFUGNKKPMBOMG-UHFFFAOYSA-N 0.000 description 1
- ACMXQHFNODYQAT-UHFFFAOYSA-N cyflufenamid Chemical compound FC1=CC=C(C(F)(F)F)C(C(NOCC2CC2)=NC(=O)CC=2C=CC=CC=2)=C1F ACMXQHFNODYQAT-UHFFFAOYSA-N 0.000 description 1
- 229960001591 cyfluthrin Drugs 0.000 description 1
- QQODLKZGRKWIFG-QSFXBCCZSA-N cyfluthrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-QSFXBCCZSA-N 0.000 description 1
- ZXQYGBMAQZUVMI-UNOMPAQXSA-N cyhalothrin Chemical compound CC1(C)C(\C=C(/Cl)C(F)(F)F)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-UNOMPAQXSA-N 0.000 description 1
- WCMMILVIRZAPLE-UHFFFAOYSA-M cyhexatin Chemical compound C1CCCCC1[Sn](C1CCCCC1)(O)C1CCCCC1 WCMMILVIRZAPLE-UHFFFAOYSA-M 0.000 description 1
- 229960005424 cypermethrin Drugs 0.000 description 1
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 1
- HAORKNGNJCEJBX-UHFFFAOYSA-N cyprodinil Chemical compound N=1C(C)=CC(C2CC2)=NC=1NC1=CC=CC=C1 HAORKNGNJCEJBX-UHFFFAOYSA-N 0.000 description 1
- OAWUUPVZMNKZRY-UHFFFAOYSA-N cyprosulfamide Chemical compound COC1=CC=CC=C1C(=O)NS(=O)(=O)C1=CC=C(C(=O)NC2CC2)C=C1 OAWUUPVZMNKZRY-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- QAYICIQNSGETAS-UHFFFAOYSA-N dazomet Chemical compound CN1CSC(=S)N(C)C1 QAYICIQNSGETAS-UHFFFAOYSA-N 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 229960002483 decamethrin Drugs 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 1
- WEBQKRLKWNIYKK-UHFFFAOYSA-N demeton-S-methyl Chemical compound CCSCCSP(=O)(OC)OC WEBQKRLKWNIYKK-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 1
- WURGXGVFSMYFCG-UHFFFAOYSA-N dichlofluanid Chemical compound CN(C)S(=O)(=O)N(SC(F)(Cl)Cl)C1=CC=CC=C1 WURGXGVFSMYFCG-UHFFFAOYSA-N 0.000 description 1
- BIXZHMJUSMUDOQ-UHFFFAOYSA-N dichloran Chemical compound NC1=C(Cl)C=C([N+]([O-])=O)C=C1Cl BIXZHMJUSMUDOQ-UHFFFAOYSA-N 0.000 description 1
- 229950001327 dichlorvos Drugs 0.000 description 1
- UWQMKVBQKFHLCE-UHFFFAOYSA-N diclomezine Chemical compound C1=C(Cl)C(C)=C(Cl)C=C1C1=NNC(=O)C=C1 UWQMKVBQKFHLCE-UHFFFAOYSA-N 0.000 description 1
- 229940004812 dicloran Drugs 0.000 description 1
- UOAMTSKGCBMZTC-UHFFFAOYSA-N dicofol Chemical compound C=1C=C(Cl)C=CC=1C(C(Cl)(Cl)Cl)(O)C1=CC=C(Cl)C=C1 UOAMTSKGCBMZTC-UHFFFAOYSA-N 0.000 description 1
- VEENJGZXVHKXNB-VOTSOKGWSA-N dicrotophos Chemical compound COP(=O)(OC)O\C(C)=C\C(=O)N(C)C VEENJGZXVHKXNB-VOTSOKGWSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- LNJNFVJKDJYTEU-UHFFFAOYSA-N diethofencarb Chemical compound CCOC1=CC=C(NC(=O)OC(C)C)C=C1OCC LNJNFVJKDJYTEU-UHFFFAOYSA-N 0.000 description 1
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 1
- BQYJATMQXGBDHF-UHFFFAOYSA-N difenoconazole Chemical compound O1C(C)COC1(C=1C(=CC(OC=2C=CC(Cl)=CC=2)=CC=1)Cl)CN1N=CN=C1 BQYJATMQXGBDHF-UHFFFAOYSA-N 0.000 description 1
- 229940019503 diflubenzuron Drugs 0.000 description 1
- CJHXCRMKMMBYJQ-UHFFFAOYSA-N dimethirimol Chemical compound CCCCC1=C(C)NC(N(C)C)=NC1=O CJHXCRMKMMBYJQ-UHFFFAOYSA-N 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- WXUZAHCNPWONDH-DYTRJAOYSA-N dimoxystrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1COC1=CC(C)=CC=C1C WXUZAHCNPWONDH-DYTRJAOYSA-N 0.000 description 1
- YKBZOVFACRVRJN-UHFFFAOYSA-N dinotefuran Chemical compound [O-][N+](=O)\N=C(/NC)NCC1CCOC1 YKBZOVFACRVRJN-UHFFFAOYSA-N 0.000 description 1
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- DOFZAZXDOSGAJZ-UHFFFAOYSA-N disulfoton Chemical compound CCOP(=S)(OCC)SCCSCC DOFZAZXDOSGAJZ-UHFFFAOYSA-N 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- PYZSVQVRHDXQSL-UHFFFAOYSA-N dithianon Chemical compound S1C(C#N)=C(C#N)SC2=C1C(=O)C1=CC=CC=C1C2=O PYZSVQVRHDXQSL-UHFFFAOYSA-N 0.000 description 1
- JMXKCYUTURMERF-UHFFFAOYSA-N dodemorph Chemical compound C1C(C)OC(C)CN1C1CCCCCCCCCCC1 JMXKCYUTURMERF-UHFFFAOYSA-N 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- GCKZANITAMOIAR-XWVCPFKXSA-N dsstox_cid_14566 Chemical compound [O-]C(=O)C1=CC=CC=C1.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H]([NH2+]C)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 GCKZANITAMOIAR-XWVCPFKXSA-N 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 1
- AWZOLILCOUMRDG-UHFFFAOYSA-N edifenphos Chemical compound C=1C=CC=CC=1SP(=O)(OCC)SC1=CC=CC=C1 AWZOLILCOUMRDG-UHFFFAOYSA-N 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000005712 elicitor Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- 239000004495 emulsifiable concentrate Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 244000079386 endoparasite Species 0.000 description 1
- RDYMFSUJUZBWLH-SVWSLYAFSA-N endosulfan Chemical compound C([C@@H]12)OS(=O)OC[C@@H]1[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl RDYMFSUJUZBWLH-SVWSLYAFSA-N 0.000 description 1
- 229960002125 enilconazole Drugs 0.000 description 1
- VMNULHCTRPXWFJ-UJSVPXBISA-N enoxastrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)\C=C\C1=CC=C(Cl)C=C1 VMNULHCTRPXWFJ-UJSVPXBISA-N 0.000 description 1
- 230000008686 ergosterol biosynthesis Effects 0.000 description 1
- NYPJDWWKZLNGGM-RPWUZVMVSA-N esfenvalerate Chemical compound C=1C([C@@H](C#N)OC(=O)[C@@H](C(C)C)C=2C=CC(Cl)=CC=2)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-RPWUZVMVSA-N 0.000 description 1
- DWRKFAJEBUWTQM-UHFFFAOYSA-N etaconazole Chemical compound O1C(CC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 DWRKFAJEBUWTQM-UHFFFAOYSA-N 0.000 description 1
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- HEZNVIYQEUHLNI-UHFFFAOYSA-N ethiofencarb Chemical compound CCSCC1=CC=CC=C1OC(=O)NC HEZNVIYQEUHLNI-UHFFFAOYSA-N 0.000 description 1
- RIZMRRKBZQXFOY-UHFFFAOYSA-N ethion Chemical compound CCOP(=S)(OCC)SCSP(=S)(OCC)OCC RIZMRRKBZQXFOY-UHFFFAOYSA-N 0.000 description 1
- BBXXLROWFHWFQY-UHFFFAOYSA-N ethirimol Chemical compound CCCCC1=C(C)NC(NCC)=NC1=O BBXXLROWFHWFQY-UHFFFAOYSA-N 0.000 description 1
- VJYFKVYYMZPMAB-UHFFFAOYSA-N ethoprophos Chemical compound CCCSP(=O)(OCC)SCCC VJYFKVYYMZPMAB-UHFFFAOYSA-N 0.000 description 1
- YKRQBWKLHCEKQH-KHPPLWFESA-N ethyl (z)-3-amino-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C(/N)C1=CC=CC=C1 YKRQBWKLHCEKQH-KHPPLWFESA-N 0.000 description 1
- IGUYEXXAGBDLLX-UHFFFAOYSA-N ethyl 3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-1,3-oxazolidine-5-carboxylate Chemical compound O=C1C(C(=O)OCC)(C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 IGUYEXXAGBDLLX-UHFFFAOYSA-N 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- YREQHYQNNWYQCJ-UHFFFAOYSA-N etofenprox Chemical compound C1=CC(OCC)=CC=C1C(C)(C)COCC1=CC=CC(OC=2C=CC=CC=2)=C1 YREQHYQNNWYQCJ-UHFFFAOYSA-N 0.000 description 1
- 229950005085 etofenprox Drugs 0.000 description 1
- IXSZQYVWNJNRAL-UHFFFAOYSA-N etoxazole Chemical compound CCOC1=CC(C(C)(C)C)=CC=C1C1N=C(C=2C(=CC=CC=2F)F)OC1 IXSZQYVWNJNRAL-UHFFFAOYSA-N 0.000 description 1
- KQTVWCSONPJJPE-UHFFFAOYSA-N etridiazole Chemical compound CCOC1=NC(C(Cl)(Cl)Cl)=NS1 KQTVWCSONPJJPE-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- JISACBWYRJHSMG-UHFFFAOYSA-N famphur Chemical compound COP(=S)(OC)OC1=CC=C(S(=O)(=O)N(C)C)C=C1 JISACBWYRJHSMG-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- LMVPQMGRYSRMIW-KRWDZBQOSA-N fenamidone Chemical compound O=C([C@@](C)(N=C1SC)C=2C=CC=CC=2)N1NC1=CC=CC=C1 LMVPQMGRYSRMIW-KRWDZBQOSA-N 0.000 description 1
- ZCJPOPBZHLUFHF-UHFFFAOYSA-N fenamiphos Chemical compound CCOP(=O)(NC(C)C)OC1=CC=C(SC)C(C)=C1 ZCJPOPBZHLUFHF-UHFFFAOYSA-N 0.000 description 1
- DMYHGDXADUDKCQ-UHFFFAOYSA-N fenazaquin Chemical compound C1=CC(C(C)(C)C)=CC=C1CCOC1=NC=NC2=CC=CC=C12 DMYHGDXADUDKCQ-UHFFFAOYSA-N 0.000 description 1
- JFSPBVWPKOEZCB-UHFFFAOYSA-N fenfuram Chemical compound O1C=CC(C(=O)NC=2C=CC=CC=2)=C1C JFSPBVWPKOEZCB-UHFFFAOYSA-N 0.000 description 1
- VDLGAVXLJYLFDH-UHFFFAOYSA-N fenhexamid Chemical compound C=1C=C(O)C(Cl)=C(Cl)C=1NC(=O)C1(C)CCCCC1 VDLGAVXLJYLFDH-UHFFFAOYSA-N 0.000 description 1
- ZNOLGFHPUIJIMJ-UHFFFAOYSA-N fenitrothion Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZNOLGFHPUIJIMJ-UHFFFAOYSA-N 0.000 description 1
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 description 1
- FKLFBQCQQYDUAM-UHFFFAOYSA-N fenpiclonil Chemical compound ClC1=CC=CC(C=2C(=CNC=2)C#N)=C1Cl FKLFBQCQQYDUAM-UHFFFAOYSA-N 0.000 description 1
- YYJNOYZRYGDPNH-MFKUBSTISA-N fenpyroximate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1CO/N=C/C=1C(C)=NN(C)C=1OC1=CC=CC=C1 YYJNOYZRYGDPNH-MFKUBSTISA-N 0.000 description 1
- WDQNIWFZKXZFAY-UHFFFAOYSA-M fentin acetate Chemical compound CC([O-])=O.C1=CC=CC=C1[Sn+](C=1C=CC=CC=1)C1=CC=CC=C1 WDQNIWFZKXZFAY-UHFFFAOYSA-M 0.000 description 1
- NJVOZLGKTAPUTQ-UHFFFAOYSA-M fentin chloride Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 NJVOZLGKTAPUTQ-UHFFFAOYSA-M 0.000 description 1
- BFWMWWXRWVJXSE-UHFFFAOYSA-M fentin hydroxide Chemical compound C=1C=CC=CC=1[Sn](C=1C=CC=CC=1)(O)C1=CC=CC=C1 BFWMWWXRWVJXSE-UHFFFAOYSA-M 0.000 description 1
- WHDGWKAJBYRJJL-UHFFFAOYSA-K ferbam Chemical compound [Fe+3].CN(C)C([S-])=S.CN(C)C([S-])=S.CN(C)C([S-])=S WHDGWKAJBYRJJL-UHFFFAOYSA-K 0.000 description 1
- GOWLARCWZRESHU-AQTBWJFISA-N ferimzone Chemical compound C=1C=CC=C(C)C=1C(/C)=N\NC1=NC(C)=CC(C)=N1 GOWLARCWZRESHU-AQTBWJFISA-N 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229940013764 fipronil Drugs 0.000 description 1
- RLQJEEJISHYWON-UHFFFAOYSA-N flonicamid Chemical compound FC(F)(F)C1=CC=NC=C1C(=O)NCC#N RLQJEEJISHYWON-UHFFFAOYSA-N 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- MXWAGQASUDSFBG-RVDMUPIBSA-N fluacrypyrim Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C(F)(F)F)=NC(OC(C)C)=N1 MXWAGQASUDSFBG-RVDMUPIBSA-N 0.000 description 1
- UZCGKGPEKUCDTF-UHFFFAOYSA-N fluazinam Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=C(Cl)C([N+]([O-])=O)=C1NC1=NC=C(C(F)(F)F)C=C1Cl UZCGKGPEKUCDTF-UHFFFAOYSA-N 0.000 description 1
- ZGNITFSDLCMLGI-UHFFFAOYSA-N flubendiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(I)=C1C(=O)NC(C)(C)CS(C)(=O)=O ZGNITFSDLCMLGI-UHFFFAOYSA-N 0.000 description 1
- MUJOIMFVNIBMKC-UHFFFAOYSA-N fludioxonil Chemical compound C=12OC(F)(F)OC2=CC=CC=1C1=CNC=C1C#N MUJOIMFVNIBMKC-UHFFFAOYSA-N 0.000 description 1
- GJEREQYJIQASAW-UHFFFAOYSA-N flufenerim Chemical compound CC(F)C1=NC=NC(NCCC=2C=CC(OC(F)(F)F)=CC=2)=C1Cl GJEREQYJIQASAW-UHFFFAOYSA-N 0.000 description 1
- GBOYJIHYACSLGN-UHFFFAOYSA-N fluopicolide Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CNC(=O)C1=C(Cl)C=CC=C1Cl GBOYJIHYACSLGN-UHFFFAOYSA-N 0.000 description 1
- UHCBBWUQDAVSMS-UHFFFAOYSA-N fluoroethane Chemical compound CCF UHCBBWUQDAVSMS-UHFFFAOYSA-N 0.000 description 1
- IPENDKRRWFURRE-UHFFFAOYSA-N fluoroimide Chemical compound C1=CC(F)=CC=C1N1C(=O)C(Cl)=C(Cl)C1=O IPENDKRRWFURRE-UHFFFAOYSA-N 0.000 description 1
- VUWZPRWSIVNGKG-UHFFFAOYSA-N fluoromethane Chemical compound F[CH2] VUWZPRWSIVNGKG-UHFFFAOYSA-N 0.000 description 1
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 description 1
- FQKUGOMFVDPBIZ-UHFFFAOYSA-N flusilazole Chemical compound C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 FQKUGOMFVDPBIZ-UHFFFAOYSA-N 0.000 description 1
- GNVDAZSPJWCIQZ-UHFFFAOYSA-N flusulfamide Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1NS(=O)(=O)C1=CC=C(Cl)C(C(F)(F)F)=C1 GNVDAZSPJWCIQZ-UHFFFAOYSA-N 0.000 description 1
- KGXUEPOHGFWQKF-ZCXUNETKSA-N flutianil Chemical compound COC1=CC=CC=C1N(CCS\1)C/1=C(C#N)/SC1=CC(C(F)(F)F)=CC=C1F KGXUEPOHGFWQKF-ZCXUNETKSA-N 0.000 description 1
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 description 1
- RMFNNCGOSPBBAD-MDWZMJQESA-N formetanate Chemical compound CNC(=O)OC1=CC=CC(\N=C\N(C)C)=C1 RMFNNCGOSPBBAD-MDWZMJQESA-N 0.000 description 1
- DUFVKSUJRWYZQP-UHFFFAOYSA-N fosthiazate Chemical compound CCC(C)SP(=O)(OCC)N1CCSC1=O DUFVKSUJRWYZQP-UHFFFAOYSA-N 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- ZEYJIQLVKGBLEM-UHFFFAOYSA-N fuberidazole Chemical compound C1=COC(C=2N=C3[CH]C=CC=C3N=2)=C1 ZEYJIQLVKGBLEM-UHFFFAOYSA-N 0.000 description 1
- 239000002316 fumigant Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- HAWJXYBZNNRMNO-UHFFFAOYSA-N furathiocarb Chemical compound CCCCOC(=O)N(C)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 HAWJXYBZNNRMNO-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- WIFXJBMOTMKRMM-UHFFFAOYSA-N halfenprox Chemical compound C=1C=C(OC(F)(F)Br)C=CC=1C(C)(C)COCC(C=1)=CC=CC=1OC1=CC=CC=C1 WIFXJBMOTMKRMM-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000000262 haloalkenyl group Chemical group 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 229910052864 hemimorphite Inorganic materials 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- RGNPBRKPHBKNKX-UHFFFAOYSA-N hexaflumuron Chemical compound C1=C(Cl)C(OC(F)(F)C(F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F RGNPBRKPHBKNKX-UHFFFAOYSA-N 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 238000003898 horticulture Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- NOVHEGOWZNFVGT-UHFFFAOYSA-N hydrazine Chemical compound NN.NN NOVHEGOWZNFVGT-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- FYQGBXGJFWXIPP-UHFFFAOYSA-N hydroprene Chemical compound CCOC(=O)C=C(C)C=CCC(C)CCCC(C)C FYQGBXGJFWXIPP-UHFFFAOYSA-N 0.000 description 1
- 229930000073 hydroprene Natural products 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- KGVPNLBXJKTABS-UHFFFAOYSA-N hymexazol Chemical compound CC1=CC(O)=NO1 KGVPNLBXJKTABS-UHFFFAOYSA-N 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- HICUREFSAIZXFQ-JOWPUVSESA-N i9z29i000j Chemical compound C1C[C@H](C)[C@@H](CC)O[C@@]21O[C@H](C\C=C(C)\[C@H](OC(=O)C(=N/OC)\C=1C=CC=CC=1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 HICUREFSAIZXFQ-JOWPUVSESA-N 0.000 description 1
- AGKSTYPVMZODRV-UHFFFAOYSA-N imibenconazole Chemical compound C1=CC(Cl)=CC=C1CSC(CN1N=CN=C1)=NC1=CC=C(Cl)C=C1Cl AGKSTYPVMZODRV-UHFFFAOYSA-N 0.000 description 1
- 229940056881 imidacloprid Drugs 0.000 description 1
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 1
- VPRAQYXPZIFIOH-UHFFFAOYSA-N imiprothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCN1C(=O)N(CC#C)CC1=O VPRAQYXPZIFIOH-UHFFFAOYSA-N 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- VBCVPMMZEGZULK-NRFANRHFSA-N indoxacarb Chemical compound C([C@@]1(OC2)C(=O)OC)C3=CC(Cl)=CC=C3C1=NN2C(=O)N(C(=O)OC)C1=CC=C(OC(F)(F)F)C=C1 VBCVPMMZEGZULK-NRFANRHFSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000012770 industrial material Substances 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- QTYCMDBMOLSEAM-UHFFFAOYSA-N ipconazole Chemical compound C1=NC=NN1CC1(O)C(C(C)C)CCC1CC1=CC=C(Cl)C=C1 QTYCMDBMOLSEAM-UHFFFAOYSA-N 0.000 description 1
- FCOAHACKGGIURQ-UHFFFAOYSA-N iprobenfos Chemical compound CC(C)OP(=O)(OC(C)C)SCC1=CC=CC=C1 FCOAHACKGGIURQ-UHFFFAOYSA-N 0.000 description 1
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 description 1
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- VROYMKJUVCKXBU-YACXGCCLSA-N irumamycin Chemical compound CCC(=O)[C@@]1(C)OC1[C@H](C)C[C@@H](C)[C@@H]1[C@H](C)C(O)[C@@H](C)/C=C/[C@H](OC2O[C@H](C)[C@@H](O)[C@H](OC(N)=O)C2)CCC/C=C(C)/[C@@H](O2)C(C)=CC[C@]2(O)CC(=O)O1 VROYMKJUVCKXBU-YACXGCCLSA-N 0.000 description 1
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 description 1
- QBSJMKIUCUGGNG-UHFFFAOYSA-N isoprocarb Chemical compound CNC(=O)OC1=CC=CC=C1C(C)C QBSJMKIUCUGGNG-UHFFFAOYSA-N 0.000 description 1
- UFHLMYOGRXOCSL-UHFFFAOYSA-N isoprothiolane Chemical compound CC(C)OC(=O)C(C(=O)OC(C)C)=C1SCCS1 UFHLMYOGRXOCSL-UHFFFAOYSA-N 0.000 description 1
- 125000001810 isothiocyanato group Chemical group *N=C=S 0.000 description 1
- WLPCAERCXQSYLQ-UHFFFAOYSA-N isotianil Chemical compound ClC1=NSC(C(=O)NC=2C(=CC=CC=2)C#N)=C1Cl WLPCAERCXQSYLQ-UHFFFAOYSA-N 0.000 description 1
- SDMSCIWHRZJSRN-UHFFFAOYSA-N isoxathion Chemical compound O1N=C(OP(=S)(OCC)OCC)C=C1C1=CC=CC=C1 SDMSCIWHRZJSRN-UHFFFAOYSA-N 0.000 description 1
- 229930014550 juvenile hormone Natural products 0.000 description 1
- 239000002949 juvenile hormone Substances 0.000 description 1
- 150000003633 juvenile hormone derivatives Chemical class 0.000 description 1
- UGWALRUNBSBTGI-ZKMZRDRYSA-N kadethrin Chemical compound C(/[C@@H]1C([C@@H]1C(=O)OCC=1C=C(CC=2C=CC=CC=2)OC=1)(C)C)=C1/CCSC1=O UGWALRUNBSBTGI-ZKMZRDRYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229930001540 kinoprene Natural products 0.000 description 1
- ZOTBXTZVPHCKPN-HTXNQAPBSA-N kresoxim-methyl Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC=C1C ZOTBXTZVPHCKPN-HTXNQAPBSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004611 light stabiliser Substances 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 229960000453 malathion Drugs 0.000 description 1
- YKSNLCVSTHTHJA-UHFFFAOYSA-L maneb Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S YKSNLCVSTHTHJA-UHFFFAOYSA-L 0.000 description 1
- 229920000940 maneb Polymers 0.000 description 1
- KLGMSAOQDHLCOS-UHFFFAOYSA-N mecarbam Chemical compound CCOC(=O)N(C)C(=O)CSP(=S)(OCC)OCC KLGMSAOQDHLCOS-UHFFFAOYSA-N 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- CIFWZNRJIBNXRE-UHFFFAOYSA-N mepanipyrim Chemical compound CC#CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 CIFWZNRJIBNXRE-UHFFFAOYSA-N 0.000 description 1
- BCTQJXQXJVLSIG-UHFFFAOYSA-N mepronil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C)=C1 BCTQJXQXJVLSIG-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- ZQEIXNIJLIKNTD-GFCCVEGCSA-N metalaxyl-M Chemical compound COCC(=O)N([C@H](C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-GFCCVEGCSA-N 0.000 description 1
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- NNKVPIKMPCQWCG-UHFFFAOYSA-N methamidophos Chemical compound COP(N)(=O)SC NNKVPIKMPCQWCG-UHFFFAOYSA-N 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- IXJOSTZEBSTPAG-UHFFFAOYSA-N methasulfocarb Chemical compound CNC(=O)SC1=CC=C(OS(C)(=O)=O)C=C1 IXJOSTZEBSTPAG-UHFFFAOYSA-N 0.000 description 1
- MEBQXILRKZHVCX-UHFFFAOYSA-N methidathion Chemical compound COC1=NN(CSP(=S)(OC)OC)C(=O)S1 MEBQXILRKZHVCX-UHFFFAOYSA-N 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- UHXUZOCRWCRNSJ-QPJJXVBHSA-N methomyl Chemical compound CNC(=O)O\N=C(/C)SC UHXUZOCRWCRNSJ-QPJJXVBHSA-N 0.000 description 1
- 229930002897 methoprene Natural products 0.000 description 1
- 229950003442 methoprene Drugs 0.000 description 1
- QCAWEPFNJXQPAN-UHFFFAOYSA-N methoxyfenozide Chemical compound COC1=CC=CC(C(=O)NN(C(=O)C=2C=C(C)C=C(C)C=2)C(C)(C)C)=C1C QCAWEPFNJXQPAN-UHFFFAOYSA-N 0.000 description 1
- GEPDYQSQVLXLEU-AATRIKPKSA-N methyl (e)-3-dimethoxyphosphoryloxybut-2-enoate Chemical compound COC(=O)\C=C(/C)OP(=O)(OC)OC GEPDYQSQVLXLEU-AATRIKPKSA-N 0.000 description 1
- KBHDSWIXRODKSZ-UHFFFAOYSA-N methyl 5-chloro-2-(trifluoromethylsulfonylamino)benzoate Chemical compound COC(=O)C1=CC(Cl)=CC=C1NS(=O)(=O)C(F)(F)F KBHDSWIXRODKSZ-UHFFFAOYSA-N 0.000 description 1
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229920000257 metiram Polymers 0.000 description 1
- VOEYXMAFNDNNED-UHFFFAOYSA-N metolcarb Chemical compound CNC(=O)OC1=CC=CC(C)=C1 VOEYXMAFNDNNED-UHFFFAOYSA-N 0.000 description 1
- HIIRDDUVRXCDBN-OBGWFSINSA-N metominostrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1OC1=CC=CC=C1 HIIRDDUVRXCDBN-OBGWFSINSA-N 0.000 description 1
- AMSPWOYQQAWRRM-UHFFFAOYSA-N metrafenone Chemical compound COC1=CC=C(Br)C(C)=C1C(=O)C1=C(C)C=C(OC)C(OC)=C1OC AMSPWOYQQAWRRM-UHFFFAOYSA-N 0.000 description 1
- 230000003641 microbiacidal effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229940124561 microbicide Drugs 0.000 description 1
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 description 1
- KCIRYJNISRMYFI-UHFFFAOYSA-N mildiomycin Natural products NC(CO)C(=O)NC1C=CC(OC1C(O)(CC(O)CNC(=N)N)C(=O)O)N2CN=C(N)C(=C2)CO KCIRYJNISRMYFI-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- NALMPLUMOWIVJC-UHFFFAOYSA-N n,n,4-trimethylbenzeneamine oxide Chemical compound CC1=CC=C([N+](C)(C)[O-])C=C1 NALMPLUMOWIVJC-UHFFFAOYSA-N 0.000 description 1
- REPVNSJSTLRQEQ-UHFFFAOYSA-N n,n-dimethylacetamide;n,n-dimethylformamide Chemical compound CN(C)C=O.CN(C)C(C)=O REPVNSJSTLRQEQ-UHFFFAOYSA-N 0.000 description 1
- YNKFZRGTXAPYFD-UHFFFAOYSA-N n-[[2-chloro-3,5-bis(trifluoromethyl)phenyl]carbamoyl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1Cl YNKFZRGTXAPYFD-UHFFFAOYSA-N 0.000 description 1
- LVCDXCQFSONNDO-UHFFFAOYSA-N n-benzylhydroxylamine Chemical compound ONCC1=CC=CC=C1 LVCDXCQFSONNDO-UHFFFAOYSA-N 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- OZGNYLLQHRPOBR-DHZHZOJOSA-N naftifine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)C\C=C\C1=CC=CC=C1 OZGNYLLQHRPOBR-DHZHZOJOSA-N 0.000 description 1
- 229960004313 naftifine Drugs 0.000 description 1
- BUYMVQAILCEWRR-UHFFFAOYSA-N naled Chemical compound COP(=O)(OC)OC(Br)C(Cl)(Cl)Br BUYMVQAILCEWRR-UHFFFAOYSA-N 0.000 description 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N naphthalene-acid Natural products C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000001069 nematicidal effect Effects 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229940079888 nitenpyram Drugs 0.000 description 1
- DCUJJWWUNKIJPH-UHFFFAOYSA-N nitrapyrin Chemical compound ClC1=CC=CC(C(Cl)(Cl)Cl)=N1 DCUJJWWUNKIJPH-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 125000005187 nonenyl group Chemical group C(=CCCCCCCC)* 0.000 description 1
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- PZXOQEXFMJCDPG-UHFFFAOYSA-N omethoate Chemical compound CNC(=O)CSP(=O)(OC)OC PZXOQEXFMJCDPG-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- UWVQIROCRJWDKL-UHFFFAOYSA-N oxadixyl Chemical compound CC=1C=CC=C(C)C=1N(C(=O)COC)N1CCOC1=O UWVQIROCRJWDKL-UHFFFAOYSA-N 0.000 description 1
- 125000003431 oxalo group Chemical group 0.000 description 1
- 238000006146 oximation reaction Methods 0.000 description 1
- 229960000321 oxolinic acid Drugs 0.000 description 1
- AMEKQAFGQBKLKX-UHFFFAOYSA-N oxycarboxin Chemical compound O=S1(=O)CCOC(C)=C1C(=O)NC1=CC=CC=C1 AMEKQAFGQBKLKX-UHFFFAOYSA-N 0.000 description 1
- PMCVMORKVPSKHZ-UHFFFAOYSA-N oxydemeton-methyl Chemical compound CCS(=O)CCSP(=O)(OC)OC PMCVMORKVPSKHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- OGYFATSSENRIKG-UHFFFAOYSA-N pencycuron Chemical compound C1=CC(Cl)=CC=C1CN(C(=O)NC=1C=CC=CC=1)C1CCCC1 OGYFATSSENRIKG-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- WBTYBAGIHOISOQ-UHFFFAOYSA-N pent-4-en-1-yl 2-[(2-furylmethyl)(imidazol-1-ylcarbonyl)amino]butanoate Chemical compound C1=CN=CN1C(=O)N(C(CC)C(=O)OCCCC=C)CC1=CC=CO1 WBTYBAGIHOISOQ-UHFFFAOYSA-N 0.000 description 1
- LKPLKUMXSAEKID-UHFFFAOYSA-N pentachloronitrobenzene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LKPLKUMXSAEKID-UHFFFAOYSA-N 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229960000490 permethrin Drugs 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- XAMUDJHXFNRLCY-UHFFFAOYSA-N phenthoate Chemical compound CCOC(=O)C(SP(=S)(OC)OC)C1=CC=CC=C1 XAMUDJHXFNRLCY-UHFFFAOYSA-N 0.000 description 1
- WSDQIHATCCOMLH-UHFFFAOYSA-N phenyl n-(3,5-dichlorophenyl)carbamate Chemical compound ClC1=CC(Cl)=CC(NC(=O)OC=2C=CC=CC=2)=C1 WSDQIHATCCOMLH-UHFFFAOYSA-N 0.000 description 1
- 150000004031 phenylhydrazines Chemical class 0.000 description 1
- BULVZWIRKLYCBC-UHFFFAOYSA-N phorate Chemical compound CCOP(=S)(OCC)SCSCC BULVZWIRKLYCBC-UHFFFAOYSA-N 0.000 description 1
- IOUNQDKNJZEDEP-UHFFFAOYSA-N phosalone Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=S)(OCC)OCC)C2=C1 IOUNQDKNJZEDEP-UHFFFAOYSA-N 0.000 description 1
- LMNZTLDVJIUSHT-UHFFFAOYSA-N phosmet Chemical compound C1=CC=C2C(=O)N(CSP(=S)(OC)OC)C(=O)C2=C1 LMNZTLDVJIUSHT-UHFFFAOYSA-N 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- HOKBIQDJCNTWST-UHFFFAOYSA-N phosphanylidenezinc;zinc Chemical compound [Zn].[Zn]=P.[Zn]=P HOKBIQDJCNTWST-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- ATROHALUCMTWTB-OWBHPGMISA-N phoxim Chemical compound CCOP(=S)(OCC)O\N=C(\C#N)C1=CC=CC=C1 ATROHALUCMTWTB-OWBHPGMISA-N 0.000 description 1
- 229950001664 phoxim Drugs 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 1
- IBSNKSODLGJUMQ-SDNWHVSQSA-N picoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC(C(F)(F)F)=N1 IBSNKSODLGJUMQ-SDNWHVSQSA-N 0.000 description 1
- 239000001739 pinus spp. Substances 0.000 description 1
- YFGYUFNIOHWBOB-UHFFFAOYSA-N pirimicarb Chemical compound CN(C)C(=O)OC1=NC(N(C)C)=NC(C)=C1C YFGYUFNIOHWBOB-UHFFFAOYSA-N 0.000 description 1
- QHOQHJPRIBSPCY-UHFFFAOYSA-N pirimiphos-methyl Chemical group CCN(CC)C1=NC(C)=CC(OP(=S)(OC)OC)=N1 QHOQHJPRIBSPCY-UHFFFAOYSA-N 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 229930189914 platycodon Natural products 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- JPFWJDMDPLEUBD-ITJAGOAWSA-N polyoxorim Polymers O[C@@H]1[C@H](O)[C@@H]([C@H](NC(=O)[C@H]([C@H](O)[C@@H](O)COC(N)=O)N)C(O)=O)O[C@H]1N1C(=O)NC(=O)C(C(O)=O)=C1 JPFWJDMDPLEUBD-ITJAGOAWSA-N 0.000 description 1
- 239000005077 polysulfide Substances 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 150000008117 polysulfides Polymers 0.000 description 1
- 150000003097 polyterpenes Chemical class 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- SMKRKQBMYOFFMU-UHFFFAOYSA-N prallethrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OC1C(C)=C(CC#C)C(=O)C1 SMKRKQBMYOFFMU-UHFFFAOYSA-N 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 description 1
- QXJKBPAVAHBARF-BETUJISGSA-N procymidone Chemical compound O=C([C@]1(C)C[C@@]1(C1=O)C)N1C1=CC(Cl)=CC(Cl)=C1 QXJKBPAVAHBARF-BETUJISGSA-N 0.000 description 1
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 1
- WZZLDXDUQPOXNW-UHFFFAOYSA-N propamocarb Chemical compound CCCOC(=O)NCCCN(C)C WZZLDXDUQPOXNW-UHFFFAOYSA-N 0.000 description 1
- ZYHMJXZULPZUED-UHFFFAOYSA-N propargite Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1C(OS(=O)OCC#C)CCCC1 ZYHMJXZULPZUED-UHFFFAOYSA-N 0.000 description 1
- BZNDWPRGXNILMS-VQHVLOKHSA-N propetamphos Chemical compound CCNP(=S)(OC)O\C(C)=C\C(=O)OC(C)C BZNDWPRGXNILMS-VQHVLOKHSA-N 0.000 description 1
- STJLVHWMYQXCPB-UHFFFAOYSA-N propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 description 1
- KKMLIVYBGSAJPM-UHFFFAOYSA-L propineb Chemical compound [Zn+2].[S-]C(=S)NC(C)CNC([S-])=S KKMLIVYBGSAJPM-UHFFFAOYSA-L 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- LZFIOSVZIQOVFW-UHFFFAOYSA-N propyl 2-hydroxybenzoate Chemical compound CCCOC(=O)C1=CC=CC=C1O LZFIOSVZIQOVFW-UHFFFAOYSA-N 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- FLVBXVXXXMLMOX-UHFFFAOYSA-N proquinazid Chemical compound C1=C(I)C=C2C(=O)N(CCC)C(OCCC)=NC2=C1 FLVBXVXXXMLMOX-UHFFFAOYSA-N 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- YRRBXJLFCBCKNW-UHFFFAOYSA-N prothiocarb Chemical compound CCSC(=O)NCCCN(C)C YRRBXJLFCBCKNW-UHFFFAOYSA-N 0.000 description 1
- FITIWKDOCAUBQD-UHFFFAOYSA-N prothiofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(Cl)C=C1Cl FITIWKDOCAUBQD-UHFFFAOYSA-N 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 229960003351 prussian blue Drugs 0.000 description 1
- 239000013225 prussian blue Substances 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- QHGVXILFMXYDRS-UHFFFAOYSA-N pyraclofos Chemical compound C1=C(OP(=O)(OCC)SCCC)C=NN1C1=CC=C(Cl)C=C1 QHGVXILFMXYDRS-UHFFFAOYSA-N 0.000 description 1
- HZRSNVGNWUDEFX-UHFFFAOYSA-N pyraclostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NN(C=2C=CC(Cl)=CC=2)C=C1 HZRSNVGNWUDEFX-UHFFFAOYSA-N 0.000 description 1
- DDIQWGKUSJOETH-UHFFFAOYSA-N pyrafluprole Chemical compound ClC=1C=C(C(F)(F)F)C=C(Cl)C=1N1N=C(C#N)C(SCF)=C1NCC1=CN=CC=N1 DDIQWGKUSJOETH-UHFFFAOYSA-N 0.000 description 1
- URXNNPCNKVAQRA-XMHGGMMESA-N pyraoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C=2C=CC(Cl)=CC=2)=NN1C URXNNPCNKVAQRA-XMHGGMMESA-N 0.000 description 1
- JOOMJVFZQRQWKR-UHFFFAOYSA-N pyrazophos Chemical compound N1=C(C)C(C(=O)OCC)=CN2N=C(OP(=S)(OCC)OCC)C=C21 JOOMJVFZQRQWKR-UHFFFAOYSA-N 0.000 description 1
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 description 1
- 229940070846 pyrethrins Drugs 0.000 description 1
- 239000002728 pyrethroid Substances 0.000 description 1
- 229940015367 pyrethrum Drugs 0.000 description 1
- CRFYLQMIDWBKRT-LPYMAVHISA-N pyribencarb Chemical compound C1=C(Cl)C(CNC(=O)OC)=CC(C(\C)=N\OCC=2N=C(C)C=CC=2)=C1 CRFYLQMIDWBKRT-LPYMAVHISA-N 0.000 description 1
- VTRWMTJQBQJKQH-UHFFFAOYSA-N pyributicarb Chemical compound COC1=CC=CC(N(C)C(=S)OC=2C=C(C=CC=2)C(C)(C)C)=N1 VTRWMTJQBQJKQH-UHFFFAOYSA-N 0.000 description 1
- CXJSOEPQXUCJSA-UHFFFAOYSA-N pyridaphenthion Chemical compound N1=C(OP(=S)(OCC)OCC)C=CC(=O)N1C1=CC=CC=C1 CXJSOEPQXUCJSA-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- MIOBBYRMXGNORL-UHFFFAOYSA-N pyrifluquinazon Chemical compound C1C2=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C2N(C(=O)C)C(=O)N1NCC1=CC=CN=C1 MIOBBYRMXGNORL-UHFFFAOYSA-N 0.000 description 1
- ZLIBICFPKPWGIZ-UHFFFAOYSA-N pyrimethanil Chemical compound CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 ZLIBICFPKPWGIZ-UHFFFAOYSA-N 0.000 description 1
- ITKAIUGKVKDENI-UHFFFAOYSA-N pyrimidifen Chemical compound CC1=C(C)C(CCOCC)=CC=C1OCCNC1=NC=NC(CC)=C1Cl ITKAIUGKVKDENI-UHFFFAOYSA-N 0.000 description 1
- XRJLAOUDSILTFT-UHFFFAOYSA-N pyroquilon Chemical compound O=C1CCC2=CC=CC3=C2N1CC3 XRJLAOUDSILTFT-UHFFFAOYSA-N 0.000 description 1
- 229960002132 pyrrolnitrin Drugs 0.000 description 1
- JYQUHIFYBATCCY-UHFFFAOYSA-N quinalphos Chemical compound C1=CC=CC2=NC(OP(=S)(OCC)OCC)=CN=C21 JYQUHIFYBATCCY-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229960001404 quinidine Drugs 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229940108410 resmethrin Drugs 0.000 description 1
- VEMKTZHHVJILDY-FIWHBWSRSA-N resmethrin Chemical compound CC1(C)[C@H](C=C(C)C)C1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-FIWHBWSRSA-N 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 229940080817 rotenone Drugs 0.000 description 1
- JUVIOZPCNVVQFO-HBGVWJBISA-N rotenone Chemical compound O([C@H](CC1=C2O3)C(C)=C)C1=CC=C2C(=O)[C@@H]1[C@H]3COC2=C1C=C(OC)C(OC)=C2 JUVIOZPCNVVQFO-HBGVWJBISA-N 0.000 description 1
- 102000042094 ryanodine receptor (TC 1.A.3.1) family Human genes 0.000 description 1
- 108091052345 ryanodine receptor (TC 1.A.3.1) family Proteins 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229910052624 sepiolite Inorganic materials 0.000 description 1
- 235000019355 sepiolite Nutrition 0.000 description 1
- 238000009366 sericulture Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- HPYNBECUCCGGPA-UHFFFAOYSA-N silafluofen Chemical compound C1=CC(OCC)=CC=C1[Si](C)(C)CCCC1=CC=C(F)C(OC=2C=CC=CC=2)=C1 HPYNBECUCCGGPA-UHFFFAOYSA-N 0.000 description 1
- MXMXHPPIGKYTAR-UHFFFAOYSA-N silthiofam Chemical compound CC=1SC([Si](C)(C)C)=C(C(=O)NCC=C)C=1C MXMXHPPIGKYTAR-UHFFFAOYSA-N 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
- 229960002218 sodium chlorite Drugs 0.000 description 1
- 239000011697 sodium iodate Substances 0.000 description 1
- 235000015281 sodium iodate Nutrition 0.000 description 1
- 229940032753 sodium iodate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- IYYIUOWKEMQYNV-UHFFFAOYSA-N sodium;ethoxy-oxido-oxophosphanium Chemical compound [Na+].CCO[P+]([O-])=O IYYIUOWKEMQYNV-UHFFFAOYSA-N 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940014213 spinosad Drugs 0.000 description 1
- 229930185156 spinosyn Natural products 0.000 description 1
- DTDSAWVUFPGDMX-UHFFFAOYSA-N spirodiclofen Chemical compound CCC(C)(C)C(=O)OC1=C(C=2C(=CC(Cl)=CC=2)Cl)C(=O)OC11CCCCC1 DTDSAWVUFPGDMX-UHFFFAOYSA-N 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- CLSVJBIHYWPGQY-GGYDESQDSA-N spirotetramat Chemical compound CCOC(=O)OC1=C(C=2C(=CC=C(C)C=2)C)C(=O)N[C@@]11CC[C@H](OC)CC1 CLSVJBIHYWPGQY-GGYDESQDSA-N 0.000 description 1
- PUYXTUJWRLOUCW-UHFFFAOYSA-N spiroxamine Chemical compound O1C(CN(CC)CCC)COC11CCC(C(C)(C)C)CC1 PUYXTUJWRLOUCW-UHFFFAOYSA-N 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical compound [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- ZOXORHGWTVOKPB-UHFFFAOYSA-N sulfinylcyanamide Chemical compound O=S=NC#N ZOXORHGWTVOKPB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 150000003458 sulfonic acid derivatives Chemical class 0.000 description 1
- XIUROWKZWPIAIB-UHFFFAOYSA-N sulfotep Chemical compound CCOP(=S)(OCC)OP(=S)(OCC)OCC XIUROWKZWPIAIB-UHFFFAOYSA-N 0.000 description 1
- 125000005555 sulfoximide group Chemical group 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- OBTWBSRJZRCYQV-UHFFFAOYSA-N sulfuryl difluoride Chemical compound FS(F)(=O)=O OBTWBSRJZRCYQV-UHFFFAOYSA-N 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- HOWHQWFXSLOJEF-MGZLOUMQSA-N systemin Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)OC(=O)[C@@H]1CCCN1C(=O)[C@H]1N(C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]2N(CCC2)C(=O)[C@H]2N(CCC2)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)CCC1 HOWHQWFXSLOJEF-MGZLOUMQSA-N 0.000 description 1
- 108010050014 systemin Proteins 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- QYPNKSZPJQQLRK-UHFFFAOYSA-N tebufenozide Chemical compound C1=CC(CC)=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 QYPNKSZPJQQLRK-UHFFFAOYSA-N 0.000 description 1
- ZZYSLNWGKKDOML-UHFFFAOYSA-N tebufenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(=CC=2)C(C)(C)C)=C1Cl ZZYSLNWGKKDOML-UHFFFAOYSA-N 0.000 description 1
- LWLJEQHTPVPKSJ-UHFFFAOYSA-N tebufloquin Chemical compound C1=C(C(C)(C)C)C=C2C(OC(=O)C)=C(C)C(C)=NC2=C1F LWLJEQHTPVPKSJ-UHFFFAOYSA-N 0.000 description 1
- AWYOMXWDGWUJHS-UHFFFAOYSA-N tebupirimfos Chemical compound CCOP(=S)(OC(C)C)OC1=CN=C(C(C)(C)C)N=C1 AWYOMXWDGWUJHS-UHFFFAOYSA-N 0.000 description 1
- XQTLDIFVVHJORV-UHFFFAOYSA-N tecnazene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl XQTLDIFVVHJORV-UHFFFAOYSA-N 0.000 description 1
- CJDWRQLODFKPEL-UHFFFAOYSA-N teflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(Cl)=C(F)C(Cl)=C1F CJDWRQLODFKPEL-UHFFFAOYSA-N 0.000 description 1
- WWJZWCUNLNYYAU-UHFFFAOYSA-N temephos Chemical compound C1=CC(OP(=S)(OC)OC)=CC=C1SC1=CC=C(OP(=S)(OC)OC)C=C1 WWJZWCUNLNYYAU-UHFFFAOYSA-N 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- UBCKGWBNUIFUST-YHYXMXQVSA-N tetrachlorvinphos Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC(Cl)=C(Cl)C=C1Cl UBCKGWBNUIFUST-YHYXMXQVSA-N 0.000 description 1
- MLGCXEBRWGEOQX-UHFFFAOYSA-N tetradifon Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)C1=CC(Cl)=C(Cl)C=C1Cl MLGCXEBRWGEOQX-UHFFFAOYSA-N 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- BAKXBZPQTXCKRR-UHFFFAOYSA-N thiodicarb Chemical compound CSC(C)=NOC(=O)NSNC(=O)ON=C(C)SC BAKXBZPQTXCKRR-UHFFFAOYSA-N 0.000 description 1
- RSPCKAHMRANGJZ-UHFFFAOYSA-N thiohydroxylamine Chemical group SN RSPCKAHMRANGJZ-UHFFFAOYSA-N 0.000 description 1
- 238000006177 thiolation reaction Methods 0.000 description 1
- OPASCBHCTNRLRM-UHFFFAOYSA-N thiometon Chemical compound CCSCCSP(=S)(OC)OC OPASCBHCTNRLRM-UHFFFAOYSA-N 0.000 description 1
- YFNCATAIYKQPOO-UHFFFAOYSA-N thiophanate Chemical compound CCOC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OCC YFNCATAIYKQPOO-UHFFFAOYSA-N 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- QSOHVSNIQHGFJU-UHFFFAOYSA-L thiosultap disodium Chemical compound [Na+].[Na+].[O-]S(=O)(=O)SCC(N(C)C)CSS([O-])(=O)=O QSOHVSNIQHGFJU-UHFFFAOYSA-L 0.000 description 1
- VJQYLJSMBWXGDV-UHFFFAOYSA-N tiadinil Chemical compound N1=NSC(C(=O)NC=2C=C(Cl)C(C)=CC=2)=C1C VJQYLJSMBWXGDV-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- OBZIQQJJIKNWNO-UHFFFAOYSA-N tolclofos-methyl Chemical compound COP(=S)(OC)OC1=C(Cl)C=C(C)C=C1Cl OBZIQQJJIKNWNO-UHFFFAOYSA-N 0.000 description 1
- HYVWIQDYBVKITD-UHFFFAOYSA-N tolylfluanid Chemical compound CN(C)S(=O)(=O)N(SC(F)(Cl)Cl)C1=CC=C(C)C=C1 HYVWIQDYBVKITD-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- YWSCPYYRJXKUDB-KAKFPZCNSA-N tralomethrin Chemical compound CC1(C)[C@@H](C(Br)C(Br)(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YWSCPYYRJXKUDB-KAKFPZCNSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- DDVNRFNDOPPVQJ-HQJQHLMTSA-N transfluthrin Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=C(F)C(F)=CC(F)=C1F DDVNRFNDOPPVQJ-HQJQHLMTSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- BAZVSMNPJJMILC-UHFFFAOYSA-N triadimenol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-UHFFFAOYSA-N 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- AMFGTOFWMRQMEM-UHFFFAOYSA-N triazophos Chemical compound N1=C(OP(=S)(OCC)OCC)N=CN1C1=CC=CC=C1 AMFGTOFWMRQMEM-UHFFFAOYSA-N 0.000 description 1
- IQGKIPDJXCAMSM-UHFFFAOYSA-N triazoxide Chemical compound N=1C2=CC=C(Cl)C=C2[N+]([O-])=NC=1N1C=CN=C1 IQGKIPDJXCAMSM-UHFFFAOYSA-N 0.000 description 1
- DQJCHOQLCLEDLL-UHFFFAOYSA-N tricyclazole Chemical compound CC1=CC=CC2=C1N1C=NN=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-N 0.000 description 1
- ONCZDRURRATYFI-TVJDWZFNSA-N trifloxystrobin Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)C1=CC=CC(C(F)(F)F)=C1 ONCZDRURRATYFI-TVJDWZFNSA-N 0.000 description 1
- HSMVPDGQOIQYSR-KGENOOAVSA-N triflumizole Chemical compound C1=CN=CN1C(/COCCC)=N/C1=CC=C(Cl)C=C1C(F)(F)F HSMVPDGQOIQYSR-KGENOOAVSA-N 0.000 description 1
- RROQIUMZODEXOR-UHFFFAOYSA-N triforine Chemical compound O=CNC(C(Cl)(Cl)Cl)N1CCN(C(NC=O)C(Cl)(Cl)Cl)CC1 RROQIUMZODEXOR-UHFFFAOYSA-N 0.000 description 1
- 239000012989 trithiocarbonate Substances 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- 229940036248 turpentine Drugs 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- JARYYMUOCXVXNK-CSLFJTBJSA-N validamycin A Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-CSLFJTBJSA-N 0.000 description 1
- LESVOLZBIFDZGS-UHFFFAOYSA-N vamidothion Chemical compound CNC(=O)C(C)SCCSP(=O)(OC)OC LESVOLZBIFDZGS-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009333 weeding Methods 0.000 description 1
- 239000004563 wettable powder Substances 0.000 description 1
- WCJYTPVNMWIZCG-UHFFFAOYSA-N xylylcarb Chemical compound CNC(=O)OC1=CC=C(C)C(C)=C1 WCJYTPVNMWIZCG-UHFFFAOYSA-N 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- 229940048462 zinc phosphide Drugs 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
- AMHNZOICSMBGDH-UHFFFAOYSA-L zineb Chemical compound [Zn+2].[S-]C(=S)NCCNC([S-])=S AMHNZOICSMBGDH-UHFFFAOYSA-L 0.000 description 1
- DUBNHZYBDBBJHD-UHFFFAOYSA-L ziram Chemical compound [Zn+2].CN(C)C([S-])=S.CN(C)C([S-])=S DUBNHZYBDBBJHD-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dentistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
201012812 六、發明說明: 【發明所屬之技術領域】 本發明係關於硫-衍生之1-畊基吡唑類,其作為殺蟲劑 及/或殺寄生蟲劑之用途及其製傷方法。 本發明還提供在製備根據本發明的硫_衍生之1_畊基吡 唑類中所得到的多種中間物。 最後’本發明也提供含此η井基π比β坐類之組成物。 【先前技術】 DE 197 51 943 Α1係關於ι_曱基_5_烷基磺醯基_、1-甲 基-5-烧基亞續酿基•及1-曱基_5_烧硫基·取代之η比嗤基吼η坐 類、其製備方法及其作為除草劑之用途。在該除草劑的對 應合成中所得到的中間物特別是5-胺基-1-曱基-3-(甲基硫 烧基)·1Η-吡唑-4-腈。但是,DE 197 51 943 Α1沒有揭示此 中間物之任何殺蟲作用。201012812 VI. Description of the Invention: TECHNICAL FIELD OF THE INVENTION The present invention relates to sulfur-derived 1-cultivated pyrazoles, their use as insecticides and/or parasiticides, and methods for their injury. The present invention also provides various intermediates obtained in the preparation of the sulfur-derived 1_cultivated pyrazole according to the present invention. Finally, the present invention also provides a composition comprising the n-well π ratio β-seat. [Prior Art] DE 197 51 943 Α1 series on ι_fluorenyl-5-alkylsulfonyl-, 1-methyl-5-alkylsulfinyl and 1-thiol_5_sulfuryl - Substituted η is based on hydrazino, its preparation method and its use as a herbicide. The intermediate obtained in the corresponding synthesis of the herbicide is especially 5-amino-1-indolyl-3-(methylthioalkyl)·1Η-pyrazole-4-carbonitrile. However, DE 197 51 943 Α 1 does not reveal any insecticidal action of this intermediate.
Liu et al·,Youji Huaxue (2006),26(11),1600-1605 也揭 示胺基-1-(癌啶_4_基)_3_(曱基硫烷基)_1H_吡唑冰腈作 除草劑合成中的中間物。Liu et al., Youji Huaxue (2006), 26(11), 1600-1605 also reveals the herbicidal ratio of amino-1-(carotidine-4-yl)_3_(mercaptosulfanyl)_1H-pyrazole glacitriene Intermediate in the synthesis of the agent.
Meegalla et al揭示作為GABA通道阻滯劑的3 -倚甲 -4-(雜)¾基-5-胺基-1-苯基α比Π坐之合成及殺蟲活性 (Bioorganic & Medicinal Chemistry Letters (2004),14, 4949-4953; WO 2001 07413)。 EP 1 829 867 A1概述藥學活性硫衍生的U畊基叹 王〇 原則上,需求其他殺蟲及/或殺寄生蟲活性的化合% 201012812 因為從先前技藝已知的活性化合物經常沒有足夠的活性及/ 或足夠寬廣的活性譜。 * 據此’本發明之目的是提供替代性的殺蟲劑及/或殺寄 - 生蟲劑,其與從先前技藝已知的活性化合物比較,具有改 進的活性及/或改進的活性譜。 此目的是經由特定硫-衍生的1-畊基吡唑類達成。 ®【發明内容】 據此,本發明提供通式(I)之硫-衍生的1-畊基吡唑類或 其N-氧化物,Meegalla et al. revealed the synthesis and insecticidal activity of 3-amino-4-(hetero) 3⁄4yl-5-amino-1-phenylα as a GABA channel blocker (Bioorganic & Medicinal Chemistry Letters) (2004), 14, 4949-4953; WO 2001 07413). EP 1 829 867 A1 summarizes the pharmaceutically active sulfur-derived U cultivating sorghum scorpion in principle, requiring a combination of other insecticidal and/or parasiticidal activities. 201012812 Since the active compounds known from the prior art often do not have sufficient activity and / or a broad spectrum of activity. * Accordingly, it is an object of the present invention to provide alternative insecticides and/or killer-like insecticides having improved activity and/or improved activity profile as compared to active compounds known from the prior art. This object is achieved via a specific sulfur-derived 1-cultivated pyrazole. ® [Summary of the Invention] Accordingly, the present invention provides a sulfur-derived 1-cultivated pyrazole of the formula (I) or an N-oxide thereof,
其中, A1及A2在各情形下彼此獨立地代表氮或C-R3 ; B代表烷基、環炫基、環烯基、環烧基烷基、齒烧基、烧 氧基烧基、氰基炫基、烧硫基烧基、烧基亞續醯基烧基、 烷基磺醯基烷基、胺基烷基、單烷基胺基烷基、雙烷基 胺基烧基、燒基幾基烧基、烧氧基幾基烧基、單烧基胺 基錄基燒基、二胺基烧基幾基烧基、烯基及炔基,其各 隨意地經選自齒基、烷基、鹵烷基、烷氧基、三烷基石夕 烷基、硝基及氰基之相同或不同的基團單-或多取代; 5 201012812Wherein, A1 and A2 each independently represent nitrogen or C-R3 in each case; B represents an alkyl group, a cyclodecyl group, a cycloalkenyl group, a cycloalkylalkyl group, a dentate group, an alkoxy group, a cyano group. Hyun base, thiol group, alkyl sulfonyl group, alkyl sulfonylalkyl group, aminoalkyl group, monoalkylaminoalkyl group, bisalkylamino group, alkyl group a ketone group, an alkoxyalkyl group, a monoalkylamino group, a diaminoalkyl group, an alkenyl group and an alkynyl group, each optionally selected from the group consisting of a dentate group and an alkyl group. , the same or different groups of haloalkyl, alkoxy, trialkyl, nitro, and cyano groups, mono- or polysubstituted; 5 201012812
苯基烷基’其在芳族部份可隨意地經選自自基、烷基、 鹵炫《基烧氧基、確基及氰基之相同或不同的取代基單 -或多取代;雜環基烷基,其在雜環基部份可隨意地經 選自-0H/=0、-SH/=S、-NH2、鹵基、烷基、鹵烷基、 烷氧基、硫烷基、烷基亞磺醯基、烷基磺醯基、單烷基 胺基、二烷基胺基、硝基及氰基之相同或不同的取代基 單-或多取代,雜芳基院基,其在雜芳族部份可隨意地 經選自-OH、-SH、-NH2、鹵基、烷基、鹵烷基、烷氧 基、硫烷基、烷基亞磺醯基、烷基磺醯基、單烷基胺基、 二烷基胺基、硝基及氰基之相同或不同的取代基單_或 多取代;苯基,其可隨意地經選自_〇h、-SH、-NH2、 鹵基、烷基、自烷基、烷氧基、硫烷基、烷基亞磺醯基、 烷基磺醯基、單烷基胺基、二烷基胺基、硝基及氰基之 相同或不同的取代基單-或多取代;雜芳基,其可隨意 地經選自-〇H、-SH、-NH2、鹵基、烷基、鹵烷基、烷 氧基、硫烷基、烷基亞磺醯基、烷基磺醯基、單烷基胺 基、二烷基胺基、硝基及氰基之相同或不同的取代基單 或多取代,或雜環基’其可隨意地經選自_〇H/=0、 -SH/=S、-NH2、鹵基、烷基、鹵烷基、烷氧基、硫烷基、 烷基亞磺醯基、烷基磺醯基、單烷基胺基、二烷基胺基、 确基及氰基之相同或不同的取代基單-或多取代; R1及R2彼此獨立地各代表氫、烷基、鹵烷基、氰基烷基、 烷氧基烷基、烷基羰基、齒烷基羰基、環烷基、環烷基 烷基、烷基磺醯基、烯基、炔基、烷氧基羰基、烯氧基 201012812 羰基、炔氧基羰基、烷氧基羰基烷基;苯基烷基,其在 芳族部份可隨意地經選自4基、烷基、鹵烷基、烷氧基、 硝基及氰基之相同或不同的取代基單-或多取代;雜環 基烷基,其在雜環基部份可隨意地經選自齒基、烷基、 鹵烧基、烧氧基、硝基及氰基之相同或不同的取代基單 -或多取代;雜芳基烷基,其在雜芳族部份可隨意地經 選自齒基、烷基、齒烷基、烷氧基、硝基及氰基之相同 ❹ 或不同的取代基單-或多取代;或苯基羰基,其在芳族 部份可隨意地經選自齒基、烷基、齒烷基、烷氧基、硝 基及氰基之相同或不同的取代基單-或多取代; 或 R1 及 R2 — 起代表=CH-NR4R5 ; R3代表鹵基、烧基、齒烧基、烧氧基、硫烧基、燒基亞續 醯基、烧基續醯基、鹵娱:氧基、鹵烧基硫烧基、_烧基 亞磺醯基、ll烷基磺醯基、烷基羰基、甲醯基、 〇 -CR6=NO-R6、烷氧基羰基、羥基、_SH、硝基、氰基、 nh2、單烷基胺基或二烷基胺基; R4及R5彼此獨立地各代表烧基或一起代表一個橋接的亞烧 基; R6代表氫或代表烧基; X代表苯基、2-吡咬基或3-吼唆基,在各情形中經一或多 個選自包括i基、烷基、!i烷基、烷氧基、烷氧基烷基、 烷氧基烷氧基、環烷基、烯氧基、炔氧基、環烷基烷氧 基、鹵烷氧基、鹵烷氧基烷基、烷基硫烷基、鹵烷基硫 201012812 烧基、烧基亞續醜基、鹵烧基亞績醯基、烧基磺龜基、 鹵燒基磺醯基、氰基、烷基羰基、烷氧基羰基、烷氧基 羰基烷基、羧基、醯胺基、二烷基醯胺基、三烷基矽烷 基、硝基、胺基、烷基胺基、二烷基胺基、烷基磺醯基 胺基、二烷基磺酿基胺基、-CR6=NO-R6、-CR6=NO-鹵 烷基及曱醯基之相同或不同的取代基單-或多取代;其 中相鄰的烷基、自烷基、烷氧基及/或卣烷氧基與和其 連接的碳原子可以形成一個五-或六-員的環狀系統其含 有〇至2的氧原子且其烷基部份可隨意地經一或多個氟 原子取代; Y代表-S-、-S(O)-、-S02-、或下面其中一個基團a phenylalkyl group which is optionally mono- or polysubstituted in the aromatic moiety via the same or different substituents selected from the group consisting of a base group, an alkyl group, a halogen group, a base group, and a cyano group; a cycloalkyl group optionally substituted at a heterocyclic group moiety selected from the group consisting of -OH/=0, -SH/=S, -NH2, halo, alkyl, haloalkyl, alkoxy, sulfanyl , the same or different substituents of the alkylsulfinyl, alkylsulfonyl, monoalkylamino, dialkylamino, nitro and cyano groups, mono- or polysubstituted, heteroaryl, It may optionally be selected from -OH, -SH, -NH2, halo, alkyl, haloalkyl, alkoxy, sulfanyl, alkylsulfinyl, alkyl sulfonate in the heteroaromatic moiety. a substituent of the same or different substituents of a mercapto group, a monoalkylamino group, a dialkylamino group, a nitro group and a cyano group, mono- or polysubstituted; a phenyl group optionally optionally selected from the group consisting of 〇h, -SH, -NH2, halo, alkyl, self-alkyl, alkoxy, sulfanyl, alkylsulfinyl, alkylsulfonyl, monoalkylamine, dialkylamine, nitro and cyanide The same or different substituents are mono- or polysubstituted; heteroaryl, which is optionally Selected from -〇H, -SH, -NH2, halo, alkyl, haloalkyl, alkoxy, sulfanyl, alkylsulfinyl, alkylsulfonyl, monoalkylamine, di The same or different substituents of the alkylamino group, the nitro group and the cyano group are mono- or polysubstituted, or the heterocyclic group 'optionally selected from _〇H/=0, -SH/=S, -NH2 Halo, alkyl, haloalkyl, alkoxy, sulfanyl, alkylsulfinyl, alkylsulfonyl, monoalkylamino, dialkylamino, deterministic and cyano Or a different substituent mono- or polysubstituted; R1 and R2 each independently represent hydrogen, alkyl, haloalkyl, cyanoalkyl, alkoxyalkyl, alkylcarbonyl, dentylcarbonyl, naphthenic Base, cycloalkylalkyl, alkylsulfonyl, alkenyl, alkynyl, alkoxycarbonyl, alkenyloxy 201012812 carbonyl, alkynyloxycarbonyl, alkoxycarbonylalkyl; phenylalkyl, in The aromatic moiety is optionally mono- or polysubstituted by the same or different substituents selected from the group consisting of 4, alkyl, haloalkyl, alkoxy, nitro and cyano; heterocyclylalkyl, in The heterocyclic moiety may optionally be selected from the group consisting of a dentate group and an alkane a substituent of the same or different substituents of a group, a haloalkyl group, an alkoxy group, a nitro group and a cyano group, mono- or polysubstituted; a heteroarylalkyl group optionally substituted at a heteroaromatic moiety, The same or different substituents of the alkyl, chiral, alkoxy, nitro and cyano groups are mono- or polysubstituted; or phenylcarbonyl, optionally in the aromatic moiety, selected from the group consisting of The same or different substituents of alkyl, dentate, alkoxy, nitro and cyano are mono- or polysubstituted; or R1 and R2 are represented by =CH-NR4R5; R3 represents halo, alkyl, and dentate An alkyl group, an alkoxy group, a thiol group, a thiol group, a ruthenium group, a halogen group, an oxy group, a halogen group, a sulfinyl group, a sulfinyl group, an alkyl group Base, alkylcarbonyl, methionyl, fluorene-CR6=NO-R6, alkoxycarbonyl, hydroxy, _SH, nitro, cyano, nh2, monoalkylamino or dialkylamino; R4 and R5 Independently representing each other independently or together representing a bridged sub-alkyl group; R6 represents hydrogen or represents a burnt group; X represents a phenyl group, a 2-pyridyl group or a 3-fluorenyl group, in each case one or more Selected from including i-based, alkyl,! i alkyl, alkoxy, alkoxyalkyl, alkoxyalkoxy, cycloalkyl, alkenyloxy, alkynyloxy, cycloalkylalkoxy, haloalkoxy, haloalkoxyalkyl Base, alkylsulfanyl, haloalkyl sulphide 201012812 alkyl, succinyl, haloalkyl, sulfonyl, halosulfonyl, cyano, alkylcarbonyl , alkoxycarbonyl, alkoxycarbonylalkyl, carboxy, decylamino, dialkyl decylamino, trialkyldecyl, nitro, amine, alkylamino, dialkylamino, alkane The same or different substituents of the monosulfonylamino group, the dialkylsulfonic acid amine group, the -CR6=NO-R6, the -CR6=NO-haloalkyl group and the fluorenyl group are mono- or polysubstituted; An adjacent alkyl group, an alkyl group, an alkoxy group, and/or a decyloxy group, and a carbon atom to which it is attached may form a five- or six-membered ring system containing an oxygen atom of from 2 to 2 and an alkane thereof. The base moiety may be optionally substituted with one or more fluorine atoms; Y represents -S-, -S(O)-, -S02-, or one of the following groups
η代表0至3 ; 且當通式(I)之化合物-如果化學上可行時_包括其氧化 物、鹽、互變異構物、非對掌異構物及光學異構物(例如如❹ 果 Υ 代表-S(0)_、-S(=N-CN)-或-S(0)-(=N-CN/=N-R6)·)。 根據本發明,經發現根據本發明之式⑴化合物具有非 常良好的殺蟲及殺寄生蟲性質且可以用在農作物保護、獸 醫衛生及物質的保護用於控制不要的害蟲例如昆蟲、 及體外寄生蟲。 本發明也提供式(I)所包含的立體異構物,及其混合 8 201012812η represents 0 to 3; and when the compound of the formula (I) - if chemically feasible - includes its oxides, salts, tautomers, non-p-isomers and optical isomers (for example, Υ stands for -S(0)_, -S(=N-CN)- or -S(0)-(=N-CN/=N-R6)·). According to the present invention, it has been found that the compound of the formula (1) according to the present invention has very good insecticidal and parasiticidal properties and can be used for crop protection, veterinary hygiene and substance protection for controlling unwanted pests such as insects and ectoparasites. . The present invention also provides stereoisomers contained in formula (I), and mixtures thereof 8 201012812
物此式(I)化合物含有一或多個不對稱的碳原子(=不對稱 f生取代的竣原子),及/或不對稱的硫原子於亞颯、亞观亞胺 或風亞胺之形式其可以存在兩種對掌異構物的形式,或是 雙鍵,其沒有在通式(I)中明確提到。可能的立體異構物, 其係經由其特定的空間形式所定義,例如對掌異構物、非 對掌異構物、Z-及E-異構物,全部都包含在式(I)内且可以 經由慣用的方法從立體異構物之混合物獲得或者是經由立 體選擇性的反應並結合使用立體化學性純的起始物質而製 備。 如果適當時,通式(I)化合物包括各對掌異構物之混合 物’其在硫官能基是對掌性The compound of the formula (I) contains one or more asymmetric carbon atoms (=asymmetric f-substituted ruthenium atom), and/or an asymmetric sulfur atom in the anthraquinone, the sub-imine or the wind imine Forms may exist in the form of two pairs of palmomers, or double bonds, which are not explicitly mentioned in formula (I). Possible stereoisomers, which are defined by their specific spatial forms, for example, palmoisomers, non-palphaliomers, Z- and E-isomers, all in formula (I) And it can be obtained from a mixture of stereoisomers via a conventional method or via a stereoselective reaction in combination with a stereochemically pure starting material. If appropriate, the compound of formula (I) includes a mixture of palmier isomers, which are palm-like in the sulfur functional group.
❹ /# # r6"=1 h/=( β N=S n# 三 R B NC ΐ " N/f 〇 β R B n/1^❹ /# #r6"=1 h/=( β N=S n# 三 R B NC ΐ " N/f 〇 β R B n/1^
R\ n 一RR n n R
其中R1、R2、R3、B、X、A1、A2及n具有上面式(I)提供 的意義。 除了對掌異構選擇性的合成(例如okrasa et al., 201012812Wherein R1, R2, R3, B, X, A1, A2 and n have the meanings given by the above formula (I). In addition to the synthesis of heterogeneous selectivity (eg okrasa et al., 201012812)
Tetrahedron: Asymmetry (2002),13(5),519-522)之外,用於 分離外消旋物之慣用方法(參見立體化學之手冊)也合適用 於製備對掌異構物。 外消旋性的混合物,例如通式(I)之光學活性亞砜類, 可以經由已知的方法製備。此用於製備外消旋物之方法是 揭示在立體化學之手冊中,例如在“Basic OrganicIn addition to Tetrahedron: Asymmetry (2002), 13(5), 519-522), conventional methods for isolating racemates (see the manual for stereochemistry) are also suitable for the preparation of palmomers. Racemic mixtures, such as optically active sulfoxides of the general formula (I), can be prepared by known methods. This method for preparing a racemate is disclosed in the manual of stereochemistry, for example, in "Basic Organic"
Stereochemistry”(Eds·: Eliel,Ernest L.; Wilen,Samuel Η·; Doyle, Michael Ρ·; 2001; John Wiley & Sons)及 “Stereochemisty of Organic Compounds”(Eds.: Eliel, Ernest L.; Wilen, Samuel H.; Mander, Lewis N.; 1994; John Wiley & Sons) 〇合適於此目的的是例如光學活性辅助之加合物形 成,分離非對掌性的加合物成為對應的非對掌異構物,例 如經由結晶、層析法、尤其是管柱層析法及高壓液體層析 法、蒸顧,如果適當時在減壓下,萃取及其他方法,且隨 後將非對掌異構物解離而得到對掌異構物。合適用於製備 量或工業規模的方法是例如非對掌異構性鹽類之結晶,其 可使用光學活性酸而從化合物(1)獲得,且如果適當時,^ 決條件是存在酸性基團’可以使用光學活性鹼。 合適經由非對掌異構性鹽類之結晶作用用於外消旋物 分離之光學活性酸是例如樟腦俩、樟職、祕腦確酸、 委寧酸、酒石酸、二苯曱職酒石酸及其他類似的酸;合 適的光學活紐是例如奎寧、辛可寧、奎尼丁、馬錢子驗、 1-笨基乙基胺及其他類似的鹼。 隨後在大4分情形下^水性或水性-有機溶劑中進行 201012812 結晶作用,如果適當時在植晶後,溶解度較低的非對掌異 構物先H經由酸化或使驗,式⑴化合物之—種對掌 異構物隨後從沈澱的鹽釋出,或其他從結晶物釋出。 =外,使用對掌性固相層可以將外消旋物層析分離。 此對掌異構物分離可以使用批次或連續操作的製備級 HPLC震置在毫克至丨⑼公斤的範圍内進行。 ❹ ❹ 式(I)提供根據本發明的化合物之一般性定義。上面 == 匕學式之較佳、特別較佳及非常特別較佳的i 全部中^ 這些㈣適用於通式(1)之最終產物以及 血f本發明的内文中,需要時可以將取代基之個別一 I,、非常特別較佳及尤其較佳的意義結 面各方面及具體實施例中的定義。此表示通 =)之化合物式經由本發明所包含,其中例如取代基乂且 有較佳的意義絲代基Rl、r2、r3及B具有—般的^ ^ 取代基B具有較佳的意義、取代基X 的= 且取代基以以辑特雌佳賴。的意義Stereochemistry" (Eds·: Eliel, Ernest L.; Wilen, Samuel Η·; Doyle, Michael Ρ·; 2001; John Wiley & Sons) and “Stereochemisty of Organic Compounds” (Eds.: Eliel, Ernest L.; Wilen , Samuel H.; Mander, Lewis N.; 1994; John Wiley & Sons) 〇 Suitable for this purpose is, for example, the formation of optically active adducts, the separation of non-pivoted adducts into corresponding non-pairs Palmomers, for example, by crystallization, chromatography, especially column chromatography and high pressure liquid chromatography, steaming, if appropriate under reduced pressure, extraction and other methods, and then will be different The structure is dissociated to obtain a palmomer. The suitable method for the preparation amount or the industrial scale is, for example, a crystal of a non-palphalinic salt, which can be obtained from the compound (1) using an optically active acid, and if Where appropriate, the conditions are such that an acidic group can be used. An optically active base can be used. Suitable optically active acids for the separation of racemates by crystallization of non-palphalinic salts are, for example, camphor, scorpion, Secret brain, acid, tartaric acid , diphenyl benzoate tartaric acid and other similar acids; suitable optical activities are, for example, quinine, cinchonine, quinidine, strychn, 1-phenylethylamine and other similar bases. In the case of a large 4 points, the crystallization of 201012812 is carried out in an aqueous or aqueous-organic solvent. If appropriate, after the crystallization, the non-palomerisomers having a lower solubility are first acidified or tested, and the compound of the formula (1) The palmomer is then released from the precipitated salt, or otherwise released from the crystal. = In addition, the racemate can be separated by chromatography using a palmitic solid phase layer. Batch or continuously operated preparative HPLC shakes are carried out in the range of milligrams to ruthenium (9) kilograms. ❹ 式 Formula (I) provides a general definition of the compounds according to the invention. Above == preferred, special Preferably, and very particularly preferably, all of the above (4) are suitable for the final product of the formula (1) and the blood f. In the context of the invention, the individual I of the substituent may be used as needed, very particularly preferably Particularly preferred aspects of the aspects and specific embodiments The definition of the compound of the formula =) is encompassed by the present invention, wherein, for example, a substituent 乂 and a preferred meaning of the filament group R1, r2, r3 and B have a general substituent B is preferred. The meaning of the substituent X, and the substituent is used to distinguish the meaning of the female
^本發明之方面巾,a1 較宜代表CH或C_R3。 η衣氣且A C-心:之二同:》表CH或 基時,在錢物… A2較在宜=触方面申’同時V較宜代表C-R3且 201012812In the aspect of the invention, a1 preferably represents CH or C_R3. η衣气 and A C-心: the second: "Table CH or base time, in the money... A2 is better than the appropriate touch" while V is more suitable for C-R3 and 201012812
在差四個-方面中,本發明還關於式(I)化合物或根據任 何第一至第三個方面之化合物其中B基 較宜代表CrC6-燒基、c3-C8-環烷基、C3_C8_環烯基、c3_c8-環烷基-CrCV烷基、鹵基_Cl_C6_烷基、Ci_c6_烷氧基_Ci_c6_ 烧基、氰基-CrC6-燒基、cvcv燒硫基_Cl_c6_烧基、C「C6-烷基亞磺醯基-CVCV烷基、CVCV·烷基磺醯基烷基、 crcv烧基幾基-Cl_C6_烧基、CrC6_燒氧基幾基_Ci_C6i 基、cvcv烯基及c^c:6-炔基’其各可隨意地經選自包括鹵 基、烷基、齒烷基、烷氧基、三-(crc4_烷基)-矽烷基、硝 基及氰基之相同或不同的取代基單_或多取代;苯基_C1_C6-烷基,其在芳基部份可隨意地經選自包括齒基、烷基、鹵 烧基、烧氧基、硝基及氰基之相同或不同的取代基單或多 取代,CVC8-雜環基-CrC6_烷基,其在雜環可隨意地經選自 包括-0H/=0、-SH/=S、-NH2、鹵基、烷基、鹵烷基、烷氧 基、烷基硫烧基、烷基亞磺醯基、烷基磺醯基、單烷基胺 基、二烷基胺基、硝基及氰基之相同或不同的取代基單_或 多取代’· C6-C!2_雜芳基-CrC6-烧基,其在雜芳基部份可隨 意地經選自包括-OH、-SH、-NH2、鹵基、烷基、鹵烧基、 烷氧基、烷基硫烷基、烷基亞磺醯基、烷基磺醯基、單烷 基胺基、二烷基胺基、硝基及氰基之相同或不同的取代基 單-或多取代;苯基,其可隨意地經選自包括-OH、-SH、 -NH2、鹵基、烷基、鹵燒基、烧氧基、烧基硫燒基、燒基 亞磺醯基、烷基磺醯基、單烷基胺基、二烷基胺基、硝基 及氰基之相同或不同的取代基單-或多取代;C6-C12-雜芳 201012812 基,其可隨意地經選自包括-OH、-SH、-NH2、鹵基、烷基、 齒燒基、烷氧基、烷基硫烷基、烷基亞磺醯基、烷基磺醯 基、單烷基胺基、二烷基胺基、硝基及氰基之相同或不同 的取代基單-或多取代;或c3-c8-雜環基,其可隨意地經選 自包括-0H/=0、-SH/=S、-NH2、鹵基、烷基、鹵烷基、烷 氧基、烷基硫烷基、烷基亞磺醯基、烷基磺醯基、單烷基 胺基'二烧基胺基、确基及氰基之相同或不同的取代基單_ ❹ 或多取代; 特別較宜代表CrC6_烷基、C3-C8•環烷基、(:3_(:8_環烯基、 齒基-CrQ-烧基、(VCV烧氧基-CrC6-烧基、CVQ-炫基羰 基-c!-cv烷基、CVCV烷氧基羰基-Q-CV烷基、C2-C6-烯基 及C^C:6-炔基,其各可隨意地經選自包括鹵基、烷基、鹵 烷基、烷氧基、三-(CrCr烷基)-矽烷基、硝基及氰基之相 同或不同的取代基單-或多取代;苯基-Cl_c6_烷基,其在芳 基部份可隨意地經選自包括鹵基、烷基、齒烷基、烷氧基、 ❹ 硝基及氰基之相同或不同的取代基單-或多取代;c6-C12-雜 芳基-CrCV·烷基,其在雜芳基部份可隨意地經選自包括 -OH、-SH、-NH2、鹵基、烷基、鹵烷基、烷氧基、烷基硫 烷基、烷基亞磺醯基、烷基磺醯基、單烷基胺基、二烷基 胺基、硝基及氰基之相同或不同的取代基單_或多取代; c6-c12-雜芳基,其可隨意地經選自包括、-SH、-NH2、 鹵基、烷基、鹵烷基、烷氧基、烷基硫烷基、烷基亞磺醯 基、烷基磺醯基、單烷基胺基、二烷基胺基、硝基及氰基 之相同或不同的取代基單-或多取代;C3-C8-雜環基-CrC6- 201012812 烧基’其在雜環可隨意地經選自包括_〇11/=0、_SH/=S ' -NH2、鹵基、烷基、鹵烷基、烷氧基、烷基硫烷基、烷基 亞磺醯基、烷基磺醯基、單烷基胺基、二烷基胺基、硝基 及氰基之相同或不同的取代基單或多取代; 非常特別較宜代表CrC6-烷基、鹵基_crC6-烷基、CrC6-烧氧基-CrC6_烷基、c^CV烷基羰基-CrC6-烷基、C2-CV烯 基、c2-c6-炔基、三-(crc4_烷基)_石夕烷&_Ci_c6_烧基;苯基 -CrC6-烧基’其在芳基部份可隨意地經選自包括氟、氣、 溴、蛾、曱基、三氟曱基及曱氧基之相同或不同的取代基 單-或多取代;及2-吡啶基-crc6-烷基; 尤其較宜代表 CH3、CH2CH3、CH(CH3)2、CH2CH2CH3、 CH2CH2CH2CH3、CH(CH3)CH2CH3、-CH2CF3、CH2CHF2、 CH2CH2CF3、CF3、CH2-苯基、CH2-4-氣苯基、CH2-4-曱氧 基苯基、CH2-2-吡啶基、CH2CH=CH2、CH2CH=CC12、 CH2CCH、CH2CH2OCH3、CH2CH2CF3、CH2CH2Si(CH3)3 及 ch2co2ch3. 另外,在第五個方面中,本發明還關於式(I)化合物或 根據任何第一至第四個方面之化合物其中R1及R2基,彼此 獨立地 較宜代表風;Ci-C6-烧基、Ci_C6-齒烧基、氛基-Ci_C6·炫基、 Cl-C6-燒氧基-Ci-C6_烧基、Ci-Cf烧基幾基、Ci-C6-鹵烧基 .基、C3-C8-環烧基、C3-C8-環烧基-Ci_C6-烧基、Ci-C6-烧 基%醯基、C2-C6-烯基、C2-CV块基、Ci-Cg-烧氧基Μ基、 C2-C6-烯氧基羰基、C2-C6-炔氧基羰基、crc6-烷氧基羰基 201012812 烷基;苯基_CrC6_烷基,其在芳基部份可隨意地經 選自包括卣基、烷基、鹵烷基、烷氧基、硝基及氰基之相 同或不同的取代基單-或多取代;雜環基烷基,其在 雜環基部份可隨意地經選自包括齒基、烧基、南烧基、、烧 氧基、硝基及氰基之相同或不同的取代基單_或多取代; 雜芳基_crC6_烧基,其在雜芳基部份可隨意地經選 自包括自基、烷基、齒烷基、烷氧基、硝基及氰基之相同 ® 或不同的取代基單-或多取代;或苯基羰基,其在芳基部份 可隨意地經選自包括函基、烷基、齒烷基、烷氧基、硝基 及氰基之相同或不同的取代基單-或多取代;或Rl及R2 一 起代表=CH-NR4R5其中R4及R5各代表Cl_C6_烷基或一起 代表橋接的c2-c4-亞烷基; 特別較宜代表氫、CrC6_烧基、CVC6-)!烧基、Ci-Q-院氧 基-CrCV烧基、Ci-Q-炫基数基、CrC6齒垸基幾基、c3_c8_ %燒基、C3-C8_環烧基-CVCV烧基、c2-C6-烯基、〇2-(:6-炔 〇 基、CrC6_烧氧基幾基、CVC6-烯氧基幾基、c2_c6_炔氧基 羰基、CkQ-烧氧基Μ基-C「C6_燒基;苯基_Crc6_烧基,其 在务基部份可隨意地經選自包括S基、烧基、齒烧基、烧 氧基、硝基及氰基之相同或不同的取代基單_或多取代; C3-Cs-雜環基_crC6_烧基’其在雜環基部份可隨意地經選自 包括自基、烧基、鹵燒基、烧氧基、石肖基及氰基之相同或 不同的取代基單-或多取代;或苯基羰基,其在芳基部份可 隨意地經選自包括函基、烷基、i烷基、烷氧基、硝基及 氰基之相同或不同的取代基單-或多取代;或R1及R2 一起 201012812 代表=ch-nr4r5其中R4及R5各代表CrC6_烷基或一起代 表橋接的CVCV亞烷基; 非常特別較宜代表氫、Cl_c6_烷基、Ci_c6_自烷基及 =ch-nr4r5 ; 尤其較宜代表氫及=CH_N(;CH3)2。 另外,在星古方面中,本發明還關於式(I)化合物或 根據任何第一至第五個方面之化合物其中如果R3基存在一 次以上(n=2或3)時,R3基彼此獨立地 較宜代表_基、CrQ-烧基、CVCV鹵烧基、q-CV燒氧基、® 燒基硫燒基、crC6-烧基亞確酿基、crC6-烧基確醢 基、CVQ-由烷氧基、crC6-齒烷基硫烷基、crC6-鹵烷基 亞確醜基、CrCV齒烷基磺醯基、CrC6-烷基羰基及甲醯基; 特別較且代表齒基、C〗-C6·烧基、烧基、q-cv烧 氧基及crc6-鹵烷氧基; 非常特別較宜代表鹵基、Ci-C6-烧基、CrCV鹵烧基及 烷氧基; 尤其較宜代表氟、氣、溴、碘、三氟曱基、甲基、乙基、© 異丙基、曱氧基及乙氧基。 另外’在第七個方面中,本發明還關於式(I)化合物或 根據任何第一至第六個方面之化合物其中X基 較且代表苯基、2-ρ比咬基或3-吼咬基,其各可隨意地經選 自包括豳基、烷基、齒烷基、烷氧基、烷氧基烷基、烷氧 基燒氧基、COOH、硝基、胺基、烷基胺基、二烷基胺基之 一或多個相同或不同的取代基單-或多取代,其中相鄰的烷 201012812 基、鹵烷基、烷氧基及/或鹵烷氧基與和其連接的碳原子可 形成五-或六-員環狀系統其含有〇至2個氧原子且其烷基部 份可隨意地經一或多個氟原子取代; 特別較宜代表苯基,其可隨意地經選自包括鹵基、烷基、 鹵院基、烧氧基、烧氧基烷基、燒氧基烧氧基、COOH、琐 基、胺基、燒基胺基、二烧基胺基之一或多個相同或不同 的取代基單-或多取代’其中相鄰的烧基、齒烧基、烷氧基 〇 及/或鹵烷氧基與和其連接的碳原子可形成五-或六-員環狀 系統其含有0至2個氧原子且其烷基部份可隨意地經一或 多個氟原子取代; 非常特別較宜代表苯基,其至少經一個選自包括齒基、 CVC6-烧基及q-C6-鹵烷基之取代基單-或多取代,其中相鄰 的烷基、_烷基、烷氧基及/或齒烷氧基與和其連接的碳原 子可形成五-或六-員環狀系統其含有〇至2個氧原子且其烷 基部份可隨意地經一或多個氟原子取代; ❹ 尤其較宜代表2-C1-笨基、2-F-6-F-苯基、3-C1-苯基、3_CF _ 苯基、4-C1-苯基、4-Br-苯基、4-1-苯基、3-Cl,4-Cl-苯基、3 3-CF3,4-Cl-苯基、3-Cl,5-Cl-苯基、3-CF3,5-F-笨基' 3-CF3,5-Cl_苯基、3-CF3,5-CF3·苯基、3-Cl,4-Cl,5-Cl-苯基、 3七3-(:1,4-0〇13,5-(:1-笨基、3-(:1,(4)-0(:1120-(5)-苯基、 3-Cl,(4)-0CF20-(5)-笨基、3-Cl,(4)-OCH2CH2-(5)-苯基、 3-Cl,4-OCH3,5-OCH3-苯基及 3-OCH3,5-CF3-苯基。 另外,在蓋八银方面中,本發明還關於式(I)化合物戋 根據任何第一至第七個方面之化合物其中γ基較宜代表 201012812 -S-、-S(O)-、-S02-或-S(=N-CN)-。 另外’在JLiA方面中’本發明還關於式⑴化合物或 根據任何第一至第八個方面之化合物其中n基 較宜代表〇、1或2 ; 非常特別較宜代表0或1。 本發明之再非常特別較佳的具體實施例包含通式⑴之 化合物,特別是根據上述方面之化合物,其中B基代表烧 基、環烷基、環烯基、環烷基烷基、齒烷基、烷氧基烷基、 氰基烷基、烷硫基烷基、烷基亞磺醯基烷基、烷基磺醯基 烷基、胺基烷基、烷基羰基烷基、烷氧基羰基烷基、烯基 及快基’其可隨意地經選自包括_基、烧基、_烧基、烧 氧基、硝基及氰基之相同或不同的取代基單-或多取代;苯 烧基’其可隨意地經選自包括鹵基、烧基、鹵烧基、烧氧 基、硝基及氰基之相同或不同的取代基單-或多取代;雜環 基烧基,其在雜環基可隨意地經選自包括-〇H/=〇、-SH/=S、 -NH2、_基、烷基、自烷基、烷氧基、烷基硫烷基、烷基 亞磺醯基、烷基磺醯基、單烷基胺基、二烷基胺基、硝基 及氰基之相同或不同的取代基單-或多取代;雜芳基烷基, 其在雜芳基部份可隨意地經選自包括-OH、-SH、-NH2、_ 基、烧基、i燒基、烧氧基、烷基硫烧基、烷基亞續醯基、 烷基磺醯基、單烷基胺基、二烷基胺基、硝基及氰基之相 同或不同的取代基單-或多取代;苯基,其可隨意地經選自 包括-OH、-SH、-NH2、鹵基、烷基、鹵烷基、烷氧基、烷 基硫燒基、烧基亞續酿基、炫基續酿基、單烧基胺基、二 201012812 烷基胺基、硝基及氰基之相同或不同的取代基單·或多取 代;雜芳基’其可隨意地經選自包括_〇H、_stI、_Nh2、_ 基、烷基、自烷基、烷氧基、烷基硫烷基、烷基亞磺醯基、 烷基磺醯基、單烷基胺基、二烷基胺基、硝基及氰基之相 同或不同的取代基單_或多取代;或雜環基,其可隨意地經 選自包括-〇H/=〇、_SH/=S、-NH2、鹵基、烷基、鹵烷基、 烧氧基、燒基硫烧基、烷基亞績醯基、烧基項醯基、單烧 e 基胺基、二烷基胺基、硝基及氰基之相同或不同的取代基 單-或多取代。據此’通式(1)化合物之定義排除特定化合物 其B基含有羰基烷基胺基及烷基胺基。B基之較佳、特別 較佳、非常特別較佳及尤其較佳的意義對應至上述定義。 通式⑴的其他基團或取代基之意義可對應至較佳、特別較 佳、非常特別較佳及尤其較佳的意義。 本發明之再非常特別較佳的具體實施例包括通式⑴之 化合物,特別是根據上述方面之化合物,其中取代基X代 0 表經取代之苯基。在此,使用的取代基可以是鹵基、烷基、 鹵烷基、烷氧基、烷氧基烷基、烷氧基烷氧基、環烷基、 烯氧基、炔氧基、環烷基烷氧基、_烷氧基、齒烷氧基烷 基、烷基硫烷基、齒烷基硫烷基、烷基亞磺醯基、齒烷基 亞磺醯基、烷基磺醯基、鹵烷基磺醯基、氰基、烷基羰基、 燒氧基幾基、烧氧基羰基烷基、羧基、醯胺基、二烷基醢 胺基、三烷基矽烷基、硝基、胺基、烷基胺基、二烷基胺 基、烷基磺醯基胺基、二烷基磺醯基胺基、-CrLNO—r6、 -CR6=NO-鹵烷基或甲醯基,其中相鄰的烷基、鹵烷基、烷 201012812 氧基及/或鹵烧氧基與和其連接的碳原子可以一起形成五_ 或六-員的環狀系統,其含有0至2個氧原子且其烷基部份In a fourth aspect, the invention also relates to a compound of formula (I) or a compound according to any of the first to third aspects, wherein the B group is preferably represented by CrC6-alkyl, c3-C8-cycloalkyl, C3_C8_ Cycloalkenyl, c3_c8-cycloalkyl-CrCV alkyl, halo-Cl_C6-alkyl, Ci_c6-alkoxy_Ci_c6_alkyl, cyano-CrC6-alkyl, cvcv sulphur-based _Cl_c6-alkyl, C"C6-alkylsulfinyl-CVCV alkyl, CVCV.alkylsulfonylalkyl, crcv alkyl-Cl_C6-alkyl, CrC6-alkoxy-Ci_C6i, cvcv alkenyl And c^c:6-alkynyl' each of which may optionally be selected from the group consisting of halo, alkyl, dentate, alkoxy, tri-(crc4-alkyl)-decyl, nitro and cyano The same or different substituents are mono- or polysubstituted; phenyl-C1_C6-alkyl, which may optionally be selected from the group consisting of a dentate group, an alkyl group, a halogen group, an alkoxy group, a nitro group in the aryl moiety. And the same or different substituents of the cyano group, mono or polysubstituted, CVC8-heterocyclyl-CrC6-alkyl, which may optionally be selected from the group consisting of -0H/=0, -SH/=S, - NH2, halo, alkyl, haloalkyl, alkoxy, alkylthioalkyl, alkylsulfinyl The same or different substituents of alkylsulfonyl, monoalkylamino, dialkylamino, nitro and cyano are mono- or polysubstituted 'C6-C!2_heteroaryl-CrC6- An alkyl group optionally substituted at the heteroaryl moiety, including -OH, -SH, -NH2, halo, alkyl, haloalkyl, alkoxy, alkylsulfanyl, alkylsulfin a mono- or poly-substituent of the same or different substituents of a mercapto group, an alkylsulfonyl group, a monoalkylamino group, a dialkylamino group, a nitro group and a cyano group; a phenyl group optionally selected from the group consisting of -OH, -SH, -NH2, halo, alkyl, haloalkyl, alkoxy, alkylthio, sulfinyl, alkylsulfonyl, monoalkylamine, dioxane The same or different substituents of the amino group, the nitro group and the cyano group are mono- or polysubstituted; a C6-C12-heteroaryl 201012812 group optionally substituted by including -OH, -SH, -NH2, a halogen group , alkyl, dentate, alkoxy, alkylsulfanyl, alkylsulfinyl, alkylsulfonyl, monoalkylamine, dialkylamine, nitro and cyano Or a different substituent mono- or polysubstituted; or a c3-c8-heterocyclic group, which may be The ground is selected from the group consisting of -0H/=0, -SH/=S, -NH2, halo, alkyl, haloalkyl, alkoxy, alkylsulfanyl, alkylsulfinyl, alkylsulfonate The same or different substituents of the fluorenyl, monoalkylamino 'dialkylamino group, the exact group and the cyano group are mono- or polysubstituted; particularly preferably represent a CrC6-alkyl group, a C3-C8• cycloalkyl group. , (: 3_(:8_cycloalkenyl, dentate-CrQ-alkyl, (VCV alkoxy-CrC6-alkyl, CVQ-homocarbonyl-c!-cv alkyl, CVCV alkoxycarbonyl- Q-CV alkyl, C2-C6-alkenyl and C^C:6-alkynyl, each optionally optionally selected from the group consisting of halo, alkyl, haloalkyl, alkoxy, tri-(CrCr) a mono- or poly-substituted substituent of the same or different substituents of a decyl group, a nitro group and a cyano group; a phenyl-Cl_c6-alkyl group optionally substituted at the aryl moiety from a group consisting of a halogen group and an alkyl group a single or polysubstituted substituent of the same or different substituents of a dentyl group, an alkoxy group, a fluorenyl group and a cyano group; a c6-C12-heteroaryl-CrCV.alkyl group which is optionally present in the heteroaryl moiety The ground is selected from the group consisting of -OH, -SH, -NH2, halo, alkyl, haloalkyl, alkoxy, alkylsulfanyl, alkyl sulfin The same or different substituents of a mercapto group, an alkylsulfonyl group, a monoalkylamino group, a dialkylamino group, a nitro group and a cyano group are mono- or polysubstituted; c6-c12-heteroaryl group, which is optional The ground is selected from the group consisting of -SH, -NH2, halo, alkyl, haloalkyl, alkoxy, alkylsulfanyl, alkylsulfinyl, alkylsulfonyl, monoalkylamine , the same or different substituents of the dialkylamino group, the nitro group and the cyano group are mono- or polysubstituted; C3-C8-heterocyclyl-CrC6-201012812 alkyl group, which is optionally selected from the heterocyclic ring _〇11/=0, _SH/=S '-NH2, halo, alkyl, haloalkyl, alkoxy, alkylsulfanyl, alkylsulfinyl, alkylsulfonyl, monoalkane The same or different substituents of alkylamino, dialkylamino, nitro and cyano are mono- or polysubstituted; very particularly preferably represent CrC6-alkyl, halo-crC6-alkyl, CrC6-alkoxy -CrC6_alkyl, c^CV alkylcarbonyl-CrC6-alkyl, C2-CV alkenyl, c2-c6-alkynyl, tris-(crc4-alkyl)-infraline &_Ci_c6-alkyl; Phenyl-CrC6-alkyl group which is optionally selected from the group consisting of fluorine, gas, bromine, moth, fluorenyl And the same or different substituents of trifluoromethyl and decyloxy are mono- or polysubstituted; and 2-pyridyl-crc6-alkyl; particularly preferably represents CH3, CH2CH3, CH(CH3)2, CH2CH2CH3, CH2CH2CH2CH3 , CH(CH3)CH2CH3, -CH2CF3, CH2CHF2, CH2CH2CF3, CF3, CH2-phenyl, CH2-4-gas phenyl, CH2-4-decyloxyphenyl, CH2-2-pyridyl, CH2CH=CH2 CH2CH=CC12, CH2CCH, CH2CH2OCH3, CH2CH2CF3, CH2CH2Si(CH3)3 and ch2co2ch3. Further, in a fifth aspect, the invention relates to a compound of formula (I) or a compound according to any of the first to fourth aspects, wherein R1 And R2 groups, independently of each other, preferably represent wind; Ci-C6-alkyl, Ci_C6-dentate, aryl-Ci_C6·Hyun, Cl-C6-alkoxy-Ci-C6_alkyl, Ci- Cf alkyl group, Ci-C6-haloalkyl group, C3-C8-cycloalkyl group, C3-C8-cycloalkyl-Ci_C6-alkyl group, Ci-C6-alkyl group, C2-C6 -alkenyl, C2-CV block, Ci-Cg-alkoxycarbonyl, C2-C6-alkenyloxycarbonyl, C2-C6-alkynoxycarbonyl, crc6-alkoxycarbonyl 201012812 alkyl; phenyl _CrC6_alkyl, which is optionally selected from the group consisting of a mercapto group and an alkyl group in the aryl moiety The same or different substituents of haloalkyl, alkoxy, nitro and cyano are mono- or polysubstituted; heterocyclylalkyl, optionally substituted at the heterocyclyl moiety, including a dentate group, The same or different substituents of the group, the south alkyl group, the alkoxy group, the nitro group and the cyano group are mono- or polysubstituted; the heteroaryl group _crC6-alkyl group, which can be optionally selected in the heteroaryl group Mono- or poly-substituted from the same ® or different substituents including a base, an alkyl group, a dentyl group, an alkoxy group, a nitro group and a cyano group; or a phenylcarbonyl group which is optionally subjected to an aryl moiety The same or different substituents including a functional group, an alkyl group, a dentyl group, an alkoxy group, a nitro group and a cyano group are mono- or polysubstituted; or R1 and R2 together represent =CH-NR4R5 wherein R4 and R5 are each Representing Cl_C6_alkyl or together represent a bridged c2-c4-alkylene; particularly preferably hydrogen, CrC6-alkyl, CVC6-), alkyl, Ci-Q-homo-CrCV, Ci- Q-Hyun base number, CrC6 dentate base, c3_c8_% alkyl, C3-C8_cycloalkyl-CVCV alkyl, c2-C6-alkenyl, 〇2-(:6-acetylene fluorenyl, CrC6_ Alkoxy group, CVC6-alkenyloxy, c2_c6_alkyne Oxycarbonyl, CkQ-alkyloxyindenyl-C "C6-alkyl"; phenyl-Crc6-alkyl group, which may optionally be selected from the group consisting of S group, alkyl group, dentate group, The same or different substituents of the alkoxy group, the nitro group and the cyano group are mono- or polysubstituted; the C3-Cs-heterocyclic group _crC6-alkyl group is optionally selected from the group consisting of a substituent of the same or different substituents of a group, a pyridyl group, a halogenated group, an alkoxy group, a fluorenyl group and a cyano group, or a phenylcarbonyl group, optionally in an aryl group, optionally comprising a functional group , the same or different substituents of alkyl, i-alkyl, alkoxy, nitro and cyano are mono- or polysubstituted; or R1 and R2 together 201012812 represents =ch-nr4r5 wherein R4 and R5 each represent CrC6-alkane The base or together represent a bridged CVCV alkylene; very particularly preferably represents hydrogen, Cl_c6-alkyl, Ci_c6_ from alkyl and =ch-nr4r5; particularly preferably represents hydrogen and =CH_N(;CH3)2. Further, in the Xingkuo aspect, the present invention also relates to the compound of the formula (I) or the compound according to any of the first to fifth aspects, wherein if the R3 group is present more than once (n=2 or 3), the R3 groups are independently of each other Preferably, it represents _ group, CrQ-alkyl group, CVCV halogen group, q-CV alkoxy group, ® alkyl group, calc6-alkyl group, crC6-alkyl group, CVQ- Alkoxy, crC6-dentylalkylsulfanyl, crC6-haloalkyl arsenyl, CrCV-dentinylsulfonyl, CrC6-alkylcarbonyl and formazan; especially more representative of dentate, C -C6·alkyl, alkyl, q-cv alkoxy and crc6-haloalkoxy; very particularly preferably halogen, Ci-C6-alkyl, CrCV haloalkyl and alkoxy; especially suitable Represents fluorine, gas, bromine, iodine, trifluoromethyl, methyl, ethyl, isopropyl, decyloxy and ethoxy. Further, in a seventh aspect, the present invention is also a compound of the formula (I) or a compound according to any of the first to sixth aspects, wherein the X group represents and represents a phenyl group, a 2-ρ ratio bite group or a 3-bite bite Any of which may optionally be selected from the group consisting of fluorenyl, alkyl, dentyl, alkoxy, alkoxyalkyl, alkoxyalkyloxy, COOH, nitro, amine, alkylamino Or one or more substituents of the same or different substituents of the dialkylamino group, wherein the adjacent alkane 201012812, haloalkyl, alkoxy and/or haloalkoxy groups are attached thereto The carbon atom may form a five- or six-membered ring system containing from 2 to 2 oxygen atoms and the alkyl moiety thereof may be optionally substituted with one or more fluorine atoms; particularly preferably a phenyl group, which is optionally Selected from the group consisting of halo, alkyl, halogen-based, alkoxy, alkoxyalkyl, alkoxy alkoxy, COOH, triage, amine, alkylamino, dialkylamino One or more of the same or different substituents mono- or polysubstituted' wherein the adjacent alkyl, dentate, alkoxy fluorene and/or haloalkoxy groups are bonded to the carbon atom to which they are attached Forming a five- or six-membered ring system having 0 to 2 oxygen atoms and having an alkyl moiety optionally substituted with one or more fluorine atoms; very particularly preferably representing a phenyl group, at least one selected from a substituent mono- or polysubstituted including a dentate group, a CVC 6-alkyl group and a q-C6-haloalkyl group, wherein an adjacent alkyl group, an alkyl group, an alkoxy group and/or a tooth alkoxy group are bonded thereto The carbon atom may form a five- or six-membered ring system containing from 2 to 2 oxygen atoms and the alkyl moiety may be optionally substituted with one or more fluorine atoms; ❹ especially preferably 2-C1-stupid Base, 2-F-6-F-phenyl, 3-C1-phenyl, 3-CF-phenyl, 4-C1-phenyl, 4-Br-phenyl, 4-1-1-phenyl, 3-Cl, 4-Cl-phenyl, 3 3-CF3,4-Cl-phenyl, 3-Cl, 5-Cl-phenyl, 3-CF3,5-F-phenyl- 3-CF3,5-Cl_benzene Base, 3-CF3, 5-CF3·phenyl, 3-Cl, 4-Cl, 5-Cl-phenyl, 3-7-(: 1,4-0〇13,5-(:1-phenyl) , 3-(:1,(4)-0(:1120-(5)-phenyl, 3-Cl, (4)-0CF20-(5)-styl, 3-Cl,(4)-OCH2CH2- (5) -Phenyl, 3-Cl,4-OCH3,5-OCH3-phenyl and 3-OCH3,5-CF3-phenyl. In addition, in the aspect of the cover eight silver, the present invention also relates to (I) A compound according to any of the first to seventh aspects, wherein the γ group is preferably represented by 201012812 -S-, -S(O)-, -S02- or -S(=N-CN)-. In the context of JLiA, the invention also relates to a compound of formula (1) or a compound according to any of the first to eighth aspects, wherein the n group preferably represents hydrazine, 1 or 2; very particularly preferably represents 0 or 1. A still very particularly preferred embodiment of the invention comprises a compound of the formula (1), in particular a compound according to the above aspect, wherein the B group represents an alkyl group, a cycloalkyl group, a cycloalkenyl group, a cycloalkylalkyl group, a dentate Alkyl, alkoxyalkyl, cyanoalkyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl, aminoalkyl, alkylcarbonylalkyl, alkoxy a carbonylalkyl group, an alkenyl group and a fast group 'which may optionally be mono- or polysubstituted with the same or different substituents selected from the group consisting of a benzyl group, a decyl group, an alkyl group, an alkoxy group, a nitro group and a cyano group; a benzoalkyl group which may optionally be mono- or polysubstituted with the same or different substituents selected from the group consisting of halo, alkyl, halo, alkoxy, nitro and cyano; heterocyclyl, It may optionally be selected from the group consisting of -〇H/=〇, -SH/=S, -NH2, _ group, alkyl, alkyl, alkoxy, alkylsulfanyl, alkyl The same or different substituents of sulfinyl, alkylsulfonyl, monoalkylamino, dialkylamino, nitro and cyano are mono- or polysubstituted; heteroarylalkyl, which is hetero Aryl moiety Optionally selected from the group consisting of -OH, -SH, -NH2, _ group, alkyl, i-alkyl, alkoxy, alkylthioalkyl, alkyl sulfhydryl, alkylsulfonyl, single a substituent of the same or different substituents of an alkylamino group, a dialkylamino group, a nitro group and a cyano group, mono- or polysubstituted; a phenyl group optionally optionally selected from the group consisting of -OH, -SH, -NH2, halogen Base, alkyl, haloalkyl, alkoxy, alkylthioalkyl, alkyl sulphonyl, succinyl, monoalkylamino, meth 201012812 alkylamino, nitro and cyano The same or different substituents are mono- or polysubstituted; heteroaryl 'which may optionally be selected from the group consisting of 〇H, _stI, _Nh2, _ group, alkyl, alkyl, alkoxy, alkyl sulphide The same or different substituents of alkyl, alkylsulfinyl, alkylsulfonyl, monoalkylamino, dialkylamino, nitro and cyano are mono- or polysubstituted; or heterocyclic , optionally selected from the group consisting of -〇H/=〇, _SH/=S, -NH2, halo, alkyl, haloalkyl, alkoxy, alkylthioalkyl, alkyl sulfhydryl , a base group, a monoalkyl group, a dialkylamine group, a nitro group And the same or different substituents of the cyano group are mono- or polysubstituted. According to this definition of the compound of the formula (1), the specific compound is excluded, and the B group thereof contains a carbonylalkylamino group and an alkylamine group. The preferred, particularly preferred, very particularly preferred and particularly preferred meanings of the B-base correspond to the above definitions. The meaning of other groups or substituents of the formula (1) may correspond to preferred, particularly preferred, very particularly preferred and especially preferred meanings. A still very particularly preferred embodiment of the invention comprises a compound of formula (1), in particular a compound according to the above aspect, wherein the substituent X represents a substituted phenyl group. Here, the substituent used may be a halogen group, an alkyl group, a haloalkyl group, an alkoxy group, an alkoxyalkyl group, an alkoxyalkoxy group, a cycloalkyl group, an alkenyloxy group, an alkynyloxy group, a cycloalkane. Alkenyloxy, _alkoxy, dentyloxyalkyl, alkylsulfanyl, dentylsulfanyl, alkylsulfinyl, decylsulfinyl, alkylsulfonyl , haloalkylsulfonyl, cyano, alkylcarbonyl, alkoxy group, alkoxycarbonylalkyl, carboxyl, amidino, dialkylguanidino, trialkyldecyl, nitro, Amino, alkylamino, dialkylamino, alkylsulfonylamino, dialkylsulfonylamino, -CrLNO-r6, -CR6=NO-haloalkyl or formazan, wherein Adjacent alkyl, haloalkyl, alkane 201012812 oxy and/or halo alkoxy groups and the carbon atom to which they are attached may together form a five- or six-membered ring system containing from 0 to 2 oxygen atoms Alkyl moiety
可隨意地經一或多個氟原子取代。特別較佳的是齒基,特 別是氟、氣、溴或蛾;鹵烷基,例如OCH3 ;以及化合物其 中相鄰的烧基、齒烧基、院氧基及/或齒烧氧基與和其連接 的碳原子可以一起形成五-或六-員的環狀系統,其含有〇至 2個氧原子且其烷基部份可隨意地經一或多個氟原子取 代。通式(I)的其他基團或取代基之意義可對應至較佳、特 別較佳、非常特別較佳及尤其較佳的意義。 本發明之再非常特別較佳的具體實施例包括通式⑴之 巧合物,特別是根據上述方面之化合物,其中取代基尺】及 R2代表氫。通式⑴的其他基團或取代基之意義可對應至較 佳、特別較佳、非常特別較佳及尤其較佳的意義。Optionally substituted with one or more fluorine atoms. Particularly preferred are dentate groups, particularly fluorine, gas, bromine or moth; haloalkyl groups such as OCH3; and compounds wherein the adjacent alkyl group, dentate group, laboxy group and/or dentate oxy group and The carbon atoms to which they are attached may together form a five- or six-membered ring system containing from 2 to 2 oxygen atoms and the alkyl portion thereof optionally substituted with one or more fluorine atoms. The meaning of the other groups or substituents of the formula (I) may correspond to preferred, particularly preferred, very particularly preferred and especially preferred meanings. Still very particularly preferred embodiments of the invention include the compounds of formula (1), particularly the compounds according to the above aspects, wherein the substituents and R2 represent hydrogen. The meaning of other groups or substituents of the formula (1) may correspond to a preferred, particularly preferred, very particularly preferred and especially preferred meaning.
尽知明之再非常特別較佳的具體實施例包括通式(1〕 化口2物,特別是根據上述方面之化合物,其中A1基代4 且A基代表CH。通式⑴的其他基團或取代基之音 應至較佳、特職佳、㈣制較佳及尤錄^^ 於人ί發明之再非f特難佳的具體實補包括通式(I) -R二是二據一 對=佳3===:= :在各情形二=特尤== 尤其較佳中提_取代基。⑽較佳”特別較佳 20 201012812 「鹵基」-詞係指氟、氯、漠麵,特別是氟、氯或壤 果該詞是用在基團時,則「鹵基」係指例如氟、氯、溴或硬原子。 鹵基-取代的基團,例如鹵烷基,是單_或多鹵基化直 最大可能數量之取代基。在多_基化之情形中,卣素原 可以是相同或不同。 飽和或步飽和的烴基例如烷基、烯基或炔基,在各俨 形下可以是直鏈或支鏈,包括與雜原子之組合,例如二 氧基中。 反 在此,烷基是直鏈或開口支鏈的烴基。「烷基」一詞包 括特別是(even)·烷基,特別較宜是(Ci_C8)_烷基,特別是 (CVC6)-烷基,尤其較宜是(q-C4)-烷基。在組合基團例如烷 氧基、鹵烷基等中包含的烷基是例如甲基、乙基、正_或異 丙基、正-、異-、第二-或2-丁基、戊基、己基例如正己基、 異己基及1,3-二甲基丁基、庚基例如正庚基、丨_曱基己基及 1,4-二甲基戊基。 1 鹵烷基及i烯基分別是烷基及烯基,其係部份或完全 經相同或不同的齒素原子取代,例如單函烷基例如 CH2CH2CL· CH2CH2F、CHC1CH3、CHFCH3、CH2C1、CH2F ·, 全鹵烷基例如CCI3或CF3或CF2CF3;多鹵烷基例如CHF2、 ch2f、ch2chfc卜 chci2、cf2cf2h、ch2ch2cf3、 CHzCHF2、CH2CF;j。此對應地適用至鹵烯基及其他經鹵基 取代的基團。 烯基還係指含有至少一個雙鍵之直鏈或開口支鏈的烴 基。「稀基」一詞包括特別是(C2-C12)-稀基,特別較宜是(c2-C8)- 201012812 烯基,特別是(c2-c6)_稀基,尤其較宜是((:2<:士婦基。 基 基 基 基 ◎ 的稀基之實例是1,3·丁二及M戊二婦基,以及稀二稀 基或含有-或多個累積的雙鍵之㈣基,例如埽丙稀基 (1,2-丙二稀基)' 1,2-丁二稀基及戊三稀基。婦基之i 他實例是乙稀基,λ可隨意地經其他烧基取代,例如丙+ 烯_1_基、丁]务1_基、烯丙基、1-甲基丙-2-稀小基、2_ 曱基丙-2-烯小基、丁 _2m、卜曱基丁』休u基及^ 甲基丁-2-烯-1-基、2-甲基丙㈣]·基、l甲基丙_卜婦-r 1-甲基丙-2-烯-1_基、2_曱基丙_2_稀小基、丁_2稀·^ 丁-3-稀小基、1-甲基丁·3_稀小基或l曱基丁_2_稀小 戊烯基、2-曱基戊烯基及己烯基。 ❹ 炔基還係指含有至少一個參鍵之直鏈或開口支鏈的烴 如果適當時,可以存在一或多個雙鍵。對應的實例是乙 炔基、丙炔基、1-甲基丙-2-炔-1·基、2-丁炔基、2-戊炔基、ΐ,3-丁二烯基及3-戊稀_1_炔-1-基或2-己炔基,較宜是丙炔基、丁_2_ 炔-1-基、丁-3-炔-1-基或1-曱基·丁_3-炔小基。 亞烧基’也例如在(CVCW-亞烷基之形式,係指經由雙 鍵連接之直鏈或開口支鏈的烴基之基團。亞烧基之天然合 適的連接點是只有在結構中存在兩個氫原子可以被雙鍵取 代之位置,基團之實例是=ch2、=CH-CH3、=C(CH3)-CH3、 =C(CH3)-C2H5 或=C(C2H5)-C2H5。 環烷基係指含有較宜3至8個環碳原子之碳環飽和的 環系統,例如環丙基、環丁基、環戊基或環己基。隨意地 經取代之環烷基包括含有取代基之環狀系統,其也包括在 201012812 環烧基含有雙鍵之取代基,例如亞烷基例如亞甲基。 隨意地經取代之環烷基包括多環脂族系統例如二環 [1.1.0]丁-1-基、二環[1.L0]丁_2_基、二環[2」叫戊小基、二 環[2.1.0]戊-2-基、二環[2.1.〇]戊_5_基、二環[2.2.1]庚_2_基、 (正莰基)、金剛-1-基及金剛基。經取代的環烷基也包括 螺環狀脂族系統例如螺[2.2]戊-1 -基、螺[2.3]己-1 -基、螺[23] 己-4-基、3-螺[2.3]己-5-基。 、.A very particularly preferred embodiment of the present invention, including a compound of the above formula (1), particularly a compound according to the above aspect, wherein A1 is 4 and A represents A. Other groups of formula (1) or Substitute sound should be better, special job is better, (4) is better, and it is better to record ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Pair = good 3 ===:= : In each case 2 = Teyou == especially preferred to mention - substituents. (10) preferably "particularly better 20 201012812 "halo" - word means fluorine, chlorine, desert The term "halo" means, for example, a fluorine, chlorine, bromine or a hard atom, and a halogen-substituted group, such as a haloalkyl group, is used in the context of a fluorine, chlorine or a soil. Single- or polyhalogenated to the largest possible number of substituents. In the case of poly-based, the halogens may be the same or different. A saturated or step-saturated hydrocarbon group such as an alkyl, alkenyl or alkynyl group, Each of the ruthenium may be a straight chain or a branched chain, including a combination with a hetero atom, such as a dioxy group. In this case, the alkyl group is a linear or open-chain branched hydrocarbon group. In particular, it is an alkyl group, particularly preferably a (Ci_C8)-alkyl group, especially a (CVC6)-alkyl group, particularly preferably a (q-C4)-alkyl group. In a combination group such as an alkoxy group The alkyl group contained in the group, haloalkyl group or the like is, for example, methyl, ethyl, n- or isopropyl, n-, i-, di- or 2-butyl, pentyl, hexyl such as n-hexyl, dissimilar And 1,3-dimethylbutyl, heptyl such as n-heptyl, fluorenyl hexyl hexyl and 1,4-dimethylpentyl. 1 haloalkyl and i alkenyl are alkyl and alkenyl, respectively , which is partially or completely substituted by the same or different dentate atoms, such as a mono-alkyl group such as CH2CH2CL.CH2CH2F, CHC1CH3, CHFCH3, CH2C1, CH2F, a perhaloalkyl group such as CCI3 or CF3 or CF2CF3; The bases are, for example, CHF2, ch2f, ch2chfc, chci2, cf2cf2h, ch2ch2cf3, CHzCHF2, CH2CF; j. This applies correspondingly to haloalkenyl and other halo-substituted groups. Alkenyl also refers to a straight group containing at least one double bond. a chain or an open-chain branched hydrocarbon group. The term "dense base" includes, in particular, (C2-C12)-dense, particularly preferably (c2-C8)-201012812 alkenyl, especially (c2-c6)-dil , Preferably, it is ((: 2 <: Shi Shiji. Examples of the base of the base group ◎ are 1,3 · butyl and M pentyl, and dilute or contain - or multiple accumulation The (4) group of the double bond, such as fluorenyl (1,2-propanediyl)' 1,2-butadienyl and pentylene. The base of the formula i is an ethylene group, λ can Optionally substituted with other alkyl groups, such as propyl + ene-1-yl, butyl] yl, allyl, 1-methylpropan-2-succinyl, 2-mercaptoprop-2-enyl , 丁_2m, 曱 曱 』 』 休 u 及 及 ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ 2-ene-1_yl, 2-mercaptopropan-2-yl, di-butadiene, di-n-butyl, 1-methylbutan-3, dilute or l-butyl _2_thin pentenyl, 2-decylpentenyl and hexenyl. Alkynyl also refers to a hydrocarbon containing at least one of the straight or open branches of the bond. If appropriate, one or more double bonds may be present. Corresponding examples are ethynyl, propynyl, 1-methylprop-2-yn-1-yl, 2-butynyl, 2-pentynyl, indole, 3-butadienyl and 3-pentene _1_Alken-1-yl or 2-hexynyl, preferably propynyl, but-2-ynyl-1-yl, but-3-yn-1-yl or 1-decyl-but-3- Alkyne small group. A sub-alkyl group is also, for example, in the form of (CVCW-alkylene, a group of a straight or open-branched hydrocarbon group bonded via a double bond. The natural suitable attachment point of the sub-alkyl group is only present in the structure. Where two hydrogen atoms may be replaced by a double bond, examples of the group are =ch2, =CH-CH3, =C(CH3)-CH3, =C(CH3)-C2H5 or =C(C2H5)-C2H5. The alkyl group means a ring system containing a carbon ring saturated with preferably 3 to 8 ring carbon atoms, such as a cyclopropyl group, a cyclobutyl group, a cyclopentyl group or a cyclohexyl group. The optionally substituted cycloalkyl group includes a substituent. a cyclic system which also includes a substituent containing a double bond in the cycloalkane at 201012812, such as an alkylene group such as a methylene group. The optionally substituted cycloalkyl group includes a polycyclic aliphatic system such as a bicyclo[1.1.0 ]]-1-yl, bicyclo[1.L0]butyl-2-yl, bicyclo[2] is pentyl, bicyclo[2.1.0]pent-2-yl, bicyclo[2.1.〇]戊5_yl, bicyclo[2.2.1]heptan-2-yl, (n-decyl), adamantyl-1-yl and adamantyl. Substituted cycloalkyl also includes spirocyclic aliphatic systems such as spiro [2.2] pent-1-yl, spiro[2.3]hex-1-yl, spiro[23]hex-4-yl, 3-spiro[2 .3] He-5-based.
環烯基是含有較宜4至8個環碳原子之碳環、非芳族、 部,不飽和的環系統’例如i•環丁烯基、或卜環己稀基、 2-環己烯基、3_環己烯基、u_環己二烯基或丨,4•環己二稀 基,同樣也包括其中在環烯基含有雙鍵之取代基,例如亞 烧基例如亞甲基。在隨意地經取代之環婦基的情形下,對 應地適用經取代的環烷基之說明。 ”方基疋含有較宜6至14,特別是6至12個環破原子之 =-、一或多環的芳族系統,例如苯基、蒸基、舊基、菲 基等’較宜是苯基。 ,意地經取代之芳基也包括多環的系統,例如四氮蒸 Ϊ。印基、^、聯苯基,其中連接點是在芳族 觀點,「隨意地經取代之苯基」—詞通常也包 siiiips 23 201012812 他碳基或雜環是隨意地經取代,其可以稍合至发 基。隨意地經取代之雜環基“狀-雜-5-氮雜·螺[2·3]已基。 狀糸、、克例如丨-氧 至6個^1 較義,雜環較宜含有3至9個環原子,特別是3 特們二,且在雜環中含有一或多個,較宜是1至4個, ,疋、或3個雜原子,較宜從包括Ν、〇及§ 兩個氧原子不能直接彼此相鄰。 中© 在本發明之内文中,雜芳基一詞係指上面在「 統’但其是絲,域是絲完全不餘的芳族雜^ 、、-或多個基團取代」之意義,除非另外定義,係指彼此 獨立的-或多個相同或不_基團,其中在作為主_環之 多個基團可以形成一或多個環。 取 經取代的基團,例如經取代的烷基、烯基、炔基、環 烷基、裱烯基、芳基、苯基、苄基、雜環基及雜芳基,是❿ 例如從未經取代的主鏈衍生之經取代的基團,取代基是例 如一或多個,較宜是i、2或3個從包括鹵基、烷氧基、烷 硫基、羥基、胺基、硝基、綾基或相當於羧基之基團、= 基、異氰氧基、叠氮基、烧氧基幾基、燒基缓基、曱酿基、 胺基甲醯基、單-及二烷基胺基羰基、經取代之胺基例如醯 基胺基、單-及二烷基胺基、三烷基矽烷基及隨意地經取代 之環烧基、隨意地經取代之芳基、隨意地經取代之雜環基, 201012812 其中各最後提到的環狀基團也可經由雜原子或二價官能基 連接如同在上面提到的烷基,及烷基亞磺醯基,其中包括 烷基亞磺酿基之兩種對掌異構物,烷基磺醯基、烷基次膦 基、烧基膦基及在環狀基團(=「環狀主鍵」)之情形中,也 包括烧基、鹵烧基、烧硫基烧基、烧氧基燒基、隨意地經 取代之單-及二烷基胺基烷基及羥基烷基;「經取代的基團」 一詞,例如經取代的烷基等,除了所提的飽和含烴基之外,取代 ❹ 基包括對應的不飽和脂族及芳族基團,例如隨意經取代之烤基、 炔基、烯氧基、炔氧基、烯硫基、炔硫基、烯氧基羰基、炔氧基 幾基、烯基幾基、炔基幾基、單-及二烯基胺基幾基、單—及二炔 基胺基羰基、單-及二烯基胺基、單-及二炔基胺基、三烯基石夕烧 基、二快基石夕烧基、隨意經取代之環埽基、隨意經取代之環炔基、 苯基、苯氧基等。在環中含有脂族部份的飽和環狀基團之情形 中,此也包括含有經由雙鍵連接至環的取代基之環狀系統,例如 經由亞烷基例如亞甲基或亞乙基、酮基、亞胺基或經取代之亞胺 基取代。 C# 如果二或多個基團形成一或多個環,這些可以是碳 環、雜環、飽和、部份飽和、不飽和,以及例如芳族且再 隨意地經取代。稠合的環較宜是5_或6_員環,特別較宜是 苯並-稠合的環。 舉例的取代基(「第一取代基層」),如果其包含含有烴 基的部份,適當時該部份可以再經取代(「第二取代基層」), 例如經由在第一取代基層中定義的其中一個取代基。可能 25 201012812 有對應的進一步取代基層。「經取代的基團」一詞較宜只 包含一或兩個取代基層。 取代基層之較佳取代基是例如胺基、羥基、自基、硝 基、氰基、異氰氧基、巯基、異硫氰氧基、緩基、趨胺基、 SFs、胺基磺醯基、烷基、環烷基、烯基、環烯基、炔基、 單烷基胺基、二烷基胺基、N-烷醯基胺基、烷氧基、烯氧 基、炔氧基、環烷氧基、環烯氧基、烷氧基羰基、烯氧基 羰基、快氧基幾基、芳氧基羰基、烧酿基、烯基幾基、炔 基羰基、芳基羰基、烧硫基、環烷硫基、烯硫基、環烯硫 基、炔硫基、烷基硫烷基、烷基亞磺醯基其中包括烷基亞 磺醯基之兩種對掌異構物、烷基磺醯基、單烷基胺基磺醯 基、二烧基胺基項醯基、烧基次膦基、烧基膦基,其中包 括烧基次膦基及烧基膦基之兩種對掌異構物、N_^基胺基 羰基、N,N-二烷基胺基羰基、N-烧醯基胺基羰基、N-炫醯 基烷基胺基羰基、芳基、芳氧基、苄基、苄氧基、苄硫 基、芳硫基、芳基胺基、苄基胺基、雜環基及三烷基矽烷 基。 取決於取代基之選擇’如果適當時與合適的無機或揪 酸形成加合物’例如無機酸特別是HC卜HBr、H2S〇4、H3P〇4 或HNO3 ’或例如有機酸特別是叛酸例如曱酸、乙酸、丙酸、 草酸、乳酸或水楊酸或例如續酸特別是對甲苯確酸,在驗 性基例如胺基、烷基胺基、二烷基胺基、六氫吡啶基、嗎 福咁基或吡啶基,通式(I)之化合物可以形成鹽類。在此情 形中,該鹽類含有酸之共耗驗作為陰離子。 201012812 酸或 鹽。 存在於去質子化的形式中的人 U下,通式⑴之化合物及复蹿井 认丄 ιβ ^ 4. ^ 、屬'類’為了簡化也稱為根 據本發明或根據本發明使用的「通物」。巧根 本發明通式(i)之化合物可以經由下面的i法製備,1 中通式(I)之化合物 、 (1) 係指通式(I_A)之化合物如果Υΐ,A cycloalkenyl group is a carbocyclic, non-aromatic, partially unsaturated ring system containing from 4 to 8 ring carbon atoms, such as i•cyclobutenyl, or cyclohexyl, 2-cyclohexene. a 3-, cyclohexenyl, u-cyclohexadienyl or anthracene, 4•cyclohexanediyl, also includes a substituent in which a cycloalkenyl group has a double bond, such as a m-alkyl group such as a methylene group. . In the case of a randomly substituted ring group, the description of the substituted cycloalkyl group applies correspondingly. " Square base 疋 contains more preferably 6 to 14, especially 6 to 12 rings of broken atoms =-, one or more aromatic systems, such as phenyl, steam, old base, phenanthryl, etc. Phenyl. The intentionally substituted aryl group also includes polycyclic systems, such as tetrakisole, imprinting, ^, biphenyl, wherein the point of attachment is in the aromatic view, "optionally substituted phenyl" - The word usually also contains siiiips 23 201012812 The carbon or heterocyclic ring is optionally substituted, which can be slightly combined to the hair base. Optionally substituted heterocyclic "hetero-hetero-5-aza-spiro[2·3] yl. 糸, 克, for example, 丨-oxygen to 6 ^1 is preferred, heterocyclic ring preferably contains 3 Up to 9 ring atoms, especially 3, and 1 or more in the hetero ring, preferably 1 to 4, oxime, or 3 heteroatoms, preferably including ruthenium, osmium and § The two oxygen atoms cannot be directly adjacent to each other. In the context of the present invention, the term heteroaryl refers to the above-mentioned "unity" but which is a silk, the domain is completely non-existing aromatic hetero-, The meaning of "or more than one group", unless otherwise defined, means independently of each other - or a plurality of identical or non-groups, wherein one or more rings may be formed in a plurality of groups as a main ring. Substituted groups, such as substituted alkyl, alkenyl, alkynyl, cycloalkyl, nonenyl, aryl, phenyl, benzyl, heterocyclyl and heteroaryl, are Substituted by the substituted backbone, the substituent is, for example, one or more, preferably i, 2 or 3, including halo, alkoxy, alkylthio, hydroxy, amine, nitro , fluorenyl or a group corresponding to a carboxyl group, a group, an isocyanato group, an azide group, an alkoxy group, a decyl group, an aryl group, an aminomethyl group, a mono- and a dialkylamine a carbonyl group, a substituted amine group such as a mercaptoamine group, a mono- and dialkylamino group, a trialkylalkylene group, and optionally substituted cycloalkyl groups, optionally substituted aryl groups, optionally substituted Heterocyclic group, 201012812 wherein the last-mentioned cyclic group may also be bonded via a hetero atom or a divalent functional group such as the alkyl group mentioned above, and an alkylsulfinyl group, including an alkyl sulfinic acid. Two kinds of palmier isomers, alkylsulfonyl, alkylphosphinyl, alkylphosphino and in the case of a cyclic group (= "cyclic primary bond") Also included are an alkyl group, a halogen group, a sulfur-burning group, an alkoxy group, a randomly substituted mono- and dialkylaminoalkyl group, and a hydroxyalkyl group; the term "substituted group" For example, a substituted alkyl group or the like, in addition to the saturated hydrocarbon-containing group, the substituted fluorenyl group includes a corresponding unsaturated aliphatic and aromatic group, such as a randomly substituted azeto group, an alkynyl group, an alkenyloxy group, Alkynyloxy, alkenylthio, alkynylthio, alkenyloxycarbonyl, alkynyloxy, alkenyl, alkynyl, mono- and dienylamino, mono- and di-alkynyl Aminocarbonyl, mono- and dienylamino, mono- and di-alkynylamino, trialkenyl, ketone, optionally substituted cyclodecyl, optionally substituted cycloalkyne Base, phenyl, phenoxy, and the like. In the case of a saturated cyclic group containing an aliphatic moiety in the ring, this also includes a cyclic system containing a substituent attached to the ring via a double bond, for example, via an alkylene group such as a methylene group or an ethylene group, Substituted by a keto group, an imido group or a substituted imido group. C# If two or more groups form one or more rings, these may be carbocyclic, heterocyclic, saturated, partially saturated, unsaturated, and, for example, aromatic and optionally substituted. The fused ring is preferably a 5- or 6-membered ring, particularly preferably a benzo-fused ring. An exemplary substituent ("first substituent layer"), if it comprises a moiety containing a hydrocarbon group, the moiety may be further substituted ("second substituent layer") as appropriate, for example via a definition in the first substituent layer One of the substituents. Possible 25 201012812 There is a corresponding replacement for the base layer. The term "substituted group" preferably contains only one or two substituents. Preferred substituents for the substituted base layer are, for example, an amine group, a hydroxyl group, a self group, a nitro group, a cyano group, an isocyanato group, a decyl group, an isothiocyanato group, a slow group, an amine group, an SF group, an amine sulfonyl group. , alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, monoalkylamino, dialkylamino, N-alkylalkylamino, alkoxy, alkenyloxy, alkynyloxy, Cycloalkoxy, cycloalkenyloxy, alkoxycarbonyl, olefinoxycarbonyl, methoxyoxy, aryloxycarbonyl, aryl, alkenyl, alkynylcarbonyl, arylcarbonyl, sulfur-burning a base, a cycloalkylthio group, an alkenethio group, a cycloalkenylthio group, an alkynylthio group, an alkylsulfanyl group, an alkylsulfinyl group, which includes two pairs of palm sulfoximine groups, an alkane isomer a sulfonyl group, a monoalkylaminosulfonyl group, a dialkylamino group fluorenyl group, a pyridylphosphinyl group, a alkylphosphino group, which includes two pairs of a phosphinylphosphino group and a decylphosphino group. Palmomer, N-(amino)carbonyl, N,N-dialkylaminocarbonyl, N-co-decylaminocarbonyl, N-nonylalkylaminocarbonyl, aryl, aryloxy, Benzyl, benzyloxy, benzylthio, arylthio, aryl Amine group, benzylamino group, heterocyclic group and trialkyldecane group. Depending on the choice of substituents 'if appropriate, an adduct is formed with a suitable inorganic or decanoic acid', for example a mineral acid, in particular HC, HBr, H2S4, H3P〇4 or HNO3' or for example an organic acid, in particular a tickic acid, for example Capric acid, acetic acid, propionic acid, oxalic acid, lactic acid or salicylic acid or, for example, a continuous acid, especially p-toluene, in an experimental group such as an amine group, an alkylamino group, a dialkylamino group, a hexahydropyridyl group, The compound of the formula (I) can form a salt. In this case, the salt contains a co-depletion of an acid as an anion. 201012812 Acid or salt. The compound of the formula (1) and the compound of the formula (1) and the genus 'class' are present in the deprotonated form, and are also referred to as "passing" according to the invention or according to the invention. Things." The compound of the formula (i) of the present invention can be produced by the following i method, wherein the compound of the formula (I), (1) refers to the compound of the formula (I_A), if
(2) 係指通式(U)之化合物如果Y=:s(=()), (3) 係指通式(I_C)之化合物如果>^4(0), (4) 係指通式(I_D)之化合物如果Y==_S(=N CN), (5) 係指通式㈣之化合物如果Y==.叫, (6) 係指通式㈣之化合物如果γ=: _s(〇)(=n (7) 係指通式(〗_G)之化合物如果玟^氫; (8) 係指通式(〗_H)之化合物如果故1及反2#氫;且 (9) 係指通式㈣之化合物如果R1及r2 一起形成亞胺 基雙鍵。 首先敘述的是一種方法〜方法^用於製備通式(i_a)之 化合物。 方法(A) 27 201012812(2) means a compound of the formula (U) if Y=:s(=()), (3) means a compound of the formula (I_C) if >^4(0), (4) means If the compound of formula (I_D) is Y==_S(=N CN), (5) means the compound of formula (4) if Y==., (6) means the compound of formula (4) if γ=: _s( 〇)(=n (7) means a compound of the formula (〖_G) if 玟^ hydrogen; (8) means a compound of the formula (〖_H) if 1 and 2# hydrogen; and (9) Refers to a compound of the formula (IV) if R1 and r2 together form an imido double bond. First, a method to a method for preparing a compound of the formula (i-a) is described. Method (A) 27 201012812
CN χCN χ
驗 1 當置 B-LG(m> (Μ) cs,, m 1當量ch3-i或 硫酸二甲酯Test 1 When B-LG (m> (Μ) cs, m 1 equivalent ch3-i or dimethyl sulfate
cs2,蠊 1當量· B-LG (VII-A)Cs2, 蠊 1 equivalent · B-LG (VII-A)
(VII-B) CN X〜S、B S'CH3 (iv-A) cs2, m CN 2 當置B-LG(m> J - (II)(VII-B) CN X~S, B S'CH3 (iv-A) cs2, m CN 2 When B-LG (m> J - (II)
水合肼 溶劑 水合胼 溶劑Hydrazine hydrate solvent hydrazine hydrazine solvent
cs2,鹼 CN 2 當量.b^coci (vm> J - (II)Cs2, base CN 2 equivalent. b^coci (vm> J - (II)
水合肼 y = s Ri = R2 = ΗHydrazine 肼 y = s Ri = R2 = Η
LG=釋離基 其中A1、A2、B、X、R3及n具有上述提供的意義且LG是 釋離基。 據此,本發明也關於一種經由下面的反應製備通式(I) 的化合物之方法LG = liberation group wherein A1, A2, B, X, R3 and n have the meanings provided above and LG is a cleavage group. Accordingly, the present invention also relates to a process for preparing a compound of the formula (I) via the following reaction.
其中R1及R2基團代表氫且R3、X、Y、B及η具有上述提 供的意義。用於此反應之起始物質是根據上面所示的反應 圖式所得。 釋離基LG沒有任何特定的限制,其可以是例如鹵基、 烧基續醯基、烧基亞橫醯基、烧基硫烧基或硝基。 28 201012812 在用於製備通式(I-A)化合物之方法(A)中,通式(IV)、 (IV- A)或(IV- B )之烯酮S,S -二硫縮醛類是在合適的溶劑中先 與肼水合物反應。通式(V)之所得的胺基吡唑類隨後與含有 合適的釋離基“LG”例如鹵基、烧基續酸醋、芳基續酸醋、 烷基磺醯基、烷基亞磺醯基、烷基硫烷基或硝基之通式(VI) 之0井基衍生物反應。 結構上相關的酮烯s,s-二硫縮醛類之合成是揭示特別 在:Wherein the R1 and R2 groups represent hydrogen and R3, X, Y, B and η have the meanings given above. The starting materials used in this reaction were obtained according to the reaction scheme shown above. The release group LG is not subject to any particular limitation, and may be, for example, a halogen group, a decyl group, a ruthenium group, a thiol group or a nitro group. 28 201012812 In the process (A) for the preparation of a compound of the formula (IA), the ketene S,S-dithioacetal of the formula (IV), (IV-A) or (IV-B) is A suitable solvent is first reacted with hydrazine hydrate. The resulting aminopyrazoles of the formula (V) are subsequently formulated with a suitable cleavage group "LG" such as a halo group, a decyl vinegar, an aryl sulphate, an alkyl sulfonyl group, an alkyl sulfin. A hydrazine-based, alkylthioalkyl or nitro group of the formula (VI) of the well derivative is reacted. The synthesis of structurally related ketone s, s-dithio acetals is revealed in particular:
Science of Synthesis (2006), Volume Date 2005, 24, 461-516 2. 3. 4. 5. 6. 7. 8. 9. 〇Science of Synthesis (2006), Volume Date 2005, 24, 461-516 2. 3. 4. 5. 6. 7. 8. 9. 〇
Chemische Berichte (1962), 95, 2861-2870 Journal of Organic Chemistry (1971), 36(22), 3386-3391 Tetrahedron (1976), 32(14), 1779-1787 Journal fur Praktische Chemie (Leipzig) (1979), 321(6), 1021-1028 US 4,389,400 JP 60/004164Chemische Berichte (1962), 95, 2861-2870 Journal of Organic Chemistry (1971), 36(22), 3386-3391 Tetrahedron (1976), 32(14), 1779-1787 Journal fur Praktische Chemie (Leipzig) (1979) , 321(6), 1021-1028 US 4,389,400 JP 60/004164
Synthesis (1991),(4),301-303Synthesis (1991), (4), 301-303
Bulletin of the Korean Chemical Society (1998), 19(11), 1262-1265 10. Yakugaku Zasshi (1969), 89(2), 203-208 11. Tetrahedron (1989), 45(6), 1801-1814 結構上相關的胺基吼哇類之合成是揭示在: 1. DD 113363 29 201012812 2. WO 2001007413Bulletin of the Korean Chemical Society (1998), 19(11), 1262-1265 10. Yakugaku Zasshi (1969), 89(2), 203-208 11. Tetrahedron (1989), 45(6), 1801-1814 Structure The synthesis of the related amino group is disclosed in: 1. DD 113363 29 201012812 2. WO 2001007413
3. EP 0 846 687 A 4. Synthetic Communications (2003), 33(4), 555-562 5. Bioorganic & Medicinal Chemistry Letters (2004), 14(19), 4949-4953 6. Tetrahedron (1990), 46(2), 577-586 7. Sulfur Letters (1993), 16(4), 165-170 8. Heterocycles (1996), 43(8), 1597-1600 本發明還提供在此合成中得到的通式(IV)之中間物3. EP 0 846 687 A 4. Synthetic Communications (2003), 33(4), 555-562 5. Bioorganic & Medicinal Chemistry Letters (2004), 14(19), 4949-4953 6. Tetrahedron (1990), 46(2), 577-586 7. Sulfur Letters (1993), 16(4), 165-170 8. Heterocycles (1996), 43(8), 1597-1600 The present invention also provides a pass obtained in this synthesis. Intermediate of formula (IV)
其中X代表Where X represents
其中G1、G2及G3彼此獨立地各選自包括鹵基、烷基、鹵〇 烷基、烷氧基、烷氧基烷基、烷氧基烷氧基、環烷基、烯 氧基、炔氧基、環烷基烷氧基、鹵烷氧基、齒烷氧基烷基、 烧基硫烧基、函烧基硫烧基、烧基亞續醢基、齒烧基亞橫 醯基、烷基磺醯基、齒烷基磺醯基、氰基、烷基羰基、烷 氧基羰基、烷氧基羰基烷基、羧基、醯胺基、二烷基醯胺 基、三烧基紗烧基、確基、胺基、烧基胺基、二烧基胺基、 烷基磺醯基胺基、二烷基磺醯基胺基、-CR6=NO-R6、 30 201012812 -CR =NO_㈣基或甲酿基,其中相鄰的烧基、㈣基、燒 氧基及/或鹵烷氧基與和其連接的碳原子可形成五-或六_員° 環狀系統其含有0至2個氧原子且其烧基部份可隨意地經 一或多個氟原子取代。 較宜G^G2及G3彼此獨立地各選自包括齒基、烷基、 鹵烷基、烷氧基、烷氧基烷基、烷氧基烷氧基、c〇〇H、硝 基、胺基、烷基胺基、二烷基胺基,其中相鄰的烷基、鹵 0 烧基、院氧基及/或鹵烧氧基與和其連接的碳原子可形成五_ 或六-員環狀系統其含有0至2個氧原子且其烷基部份可隨 意地經一或多個氟原子取代。 特別較宜G1、G2及G3彼此獨立地各選自包括鹵基、 Ci-CV鹵烧基及Ci-C6·烧氧基’其中相鄰的烷基、齒烷基、 烷氧基及/或鹵烷氧基與和其連接的碳原子可形成五_或六_ 員環狀系統其含有0至2個氧原子且其烧基部份可隨意地 經一或多個氟原子取代。 ❹ 非常特別較宜Gl、G2及G3彼此獨立地各選自包括氟、 氯、溴、蛾、CF3、CH30、0CH20、0CH2CH2 及 ocf2o。 尤其較宜X具有其中一個下面的意義: 2-C1-苯基、2-F-6-F-苯基、3-C1-苯基、3-CF3-苯基、4-C1-苯基、4-Br-苯基、4-1-苯基、3-Cl,4-Cl-苯基、3-CF3,4-Cl-苯基、3-Cl,5-Cl-苯基、3-CF3,5-F-苯基、3-CF3,5-Cl-苯基、 3-CF3,5-CF3-苯基、3_C1,4-C1,5-C1-苯基、 3{3-(:1,4-〇〇13,5-〇-苯基、3-(:1,(4)-0〇120_(5)-苯基、 3-Cl,(4)-0CF20-(5)-苯基、3-Cl,(4)-OCH2CH2-(5)-苯基、 201012812 3-Cl,4-0CH3,5-0CH3·苯基及 3-〇CH3,5-CF3-苯基。 本發明還提供在此合成中得到的通式(IV-A)之中間物Wherein G1, G2 and G3 are each independently selected from the group consisting of halo, alkyl, haloalkyl, alkoxy, alkoxyalkyl, alkoxyalkoxy, cycloalkyl, alkenyloxy, alkyne Oxyl, cycloalkylalkoxy, haloalkoxy, orthooxyalkyl, thiol thiol, calcinyl thiol, decyl sulfhydryl, dentate hydrazino, Alkylsulfonyl, tert-alkylsulfonyl, cyano, alkylcarbonyl, alkoxycarbonyl, alkoxycarbonylalkyl, carboxyl, decylamino, dialkylguanidino, trialkyl Base, exact group, amine group, alkylamino group, dialkylamino group, alkylsulfonylamino group, dialkylsulfonylamino group, -CR6=NO-R6, 30 201012812 -CR =NO_(tetra) Or a ketone group in which an adjacent alkyl group, a (tetra) group, an alkoxy group and/or a haloalkoxy group and a carbon atom to which it is attached may form a five- or six-membered ring system containing 0 to 2 The oxygen atom and its alkyl moiety may be optionally substituted with one or more fluorine atoms. Preferably, G^G2 and G3 are each independently selected from the group consisting of dentate, alkyl, haloalkyl, alkoxy, alkoxyalkyl, alkoxyalkoxy, c〇〇H, nitro, amine a base, an alkylamino group, a dialkylamino group, wherein an adjacent alkyl group, a halogen group, an alkoxy group, and/or a halogen alkoxy group, and a carbon atom to which it is attached may form a five- or six-member The cyclic system contains from 0 to 2 oxygen atoms and its alkyl moiety is optionally substituted with one or more fluorine atoms. Particularly preferably, G1, G2 and G3 are each independently selected from the group consisting of halo, Ci-CV haloalkyl and Ci-C6·alkoxy, wherein adjacent alkyl, chiral alkyl, alkoxy and/or The haloalkoxy group and the carbon atom to which it is attached may form a five- or six-membered ring system containing 0 to 2 oxygen atoms and the alkyl moiety thereof may be optionally substituted with one or more fluorine atoms. Very particularly preferably Gl, G2 and G3 are each independently selected from the group consisting of fluorine, chlorine, bromine, moth, CF3, CH30, 0CH20, 0CH2CH2 and ocf2o. Particularly preferably, X has one of the following meanings: 2-C1-phenyl, 2-F-6-F-phenyl, 3-C1-phenyl, 3-CF3-phenyl, 4-C1-phenyl, 4-Br-phenyl, 4-phenyl-phenyl, 3-Cl,4-Cl-phenyl, 3-CF3,4-Cl-phenyl, 3-Cl, 5-Cl-phenyl, 3-CF3 , 5-F-phenyl, 3-CF3, 5-Cl-phenyl, 3-CF3, 5-CF3-phenyl, 3-C1,4-C1, 5-C1-phenyl, 3{3-(:1 , 4-〇〇13,5-〇-phenyl, 3-(:1,(4)-0〇120_(5)-phenyl, 3-Cl,(4)-0CF20-(5)-phenyl , 3-Cl, (4)-OCH2CH2-(5)-phenyl, 201012812 3-Cl, 4-0CH3, 5-0CH3·phenyl and 3-indene CH3, 5-CF3-phenyl. The invention also provides Intermediate of the general formula (IV-A) obtained in this synthesis
其中X代表Where X represents
其中G1、G2及G3彼此獨立地各選自包括鹵基、烷基、鹵 烷基、烷氧基、烷氧基烷基、烷氧基烷氧基、環烷基、烯 氧基、炔氧基、環烷基烷氧基、_烷氧基、齒烷氧基烷基、 烷基硫烷基、齒烷基硫烷基、烷基亞磺醯基、li烷基亞磺 醯基、烷基磺醯基、齒烷基磺醯基、氰基、烷基羰基、烷 氧基羰基、烷氧基羰基烷基、羧基、醯胺基、二烷基醯胺 基、三烷基矽烷基、硝基、胺基、烷基胺基、二烷基胺基、 烷基磺醯基胺基、二烷基磺醯基胺基、-CR6=NO_R6、 -CR6=NO-鹵烷基或甲醯基,其中相鄰的烷基、鹵烷基、烷 氧基及/或函烷氧基與和其連接的碳原子可形成五-或六-員 環狀系統其含有〇至2個氧原子且其烷基部份可隨意地經 一或多個氟原子取代。 較宜G、G2及G3彼此獨立地各選自包括鹵基、烷基、 鹵烷基、烷氧基、烷氧基烷基、烷氧基烷氧基、COOH、硝 基、胺基、烷基胺基、二烷基胺基,其中相鄰的烷基、鹵 201012812 烷基、烷氧基及/或鹵烷氧基與和其連接的碳原子可形成五_ 或六-員環狀系統其含有0至2個氧原子且其烷基部份可隨 意地經一或多個氟原子取代。 特別較宜G1、G2及G3彼此獨立地各選自包括齒基、 Ci-CV鹵烧基及Ci-CV烧氧基’其中相鄰的燒基、由烧基、 烧氧基及/或鹵烧氧基與和其連接的碳原子可形成五-或丄 員環狀系統其含有〇至2個氧原子且其烷基部份可隨意地 經一或多個說原子取代。 非常特別較宜G1、G2及G3彼此獨立地各選自包括氣、 氯、溴、碘、cf3、ch3o、och2o、〇CH2CH2 及 〇CF2〇。 尤其較宜X具有其中一個下面的意義: 2-C1-苯基、2-F-6-F-苯基、3-C1-苯基、3-CF3-笨基、4_q 苯基、4-Br-苯基、4-1-苯基、3-Cl,4-Cl-苯基、3-CF3,4-Cl-苯基、3-Cl,5-Cl-苯基、3-CF3,5-F-苯基、3_CF3,5-C1-苯基、 3-CF3,5-CF3-苯基、3-Cl,4_Cl,5-Cl-苯基、 3-厂3-<:1,4-0(:113,5-0:1-苯基、3-0:以4)-0(:1120-(5)-笨基、 3-Cl,(4)-0CF20-(5)-苯基、3-Cl,(4)-OCH2CH2-(5)_笨基、 3-Cl,4-OCH3,5-OCH3-苯基及 3-OCH3,5-CF3-苯基。 本發明還提供在此合成中得到的通式(V)之中間物 NH2 Μ 其中χ代表 33 201012812 G1 G1Wherein G1, G2 and G3 are each independently selected from the group consisting of halo, alkyl, haloalkyl, alkoxy, alkoxyalkyl, alkoxyalkoxy, cycloalkyl, alkenyloxy, alkynyloxy , cycloalkylalkoxy, _alkoxy, dentateoxyalkyl, alkylsulfanyl, dentylsulfanyl, alkylsulfinyl, li alkylsulfinyl, alkane Sulfosyl, tert-alkylsulfonyl, cyano, alkylcarbonyl, alkoxycarbonyl, alkoxycarbonylalkyl, carboxyl, decylamino, dialkylguanidino, trialkyldecyl, Nitro, amine, alkylamino, dialkylamino, alkylsulfonylamino, dialkylsulfonylamino, -CR6=NO_R6, -CR6=NO-haloalkyl or formamidine a group wherein the adjacent alkyl, haloalkyl, alkoxy and/or alkoxy groups and the carbon atom to which they are attached may form a five- or six-membered ring system containing from 2 to 2 oxygen atoms and The alkyl moiety can be optionally substituted with one or more fluorine atoms. Preferably, G, G2 and G3 are each independently selected from the group consisting of halo, alkyl, haloalkyl, alkoxy, alkoxyalkyl, alkoxyalkoxy, COOH, nitro, amine, alkane An amino group, a dialkylamino group, wherein an adjacent alkyl group, a halogen 201012812 alkyl group, an alkoxy group, and/or a haloalkoxy group, and a carbon atom to which it is attached may form a five- or six-membered ring system It contains 0 to 2 oxygen atoms and its alkyl moiety can be optionally substituted with one or more fluorine atoms. Particularly preferably, G1, G2 and G3 are each independently selected from the group consisting of a dentate group, a Ci-CV haloalkyl group and a Ci-CV alkoxy group, wherein the adjacent alkyl group, the alkyl group, the alkoxy group and/or the halogen group The alkoxy group and the carbon atom to which it is attached may form a five- or oxime ring system containing from 2 to 2 oxygen atoms and the alkyl portion thereof may be optionally substituted with one or more atoms. Very particularly preferably, G1, G2 and G3 are each independently selected from the group consisting of gas, chlorine, bromine, iodine, cf3, ch3o, och2o, 〇CH2CH2 and 〇CF2〇. Especially preferred X has one of the following meanings: 2-C1-phenyl, 2-F-6-F-phenyl, 3-C1-phenyl, 3-CF3-styl, 4_q phenyl, 4-Br -phenyl, 4-phenyl, 3-Cl, 4-Cl-phenyl, 3-CF3,4-Cl-phenyl, 3-Cl, 5-Cl-phenyl, 3-CF3, 5- F-phenyl, 3-CF3, 5-C1-phenyl, 3-CF3, 5-CF3-phenyl, 3-Cl, 4_Cl, 5-Cl-phenyl, 3-factor 3-<:1,4- 0(:113,5-0:1-phenyl, 3-0: to 4)-0(:1120-(5)-styl, 3-Cl, (4)-0CF20-(5)-phenyl , 3-Cl, (4)-OCH2CH2-(5)-styl, 3-Cl, 4-OCH3, 5-OCH3-phenyl and 3-OCH3, 5-CF3-phenyl. The invention is also provided herein The intermediate NH2 of the general formula (V) obtained in the synthesis, wherein χ represents 33 201012812 G1 G1
其中G1、G2及G3彼此獨立地各選自包括鹵基、烧基、鹵 烷基、烷氧基、烷氧基烷基、烷氧基烷氧基、環烷基、烯 氧基、炔氧基、環烷基烷氧基、函烷氧基、鹵烷氧基烷基、 烷基硫烷基、齒烷基硫烷基、烷基亞磺醯基、函烷基亞磺 醯基、烷基磺醯基、齒烷基磺醯基、氰基、烷基羰基、烷 氧基羰基、烷氧基羰基烷基、羧基、醯胺基、二烷基醯胺❹ 基、三烷基矽烷基、硝基、胺基、烷基胺基、二烷基胺基、 烷基磺醯基胺基、二烷基磺醯基胺基、-CR6=NO-R6、 -CR6=NO-鹵烧基或曱醯基,其中相鄰的院基、鹵统基、烧 氧基及/或i烷氧基與和其連接的碳原子可形成五·或六-員 環狀系統其含有〇至2個氧原子且其烷基部份可隨意地經 一或多個氟原子取代。 較宜G1、G2及G3彼此獨立地各選自包括鹵基、烧基、 鹵烷基、烷氧基、烷氧基烷基、烷氧基烷氧基、COOH、硝❹ 基、胺基、烷基胺基、二烷基胺基,其中相鄰的烷基、鹵 烷基、烷氧基及/或齒烷氧基與和其連接的碳原子可形成五-或六-員環狀系統其含有0至2個氧原子且其烷基部份可隨 意地經一或多個氟原子取代。 特別較宜G1、G2及G3彼此獨立地各選自包括鹵基、 C^CVi烷基及G-C6-烷氧基,其中相鄰的烷基、齒烷基、 烧氧基及/或齒烧氧基與和其連接的碳原子可形成五-或六- 34 201012812 員壞狀糸統其含有0至2個氧原子且其垸基部份可隨音地 經一或多個氣原子取代。 非常特別較宜G\G2及G3彼此獨立地各選自包括氣、 氯、溴、碘、CF3、CH30、0CH20、〇CH2CH2 及 〇CF20。 尤其較宜X具有其中一個下面的意義: 2-C1-苯基、2-F-6-F-苯基、3-C1-苯基、3-CF3-苯基、4-Cl_ 本基、4-Br-苯基、4-1-苯基、3-Cl,4-Cl-苯基、3-CF3,4-Cl_ 苯基、3-Cl,5-Cl-苯基、3-CF3,5-F-苯基、3-CF3,5-Cl-苯基、 3-CF3,5-CF3-苯基、3-Cl,4-Cl,5-Cl-苯基、 3七3-(:1,4-0(:113,5-(:1-笨基、3-(:1,(4)-0(:1120-(5)-笨基、 3-Cl,(4)-0CF20-(5)-苯基、3-Cl,(4)-OCH2CH2-(5)-笨基、 3-Cl,4_OCH3,5-OCH3-苯基及 3-OCH3,5-CF3-苯基。 方法(B) 式(I-B)及(Ι-C)之化合物可以例如根據下面的方法(B) 合成:Wherein G1, G2 and G3 are each independently selected from the group consisting of halo, alkyl, haloalkyl, alkoxy, alkoxyalkyl, alkoxyalkoxy, cycloalkyl, alkenyloxy, alkynyloxy , cycloalkylalkoxy, alkoxy, haloalkoxyalkyl, alkylsulfanyl, dentylsulfanyl, alkylsulfinyl, alkylsulfinyl, alkane Sulfosyl, tert-alkylsulfonyl, cyano, alkylcarbonyl, alkoxycarbonyl, alkoxycarbonylalkyl, carboxyl, decylamino, dialkylguanidinium, trialkyldecyl , nitro, amine, alkylamino, dialkylamino, alkylsulfonylamino, dialkylsulfonylamino, -CR6=NO-R6, -CR6=NO-halogen Or a sulfhydryl group, wherein adjacent theater groups, halo groups, alkoxy groups and/or i alkoxy groups and the carbon atoms to which they are attached may form a five- or six-membered ring system containing from 〇 to 2 The oxygen atom and its alkyl moiety are optionally substituted with one or more fluorine atoms. Preferably, G1, G2 and G3 are each independently selected from the group consisting of halo, alkyl, haloalkyl, alkoxy, alkoxyalkyl, alkoxyalkoxy, COOH, nitroxide, amine, An alkylamino group, a dialkylamino group, wherein an adjacent alkyl group, a haloalkyl group, an alkoxy group, and/or a tooth alkoxy group, and a carbon atom to which it is attached may form a five- or six-membered ring system It contains 0 to 2 oxygen atoms and its alkyl moiety can be optionally substituted with one or more fluorine atoms. Particularly preferably, G1, G2 and G3 are each independently selected from the group consisting of halo, C^CVi alkyl and G-C6-alkoxy, wherein adjacent alkyl, aldentyl, alkoxy and/or dentate The alkoxy group and the carbon atom to which it is attached may form a five- or six-34 201012812 member of the ruthenium system which contains 0 to 2 oxygen atoms and whose thiol moiety may be substituted with one or more gas atoms. . Very particularly preferably G\G2 and G3 are each independently selected from the group consisting of gas, chlorine, bromine, iodine, CF3, CH30, 0CH20, 〇CH2CH2 and 〇CF20. In particular, X has one of the following meanings: 2-C1-phenyl, 2-F-6-F-phenyl, 3-C1-phenyl, 3-CF3-phenyl, 4-Cl-benz, 4 -Br-phenyl, 4-phenyl-phenyl, 3-Cl,4-Cl-phenyl, 3-CF3,4-Cl-phenyl, 3-Cl, 5-Cl-phenyl, 3-CF3,5 -F-phenyl, 3-CF3,5-Cl-phenyl, 3-CF3, 5-CF3-phenyl, 3-Cl, 4-Cl, 5-Cl-phenyl, 3-7-(:1 , 4-0(:113,5-(:1-stupyl, 3-(:1,(4)-0(:1120-(5)-stupyl, 3-Cl, (4)-0CF20-( 5) -Phenyl, 3-Cl, (4)-OCH2CH2-(5)-phenyl, 3-Cl, 4_OCH3, 5-OCH3-phenyl and 3-OCH3, 5-CF3-phenyl. The compounds of the formula (IB) and (Ι-C) can be synthesized, for example, according to the following method (B):
2氧化 當量 其中尺1、^2、入1、八2、6、又、尺3及11具有上面提供的意義。 在根據本發明用於製備通式(I-B)化合物之方法(b) 中’通式(Ι-A)之對應的硫醚類是與1莫耳的合適氧化劑例 35 201012812 如Η”2、過碘酸鈉、 亞氣酸納Naao2、·=酸第三τδΙ、次氯酸約Ca(〇C1)2、 的石肖酸㈣反應。NaQel Q2 ΛΑ备儿… ^ 之所得的亞规類可再與1莫耳 、」反.,伸到通式(I-C)之艰類。通式(I_A)之化合物 =—或夕自量的氧化劑存在下直接氧化而得到通式 (i-c)之砚類。 士少這些氧化反應本身是從事此項技藝者已知且經敘述在 許夕有機製備化學之教科書内。用於硫醚類反應的氧化方 法之回顧可見於例如在J. March "Advanced Organic2 Oxidation equivalents wherein the rule 1, 2, 2, 8, 2, 6, and 3 and 11 have the meanings provided above. In the method (b) for the preparation of the compound of the formula (IB) according to the invention, the corresponding thioether of the formula (Ι-A) is a suitable oxidizing agent with 1 mol of the example 35 201012812 Η 2、 2 Sodium iodate, sodium sulphate Naao2, ·= acid third τδΙ, hypochlorous acid about Ca(〇C1)2, oxalic acid (tetra) reaction. NaQel Q2 ΛΑ prepare... ^ The obtained sub-class can be further With 1 m, "reverse," to the hardship of the general formula (IC). The compound of the formula (I-A) is directly oxidized in the presence of an oxidizing agent to obtain an anthracene of the formula (i-c). These oxidation reactions are themselves known in the textbooks known to those skilled in the art and described in Xu Xi Organic Preparation Chemistry. A review of the oxidation method for thioether reactions can be found, for example, in J. March "Advanced Organic
Chemistry” 4th Edition,John Wiley & Sons,1992, ρ· 1202 及 其中提到的文獻。 據此,本發明也關於一種經由下面的反應用於製備通 式(Ι-Β)化合物之方法(Β),其中Y=-S(0)-(通式(Ι-Β)化合物):Chemistry" 4th Edition, John Wiley & Sons, 1992, ρ. 1202 and the documents mentioned therein. Accordingly, the present invention also relates to a method for preparing a compound of the formula (Ι-Β) via the following reaction (Β) ), wherein Y=-S(0)-(general (Ι-Β) compound):
其中尺1、尺2、113、又、3及11具有上面提供的意義。用於此 反應之起始物質是根據上面所示的反應圖式所得。 據此,本發明也關於一種經由下面的反應用於製備通 式(Ι-C)化合物之方法’其中Y=-S(0)2_(通式(i_c)化人物)· 36 201012812Among them, rule 1, ruler 2, 113, again, 3 and 11 have the meanings provided above. The starting materials used in this reaction were obtained according to the reaction scheme shown above. Accordingly, the present invention also relates to a method for preparing a compound of the general formula (Ι-C) via the following reaction, wherein Y = -S(0)2_(generalized (i_c) person) 36 201012812
2氧化 當量 其中Rl、R2、R3、X、B及η具有上面提供的意義。用於此 反應之起始物質是根據上面所示的反應圖式所得。 方法(a 通式(I>D)、(Ι-E)及(Ι-F)之化合物可以根據例如下面的 方法(C)合成:2 Oxidation equivalents wherein R1, R2, R3, X, B and η have the meanings given above. The starting materials used in this reaction were obtained according to the reaction scheme shown above. Process (a) The compounds of the formula (I>D), (Ι-E) and (Ι-F) can be synthesized according to, for example, the following method (C):
(I-A) Y = S R1 s R2 β Η NH2CN (IX) mm(I-A) Y = S R1 s R2 β Η NH2CN (IX) mm
0-D) Y = S(=N-CN) Ri * R2 « H 1氣化 當置0-D) Y = S(=N-CN) Ri * R2 « H 1 gasification
Ο-E) Y = S(0)(=N-CN) R1 = R2 * HΟ-E) Y = S(0)(=N-CN) R1 = R2 * H
^X)^X)
d-F) Y * S(〇)(sN*R6) R1 = R2=H 其中A1、A2、B、X、r3、R6及n具有上面提供的意義。 在用於製備通式(Ι-D)化合物之方法(C)中,通式(Ι-a) 之對應的硫醚類是與1莫耳的合適氧化劑例如NBS或碘及 氰氨(IX)反應。通式(I_D)之所得的N-氰基-硫亞胺類再與1 莫耳當量的合適氧化劑反應而得到通式(Ι-E)之N-氰基砜亞 37 201012812 胺類,例如與h2〇2、過碘酸鈉、次氣酸第三丁酯、次氯酸 妈Ca(OCl)2、亞氯酸鈉NaCl〇2、次氣酸納NaOCl、過酸類 或02及催化的硝酸銨鈽。水解後得到NH-砜亞胺類(i_F: R6=H),其本身可烧基化而得到N-烷基砜亞胺類(I-F:r6= 烧基)。 據此,本發明也關於一種經由下面的反應用於製備通 式(I)化合物之方法,其中Y=-S(0)(=N-CN)-: R\d-F) Y * S(〇)(sN*R6) R1 = R2=H where A1, A2, B, X, r3, R6 and n have the meanings provided above. In the process (C) for the preparation of a compound of the formula (Ι-D), the corresponding thioether of the formula (Ι-a) is a suitable oxidizing agent with 1 mole such as NBS or iodine and cyanamide (IX) reaction. The N-cyano-sulfilimines of the formula (I-D) are further reacted with a suitable molar amount of 1 mM equivalent of an oxidizing agent to give an N-cyanosulfonate 37 201012812 amine of the formula (Ι-E), for example with H2〇2, sodium periodate, tert-butyl acid tert-butylate, hypochlorite mom Ca(OCl)2, sodium chlorite NaCl1, sodium hypochlorite NaOCl, peracid or 02 and catalyzed ammonium nitrate Hey. After hydrolysis, NH-sulfone imines (i_F: R6=H) are obtained, which are themselves calcinable to give N-alkylsulfoximines (I-F: r6 = alkyl). Accordingly, the present invention also relates to a process for the preparation of a compound of the general formula (I) via the following reaction, wherein Y = -S(0)(=N-CN)-: R\
(I-E) Y = S(0)(=N-CN) •,R*-LG(X) rVr1(I-E) Y = S(0)(=N-CN) •, R*-LG(X) rVr1
Y = S(0)(=N-R6)Y = S(0)(=N-R6)
其中A1、A2、B、X、R3、尺6及n具有上面提供的意義。 用於此反應的通式⑴之起始物質其中γ= _S(=N-CN)、 (通式(I_D)之化合物)或_s(〇)(=N-CN)-(通式(I-E)之化合物) 較宜經由下面的反應獲得,其也形成本發明主題之一部份:Wherein A1, A2, B, X, R3, 6 and n have the meanings provided above. The starting material of the formula (1) used in this reaction wherein γ = _S (= N-CN), (compound of the formula (I_D)) or _s (〇) (= N-CN) - (formula (IE) The compound) is preferably obtained via the following reaction, which also forms part of the subject matter of the present invention:
1¾¾ B ㈡S 1氣化 當釐 NH2CN (IX) 觸媒13⁄43⁄4 B (2) S 1 gasification When PCT NH2CN (IX) catalyst
N-氛基-硫亞胺類、队氰基砜亞胺類及nh_砜亞胺類之 合成,是例如敘述在:The synthesis of N-aryl-thiaimines, cyano sulfone imines and nh-sulfoximines is, for example, described in:
Organic Letters (2007), 9(19), 3809-3811. 38 201012812 2. Organic Letters (2007), 9(15), 2951-2954Organic Letters (2007), 9(19), 3809-3811. 38 201012812 2. Organic Letters (2007), 9(15), 2951-2954
3. WO 96/39389 A 4. US 2005/228027 A 方法(m 式(I-G)及(I-H)之化合物是例如根據下面的方法(D)合 成’如果使用的起始物質是通式(Ι-A)至(I-F)之化合物其中 胺官能基只帶有氫取代基或至少一個氫取代基。此方法也 〇 形成本發明主題之一部份:3. WO 96/39389 A 4. US 2005/228027 A Method (The compound of formula (IG) and (IH) is synthesized, for example, according to the following method (D) 'If the starting material used is a formula (Ι- A) to (IF) compounds wherein the amine functional group bears only a hydrogen substituent or at least one hydrogen substituent. This method also forms part of the subject matter of the present invention:
其中A1、A2、B、X、Y、R1、R2、R3及η具有上面提供的 意義。 在根據本發明用於製備式(I-G)及(Ι-Η)之化合物的方法 39 201012812 (D)中,化合物(I-A) - (Ι-F)之自由態NH2基是根據用於基本 烷基化或醯基化之一般已知方法與對應的烷基化或醯基化 劑(XI)及(XII)反應。 例如WO 2002/008196 A揭示5-胺基吡唑類之反應。 方法(E) 式(I-J)之化合物是例如根據下面的方法(E)合成:Wherein A1, A2, B, X, Y, R1, R2, R3 and η have the meanings provided above. In the process 39 201012812 (D) for the preparation of compounds of the formula (IG) and (Ι-Η) according to the invention, the free NH 2 group of the compound (IA) - (Ι-F) is based on the basic alkyl group The generally known methods of hydration or thiolation are carried out with the corresponding alkylating or oximation agents (XI) and (XII). For example, WO 2002/008196 A discloses the reaction of 5-aminopyrazoles. Process (E) A compound of the formula (I-J) is synthesized, for example, according to the following method (E):
Y = S02 Y=S(〇K=N-Re) R1 = R2 = H Ri a R2 = Η 其中A1、A2、B、X、Y、R3、R4、R5及n具有上面提供的 意義。 此反應也形成本發明主題之一部份。 雜環狀ΝΗ2基轉化成亞胺類是從文獻得知且揭示在例 如 Combinatorical Chemistry & High Throughput Screening 2005, 8, 617-622。 201012812 據此,本發明也關於經由下面的反應製備通式⑴的化 合物之方法:Y = S02 Y=S(〇K=N-Re) R1 = R2 = H Ri a R2 = Η where A1, A2, B, X, Y, R3, R4, R5 and n have the meanings provided above. This reaction also forms part of the subject matter of the present invention. The conversion of a heterocyclic quinone to an imine is known from the literature and is disclosed, for example, in Combinatorical Chemistry & High Throughput Screening 2005, 8, 617-622. According to this, the present invention also relates to a process for producing a compound of the formula (1) via the following reaction:
(I-A) Y = S Ri = R2 = Η (*-D) Y = S(=N-CN) R1 = R2 = Η 棚酸酯,HNRWXin) for = R5 = CH3 dmf縮酸,溶劑(I-A) Y = S Ri = R2 = Η (*-D) Y = S(=N-CN) R1 = R2 = Η shed, HNRWXin) for = R5 = CH3 dmf acid, solvent
R3nR3n
(I-E) Y = S(0)(=N-CN) R1 = R2 = Η(I-E) Y = S(0)(=N-CN) R1 = R2 = Η
(l-F)(l-F)
γ = S(0)(=N-R6) R1 = R2 = H 其中A1、A2、B、X、Y、R3、R4、R5及n具有上面提供的 意義。 41 201012812 方法(f) 式(Ι-Α)之化合物是例如根據下面的方法(F)合成:γ = S(0)(=N-R6) R1 = R2 = H where A1, A2, B, X, Y, R3, R4, R5 and n have the meanings provided above. 41 201012812 Method (f) A compound of the formula (Ι-Α) is synthesized, for example, according to the following method (F):
v*s R1 = R2 = Η 在根據本發明用於製備通式(Ι_Α)化合物之方法(F) 中,使用本身從文獻已知的方法,也可以製備通式(χνΙΠ) 的叛酸醋類或其羧酸作為中間物,其經去羧酸化後,得到 通式(XIX)之胺基吡唑類作為中間物。通式(ΧΙΧ)化合物之 鹵基化是在合適的溶劑例如在氣苯、氯仿、四氣化碳或冰 醋酸中使用合適的鹵基化劑例如溴、碘、NBS或NIS進行。 在最後的步驟中’在此方法中產生的通式(χχ)之鹵化物在 合適的Pd觸媒存在下與硼酸或硼酸酯反應而得到根據本發 明的通式(Ι-A)之化合物。 42 201012812 類似地’ WO 2001/07413揭示此合成序列用於製備ι_ 芳基-3-硫烷基吡唑類。 方法(G)v*s R1 = R2 = Η In the method (F) for preparing a compound of the formula (Ι_Α) according to the invention, it is also possible to prepare a vinegar of the formula (χνΙΠ) using a method known per se from the literature. Or a carboxylic acid thereof as an intermediate which, after decarboxylation, gives an aminopyrazole of the formula (XIX) as an intermediate. Halogenation of a compound of the formula (ΧΙΧ) is carried out in a suitable solvent such as benzene, chloroform, carbon tetrahydrate or glacial acetic acid using a suitable halogenating agent such as bromine, iodine, NBS or NIS. In the final step, the halide of the formula (χχ) produced in this process is reacted with boric acid or a boronic acid ester in the presence of a suitable Pd catalyst to give a compound of the formula (Ι-A) according to the invention. . 42 201012812 Similarly, WO 2001/07413 discloses that this synthetic sequence is useful for the preparation of iota-aryl-3-sulfanylpyrazoles. Method (G)
式(Ι-A)之化合物是例如根據下面的方法(⑺合成:The compound of the formula (Ι-A) is, for example, synthesized according to the following method ((7):
R1 = R2 = Η 其中人1、人2、3、乂、尺3及11具有上面提供的意義且1^0代 表任何釋離基。 ❹ 用於從三硫碳酸酯(XXII)製備VII-Α之此合成序列是類 似地揭示在:Journal of the Chemical Society,Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999) (1984), (1),85-90 ;同等轉化成SH-吡唑(XXIII) 是提供在Synthetic Communications,33(4), 555-562; 2003。 本發明還提供在此合成中所得的通式(XXIII)之中間物R1 = R2 = Η where 1, person 2, 3, 乂, feet 3 and 11 have the meanings provided above and 1^0 represents any release group.合成 This synthetic sequence for the preparation of VII-oxime from trithiocarbonate (XXII) is similarly disclosed in: Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999) (1984), (1), 85-90; equivalent conversion to SH-pyrazole (XXIII) is provided in Synthetic Communications, 33(4), 555-562; 2003. The present invention also provides an intermediate of the general formula (XXIII) obtained in the synthesis.
Η 43 201012812 其中X代表Η 43 201012812 where X stands for
其中G1、G2及G3彼此獨立地各選自包括鹵基、烷基、鹵 烷基、烷氧基、烷氧基烷基、烷氧基烷氧基、環烷基、烯 氧基、炔氧基、環烷基烷氧基、鹵烷氧基、函烷氧基烷基、 烷基硫烷基、i烷基硫烷基、烷基亞磺醯基、函烷基亞磺 醯基、烷基磺醯基、鹵烷基磺醯基、氰基、烷基羰基、烷 氧基羰基、烷氧基羰基烷基、羧基、醯胺基、二烷基醯胺 基、三烷基矽烷基、硝基、胺基、烷基胺基、二烷基胺基、 烷基磺醯基胺基、二烷基磺醯基胺基、-CR6=NO-R6、 -CR^NO-鹵燒基或甲酿基,其中相鄰的烧基、鹵烧基、烧 氧基及/或函烷氧基與和其連接的碳原子可形成五-或六-員 環狀系統其含有0至2個氧原子且其烷基部份可隨意地經 一或多個氟原子取代。 較宜G^G2及G3彼此獨立地各選自包括鹵基、烷基、 鹵烷基、烷氧基、烷氧基烷基、烷氧基烷氧基、COOH、硝 基、胺基、烷基胺基、二烷基胺基,其中相鄰的烷基、鹵 烷基、烷氧基及/或鹵烷氧基與和其連接的碳原子可形成五_ 或六-員環狀系統其含有0至2個氧原子且其烷基部份可隨 意地經一或多個氟原子取代。 特別較宜G1、G2及G3彼此獨立地各選自包括鹵基、 CbCV鹵烧基及Ci-CV貌氧基,其中相鄰的烧基、鹵烧基、 201012812 烧氧基及/或鹵烧氧基與和其連接的碳原子可形成五戈上 員環狀系統其含有0至2個氧原子且其烷基部份可隨意= 經一或多個氟原子取代。 ^ 非常特別較宜G、G2及G3彼此獨立地各選自包括氣、 氣、溴、硤、cf3、ch3o、och2o、och2ch2 及 OCF2〇。 尤其較宜X具有其中一個下面的意義: 2-C1-本基、2-F-6-F-苯基、3-C1-苯基、3-CF3-笨基、4_ci ❹ 苯基、4-Βγ-苯基、4-1·苯基、3-Cl,4-Cl-苯基、3-c^,4_c1_ 苯基、3-Cl,5-Cl-苯基、3-CF3,5-F-苯基、3-CF3,5-Cl-苯基、 3-CF3,5-CF3-苯基、3-Cl,4-Cl,5-Cl-苯基、 3-F,3-Cl,4-〇CH3,5-Cl-苯基、3-Cl,(4)-OCH2〇-(5)-笨其、 3-Cl,(4)-0CF20-(5)-苯基、3-Cl,(4)-OCH2CH2-(5)-笨基、 3-Cl,4-OCH3,5-〇CH3-苯基及 3-OCH3,5-CF3-苯基。 根據本發明之活性化合物,結合良好的植物耐受性及 對溫血動物之合適的毒性並對環境有良好的相容性,合適 ❾ 用於保護植物及植物器官,用於增加產量,用於改良收穫 穀物之品質及用於控制動物害蟲,特別是昆蟲、蝶、螺蟲、 線蟲及軟體動物,其係在農業、園藝、動物飼養、森林、 花園及休閒設施、在儲存的產品及原料之保護、及在衛生 部門中發現。其可以較宜作為植物保護劑使用。其可以活 性對抗通常是敏性及抗藥性的物種及對抗全部或個別的發 育階段。上述害蟲包括: 從風目例如恙蟲屬、血風屬、長顎虱屬、風屬、風兹 屬、犬毛兹屬。 45 201012812 從蛛形綱例如粗足粉蟎、瘤節蜱、刺皮節蟎屬、Aculus 屬、黑养命球腹蛛、粗腳粉蜗、隱聲碑種、純蜱種、雞皮 刺蟎、Hemitarsonemus spp.、癭蟎、橘銹蟎、牛蜱種、扇頭 蜱種、花蜱種、璃眼蜱種、硬碑種、瘙蟎種、癢蟎種、济 蜗種、跗線端種、苜蓿苔蝶、中東金蝎、全爪蜗種、葉螨 種、短須蜗種。 從雙殼貝類動物綱例如菜給屬。 從唇足亞綱例如Geophilus屬、姑蜒屬。 從勒翅目例如大豆象、金龜子屬、agelastica alni、叩 頭蟲屬、amphimallon solstitialis、Anobiumpunctatum、星 天牛屬、象曱屬、皮蠹屬、Apogoniaspp.、榖類財蟲屬、 黑皮蠹屬、白帶長角天牛、豆象屬、Ceuthorrynchus spp.、 Cleonus mendicus、Conoderus spp.、象鼻蟲屬、草地蜻螬、 麻櫟果實象鼻蟲屬、柳小隱β彖象曱、皮蠹屬、Diabrotica spp.、Epilachna spp.、虫主莖象曱、麥珠甲、Heteronychus arator、Hylamorpha elegans、家天牛、苜蓿象鼻蟲^、 Hypothenemus spp.、Lachnosterna consanguinea、科羅拉多 金花蟲、稻象曱、Lixus spp.、Lyctus spp.、花粉曱蟲、大栗 總角金龜、Migdolus spp.、Monochamus spp.、Naupactus xanthographus、黃蛛曱、Oryctes rhinoceros、鑛穀盜、葡萄 黑耳°彖象、銀點花金龜、Phaedon cochleariae、Phyllophaga spp.、曰本麗金龜、安第斯馬鈴薯象屬、油菜蘭跳曱、Ptinus spp.、黑根瓢蟲、穀蠹、倉儲稻穀象鼻蟲屬、Sphenophorus spp.、Sternechus spp.、Symphyletes spp.、黃粉甲、擬穀盜 201012812 屬、斑皮橐屬、Tychius spp.、虎天牛屬、Zabrus spp.。 從彈尾目例如甜菜跳蟲。 從革翅目例如歐洲球螋。 攸一足目例如 Blaniulus guttulatus 〇 從雙翅目例如伊蚊種、按蚊種、Bibio hortulanus、紅頭 麗繩、地中海實蠅、麗蠅屬、錐蠅屬、人皮蠅、家蚊屬、 野生齧齒蠅屬、油橄欖實蠅、人膚蠅、小果蠅屬、Fannia ❹ SPP.、馬繩屬、黑繩屬、Hypobosca spp.、犛牛牛皮繩屬、 斑潛繩屬、綠頭蒼蜗屬、家繩屬、Nezara spp.、羊狂繩屬、 瑞典蠅、甜菜潛葉蠅、蚤蠅種、廢蠅屬、虻種、Tanniaspp、 歐洲大蚊、黑鬚污蠅屬。 從腹足綱例如Arion spp.、扁形捲螺屬、Bulinus spp.、Wherein G1, G2 and G3 are each independently selected from the group consisting of halo, alkyl, haloalkyl, alkoxy, alkoxyalkyl, alkoxyalkoxy, cycloalkyl, alkenyloxy, alkynyloxy , cycloalkylalkoxy, haloalkoxy, alkoxyalkyl, alkylsulfanyl, ialkylsulfanyl, alkylsulfinyl, alkylsulfinyl, alkane Sulfosyl, haloalkylsulfonyl, cyano, alkylcarbonyl, alkoxycarbonyl, alkoxycarbonylalkyl, carboxyl, decylamino, dialkylguanidino, trialkyldecyl, Nitro, amine, alkylamino, dialkylamino, alkylsulfonylamino, dialkylsulfonylamino, -CR6=NO-R6, -CR^NO-haloalkyl or A ketone group in which an adjacent alkyl group, a halogen group, an alkoxy group, and/or an alkoxy group and a carbon atom to which it is attached may form a five- or six-membered ring system containing 0 to 2 oxygen atoms. The atom and its alkyl moiety are optionally substituted with one or more fluorine atoms. Preferably, G^G2 and G3 are each independently selected from the group consisting of halo, alkyl, haloalkyl, alkoxy, alkoxyalkyl, alkoxyalkoxy, COOH, nitro, amine, alkane. An amino group, a dialkylamino group, wherein an adjacent alkyl group, a haloalkyl group, an alkoxy group and/or a haloalkoxy group and a carbon atom to which it is attached may form a five- or six-membered ring system It contains 0 to 2 oxygen atoms and its alkyl moiety is optionally substituted by one or more fluorine atoms. Particularly preferably, G1, G2 and G3 are each independently selected from the group consisting of a halogen group, a CbCV halogen group and a Ci-CV morphoxy group, wherein an adjacent alkyl group, a halogen group, a 201012812 alkoxy group and/or a halogen group are burned. The oxy group and the carbon atom to which it is attached may form a five-membered ring system containing 0 to 2 oxygen atoms and the alkyl moiety thereof may be optionally substituted with one or more fluorine atoms. Very particularly preferably G, G2 and G3 are each independently selected from the group consisting of gas, gas, bromine, hydrazine, cf3, ch3o, och2o, och2ch2 and OCF2. Particularly preferably, X has one of the following meanings: 2-C1-bens, 2-F-6-F-phenyl, 3-C1-phenyl, 3-CF3-styl, 4_ci phenyl, 4- Βγ-phenyl, 4-1·phenyl, 3-Cl,4-Cl-phenyl, 3-c^,4_c1_phenyl, 3-Cl, 5-Cl-phenyl, 3-CF3,5-F -phenyl, 3-CF3,5-Cl-phenyl, 3-CF3, 5-CF3-phenyl, 3-Cl, 4-Cl, 5-Cl-phenyl, 3-F,3-Cl, 4 -〇CH3,5-Cl-phenyl, 3-Cl, (4)-OCH2〇-(5)- stupid, 3-Cl, (4)-0CF20-(5)-phenyl, 3-Cl, (4) -OCH2CH2-(5)-styl, 3-Cl,4-OCH3, 5-anthracepin-3-phenyl and 3-OCH3,5-CF3-phenyl. The active compound according to the invention, in combination with good plant tolerance and suitable toxicity to warm-blooded animals, has good compatibility with the environment, and is suitable for protecting plants and plant organs for increasing yield and for Improve the quality of harvested grains and control animal pests, especially insects, butterflies, snails, nematodes and mollusks, in agriculture, horticulture, animal husbandry, forests, gardens and leisure facilities, in stored products and raw materials. Protected and found in the health sector. It can be preferably used as a plant protection agent. It can be active against species that are usually sensitive and resistant and against all or individual stages of development. The above pests include: From the wind, such as the genus Aphid, the genus Hemophilia, the genus genus, the genus, the genus, the genus. 45 201012812 From arachnids such as scoparia, scorpion scorpion, scorpion scorpion, Aculus genus, black scorpion, snail, snail, sacred, pure scorpion, chicken skin hedgehog, Hemitarsonemus spp., medlar, orange rust, burdock, scorpion, scorpion, scorpion, hard monument, scorpion, itch, snail, scorpion Brassica butterfly, Middle Eastern golden scorpion, full-claw snail, leaf scorpion, and short-stalked snail. From the bivalve mollusc class, for example, to the genus. From the subgenus of the lip, such as the genus Geophilus, the genus Aunt. From the order of the genus Lepidoptera, for example, soybean, genus, agelastica alni, genus, amphimallon solstitialis, Anobiumpunctatum, ostracod, genus, genus, Apogoniaspp., genus, genus, genus Platycodon elegans, Beans, Ceuthorrynchus spp., Cleonus mendicus, Conoderus spp., Weevil, Grasshopper, Paralyzed genus, Rhododendron, 彖, 蠹, Diabrotica spp ., Epilachna spp., worm main stem 麦, 麦 beetle, Heteronychus arator, Hylamorpha elegans, house beetle, 苜蓿 weevil ^, Hypothenemus spp., Lachnosterna consanguinea, Colorado golden bud, rice locust, Lixus spp Lyctus spp., pollen aphid, big chestnut tortoise, Migdolus spp., Monochamus spp., Naupactus xanthographus, yellow spider mites, Oryctes rhinoceros, mine thieves, grape black ear 彖 elephant, silver dot flower golden tortoise, Phaedon Cochleariae, Phyllophaga spp., 曰本丽金龟, Andean potato genus, rapeseed flea, Ptinus spp., black root ladybug, glutinous rice, storage rice weevil , Sphenophorus spp., Sternechus spp., Symphyletes spp., Tenebrio molitor, Tribolium 201012812 genus, genus sack maculata, Tychius spp., Tiger beetles belong, Zabrus spp .. From the tail of the bullet, such as beet hoppers. From the genus Ganoderma, such as the European ball python. One foot, for example, Blaniulus guttulatus 〇 from Diptera such as Aedes, Anopheles, Bibio hortulanus, Red-headed lynx, Mediterranean fruit fly, Drosophila, Drosophila, human flies, Musca domestica, wild rodent flies Genus, olive fruit fly, human skin fly, genus Drosophila, Fannia ❹ SPP., genus, black genus, Hypobosca spp., yak leather genus, genus genus, genus, genus Genus, Nezara spp., sheep genus, swedish fly, beet leaf miner, cockroach fly, genus, fly genus, Tanniaspp, European mosquito, black beetle. From the gastropods such as Arion spp., the flat genus, Bulinus spp.,
Deroceras spp.、Galba spp.、Lymnaea spp.、釘螺屬、琥拍 堝牛屬。 從螺蟲綱例如十二指腸鉤蟲、錫蘭鉤蟲、巴西鉤蟲、 ❹ 鉤蟲屬、蛔蟲、Ascarisspp·、馬來亞絲蟲、帝汶絲蟲、Deroceras spp., Galba spp., Lymnaea spp., snail, amber yak. From the genus Spirulina, such as the duodenal hookworm, Ceylon hookworm, the Brazilian hookworm, the genus Hookworm, the locust, the Ascarisspp, the Malayan filaria, the Timorese worm,
Bunostomumspp.、羊腸線蟲屬、支睪屬、梳狀古巴毛樣線 蟲屬、肝吸蟲屬、絲狀網尾線虫、廣節裂頭絛蟲、麥地那 線蟲、單房性包蟲、多房性包蟲、蟯蟲、Faci〇ia Spp.、血 矛線蟲屬、目肪蟲屬、短小包膜絛蟲、Hy0str〇ngulus spp.、 眼絲蟲、線蟲屬、牛腸結節蟲屬、肝吸蟲屬、蟠尾絲蟲、 胃絲蟲屬、並殖吸蟲屬、血吸蟲屬、類圓線蟲、糞小桿線蟲、 Strcmyloides sPP.、無條蟲、有條蟲、旋毛蟲、旋毛形線蟲、 Trichinella bdtovi、納氏旋毛蟲、Trichindla、 201012812 毛圓線蟲屬、鞭蟲、班氏絲蟲。 其還可能控制原蟲,例如艾美求蟲。 從異翅亞目例如南瓜緣蜂、Antestiopsis spp.、Blissus spp.、Calocoris spp.、盲蝽、Cavelerius spp.、Cimex spp·、 綠盲培、緣培、Dichelops furcatus、Diconocoris hewetti、 Dysdercus spp.、Euschistus spp.、褐盾蜂種、Heliopeltis spp.、Horcias nobilellus、大稻緣蝽屬、Leptoglossus phyllopUS、盲椿屬、;\1&〇*0卩65 6乂。&乂&^13、盲培科、綠椿象 屬、Oebalus spp.、Pentomidae、蜂象、Piezodorus spp.、棉 跳盲蜂、Pseudacystapersea、錐鼻蟲屬、可可褐盲、黑椿象 屬、梨冠軍配蟲、Tibracaspp.、吸企獵蜂種。 從同翅目例如Acyrthosipon spp.、稻褐飛乱屬、 Agonoscenaspp.、菸草粉蝨屬、甘蔗穴粉蝨、leur〇thrixus spp·、小綠葉禪屬、Anuraphis cardui、赤圓介殼蟲屬、梨瘤 蚜、種棉蚜屬、葡萄浮塵子、小圓盾介殼蟲屬、接穗上介 殼蟲屬、Atanus spp.、馬铃薯財、Bemisia spp.、Brachycaudus helichrysii、短足角蟾屬、甘藍蚜、Calligyponamarginata、 Carneocephalafulgida、甘蔗綿辑、泳蟬科、角躐蛉屬、Bunostomumspp., Nematode, Branch genus, Comb-like genus of the genus Helicover, Liver genus, Filamentous nematode, Aphis gossypii, Medina nematode, Single-roomed worm, Multi-room Echinococcosis, aphid, Faci〇ia Spp., Haemonchus, genus, genus Short-coated mites, Hy0str〇ngulus spp., filaria, nematode, genus Bovine genus, liver genus , Iris, Gastroin, Paragonimus, Schistosoma, A. elegans, C. elegans, Strcmyloides sPP., wormless, worm, Trichinella, Trichinella, Trichinella bdtovi , Trichinella, Trichindla, 201012812, Trichoderma, Whipworm, B. elegans. It may also control protozoa, such as Amy. From the genus Heteroptera, such as the pumpkin bee, Antestiopsis spp., Blissus spp., Calocoris spp., scorpion, Cavelierius spp., Cimex spp., green blind, marginal culture, Dielops furcatus, Diconocoris hewetti, Dysdercus spp. Euschistus spp., brown shield bee species, Heliopeltis spp., Horcias nobilellus, O. striata, Leptoglossus phyllopUS, genus genus, \1&〇*0卩65 6乂. &乂&^13, Blinds, Green genus, Oebalus spp., Pentomidae, Bee, Piezodorus spp., Cotton Sweeping Bee, Pseudacystapersea, Cone, Cocoa, Black Stork, Pear Champion, Tibracaspp., and beekeeping. From the Homoptera such as Acyrthosipon spp., the rice brown genus, Agonoscenaspp., Tobacco genus, sugarcane, whitefly, leur〇thrixus spp, small green leaf genus, Anuraphis cardui, red scale genus, pear蚜, cotton genus, grape ash, small round Shield, genus, stalk, Atanus spp., potato, Bemisia spp., Brachycaudus helichrysii, Brachypodium, Brassica, Calligyponamarginata, Carneocephalafulgida, sugar cane cotton, swimming cricket, horned genus,
Chaetosiphon fragaefolii、Chionaspis tegalensis、Chlorita onukii、核桃黑斑財、褐圓介殼蟲、Cicadulina mbila、 Coccomytilus halli、Coccus spp.、Cryptomyzus ribis、葉蟬 屬、粉蟲屬、木兹屬、介殼蟲屬、履綿纷屬、Dysaphis spp.、 娟粉介殼蟲屬、棉花小綠葉轉屬、蘋果綿財屬、Erythroneura spp.、Euscelis bilobatus、咖啡荒粉蚧、琉璃葉蟬、桃粉蚜、 201012812Chaetosiphon fragaefolii, Chionaspis tegalensis, Chlorita onukii, Walnut black spotted, brown round scale insect, Cicadulina mbila, Coccomytilus halli, Coccus spp., Cryptomyzus ribis, Aphis, Trichoderma, Woods, Scales, crawling Dysaphis spp., genus Pseudomonas, cotton leafy genus, apple genus, Erythroneura spp., Euscelis bilobatus, coffee powder glutinous rice, glazed leaf mites, peach glutinous rice, 201012812
Icerya spp.、Idiocerus spp.、綠葉禪屬、斑飛蟲、Lecanium spp.、Lepidosaphes spp.、萝卜財、Macrosiphum spp.、 Mahanarva fimbriolata、高粱黍辑、Metcalfiella spp·、紫羅 蘭瘤額財、Monellia costalis、Monelliopsis pecanis、桃财屬、 萵苣財蟲、黑尾葉蟬屬、褐飛蟲、Oncometopia spp.、Orthezia praelonga、粉蝨、Paratrioza spp.、黑點介殼蟲屬、Pemphigus spp·、玉米飛兹、Phenacoccus spp.、Phloeomyzus passerinii、 額財、Phylloxera spp.、柑桔並盾介殼蟲、Planococcus spp.、 厚綠原綿介殼蟲、桑介殼蟲、尾粉介殼蟲屬、木蝨屬、 Pteromalus spp.、普路沙游蠛蟬屬、梨圓价屬、Quesada gigas、粉介殼蟲屬、常财屬、半圓堅介殼蟲屬、Scaphoides titanus、麥二叉对、刺盾纷、白背飛風屬、背飛兹、Sogatodes spp.、Stictocephala festina、Tenalaphara malayensis、 Tinocallis caryaefoliae、Tomaspis spp·、oxoptera spp.、溫室 粉兹、木兹屬、小葉禪屬、介殼蟲屬、蘋果小食心蟲。 從膜翅目例如葉蜂屬、李葉蜂屬、Lasius spp.、厨議、 虎頭蜂屬。 從等足目例如Armadium vulgare、寶螺、鼠婦蟲。 從等翅目例如白蟻屬、姬白蟻屬。 從鱗翅目例如Acronicta major、白斑煩夜蛾、小地老 虎屬、棉樹葉A、Anticarsia spp.、甘藍夜蛾、Bucculatrix thurberiella、松尺護、Cacoecia podana、Capua reticulana、 蘋果蠹蛾、Cheimatobiabrumata、Chilo spp.、樅色捲蛾、 葡萄填蛾、Cnaphalocerus spp.、Earias insulana、地中海粉 49 201012812 斑螟、褐尾蛾、Euxoa spp.、Feltia spp.、大蠟蛾、夜蛾屬、 棉铃蟲屬、褐織葉模、捲心蟲、Hyponomeutapadella、甜 菜夜蛾屬、金紋細蛾、Lithophane antennata、Loxagrotis albicosta、舞毒蛾屬、天幕枯葉蛾、甘藍夜蛾、毛脛夜蛾、 白脈黏夜蛾、Oria spp·、負泥蟲、冬夜蛾、棉紅鈐蟲、柑桔 潛葉蛾、Pieris spp.、小菜蛾、pr〇denia spp.、Pseudaletia spp.、大豆夜蛾、鐘麻粟螟、夜盜蟲屬、Thermesia gemmatalis、衣蛾、Tineola bisselliella、Tortrix viridana、 紋夜蛾屬。 從緋蠊目例如蟋埤、東方蜡蠊、德國蟑螂、螻蛄屬、 佛羅里達蟑螂、飛蝗屬、黑蝗屬、美洲蜚蠊、非洲沙漠蝗 蟲。 從蚤目例如禽蚤、東方鼠蚤。 從綜合綱例如白松蟲。 從缕翅目例如稻薊馬、Enneothrips flavens、花薊馬屬、 溫室薊馬屬、褐帶溫室薊馬、腹鉤薊馬、小黃薊馬、 Taeniothrips cardamoni、花韵馬屬。 從雙尾目例如西洋衣魚。 植物性寄生線蟲包括例如腫癭·線蟲、葉芽線蟲、 Belonoaimus spp.、松材線蟲、莖線蟲、黃金線蟲、 Heliocotylenchus spp.、包囊線蟲、針線蟲、根瘤線蟲、根 腐線蟲、螺旋形線蟲、穿孔線蟲、殘根線蟲、柑桔線蟲、 烏它形線蟲、掛結線蟲、劍線蟲。 植物性寄生線蟲包括例如腫癭線蟲、葉芽線蟲、 201012812Icerya spp., Idiocerus spp., Eucalyptus spp., Lepidium spp., Lepidosaphes spp., Radish, Macrosiphum spp., Mahanarva fimbriolata, sorghum, Metcalfiella spp, Violet tumor, Monellia costalis, Monelliopsis pecanis, Peach genus, Lettuce, Black-tailed genus, Brown worm, Oncometopia spp., Orthezia praelonga, Whitefly, Paratrioza spp., Black-spotted genus, Pemphigus spp·, Cornfinch, Phenacoccus Spp., Phloeomyzus passerinii, 财, Phylloxera spp., citrus and Shield Shield, Planococcus spp., thick green worm, scale insect, tail powder scale, hibiscus, Pteromalus spp., Pulu Sand scorpion, Pear genus, Quesada gigas, Pleurotus genus, genus, semi-circular genus, Scaphoides titanus, maiden, thorn shield, white-backed genus, back-flying , Sogatodes spp., Stictocephala festina, Tenalaphara malayensis, Tinocallis caryaefoliae, Tomaspis spp·, oxoptera spp., Greenhouse powder, Muz, Phyllostachys, shell Genera, apple borer. From the Hymenoptera, such as the genus Hymenoptera, Liriodendron, Lasius spp., the kitchen, the genus. From the Isopods such as Armadium vulgare, Baoluo, Rats. From the order of the isopods such as the termite genus and the genus Artemis. From Lepidoptera such as Acronicta major, P. sylvestris, C. sylvestris, cotton leaf A, Anticarsia spp., Cabbage worm, Bucculatrix thurberiella, Pine stalk, Cacoecia podana, Capua reticulana, Codling moth, Cheimatobiabrumata, Chilo spp ., 枞色卷蛾, Grape-filled moth, Cnaphalocerus spp., Earias insulana, Mediterranean flour 49 201012812 Cantharidin, brown-tailed moth, Euxoa spp., Feltia spp., Great wax moth, Noctuidae, Helicoverpa armigera, brown Weaver leaf mold, Coiliate, Hyponomeutapadella, Beet armyworm, Golden moth, Lithhophane antennata, Loxalactis albicosta, Gypsy moth, Canopy leaf moth, Cabbage worm, Spodoptera frugiperda, Spodoptera frugiperda, Oria spp· , negative worm, winter moth, cotton red locust, citrus leaf miner, Pieris spp., diamondback moth, pr〇denia spp., Pseudaletia spp., soybean nocturnal moth, marigold, genus , Thermesia gemmatalis, Moth, Tineola bisselliella, Tortrix viridana, Spodoptera. From the order of the cockroach, such as cockroach, oriental wax cockroach, German cockroach, genus genus, Florida cockroach, cockroach, cockroach, American cockroach, African desert locust. From the eye to the eye, such as the fowl, the oriental groin. From the general outline such as white pine worm. From the order of the genus Hymenoptera, such as the scorpion horse, Enneothrips flavens, the flower scorpion, the greenhouse, the genus, the brown belt, the hummer, the scorpion, the scorpion, the Taeniothrips cardamoni, the genus. From the two-tailed eye, such as the western piranha. Plant parasitic nematodes include, for example, sputum nematode, leaf bud nematode, Belonoaimus spp., pine wood nematode, stem nematode, golden nematode, Heliocotylenchus spp., cyst nematode, needle nematode, nodule nematode, root rot nematode, spiral nematode, Perforated nematodes, remnant nematodes, citrus nematodes, Ukrainian nematodes, knotted nematodes, and sword nematodes. Plant parasitic nematodes include, for example, nematode, nematode, 201012812
Bekmoaimus spp.、松材線蟲、莖線蟲、黃金線蟲、Bekmoaimus spp., pine wood nematode, stem nematode, golden nematode,
Heliocotylenchus spp.、包囊線蟲、針線蟲、根瘤線蟲、根 腐線蟲、螺旋形線蟲、穿孔線蟲、殘根線蟲、柑桔線蟲、 4它形線蟲、柑桔線蟲、劍線蟲。 v 如果適當時,根據本發明之化合物在某種濃度或使用 率下,也可以作為除草劑、安全劑、生長調節劑或改良植 物性質的藥劑使用,或作為殺微生物劑,例如作為殺真菌 ❹ 劑、抗黴菌劑、殺菌劑、殺病毒劑(包括抗擬病毒的藥劑) 或作為抗MLOs (擬菌質體)及RL〇s (類立克次體)的藥劑。 如果適▲4,其也可以作為合成其他活性化合物的中間體 或前驅物使用。 該活性化合物可以轉化成慣用的調製物例如溶液、乳 液、可溼化的粉劑、水·及油_基質的懸浮液、粉劑、灰劑、 糊劑、可溶解的粉劑、可溶解的粒劑、用餘播撒的粒劑、 懸浮乳液濃縮劑、浸透活性化合物之天然物質、浸透活性 ❹ 化合物之合成的物質、在聚合物質中的肥料及微囊化劑。 這些化合物是在已知的方式下生產,例如經由將活性 化合物與延伸劑混合也就是液體溶劑及/或固體載劑,隨意 地使用表面活性劑,也就是乳化劑及/或分散劑及/或泡沫形 成劑。該調製物是在合適的植物中或者是在使用前或使用 期間製備。 可以使用的輔劑是可使賦予組成物本身及/或從其衍生 的製劑(例如喷霧混合物、種子敷料)有特定性質例如某些技 術性質及/或特定生物性質之彼等物質。合適的典型辅劑 201012812 是:延伸劑、溶劑及载劑。 合適的延伸劑是例如水、極性及非極性有機化學液體 例如從芳族及非芳族烴類(例如烷屬烴、烷基苯、烷基萘、 氣苯)、醇及多兀醇類(其可隨意地經取代、醚化及/或酯 化)、酮類(例如丙酮、環己酮)、酯類(包括脂肪及油類)及(聚) 醚類、未經取代及經取代的胺類、醯胺類、内醯胺類(例如 N-烷基吡咯啶)及内酯類、砜及亞砜類(例如二曱亞砜)。 如果使用的延伸劑是水,也可以使用輔助溶劑,例如 有,溶劑。實質上合適的液體溶劑是:芳族例如二曱苯、© 甲苯或烧基萘’氣化芳族、或氣化脂族烴類例如氣苯、氯 乙烯或二氯曱烧’脂族煙類例如環己烧或鍵烧經例如礦物 油館份、礦物及植物油,醇類例如丁醇或甘醇及其謎類及 醋類’酮類例如丙_、甲基乙基嗣、甲基異丁基酮或環已 嗣,強極性溶劑例如二甲基甲醯胺及二甲亞似水。 合適的固體載劑是: 〇 例如,鹽及粉碎的天然礦物例如高嶺土、黏土、滑石 石灰;5英、;5夕鎂土、蒙脫土切藻土,及粉碎的合成確 物例如微細刀粒的—氧化⑦、氧化紹及⑦酸鹽;用於粒劑 之合適的固體載劑是:例如壓碎且分級的天然岩石例如方 Γ右嬙石浮石、海泡石及白雲石’或是合成的無機 止4 之顆粒,及有機物質例如财屑、椰子殼、玉 二2草莖之顆粒;合適的乳化劑及/或泡沫形成劑是: = 子及陰離子性乳化#1例如聚氧乙稀脂肪酸酿、 ^氧乙烯脂肪義’例域基芳絲甘_、賴烧i旨、 52 201012812 硫酸烷酯、磺酸芳酯,或蛋白質水解物;合適的分散劑是: 非離子及/或離子性物質,例如從醇_p〇E及/或—POP驗類、 酸及/或POP-POE醋類、烧基芳基及/或p〇p_p〇E趟類、脂 肪及/或POP-POE加成物、p〇p_&/或卩〇1>_多元醇衍生物、 l〇E-及/或P0P_山梨糖醇軒或·糖加合物、硫酸烧醋或硫酸 芳酯、磺酸烷酯或磺酸芳酯及磷酸烷酯或磷酸芳醋、或對Heliocotylenchus spp., cyst nematode, needle nematode, root nodule nematode, root rot nematode, spiral nematode, perforated nematode, remnant nematode, citrus nematode, 4 elegans, citrus nematode, sword nematode. v If appropriate, the compounds according to the invention may also be used as herbicides, safeners, growth regulators or agents for improving plant properties, or as microbicides, for example as fungicides, at a certain concentration or rate of use. Agents, antifungal agents, fungicides, viricides (including antiviral agents) or as anti-MLOs (bacteria) and RL〇s (like rickettsia). If appropriate, it can also be used as an intermediate or precursor for the synthesis of other active compounds. The active compound can be converted into conventional preparations such as solutions, emulsions, wettable powders, water and oil-base suspensions, powders, ash, pastes, soluble powders, soluble granules, The granules, the emulsified concentrate, the natural substance impregnated with the active compound, the synthetic substance impregnated with the active hydrazine compound, the fertilizer in the polymeric substance, and the microencapsulating agent are used. These compounds are produced in a known manner, for example by mixing the active compound with an extender, that is to say a liquid solvent and/or a solid carrier, optionally using surfactants, ie emulsifiers and/or dispersants and/or Foam former. The preparation is prepared in a suitable plant or prior to use or during use. Adjuvants which may be employed are those which impart specific properties such as certain technical properties and/or specific biological properties to the formulation itself (and/or the spray mixture, seed dressing) imparted to and/or derived from the composition. A suitable typical adjuvant 201012812 is: extender, solvent and carrier. Suitable extenders are, for example, water, polar and non-polar organic chemical liquids such as from aromatic and non-aromatic hydrocarbons (eg, paraffins, alkylbenzenes, alkylnaphthalenes, gaseous benzenes), alcohols, and polyterpenes ( It can be optionally substituted, etherified and/or esterified), ketones (such as acetone, cyclohexanone), esters (including fats and oils) and (poly)ethers, unsubstituted and substituted. Amines, guanamines, indoleamines (such as N-alkylpyrrolidines) and lactones, sulfones and sulfoxides (such as disulfoxide). If the extender used is water, an auxiliary solvent such as a solvent may also be used. Substantially suitable liquid solvents are: aromatics such as diphenylbenzene, © toluene or alkyl naphthalene 'gasified aromatics, or gasified aliphatic hydrocarbons such as benzene, vinyl chloride or dichlorohydrin-' aliphatic cigarettes For example, cyclohexane or bond burns such as mineral oil, minerals and vegetable oils, alcohols such as butanol or glycol and their mysteries and vinegars such as propyl, methyl ethyl hydrazine, methyl isobutyl The ketone or ring is ruthenium, and strong polar solvents such as dimethylformamide and dimethylene are water. Suitable solid carriers are: for example, salts and pulverized natural minerals such as kaolin, clay, talc lime; 5 inches; 5 kiwi, montmorillonite, and comminuted synthetics such as fine knives - Oxidation 7, Oxidation and 7 acid salts; suitable solid carriers for granules are: for example crushed and graded natural rocks such as valence orbital pumice, sepiolite and dolomite ' or synthetic Inorganic stop 4 particles, and organic materials such as granules, coconut shell, jade 2 grass stem particles; suitable emulsifiers and / or foam forming agents are: = sub and anionic emulsification #1 such as polyoxyethylene Fatty acid brewing, ^oxyethylene fat meaning 'example domain aryl sylvestre _, 赖 烧 依, 52 201012812 alkyl sulfate, aryl sulfonate, or protein hydrolysate; suitable dispersing agent is: non-ionic and / or ion Sex substances, for example from alcohol _p〇E and / or - POP, acid and / or POP-POE vinegar, alkyl aryl and / or p〇p_p〇E 趟, fat and / or POP-POE Adduct, p〇p_&/or 卩〇1>_polyol derivative, l〇E- and/or P0P_sorbitol or sugar Compound, sulfuric acid vinegar or aryl sulfate, sulfonic acid alkyl or sulfonic acid aryl ester and alkyl phosphate or aromatic acid vinegar, or
應的PO-醚加合物。其他合適的是寡_或聚合物,例如衍生 自乙烯系單體、丙稀酸、EO及/或p〇本身或結合例如(聚) 醇類或(聚)胺類。也可以使用木質素及其磺酸衍生物、未經 改良及經改良的纖維素、芳族及/或脂族磺酸、及其與甲醛 之加合物。 在調製物中可以使用稠化劑例如粉末、顆粒或膠乳形 式之竣甲基纖維素、天然與合成的聚合物,例如阿拉伯膠、 =稀醇及聚崎乙_,或者是天然_旨例如觸脂及 卵嶙脂及合成的磷脂。 可以使用染劑例如無機顏料例如氧化鐵、氧化鈦及普 魯士藍,及有機染劑例如茜素藍染劑、偶氮 二 花青染劑’及微量營養劑例如鐵、猛♦二金 辞之鹽類。 其他可能的添加劑是香料、隨意經改良礦物或植物 油、壤及營養劑(包括微量營養劑),例如鐵、鍾、爛、銅, 敍、鉬及鋅之鹽類。 也可以存在安定劑例如低溫安定劑、防腐劑、抗氧化 劑、光安定劑或改良化學及/或物理安定性的其他藥劑。 53 η 201012812 該調製物通常含有0.01及98重量之間的活性化合物, 較宜是0.5及90%之間。 根據本發明之活性物質組合物可以在目前商業化供應 的調製物形式或從這些調製物與其他活性物質例如殺昆蟲 劑、誘引劑、消毒劑、殺菌劑、殺蟎劑、殺線蟲劑、殺真 菌劑、生長調節劑、除草劑、安全劑、肥料或化學傳訊素 製備成混合物之使用形式使用。 特別有利的混合成份是例如下面的化合物: 殺真菌劑: (1) 核酸合成抑制劑,例如本達樂(benaiaxyi)、精苯霜靈 (benalaxyl-M)、布瑞莫(bupirimate)、克羅康(clozylacon)、 一曱嘴紛(dimethirimol)、乙嘲紛(ethirimol)、吱霜靈 (furalaxyl)、殺紋寧(hymexazol)、滅達樂(metalaxyl)、右滅 達樂(metalaxyl-M)、咬酿胺(〇furace)、歐殺斯(oxadixyl)及 歐索林酸(oxolinic acid)。 (2) 有絲为裂及細胞分裂抑制劑’例如免賴得(ben〇my 1)、貝 芬替(carbendazim)、克芬唑(chl〇rfenazole)、乙霉威 (diethofencarb)、噻唑菌胺(ethaboxam)、麥穗寧 (fuberidazole)、負克隆(pencycuron)、腐絕(thiabendazole)、 多保淨(thiophanate)、曱基多保淨(thi〇phanate-methyl)及座 赛胺(zoxamide)。 (3) 啤吸抑制劑(呼吸鏈之抑制劑),例如二氟林(difiumet〇rini) 在呼吸鏈的複合物Ϊ上作為抑制劑;拜芬(bixafen)、白克列 (boscalid)、萎銹靈(carboxin)、曱呋醯胺(fenfuram)、福多寧 201012812 (flutolanil)、氣比菌酿胺(fluopyram)、福拉比(furametpyr)、 福滅克(furmecyclox)、異比蘭(isopyrazam)(順-差向外消旋 物IRS、4SR、9RS及反-差向外消旋物IRS、4SR、9SR之 混合物)、異比蘭(順-差向外消旋物1RS、4SR、9RS)、異比 蘭(順-差向外消旋物1R、4S、9R)、異比蘭(順_差向外消旋 物18、4尺、98)、異比蘭(反_差向外消旋物1118、4811、9811)、 異比蘭(反-差向外消旋物1R、4S、9S)、異比蘭(反-差向外 消旋物 IS、4R、9R)、 滅普寧(mepronil)、嘉保信(oxycarboxin)、本福芬 (penflufen)、吼喧菌胺(penthiopyrad)、赛達(sedaxane)、賽 氟滅(thifluzamid)在呼吸鏈的複合物II上作為抑制劑;引嗤 續菌胺(amisulbrom)、亞托敏(azoxystrobin)、賽座滅 (cyazofamid)、醚菌胺(dimoxystrobin)、烯月亏菌醋 (enestroburin)、凡殺克絕(famoxadone)、咪唾菌 _ (fenamidone)、氟嘴菌酉旨(fuoxastrobin)、克收欣 (kresoxim-methyl)、苯氧菌胺(metominostrobin)、肟醚菌胺 (orysastrobin)、咬氧菌醋(picoxystrobin)、百克敏 (pyraclostrobin)、嗜菌酉旨(pyraoxystrobin)、必瑞滅 (pyrametostrobin)、必本克(pyribencarb)、三氟敏 (trifloxystrobin)在呼吸鏈的複合物III上作為抑制劑。 (4) 去偶合劑,例如百滿克(binapacryl)、消螨普(dinocap)、 扶吉胺(fluazinam)及滅敵克(meptyldinocap) 〇 (5) ATP 製造抑制劑’例如(fentin acetate)、(fentin chloride)、 (fentin hydroxide)及(silthiofam) 〇 55 201012812 (6) 胺基酸及蛋白質生物合成抑制劑,例如安多普 (andoprim)、保米徽素(blasticidin-S)、赛普洛(cyprodinil)、 嘉賜擻素(kasugamycin)、嘉賜徽素水合鹽酸鹽(kasugamycin hydrochloride hydrate)、滅派林(mepanipyrim)及嘴霉胺 (pyrimethanil)。 (7) 訊號轉導抑制劑’例如播種咯(fenpiclonil)、護汰寧 (fludioxonil)及快諾芬(qUinoXyfen) 〇 (8) 脂質及膜合成抑制劑,例如聯苯(biphenyl)、平克座 (chlozolinate)、護粒松(edifenphos)、依得利(etridiazole)、 峨克(iodocarb)、丙基喜樂松(iprobenfos)、依普同 (iprodione)、亞賜圃(isoprothiolane)、撲滅寧(procymidone)、 普拔克(propamocarb)、普拔克鹽酸鹽(propamocarb hydrochloride)、白粉松(pyrazophos)、脫克松 (tolclofos-methyl)及免克寧(vinclozolin)。 (9) 麥角脂醇生物合成抑制劑,例如歐地莫(aldimorph)、氧 環嗤(azaconazole)、比多農(bitertanol)、糖菌嗤 (bromuconazole)、環克座(cyproconazole)、苄氣三嗤醇 (diclobutrazole)、待克利(difenoconazole)、浠口坐醇 (diniconazole)、達克利(diniconazole-M)、多地莫 (dodemorph)、多地莫醋酸鹽(dodemorph acetate)、敦環口坐 (epoxiconazole)、乙環唾(etaconazole)、芬瑞莫(fenarimol)、 腈苯°^(fenbuconazole)、環醯菌胺(fenhexamid)、苯鎮咬 (fenpropidin)、芬普福(fenpropimorph)、氣坐 (fluquinconazole)、吱喊醇(flurprimidol)、護石夕得 201012812 (flusilazole)、護芬汰(flutriafol)、吱菌唾(furconazole)、順-呋菌唑(furconazole-cis)、菲克利(hexaconazole)、依滅列 (imazalil)、依滅列硫酸鹽(imazalil sulphate)、易胺座 (imibenconazole)、種菌嗤(ipconazole)、滅特座 (metconazole)、邁尼克(myclobutanil)、萘替芬(naftifine)、 尼瑞莫(nuarimol)、畤咪嗤(0Xp0C0naz0ie)、巴克素 (paclobutrazol)、稻瘂酯(pefurazoate)、平克座 (penconazole)、粉病靈(piperalin)、撲克拉(prochloraz)、普 克利(propiconazole)、丙硫菌嗤(prothioconazole)、稗草丹 (pyributicarb)、比芬諾(pyrifenox)、快克唑(quinconazole)、 石夕氣《^(simeconazole)、螺環菌胺(spiroxamine)、得克利 (tebuconazole)、特比耐芬(terbinaflne)、四克利 (tetraconazole)、三唾酮(triadimefon)、三泰隆(triadimenol)、 三得芬(tridemorph)、賽福座(triflumizole)、赛福寧 (triforine)、滅菌嗤(triticonazole)、晞效嗤(uniconazole)、氯 康0坐(viniconazole)及伏立康嗤(voriconazole)。 (10) 細胞壁合成抑制劑,例如苯售菌胺(benthiavalicarb)、達 滅芬(dimethomorph)、氟嗎嚇(flumoi^ph)、異丙菌胺 (iprovalicarb)、雙快酿菌胺(mandipropamid)、保粒丹 (polyoxins)、保粒黴素(polyoxorim)、硫菌威(prothiocarb)、 維利黴素(validamycin A)及維利芬(valefenalate)。 (11) 黑色素生物合成抑制劑,例如加普胺(carpropamid)、雙 氣氰菌胺(diclocymet)、氰菌胺(fenoxanil)、熱必斯 (phthalide)、百快隆(pyroquilon)及三赛°^(tricyclazole)。 57 201012812 (12) 抵抗誘發劑,例如阿拉酸式苯_s•甲基 (acibenzolar-S-methyl)、撲殺熱(probenazole)及泰地尼 (tiadinil)。 (13) 具有多重部位活性之化合物,例如波爾多混合劑 (Bordeaux mixture)、避菌丹(captaf〇l)、蓋普丹(captan)、四 氯異苯(〇111〇1*〇1;11&1〇11丨1)、環烧酸銅((;〇卩卩61:11&卩111:1161^6)、氧 化銅(copper oxide)、氧氣化銅(copper oxychloride)、(銅製 劑例如氫氧化銅、硫酸銅、益發靈(dichlofluanid)、腈硫醌q (dithianon)、多果定(dodine)及其自由態鹼、福美鐵 (ferbam)、N_鄰苯二曱醯亞胺(fluorofolpet)、滅菌丹(f〇lpet)、 雙胍辛(81^&11116)、雙胍辛醋酸鹽(811&2£1如63(^扯)、克熱 淨(iminoctadine)、克熱淨烷苯績酸鹽(iminoctadine albesilate)、克熱淨二醋酸鹽(iminoctadine triacetate)、代森 錳銅(mancopper)、代森錳辞(mancozeb)、代森猛(maneb)、免 得爛(metiram)、免得爛鋅(metiramzinc)、快得寧 (oxine-copper)、普波咪定(pr〇painidine)、曱基鋅乃浦 (propineb)、硫及硫製劑例如多硫化鈣、得恩地(thiram)、甲〇 基益發靈(tolylfluanid)、代森鋅(zineb)及福美鋅(ziram)。 (14) 其他化合物’例如2,3-二丁基-6-氯噻吩並[2,3-d]喷咬 -4(3H)-酮、(2Z)-3-胺基-2-氰基-3-苯基丙-2-烯酸乙酯、 N-[2_(l,3-二曱基丁基)苯基]氟-1,3-二甲基-iH_吡唑-4•醯 胺、3-(二氟曱基)-1-曱基-N-(3,,4,,5,-三氟聯苯-2-基)-lH-比 唑-4-醯胺、3-(二氟甲基)-N_[4_氟-2-(^2,3,3,3-六氟丙氧 基)苯基]-1-曱基-1H-吡唑-4-醯胺、(2Ε)-2·(2-{[6-(3-氣-2-甲 201012812 基苯氧基)-5-氟嘧啶-4-基]氧基}苯基)-2-(甲氧基亞胺基)_N-曱基乙醯胺、(2E)-2-{2-[({[(2E,3E)-4-(2,6 二氣苯基)亞丁-3_ 烯-2-基]胺基}氧基)甲基]苯基卜2-(甲氧基亞胺基)_n甲基 乙醯胺、2-氯-N-(l,l,3-三甲基-2,3-二氫-1H-茚-4-基)吼啶-3-醯胺、N-(3-乙基-3,5,5-三曱基環己基)_3-(甲醯基胺基)_2·羥 基苄醯胺、5·甲氧基-2-甲基_4-(2-{[({(1Ε)_1-[3-(三氟甲基) 笨基]亞乙基}胺基)氧基]甲基}苯基)_2,4_二氫_3H-1,2,4-三 ❹ 唾_3_酮、(2Ε)·;2-(甲氧基亞胺基)·ν_甲基 -2-(2-{[({(lEH-[3-(三氟甲基)苯基]亞乙基}胺基)氧基]甲 基}苯基)乙醯胺、(2E)-2-(甲氧基亞胺基)_N-甲基 -2-{2-[(Ε)-({1-[3-(三氟甲基)苯基]乙氧基)亞胺基)甲基]苯 基}乙醯胺、(2Ε)-2-{2-[({[(1Ε)-1-(3-{[(Ε)-1-氟-2-苯基乙烯 基]氧基}苯基)亞乙基]胺基}氧基)甲基]苯基卜2-(甲氧基亞 胺基:hN-曱基乙醯胺、氯苯基pah-u‘三唑+基) %庚醇、1-(2,2-一甲基-2,3-二氳-1H-茚-1-基米 η坐 _5_ 緩 ❹ 酸甲酯、Ν-乙基_Ν_甲基-Ν,-{2_甲基_5_(三氟甲基)_4·[3_(三 曱基矽烷基)丙氧基]苯基}亞胺基曱醯胺、Ν,_{5_(二氟曱 基)_2·曱基-4-[3-(三曱基矽烷基)丙氧基]苯基}_Ν_乙基_Ν_曱 基亞胺基曱醯胺、0-{1-[(4-甲氧基苯氧基)甲基]_2,2_二甲基 丙基} 1Η-咪唾-1-緩硫代酸酯、氯苯基)丙·2_ 炔-1-基]氧基}-3-甲氧基苯基)乙基]_Ν2-(曱基磺醯基)顧胺 醯胺、5-氯-7-(4-甲基六氫吡咬_1_基)_6_(2,4,6-三氟苯 基)[1,2,4]三唑並[1,5-a]嘧啶、5_胺基-1,3,4-噻二唑-2-硫、普 巴克(propamocarb-fosetyl)、1Η-咪唑-1-羧酸 l-[(4-甲氧基苯 201012812 氧基)甲基]-2,2-二曱基丙酯、1·甲基·Ν-[2-(1,1,2,2-四氟乙氧 基)苯基]-3-(三氟曱基)-1Η-吡唑-4·醯胺、2,3,5,6-四氣-4-(曱 基磺醯基)吡啶、2-丁氧基-6-碘-3-丙基-4Η-咣烯-4-酮、2-苯基酚及其鹽類、3-(二氟甲基)-1-甲基-!^-[2-(1,1,2,2-四氟 乙氧基)苯基]-1Η·吡唑-4-醯胺、3,4,5-三氣吡啶-2,6-二腈、 Η5-(4-氯苯基)-2,3-二曱基異噚唑啶_3·基]吡啶、3-氯-5-(4-氣苯基)-4-(2,6-二氟苯基)-6-曱基嗒啡、4-(4-氣苯基)-5-(2,6-二氟苯基)-3,6-二曱基塔呼、8-經基《I·1#、8-經基4°#硫酸 鹽、地布洛(tebufloquin)、5-甲基-6-辛基-3,7-二氫[1,2,4]三 唑並[1,5-a]嘧啶-7-胺、5·乙基-6-辛基-3,7-二氳[1,2,4]三唑並 [l,5-a],唆-7-胺、阿滅多(ametoctradin)、苯嗟菌清 (benthiazol)、〇塞菌_(匕61;11〇父压2111)、蓋西素(capsimycin)、卡 隆(carvone)、啥菌嗣(chinomethionat)、地茂散(chloroneb)、 σ夫菌清(cufraneb)、環敗菌胺(cyflufenamide)、克絕 (cymoxanil)、賽普確酿胺(cyprosulfamide)、邁隆(dazomet)、 口糸菌威(debacarb)、雙氯紛(dichlorophen)、達滅淨 (diclomezine)、大克爛(dicloran)、野燕枯(difenzoquat)、野燕 枯甲基橫酸鹽((^6112(^仙1:11^也7131111)1^16)、二苯胺 (diphenylamin)、依克滅(ecomat)、富米熱斯(ferimzone)、伏 滅多(flumetover)、氟0比菌胺(fluopicolide)、伏洛米 (fluoromide)、氟硫滅(flusulfamide)、伏地尼(flutianil)、福賽 得(fosetyl-aluminium)、1弓福赛得(fosetyl-calcium)、納福賽得 (fosetyl-sodium)、六氯苯(hexachlorobenzene)、人間黴素 (irumamycin)、依梭地尼(isotianil)、滅速克(methasulfocarb)、 201012812 (2E)-2-{2-[({環丙基[(4-曱氧基苯基)亞胺基]甲基}硫基)甲 基]苯基}-3-甲氧基丙烯酸甲酯、異硫氰酸曱酯、滅芬農 (metrafenone)、(5-氯-2-甲氧基-4-甲基吡啶-3-基)(2,3,4-三甲 氧基-6-曱基苯基)甲酮、滅粉黴素(mildiomycin)、甲確菌胺 (tolnifanide)、N-(4-氯苄基)-3·[3-曱氧基-4-(丙-2-炔-1-基氧 基)苯基]丙醯胺、Ν-[(4-氣苯基)(氰基)甲基]-3-[3-曱氧基 -4-(丙-2-炔-1-基氧基)苯基]丙酿胺、Ν-[(5-漠-3-氯0比咬-2-基)曱基]-2,4-二氯吡啶-3-醯胺、Ν-[1-(5·溴-3-氯吡啶-2-基) 乙基]-2,4-二氯吡啶-3-醯胺、N-[l-(5-溴-3-氯吡啶-2-基)乙 基]-2-氟_4_碘吡啶-3-醯胺、Ν-{(Ζ)-[(環丙基曱氧基)亞胺 基][6-(二氟甲氧基)-2,3-二氟苯基]甲基}-2-苯基乙醯胺、 Ν-{(Ε)-[(環丙基曱氧基)亞胺基][6-(二氟甲氧基)-2,3-二氟 苯基]甲基}-2-苯基乙醯胺、納他霉素(natamycin)、二甲基二 硫胺基甲酸錄(nickel dimethyldithiocarbamate)、酞菌酉旨 (nitrothal-isopropyl)、辛嗟酮(octhilinone)、歐莫克 (oxamocarb)、氧芬因(oxyfenthiin)、五氯盼 (pentachlorophenol)及其鹽類、吩β井_1_叛酸 (phenazine-1-carboxylic acid)、盼丁滅寧(phenothrin)、碌酸 及其鹽類、霜霉威乙膦酸鹽(propamocarbfosetylate)、普本素 (propanosine-sodium)、丙氧喧嚇_(proquinazid)、硝°比咯菌素 (pyrrolnitrin)、五氯>6肖基苯(quintozene)、S-5-胺基-2-(1-甲基 乙基)-4-(2-曱基苯基)-3-酮基-2,3-二氫-1H-吡唑_1_硫代甲 酸丙-2-浠-1-醋、克枯爛(tecloftalam)、四氧确基苯 (tecnazene)、p米嗤嗪(triazoxide)、三克爛(trichlamide)、5-氯 61 201012812 -N1-苯基-Ϊ^Γ-丙-2-块-1-基嗔吩-2-續酿月井、拉酿胺 (zarilamide)、Ν-甲基-2-(1-{[5-曱基-3-(三氟甲基)-1Η-吡唑 -1-基]乙醯基}六氫吡啶-4_基)_N-[(1R)-1,2,3,4-四氫萘-1-基]-1,3-噻唑-4-醯胺、N-甲基-2-(l-{[5-甲基-3-(三氟甲 基)-1Η-吡唑-1-基]乙醯基}六氫吡啶-4-基)-N-(l,2,3,4-四氫 萘-1-基)-1,3-噻唑-4-醯胺、3-(二氟曱基)-N-[4_氟 -2-(l,l,2,3,3,3-六氟1丙氧基)苯基]-1-曱基-1Η-σ比0坐-4-酿胺及 {6-[({[(1-曱基-1Η-四唑-5-基)(苯基)亞曱基]胺基}氧基)曱 基]吡啶-2-基}胺基曱酸戊酯。 殺菌劑: 漠硝丙二醇(Bronopol)、二氣盼(dichlorophen)、氯咬 (nitrapyrin)、二曱基二硫胺基曱酸鎳(nickel dimethyldithiocarbamate)、嘉賜黴素(kasugamycin)、歐利酮 (〇(^11丨1111〇1^)、吱喃魏酸(£!«^11〇&1:1)(^>^〇&(^(1)、經四環黴素 (oxytetracycline)、撲殺熱(probenazole)、鏈黴素 (streptomycin)、克枯爛(tecloftalam)、硫酸銅及其他銅製劑。 殺蟲劑/殺劑/殺線蟲劑: 在此說明書中經由其「俗名」所述之活性化合物是已 知自例如“The Pesticide Manual”,14th Ed” British CropThe PO-ether adduct should be applied. Other suitable are oligo- or polymers, for example derived from vinyl monomers, acrylic acid, EO and/or p〇 itself or in combination with, for example, (poly)alcohols or (poly)amines. Lignin and its sulfonic acid derivatives, unmodified and modified cellulose, aromatic and/or aliphatic sulfonic acids, and adducts thereof with formaldehyde can also be used. Thickeners such as yttrium methylcellulose in the form of powders, granules or latex, natural and synthetic polymers such as gum arabic, = dilute alcohol and yoghurt y, or natural Lipid and egg yolk and synthetic phospholipids. It is possible to use dyes such as inorganic pigments such as iron oxide, titanium oxide and Prussian blue, and organic dyes such as alizarin blue dye, azobiscyanine dyes, and micronutrients such as iron, turmeric and turmeric salts. . Other possible additives are perfumes, optionally modified minerals or vegetable oils, soils and nutrients (including micronutrients) such as salts of iron, bell, rotten, copper, sulphur, molybdenum and zinc. Stabilizers such as low temperature stabilizers, preservatives, antioxidants, light stabilizers or other agents which improve chemical and/or physical stability may also be present. 53 η 201012812 The preparation usually contains between 0.01 and 98 parts by weight of active compound, more preferably between 0.5 and 90%. The active substance composition according to the invention may be in the form of a currently commercially available preparation or from these preparations with other active substances such as insecticides, attractants, disinfectants, bactericides, acaricides, nematicides, killing A fungal agent, a growth regulator, a herbicide, a safener, a fertilizer or a chemical carrier is used in the form of a mixture. Particularly advantageous mixed ingredients are, for example, the following compounds: Fungicides: (1) Inhibitors of nucleic acid synthesis, such as benaiaxyi, benaxyl-M, bupirimate, cro Clozylacon, dimethirimol, ethirimol, furaxaxyl, hymexazol, metalaxyl, metalaxyl-M , 〇furace, oxadixyl and oxolinic acid. (2) Silk fissure and cell division inhibitors such as ben〇my 1 , carbendazim, chl〇rfenazole, diethofencarb, ethaboxam (ethaboxam), fuberidazole, pencycuron, thiabendazole, thiophanate, thi〇phanate-methyl and zoxamide. (3) Beer inhibitors (inhibitors of the respiratory chain), such as difluium (difiumet〇rini) as an inhibitor on the complex of the respiratory chain; bixafen, boscalid, wilt Carboxin, fenfuram, futonin 201012812 (flutolanil), floopyram, furametpyr, furmecyclox, isopyrazam ) (cis-poor racemate IRS, 4SR, 9RS and anti-difference racemics IRS, 4SR, 9SR mixture), isabiran (cis-poor racemate 1RS, 4SR, 9RS) ), isabiran (cis-poor racemate 1R, 4S, 9R), heterobiland blue (cis-poor racemate 18, 4 feet, 98), heterobiland blue (anti-poor outward) Racemates 1118, 4811, 9811), Isochram (anti-poor racemates 1R, 4S, 9S), Isochram (anti-poor racemates IS, 4R, 9R), chlorpheniramine (mepronil), oxycarboxin, penflufen, penthiopyrad, sedaxane, thifluzamid as inhibitors in the complex of the respiratory chain; Aleuric brom, atopol (azoxystrobin), cyazofamid, dimoxystrobin, enestroburin, famoxadone, fenamidone, flufenstrobin ), kresoxim-methyl, metominostrobin, oressastrobin, picoxystrobin, pyraclostrobin, pyraoxystrobin, must Pyraetostrobin, pyribencarb, and trifloxystrobin act as inhibitors on Complex III of the respiratory chain. (4) Decoupling agents, such as binapacryl, dinocap, fluazinam, and meptyldinocap 〇 (5) ATP manufacturing inhibitors such as fentin acetate, (fentin chloride), (fentin hydroxide) and (silthiofam) 〇55 201012812 (6) Amino acids and protein biosynthesis inhibitors, such as andoprim, blasticidin-S, spiro (cyprodinil), kasugamycin, kasugamycin hydrochloride hydrate, mepanipyrim, and pyrimethanil. (7) Signal transduction inhibitors such as fenpiclonil, fludioxonil and qnuinoXyfen 8 (8) lipid and membrane synthesis inhibitors, such as biphenyl, pingke ( Chlozolinate), edifenphos, etridiazole, iodocarb, iprobenfos, iprodione, isoprothiolane, procymidone , propamocarb, propamocarb hydrochloride, pyrazophos, tolclofos-methyl, and vinclozolin. (9) ergosterol biosynthesis inhibitors, such as aldimorph, azaconazole, bitertanol, bromuconazole, cyproconazole, benzyl Diclobutrazole, difenoconazole, diniconazole, diniconazole-M, dodemorph, dodemorph acetate, dunkou mouth (epoxiconazole), etaconazole, fenarimol, fenbuconazole, fenhexamid, fenpropidin, fenpropimorph, stagnation (fluquinconazole), flurprimidol, flusilazole, flutriafol, furconazole, furconazole-cis, hexaconazole , Imazalil, Imazalil sulphate, imibenconazole, ipconazole, metconazole, myclobutanil, naftifine , nuarimol, 畤咪嗤 (0Xp0C0naz0ie) Paclobutrazol, pefurazoate, penconazole, piperalin, prochloraz, propiconazole, prothioconazole, valerian (pyributicarb), pyrifenox, quinconazole, simeconazole, spiroxamine, tebuconazole, terbinaflne, four Tetraconazole, triadimefon, triadimenol, tridemorph, triflumizole, triforine, triticonazole, uniconazole ), chloroconazole (voriconazole) and voriconazole. (10) Cell wall synthesis inhibitors, such as benthiavalicarb, dimethomorph, flomoi^ph, iprovalicarb, mandipropamid, Polyoxins, polyoxorim, prothiocarb, validamycin A, and valefenalate. (11) Melanin biosynthesis inhibitors such as carpropamid, dilococymet, fenoxanil, phthalide, pyroquilon and three races ^(tricyclazole). 57 201012812 (12) Resistance-inducing agents, such as acibenzolar-S-methyl, probenazole, and tiadinil. (13) Compounds having multiple site activities, such as Bordeaux mixture, captaf〇l, captan, tetrachloroisophthalene (〇111〇1*〇1; 11& 1〇11丨1), copper succinate ((;〇卩卩61:11&卩111:1161^6), copper oxide, copper oxychloride, (copper preparation such as hydroxide Copper, copper sulphate, dichlofluanid, dithianon, dodine and its free base, ferbam, fluorofolpet, Sterilized dan (f〇lpet), bismuthin (81^&11116), bismuth octanoic acid acetate (811&2£1 such as 63 (^), gram heat (iminoctadine), gram calamine (iminoctadine albesilate), iminoctadine triacetate, mancopper, mancozeb, maneb, metiram, free of zinc (metiramzinc) ), oxine-copper, pr〇painidine, propineb, sulfur and sulfur preparations such as calcium polysulfide, derdi (thir) Am), tolylfluanid, zineb and ziram. (14) Other compounds 'eg 2,3-dibutyl-6-chlorothieno[2,3- d] spray bite-4(3H)-ketone, (2Z)-3-amino-2-cyano-3-phenylprop-2-enoate ethyl ester, N-[2_(l,3-dioxime) Butyl)phenyl]fluoro-1,3-dimethyl-iH-pyrazole-4•decylamine, 3-(difluoroindolyl)-1-indenyl-N-(3,,4,, 5,-Trifluorobiphenyl-2-yl)-lH-pyrazole-4-decylamine, 3-(difluoromethyl)-N_[4_fluoro-2-(^2,3,3,3- Hexafluoropropoxy)phenyl]-1-indenyl-1H-pyrazole-4-decylamine, (2Ε)-2·(2-{[6-(3-gas-2-methyl 201012812 phenyloxy) (5-fluoropyrimidin-4-yl)oxy}phenyl)-2-(methoxyimino)-N-mercaptoacetamide, (2E)-2-{2-[({[ (2E,3E)-4-(2,6 diphenyl)butylene-3-en-2-yl]amino}oxy)methyl]phenyl-2-(methoxyimino)-n- Ethylamine, 2-chloro-N-(l,l,3-trimethyl-2,3-dihydro-1H-indol-4-yl)acridin-3-ylamine, N-(3- Ethyl-3,5,5-trimethylcyclohexyl)-3-((methylhydrazino)-2.hydroxybenzylamine,5.methoxy-2-methyl_4-(2-{[( {(1Ε)_1-[3-(Trifluoromethyl)phenyl]ethyl}amino)oxy]A }}phenyl)_2,4_dihydro_3H-1,2,4-triterpene salivary _3-ketone, (2Ε)·; 2-(methoxyimino)·ν_methyl-2 -(2-{[({(lEH-[3-(trifluoromethyl)phenyl)ethyl]amino)amino)oxy]methyl}phenyl)acetamide, (2E)-2-( Methoxyimino)_N-methyl-2-{2-[(Ε)-({1-[3-(trifluoromethyl)phenyl]ethoxy)imido)methyl]benzene Ethylamine, (2Ε)-2-{2-[({[(1Ε)-1-(3-{[(Ε)-1-fluoro-2-phenylvinyl]oxy}phenyl) Ethylene]amino]amino)methyl]phenyl] 2-(methoxyimino: hN-mercaptoacetamide, chlorophenyl pah-u' triazole + yl) % heptanol , 1-(2,2-monomethyl-2,3-dioxin-1H-indol-1-ylmi η sitting_5_ ❹ ❹ acid methyl ester, Ν-ethyl Ν 甲基 methyl hydrazine, - {2_Methyl_5_(trifluoromethyl)_4·[3_(tridecylfluorenyl)propoxy]phenyl}imidoamine, hydrazine, _{5_(difluoroindolyl)_2 · Mercapto-4-[3-(tridecyldecylalkyl)propoxy]phenyl}_Ν_ethyl_Ν_mercaptosylamine, 0-{1-[(4-methoxy) Phenyloxy)methyl]_2,2-dimethylpropyl} 1Η-imidazole-1-sulfonate, chlorophenyl)propan-2-alkyn-1-yl]oxy}-3- Methoxyphenyl)ethyl]_Ν2-( Sulfosyl) guanamine, 5-chloro-7-(4-methylhexahydropyridyl-1-yl)_6_(2,4,6-trifluorophenyl)[1,2,4] Triazolo[1,5-a]pyrimidine, 5-amino-1,3,4-thiadiazole-2-sulfo, propamocarb-fosetyl, 1Η-imidazole-1-carboxylic acid l-[ (4-methoxybenzene 201012812 oxy)methyl]-2,2-dimercaptopropyl ester, 1·methyl·Ν-[2-(1,1,2,2-tetrafluoroethoxy) Phenyl]-3-(trifluoromethyl)-1Η-pyrazole-4·decylamine, 2,3,5,6-tetraki-4-(indolylsulfonyl)pyridine, 2-butoxy -6-iodo-3-propyl-4Η-decene-4-one, 2-phenylphenol and its salts, 3-(difluoromethyl)-1-methyl-!^-[2-( 1,1,2,2-tetrafluoroethoxy)phenyl]-1Η·pyrazole-4-decylamine, 3,4,5-trispyridine-2,6-dicarbonitrile, Η5-(4- Chlorophenyl)-2,3-dimercaptoisoxazole pyridine-3-yl]pyridine, 3-chloro-5-(4-phenylphenyl)-4-(2,6-difluorophenyl)- 6-mercapto-morphine, 4-(4-phenylphenyl)-5-(2,6-difluorophenyl)-3,6-dimercapto, and 8-ion-based "I·1#, 8-ionyl 4°#sulfate, tebufloquin, 5-methyl-6-octyl-3,7-dihydro[1,2,4]triazolo[1,5-a] Pyrimidine-7-amine, 5·ethyl-6-octyl-3,7-dioxa[1,2,4]triazolo[l,5-a], hydrazine -7-amine, ametoctradin, benthiazol, sputum _(匕61;11〇父2111), capsimycin, carvone, sputum (chinomethionat), chloroneb, cufraneb, cyflufenamide, cymoxanil, cyprosulfamide, dazomet, sputum Debacarb, dichlorophen, diclomezine, dicloran, difenzoquat, wild swallow methyl sulphate ((^6112(^仙1) :11^也7131111)1^16), diphenylamin, ecotam, ferimzone, fluxover, fluopicolide, flumamine (fluoromide), flusulfamide, flutianil, fosetyl-aluminium, 1 fosetyl-calcium, fosetyl-sodium, hexachlorobenzene Hexachlorobenzene), irumamycin, isotianil, methasulfocarb, 201012812 (2E)-2-{2-[({cyclopropyl[(4-methoxyphenyl) Imino]methyl Methyl thio)methyl]phenyl}-3-methoxy acrylate, decyl isothiocyanate, metrafenone, (5-chloro-2-methoxy-4-methylpyridine -3-yl)(2,3,4-trimethoxy-6-nonylphenyl)methanone, mildiomycin, tolnifanide, N-(4-chlorobenzyl -3·[3-decyloxy-4-(prop-2-yn-1-yloxy)phenyl]propanamine, hydrazine-[(4-phenylphenyl)(cyano)methyl] -3-[3-decyloxy-4-(prop-2-yn-1-yloxy)phenyl]propanol, hydrazine-[(5--------- ) fluorenyl]-2,4-dichloropyridin-3-indoleamine, hydrazine-[1-(5.bromo-3-chloropyridin-2-yl)ethyl]-2,4-dichloropyridine-3 - decylamine, N-[l-(5-bromo-3-chloropyridin-2-yl)ethyl]-2-fluoro_4_iodopyridin-3-ylamine, Ν-{(Ζ)-[( Cyclopropyl decyloxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide, Ν-{(Ε)- [(Cyclopropyl decyloxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide, Natamycin ( Natamycin), nickel dimethyldithiocarbamate, nitrothal-isopropyl, octhiminone, Oxamocarb, oxyfenthiin, pentachlorophenol and its salts, phenazine-1-carboxylic acid, phenothrin, Acid and its salts, propamocarbfosetylate, propanosine-sodium, proquinazid, pyrrolnitrin, pentachloro> 6 quintozene, S-5-amino-2-(1-methylethyl)-4-(2-mercaptophenyl)-3-keto-2,3-dihydro-1H -pyrazole_1_thio-2-indole-1-acetate, tecloftalam, tecnazene, triazoxide, tricholamide, 5-Chloro 61 201012812 -N1-Phenyl-Ϊ^Γ-propan-2-block-1-yl porphin-2-Continuous brewing of moon well, zarilamide, Ν-methyl-2-(1 -{[5-mercapto-3-(trifluoromethyl)-1Η-pyrazol-1-yl]ethenyl}hexahydropyridine-4_yl)_N-[(1R)-1,2,3 , 4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-decylamine, N-methyl-2-(l-{[5-methyl-3-(trifluoromethyl)-1Η -pyrazol-1-yl]ethenyl}hexahydropyridin-4-yl)-N-(l,2,3,4-tetrahydronaphthalen-1-yl)-1,3-thiazol-4-indole Amine, 3-(difluoroindenyl) -N-[4_fluoro-2-(l,l,2,3,3,3-hexafluoro1propyloxy)phenyl]-1-indenyl-1Η-σ ratio 0 sit 4-bristamine And {6-[({[(1-]-yl-1Η-tetrazol-5-yl)(phenyl)phosphonium]amino}oxy)indolyl]pyridin-2-yl}amino decanoic acid Amyl ester. Fungicides: Bronopol, dichlorophen, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, orolone 〇(^11丨1111〇1^), 吱和魏酸(£!«^11〇&1:1)(^>^〇&(^(1), via oxytetracycline , probenazole, streptomycin, tecloftalam, copper sulphate and other copper preparations. Insecticides/killers/nematicides: as described in this specification by its "common name" The active compound is known, for example, from "The Pesticide Manual", 14th Ed" British Crop
Protection Council 2006,及從網頁 http://www.alanwood.net/pesticides/。 (1)乙醯基膽鹼酯酶(AChE)抑制劑類’例如胺基甲酸鹽 類,例如棉鈴威(alanycarb)、得滅克Oldicarb)、免敵克 (bendiocarb)、免扶克(benfuracarb)、佈嘉(butocarb〇xim)、 62 201012812 丁酮威(butoxycarboxim)、加保利(carbaryl)、加保扶 (carbofuran)、丁基加保扶(carbosulfan)、愛芬克 (ethiofencarb)、丁基滅必蝨(fen〇bucarb)、覆滅蟎 (formetanate)、扶線威(furathiocarb)、滅必蝨(isoprocarb)、 滅賜克(methiocarb)、納乃得(methomyl)、治滅蝨 (metolcarb)、歐殺滅(oxamyl)、比加普(pirimicarb)、安丹 (propoxur)、硫敵克(thiodicarb)、硫伐隆(thiofanox)、唑蚜威 (triazamate)、混殺威(trimethacarb)、XMC 及滅爾蟲 (xylylcarb);或 有機填酸鹽類,例如歐殺松(acephate)、亞滅松 (azamethiphos)、谷速松(azinphos)(-甲基、-乙基)、硫線構 (cadusafos)、氯氧填(chlorethoxyfos)、克芬松 (chlorfenvinphos)、氣甲硫鱗(chlormephos)、桃斯松 (chlorpyrifos )(-曱基)、牛壁逃(coumaphos)、氰乃松 (cyanophos)、滅賜松(demeton-S-methyl)、大利松(diazinon)、 二氯松(dichlorvos)/DDVP、雙特松(dicrotophos)、大滅松 (dimethoate)、曱基毒蟲畏(dimethylvinphos)、二硫松 (disulfoton)、EPN、愛殺松(ethion)、普伏松(ethoprophos)、 氨績填(famphur)、芬滅松(fenamiphos)、撲滅松 (fenitrothion)、芬殺松(fenthion)、福赛絕(fosthiazate)、飛達 松(heptenophos)、亞芬松(isofenphos)、(0-(甲氧基胺基硫構 醯基)水楊酸異丙酯)、加福松(isoxathion)、馬拉松 (malathion)、滅加松(mecarbam)、達馬松(methamidophos)、 滅大松(methidathion)、美文松(mevinphos)、亞素靈 63 201012812 (monocrotophos)、乃力松(naled)、歐滅松(omethoate)、滅多 松(oxydemeton-methyl)、巴拉松(parathion)(-曱基)、赛達松 (phenthoate)、福瑞松(phorate)、裕必松(phosalone)、益滅松 (phosmet)、福賜米松(phosphamidon)、巴赛松(phoxim)、亞 特松(pirimiphos-methyl)、佈飛松(profenofos)、撲達松 (propetamphos)、普硫松(prothiofos)、白克松(pyraclofos)、 必芬松(pyridaphenthion)、拜裕松(quinalphos)、硫特普 (sulfotep)、丁嘴硫麟(tebupirimfos)、亞培松(temephos)、托 福松(terbufos)、樂本松(tetrachlorvinphos)、硫滅松 (thiometon)、三落松(triazophos)、唾財威(triazamate)、三氣 松(triclorfon)及繁米松(vamidothion)。 (2) GABA-調控的氯通道拮抗劑,例如有機氯類,例如 克氣丹(chlordane)及安殺番(endosulfan)(alpha-);或苯基〇比 °^(fiproles)(苯基吼°坐類),例如乙蟲清(ethiprole)、芬普尼 (fipronil)、必瑞伏(pyrafluprole)及必瑞譜(pyriprole)。 (3) 鈉通道調節劑/電壓依賴性鈉通道阻滯劑類,例如除 蟲菊精類(pyrethroids),例如阿納寧(acrinathrin)、亞列寧 (allethrin) (d-順-反、d-反)、畢芬寧(bifenthrin)、生物烯丙菊 酯(bioallethrin)、生物烯丙菊酯-S-環戊烯基 (bioallethrin-S-cyclopentenyl)、生物苄吱菊酯 (bioresmethrin)、乙氰菊酯(cycloprothrin)、赛伏寧(cyfluthrin) (beta-)、益洛寧(cyhalothrin) (gamma-、lambda-)、亞滅寧 (cypermethrin) (alpha-、beta-、theta-、zeta_)、苯氰菊 g旨 (cyphenothrin) [(li?)-反-異構物]、第滅寧(deltamethrin)、四 201012812 氟甲謎菊酯(dimefluthrin)、右旋烯炔菊酯(empenthrin) [(五Z)-(l及)-異構物]、益化利(esfenvalerate)、依芬寧 (etofenprox)、芬普寧(fenpropathrin)、芬化利(fenvalerate)、 護赛寧(flueythrinate)、氟氯苯菊酯(flumethrin)、福化利 (fluvalinate) (tau-)、合芬寧(halfenprox)、依普寧 (imiprothrin)、美特寧(metofluthrin)、百滅寧(permethrin)、 酿丁滅兹(phenothrin) [(li?)-反-異構物]、普亞列寧 (prallethrin)、普伏寧(profluthrin)、除蟲菊素(pyrethrins )、 除蟲菊(pyrethrum)、異列滅寧(resmethrin)、RU 15525、氟 梦菊酯(silafluofen)、七氟菊酯(tefluthrin)、胺菊酯 (tetramethrin) [(li?)-異構物]、四溴菊酯(tralomethrin)、四氟 菊酯(transfluthrin)及ZXI 8901;或DDT;或曱氧滴滴涕 (methoxychlor)。 (4)菸鹼能乙醯基膽鹼受體激動劑類,例如新菸鹼類,例 如亞滅培(acetamiprid)、可尼丁(clothianidin)、達特南 (dinotefuran)、益達胺(imidacloprid)、烯啶蟲胺(nitenpyram)、 嘆蟲琳(thiacloprid)、賽速安(thiamethoxam);或尼古丁 (nicotine)。 (5 )異位乙醯基膽鹼受體調節劑(激動劑),例如賜諾斯類 (spinosyns),例如賜諾特(spinetoram)及賜諾殺(spinosad)。 (6) 氯離子通道活化劑,例如阿維菌素(averrnectins)/米貝 素(milbemycins),例如阿巴汀(abamectin)、因滅汀(emamectin benzoate)、利必汀(lepimectin)及密滅汀(milbemectin)。 (7) 保幼激素同系物,例如海普(hydroprene)、奇諾普 65 201012812 (kinoprene)、稀森醋(methoprene);或芬諾克(fenoxycarb);百 利普芬(pyriproxyfen)。 (8) 具有已知或非專一性作用機制之活性化合物,例如 燻蒸劑類,例如甲基溴及其他烷基齒化物;或氣化苦 (chloropicrin);硫醯氟(sulphuryl fluoride);领砂(borax); 酒石酸氧録鉀(tartar emetic)。 (9) 選擇性拒食素’例如派滅淨(pymetr〇zine)或氟尼胺 (flonicamid) ° (10) 蟎生長抑制劑,例如克芬蟎(cl〇fentezine)、二伏達 (diflovidazin)、合赛多(hexythiazox)、依殺蜗(etoxazole)。 (11) 昆蟲腸膜之微生物干擾劑,例如蘇雲金芽孢桿菌亞 種蘇力菌以色列變種、球形芽孢桿菌、蘇雲金芽孢桿菌亞種亞莎 華種、蘇雲金芽孢桿菌亞種卻氏卡奇種、蘇雲金芽孢桿菌亞種擬 步4亍蟲種’及BT植物蛋白質例如Cry 1 Ab、Cry 1 Ac、Cry 1 Fa、Protection Council 2006, and from the web page http://www.alanwood.net/pesticides/. (1) Acetylcholinesterase (AChE) inhibitors such as amine carbamates such as alanycarb, Oldicarb, bendiocarb, benfuracarb Butocarb〇xim, 62 201012812 butoxycarbboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, butyl 〇〇bucarb, formetanate, furathiocarb, isoprocarb, metiocarb, methomyl, metolcarb, Europe Oxalyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC, and extinction Xylylcarb; or organic acid salt, such as acephate, azamethiphos, azinphos (-methyl, -ethyl), cadusafos , chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos (-mercapto), cattle Coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos/DDVP, dicrotophos, dimethoate ), dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, chlorpyrifos (fenitrothion), fenthion, fosthiazate, heptenophos, isofenphos, (0-(methoxyaminothio-thiol) salicylic acid Propyl ester), isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, sulphate 63 201012812 (monocrotophos), Naled, omethoate, oxydemeton-methyl, parathion (-mercapto), phenthoate, phorate, yubisson (phosalone), phosmet, phosphamidon, phoxim, pirimiphos-methyl, profenof Os), propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos , temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, triazamate, triclofon and Michelon (vamidothion). (2) GABA-regulated chloride channel antagonists, such as organochlorines, such as chlordane and endosulfan (alpha-); or phenyl hydrazine ratio (fiproles) (phenyl hydrazine) ° Sitting class), such as ethiprole, fipronil, pyrafluprole, and pyriprole. (3) Sodium channel modulators/voltage-dependent sodium channel blockers, such as pyrethroids, such as acrinathrin, allethrin (d-cis-trans, d-reverse) ), bifenthrin, bioallethrin, bioalethrin-S-cyclopentenyl, bioresmethrin, fenpropathrin Cycloprothrin), cyfluthrin (beta-), cyhalothrin (gamma-, lambda-), cypermethrin (alpha-, beta-, theta-, zeta_), cyanidia g(cyphenothrin) [(li?)-trans-isomer], deltamethrin, four 201012812 dimefluthrin, impenthrin [(five Z) -(l and)-isomers], esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flueythrinate, flumethrin (flumethrin), fluvalinate (tau-), halfenprox, imiprothrin, metofluthrin, permethrin, brewing Phenothrin [(li?)-trans-isomer], prallethrin, profluthrin, pyrethrins, pyrethrum, heterologous Resmethrin, RU 15525, silafluofen, tefluthrin, tetramethrin [(li?)-isomer], tetramethrin (tralomethrin), Transfluthrin and ZXI 8901; or DDT; or methoxychlor. (4) Nicotinic acetylcholine receptor agonists, such as neonicotinoids, such as acetamiprid, clothianidin, dinotefuran, imidacloprid ), nitenpyram, thiacloprid, thiamethoxam; or nicotine. (5) ectopic acetylcholine receptor modulators (agonists), such as spinosyns, such as spinetoram and spinosad. (6) Chloride channel activators, such as averrnectins/milbemycins, such as abamectin, emamectin benzoate, lepimectin, and thiophene Milbemectin. (7) Juvenile hormone homologs, such as hydroprene, chinop 65 201012812 (kinoprene), methoprene; or fenoxycarb; pyriproxyfen. (8) Active compounds having known or non-specific mechanisms of action, such as fumigants, such as methyl bromide and other alkyl dentates; or chloropicrin; sulphuryl fluoride; (borax); tartar emetic. (9) Selective antifeedant's such as pymetr〇zine or flonicamid ° (10) 螨 growth inhibitors, such as cl〇fentezine, diflovidazin, Hexythiazox, etoxazole. (11) Microbial interfering agents for insect intestinal membranes, such as Bacillus thuringiensis subsp. suricus, Israeli variants, Bacillus sphaericus, Bacillus thuringiensis subspecies, A. sinensis, Bacillus thuringiensis subspecies, Chaucer, and Bacillus thuringiensis Bacillus subspecies, 4 locust species, and BT plant proteins such as Cry 1 Ab, Cry 1 Ac, Cry 1 Fa,
Cry2Ab、mCry3A、Cry3Ab、Cry3Bb、Cry34/35Abl。 (12) 氧化性磷酸化抑制劑、ATP干擾劑,例如汰芬諾克 (diafenthiuron);或有機錫化合物,例如三唑錫 (azocyclotin)、二環錫(cyhexatin)、芬佈賜(fenbutatin oxide); 或毆蟎多(propargite);得脫蟎(tetradifon)。 (13) 經由干擾Η質子梯度而作用之氧化性磷酸化去偶 合劑,例如克凡派(chlorfenapyr)及DNOC。 (14) 於驗能乙醢基膽驗受體拮抗劑,例如免速達 (bensultap)、培丹(cartap)(鹽酸鹽)、硫賜安(thiocyiam)及殺 蟲雙(thiosultap-sodium) 〇 66 201012812 (15) 第0型曱殼素生物合成抑制劑,例如苯曱醯基脲 類,例如雙三氟蟲腺(bistrifluron)、克福隆(chl〇rfluazur〇n)、 二福隆(diflubenzuron)、氟螨脲(flucycl〇xur〇n)、說芬隆 (fhifenoxuron)、六伏隆(heXaflumuron)、祿芬隆(lufenur〇n)、 諾伐隆(novaluron)、諾伏隆(noviflumuron)、說苯脲 (teflubenzuron)及三伏隆(triflumuron)。 (16) 第1型曱殼素生物合成抑制劑,例如嘆嗪酮 (buprofezin)。 (17) 脫皮干擾劑’例如賽滅淨(cyr〇mazine)。 (18) 蜆皮激素激動劑/干擾劑’例如二醯基胼類,例如可 芬諾(chromafenozide)、氯蟲醯胼(hal〇fenozide)、滅芬諾 (methoxyfenozide)及得芬諾(tebufenozide)。 (19) 章魚胺能激動劑,例如三亞蟎(amitraz)。 (20) 部位III電子輸送抑制劑/部位π電子輸送抑制劑, 例如海滅隆(hydramethylnone)、亞酿^(acequinocyl)、喷编酉旨 (fluacrypyrim)、或丁 氟蟎酯(cyflumetofen)及西諾芬 (cyenopyrafen) ° (21) 電子輸送抑制劑,例如從METI殺蟎劑之部位I電 子輸送抑制劑’例如芬殺蜗(fenazaquin)、芬普蜗 (fenpyroximate)、畢汰芬(Pyrimidifen)、畢達本(pyridaben)、 得芬瑞(tebufenpyrad)、脫芬瑞(t〇lfenpyrad);或魚藤酮 (rotenone) (Derris). (22) 電壓依賴性鈉通道阻滯劑,例如因得克 (indoxacarb)、美氟综(metaflumizone)。 67 201012812 (23) 乙醯基-CoA羧化酶之抑制劑,例如季酮酸 acid)衍生物,例如賜派芬(spirodiclofen)及螺曱蜗g旨 (spiromesifen);或特密酸(tetramic acid)衍生物,例如螺蟲乙 酉旨(spirotetramat)。 (24) 部位IV電子輸送抑制劑,例如罐化物類,例如填 化鋁、磷化鈣、磷化氫、磷化鋅;或氰化物。 (28)雷諾定(Ryanodine)受體效能劑,例如二醯胺類,例 如氣蟲醯胺(chlorantraniliprole) (Rynaxypyr)、氰特普 (cyantraniliprole) (Cyazypyr)及氟蟲醯胺(flubendiamide)。 具有未知作用機制之其他活性化合物,例如印楝素 (azadirachtin)、阿米多(amidoflumet)、西脫蜗(benzoximate)、 聯苯肼S旨(bifenazate)、蜗離丹(chinomethionat)、冰晶石 (cryolite)、大克蜗(dicofol)、伏芬靈(flufenerim)、咬蟲丙轉 (pyridaly 1)及必伏隆(pyrifluquinazon);或下面的已知活性 化合物 4-{[(6-溴吡啶-3-基)甲基](2-氟乙基)胺基}呋喃-2(5H)-酮(已知自賈〇2007/115644)、4-{[(6-氟吡啶-3-基)曱基](2,2-二氟乙基)胺基}呋喃-2(5H)-酮(已知自WO 2007/115644)、 4-{[(2-氯-1,3-噻唑-5-基)曱基](2-氟乙基)胺基}呋喃-2(5H)-酮(已知自 WO 2007/115644)、4-{[(6-氯吡啶-3-基)曱基](2-氟乙基)胺基}呋喃-2(5H)-酮(已知自WO 2007/ 115644)、 氯吡啶-3-基)曱基](2,2_二氟乙基)胺基}呋喃_2(5H)_ 酮(已知自WO 2007/115644)、4-{[(6-氯-5-氟吡啶-3-基)曱 基](甲基)胺基}呋喃-2(5H)-酮(已知自WO 2007/115643)、 201012812 4-{[(5,6-一氣0比咬-3-基)曱基](2-氟乙基)胺基)吱喃_2(5印· 酮(已知自WO 2007/115646)、4-{[(6-氯-5_氟吡啶_3_基)甲 基](環丙基)胺基}呋喃-2(5Η)-嗣(已知自w〇 2007Π15643)、4-{[(6-氯吡咬-3-基)甲基](環丙基)胺基}呋喃 -2(5Η)-嗣(已知自 ΕΡ-Α-0 539 588)、4-{[(6_氯吡啶_3_基)曱 基](曱基)胺基}0夫喃-2(5Η)-酮(已知自ΕΡ-Α-0 539 588)、[(6_ 氯吡啶-3-基)曱基](曱基)氧撐·λ4-亞硫燒基氰醯胺(已知自 Ο WO 2007/149134)、[1-(6·氯吡咬-3-基)乙基](曱基)氧撐·λ4_ 亞硫烷基氰醯胺(已知自WO 2007/149134)及其非對掌異構 物(A)及(B) ?H3Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34/35Abl. (12) oxidative phosphorylation inhibitors, ATP interfering agents such as diafenthiuron; or organotin compounds such as azocyclotin, cyhexatin, fenbutatin oxide ; or more (propargite); get rid of (tetradifon). (13) Oxidative phosphorylation decoupling agents acting through interfering proton proton gradients, such as chlorfenapyr and DNOC. (14) In the detection of acetylcholine receptor antagonists, such as bensultap, cartap (hydrochloride), thiocyiam and thiosultap-sodium 〇 66 201012812 (15) Type 0 chitin biosynthesis inhibitors, such as phenylhydrazines, such as bistrifluron, chl〇rfluazur〇n, diflubenzuron ), flucycline xur〇n, fhefenoxuron, heXaflumuron, lufenur〇n, novaluron, noivifuron, Said phenylurea (teflubenzuron) and triflumuron (triflumuron). (16) A type 1 chitin biosynthesis inhibitor such as buprofezin. (17) Peeling interfering agent ', for example, cyr〇mazine. (18) Ecdysone agonists/interfering agents such as diterpenoids such as chromafenozide, hal〇fenozide, methoxyfenozide and tebufenozide . (19) Octopaminergic agonists, such as amitraz. (20) Site III electron transport inhibitor/site π electron transport inhibitors, such as hydramethylnone, acequinocyl, fluacrypyrim, or cyflumetofen and west Cynopyrafen ° (21) Electron transport inhibitors, such as electron transport inhibitors from sites of METI acaricides such as fenazaquin, fenpyroximate, Pyrimidifen, Pyrababen, tebufenpyrad, t〇lfenpyrad, or rotenone (Derris). (22) Voltage-dependent sodium channel blockers, such as indoxacarb ), the United States Fluorine (metaflumizone). 67 201012812 (23) Inhibitors of acetyl-CoA carboxylase, such as quaternary acid acid derivatives, such as spirodiclofen and spiromesifen; or tetramic acid a derivative, such as a spirotetramat. (24) Site IV electron transport inhibitors, such as cans, such as aluminum, calcium phosphide, phosphine, zinc phosphide; or cyanide. (28) Ryanodine receptor potentiators, such as diamines, such as chlorantraniliprole (Rynaxypyr), cyantraniliprole (Cyazypyr), and flubendiamide. Other active compounds with unknown mechanisms of action, such as azadirachtin, amidoflumet, benzoximate, bifenazate, chinomethionat, cryolite ( Cryolite), dicofol, flufenerim, pyridaly 1 and pyrifluquinazon; or the following known active compound 4-{[(6-bromopyridine) 3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one (known from Jiayu 2007/115644), 4-{[(6-fluoropyridin-3-yl) (2,2-difluoroethyl)amino}furan-2(5H)-one (known from WO 2007/115644), 4-{[(2-chloro-1,3-thiazole-5) -yl)mercapto](2-fluoroethyl)amino}furan-2(5H)-one (known from WO 2007/115644), 4-{[(6-chloropyridin-3-yl)indolyl (2-fluoroethyl)amino}furan-2(5H)-one (known from WO 2007/115644), chloropyridin-3-yl)indenyl](2,2-difluoroethyl)amine Furan-2-(5H)-ketone (known from WO 2007/115644), 4-{[(6-chloro-5-fluoropyridin-3-yl)indolyl](methyl)amino}furan- 2(5H)-ketone (known from WO 2007/115643), 201012812 4-{[(5,6-one gas 0 to bite-3-yl (曱)](2-fluoroethyl)amino)furan-2 (5-indicole (known from WO 2007/115646), 4-{[(6-chloro-5-fluoropyridine-3-yl) Methyl](cyclopropyl)amino}furan-2(5Η)-嗣 (known from w〇2007Π15643), 4-{[(6-chloropyridin-3-yl)methyl](cyclopropyl) Amino}furan-2(5Η)-嗣 (known from ΕΡ-Α-0 539 588), 4-{[(6-chloropyridine-3-yl)indolyl](fluorenyl)amino}0 Furan-2(5Η)-ketone (known from ΕΡ-Α-0 539 588), [(6_ chloropyridin-3-yl)indolyl](indenyl)oxybutanium λ4-sulfinyl cyanoguanidine Amines (known from 2007 WO 2007/149134), [1-(6·chloropyridin-3-yl)ethyl](indenyl)oxybutanium λ4_sulfinyl cyanamide (known from WO 2007 /149134) and its non-paired isomers (A) and (B) ?H3
(A) 9h3(A) 9h3
(也已知自WO 2007/149134)、[(6-三氟曱基吡啶·3-基) 甲基](甲基)氧撐44_亞硫烷基氰醯胺(已知自WO 2007/095229)、赛伏樂(sulfoxaflor)(也已知自 w〇 2007/149134),11-(4-氯-2,6-二曱基苯基)-12-羥基-1,4-二氧 雜-9-氮雜二螺[4.2.4.2]十四烷-11-烯-10-酮(已知自 W02006/089633)、3-(4'-氟-2,4-二甲基聯苯-3-基)-4-經基-8-氧雜-1-氮雜螺[4.5]癸-3-烯-2-酮(已知自WO 2008/067911) 及1-{2,4-二曱基_5-[(2,2,2-三氟乙基)亞磺醯基]苯基}-3-(三 氟甲基)-1Η·1,2,4-三峻(已知自 WO 1999/55668)。 69 201012812 也可能是與其他已知的活性化合物例如除草劑、肥 料、生長調節劑、安全劑、化學傳訊素、或與 質的藥劑之混合物。 當作為殺昆蟲劑使用時,在其商業上供應的調製物及 從這些調製物製備的使用形式之根據本發明之活性化合 物’可另外存在為與協同增效劑之混合物。協同增效劑是 可增加活純合物雜德合物,活純合物本身並非必 要添加協同增效劑。 當作為殺昆蟲劑使用時,在其商業上供應的調製物及 從這些調製物製備的使用形式之根據本發明之活性物質組 合物可另外存在為與抑制劑之混合物,其應用後,防止活 14物質在植物的環境、植物體的表面或植物組織中降解。 從商業上供應的調製物製備的使用形式之活性化合物 含I可在大範圍内變。使用形式之活性化合物濃度可從 0.00000001至95重量%之活性化合物,較宜是〇 〇〇〇〇1及 1重量%之間。 該化合物是在合適於使用形式之慣用方式下使用。 可以根據本發明處理全部植物及植物部份。在本文 中,植物係指全部的植物及植物數,例如需要及不需要的 野生植物或農作物(包括天然出現的農作物)。農作物可以是 植物其係得自傳統的播種及最適化的方法或經由生物科技 及再重組的方法,或這些方法之組合,包括基因轉殖的植 物並包括可以或未經Plant Breeders,Rights保護的植物變 種。植物部份係指植物的全部地上及地下部份及器官,例 201012812 如苗芽、葉子、花及根,可以舉例的是葉子、針、莖、幹、 花、子實體、果實及種子,以及根、塊莖及根莖。植物部 份也包括收穫的物質及生長與生殖傳播的物質,例如插條、 塊莖、根莖、分株及種子。 根據本發明用活性化合物處理植物或植物部份是經由 慣用的處理方法直接進行或經由作用在其環境、住所或儲 存室,例如經由浸潰、喷灑、蒸發、霧化、散播、塗覆、 Ο(also known from WO 2007/149134), [(6-trifluorodecylpyridin-3-yl)methyl](methyl)oxylated 44-sulfinyl cyanamide (known from WO 2007/ 095229), sulfoxaflor (also known from w〇2007/149134), 11-(4-chloro-2,6-diamidinophenyl)-12-hydroxy-1,4-dioxene -9-azaspiro[4.2.4.2]tetradecane-11-ene-10-one (known from WO2006/089633), 3-(4'-fluoro-2,4-dimethylbiphenyl- 3-yl)-4-transyl-8-oxa-1-azaspiro[4.5]indole-3-en-2-one (known from WO 2008/067911) and 1-{2,4-di Indenyl_5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1Η·1,2,4-tris (known from WO 1999/55668). 69 201012812 may also be a mixture with other known active compounds such as herbicides, fertilizers, growth regulators, safeners, chemical carriers, or pharmaceutically acceptable agents. When used as an insecticide, the commercially available preparations and the active compounds according to the invention prepared from these preparations may additionally be present as a mixture with a synergist. Synergists can increase the activity of living complexes, and it is not necessary to add synergistic synergists to the living complex itself. When used as an insecticide, the commercially available preparations and the active substance compositions according to the invention prepared from these preparations may additionally be present as a mixture with an inhibitor, which, after application, prevents 14 Substances are degraded in the environment of plants, on the surface of plants or in plant tissues. The active compound containing I prepared from commercially available formulations can vary over a wide range. The active compound concentration in the form of use may range from 0.00000001 to 95% by weight of active compound, more preferably between 1 and 1% by weight. The compound is used in a conventional manner suitable for the form of use. All plants and plant parts can be treated in accordance with the present invention. As used herein, plant refers to the total number of plants and plants, such as wild plants or crops (including naturally occurring crops) that are needed and not needed. The crop may be a plant obtained from traditional methods of sowing and optimization or via biotechnology and recombination, or a combination of these methods, including genetically transformed plants and including or without Plant Breeders, Rights protected. Plant variety. Plant parts refer to all above-ground and underground parts and organs of plants. For example, 201012812, such as seedlings, leaves, flowers and roots, can be exemplified by leaves, needles, stems, stems, flowers, fruiting bodies, fruits and seeds, and Roots, tubers and rhizomes. Plant parts also include harvested material and substances that are transmitted and reproductively transmitted, such as cuttings, tubers, rhizomes, ramets and seeds. The treatment of plants or plant parts with the active compounds according to the invention is carried out directly or via the usual treatment methods in their environment, dwelling or storage chamber, for example by dipping, spraying, evaporating, atomizing, spreading, coating, Ο
^射,以及在播種物質之情形中,特別是在種子之情形, 避可經由塗覆一或多個塗層。 如上所述’根據本發明可以處理整株植物或其部份。 ^個較佳的具體實施例中,是處理野生植物類及植物栽 β 種或經由傳統生物培養方法例如交換或原生質體融 口所得者,及其部份。在一個更佳的具體實施例中,是處 理基因轉殖植物及經由基因玉程方法所得的植物栽培品種 如果適虽時’結合傳統方法(Genetically 出ed 〇rganisms),及其部份。「部份」、「植物的部份」及「植物部份 」已在上文解釋。 在各If形下商業化供應或使用的植物栽培品種之植物 ’特別較宜根據本發明處^植物栽培品種係指經由傳統 種、生物-或基因 :養二由「突σ變形成或經由*組的DNA技術而得到新的性 質之植物(品種」)。這些可以是栽培品 品種。 =於,物種類或植物栽培、其處所及其生長情形(土 、、氣、、長期、言養),根據本發明之處理也可導致超 71 〜 201012812 加成(「協同增效」)效應。據此,例如可能有超越實際預期 的效應之τ舰應··減少施加率及/或敎雜效應及/或增 加可以根據本發喊料活性物f及域物之活性,較佳 的植物生長、增加對高或低溫之耐受度、增加對乾旱或水 或土壤,分之耐受度、增加職表現、容㈣成、加速成 吏、、更南的產量、較大的果實、較大的植物高度強化葉 子的綠色、容易開花、較佳的品#及/或收成產物有更高的^ shot, and in the case of sowing of matter, especially in the case of seeds, avoiding the application of one or more coatings. As described above, the whole plant or a part thereof can be treated according to the present invention. In a preferred embodiment, the wild plants and plant beta species or those obtained by conventional biological culture methods such as exchange or protoplast melting, and portions thereof. In a more preferred embodiment, the genetically-transplanted plants and the plant cultivars obtained by the genetic method are combined, if appropriate, in combination with traditional methods (Genetically ed 〇rganisms), and portions thereof. The "parts", "plant parts" and "plant parts" have been explained above. Plants of plant cultivars that are commercially supplied or used under each If form are particularly suitable according to the invention. Plant cultivars are those formed by conventional species, organisms, or genes: A group of DNA techniques to obtain new plants (variety). These can be cultivated varieties. =, the species or plant cultivation, its location and its growth (soil, gas, long-term, speech), the treatment according to the invention can also lead to the super 71 ~ 201012812 addition (" synergistic effect") effect . Accordingly, for example, there may be an effect that exceeds the actual expected effect. The reduction of the application rate and/or the noisy effect and/or the increase may be based on the activity of the active substance f and the domain, and the preferred plant growth. Increase tolerance to high or low temperature, increase tolerance to drought or water or soil, increase job performance, capacity (four), accelerate into sputum, more southerly yield, larger fruit, larger Plants are highly fortified with green leaves, easy to flower, better products # and / or harvest products have higher
營養價值、果實中有較高的糖漢度、收成產物有較佳的儲 存能力及/或處理性。 較宜根據本發明處理的基因轉殖植物或植物栽培品種 (經由基因工程所得)包括全部植物其本質上t經基因改良 二接收基因物質其賦予這些植物特別有利、有用的特質。 =些2質之實例是較佳的植物生長、增加對高或低溫的耐 二层曰^乾旱或水或土壤鹽含量之财受、增加開花表現 V、: 士认加速成熟、較高的收成產量、較佳的品質及/ 品有較高的營養價值、較佳的儲存安定性及/或 扣之加工性。此特質之其他及❹ 對=r?害蟲之較佳防禦力,例如對二 除草:性菌及/或病毒’以及增加植物對於某些 例3會要的曾〇物之耐受。可以列舉的基因轉殖植物之實 土 =v_:、麥、大米)、玉米、大豆、 、油菜及果_=罢腕豆和其它蔬菜品種、棉花、煙草 強調的是玉n頻果、梨、掛_水果和葡萄),且特別 且、馬鈴薯、棉祀、煙草和油菜。特別 201012812 強調的特質是增加植物對抗昆蟲、蟎、線蟲、蛞蝓和蝸牛 在植物上形成的毒素之防禦,特別是經由從蘇雲金芽孢桿 菌的基因物質(例如基因CryiA(a)、CrylA(b)、CrylA(c)、The nutritional value, the higher sugar content in the fruit, and the harvest product have better storage capacity and/or treatment. Genetically transgenic plants or plant cultivars (obtained via genetic engineering) which are preferably treated according to the invention include all plants which are essentially genetically modified to receive genetic material which confers particularly advantageous and useful qualities to these plants. = Some examples of quality are better plant growth, increase the resistance to high or low temperature, or the water or soil salt content, increase the flowering performance V,: accelerate the mature, higher harvest Yield, better quality and/or product have higher nutritional value, better storage stability and/or processability. The other traits of this trait are the better defense against =r? pests, such as for two weeding: sex bacteria and/or viruses' and increasing the tolerance of plants to certain larvae that are required for some of them. It can be enumerated as the actual soil of genetically transgenic plants = v_:, wheat, rice), corn, soybeans, rapeseed and fruit _=Wars and other vegetable varieties, cotton, tobacco emphasizes jade, fruit, pear, Hanging _ fruit and grapes), and especially, potatoes, cotton aphid, tobacco and canola. In particular, 201012812 emphasizes the trait of increasing the defense of plants against toxins formed by insects, mites, nematodes, mites and snails on plants, in particular via genetic material from Bacillus thuringiensis (eg genes CryiA(a), CrylA(b), CrylA(c),
CryllA、CrylllA、CryIIIB2、Cry9c、Cry2Ab、Cry3Bb及 CrylF Ο Ο 及其組合)在植物中所形成者(以下稱為「Bt植物」p也特 別強調的特質是經由整體性所得到的抵抗性⑴八尺)、系統素 、植物抗毒素、激發子、抵抗性基因及對應表達的蛋白質 及毒素,增加植物對抗真菌、細菌及病毒之防禦。更特別 強調的特質是增加植物對於某些除草活性化合物之耐受, 例如咪唑啉酮類、磺醯脲類、草甘膦或草胺磷⑦h〇sphin〇tricin) (例如PAT”基ϋ)。給予所要的特質之基@也可以彼此結合 存在於基因轉殖植物内。可以列舉的「所植物」之實例是玉 米變種、棉花變種、大豆變種及馬鈴薯變種,其係在商標名稱 YIELD GARD® (例如玉米、棉花、大豆)、Kn〇ck〇ut(g)(例 如玉米)、StarLmk® (例如玉米)、B〇Ugard@ (棉花)、 Nucotn® (棉;fb^NewLeaf(g)(馬鈴箸)之下販賣。可以列舉 的,除草劑耐受之植物是在商標名觀_卿…咖⑧(耐 =草甘膦例如玉米、棉花、大豆)、⑽吻[地⑧(耐受草 胺碟例如油菜)、IMI⑧(耐受味唑琳刚員)及sts⑧(耐受碏 醯脲類’例如玉米)之下販$之玉米變種、棉花變種及大豆變種 二列f的對除草劑耐受之植物(在傳統方式下栽培㈣ 矛、劑耐受的植物)包括在商標名稱Clearfidd⑧(例如玉米) 然',這些說明也適用於具有這些基因 次仍待發展的基因特質之植物栽培品種,這些植物栽 201012812 培品種將會在未來發展及/或上市。 之通別有利的方式下使用根據本發明 之通式(I)化合物及/或根據本發明之 理。上述對於活性化合物$化口物屁口物處 ... 物次混合物之較佳範圍也適用於這 合物處理植物 ΐί理’特別強調的是用本文中明確提出的活性化 本發明之化合物可㈣於控财種害蟲,包括 例如有害的吸錄昆蟲、叮咬似蟲及其他錄寄生性害蟲、儲 糧害蟲、槪工㈣料的害蟲,及衛生害蟲,包括寄生蟲,在獸〇 醫領域且可用於為其控制,例如其消滅及滅絕。因此,本 包括控制有害的害蟲之方法。 € 在獸醫領域’也就是在獸醫醫學之領域,根據本發明之活 性化合物可以活性對抗動物寄生蟲,特別是體外寄生蟲 體内寄生蟲。體内寄生蟲-詞包括制是螺蟲,例如條蟲、 線蟲和吸蟲及原生動物例如如球蟲。體外寄生蟲通常且較宜是 節肢動物,尤其是昆蟲,例如蒼繩(刺痛和踩)、寄生繩的幼 蟲、蝨子、頭髮蝨子、禽流蝨子、跳蚤等;或蟎,例如蝨等,❹ 例如硬蜱或軟蜱或蟎類,例如赤黴病蟎,秋蟎,鳥端等。 這些寄生蟲包括: 從虱目例如血虱屬、長顎虱屬、虱屬、陰乳屬吸唆 虱屬;特別實例是··犬虱、狐顎虱、綿羊顎虱、長顯牛風 、足顎虱、山羊虱、馬虱、牛虱、豬虱、人頭風、人體或 、Phylloera vastatrix、陰風、小短鼻牛風。 從食毛目及Amblycerina與Ischnocerina亞目例如 74 201012812CryllA, CrylllA, CryIIIB2, Cry9c, Cry2Ab, Cry3Bb, and CrylF Ο Ο and combinations thereof are also formed in plants (hereinafter referred to as "Bt plants". The special emphasis is also on the resistance obtained through holism (1) Rulers, systemin, phytoalexins, elicitors, resistance genes and correspondingly expressed proteins and toxins increase the defense of plants against fungi, bacteria and viruses. A more particularly emphasized trait is to increase the tolerance of plants to certain herbicidal active compounds, such as imidazolinones, sulfonamides, glyphosate or glufosinate 7h〇sphin〇tricin (eg PAT). The basis for giving the desired traits can also be combined with each other in the gene transfer plant. Examples of "plants" that can be enumerated are corn varieties, cotton varieties, soybean varieties and potato varieties under the trade name YIELD GARD® ( For example, corn, cotton, soybeans, Kn〇ck〇ut(g) (for example, corn), StarLmk® (for example, corn), B〇Ugard@ (cotton), Nucotn® (cotton; fb^NewLeaf(g) (mamble)贩) under the sale. As can be cited, the herbicide tolerant plant is in the brand name _ Qing ... coffee 8 (resistant = glyphosate such as corn, cotton, soybean), (10) kiss [ground 8 (tolerant oxalate Herbicide tolerance to dishes such as rapeseed), IMI8 (tolerant to the oxazoline) and sts8 (tolerant urests such as corn) under the corn variety, cotton varieties and soybean varieties Plant (cultivated in a traditional manner (4) spear, tolerant plants) Included in the trade name Clearfidd8 (eg corn), these instructions also apply to plant cultivars with genetic traits that are still to be developed for these genes, which will be developed and/or marketed in the future. The compounds of the general formula (I) according to the invention and/or the principles according to the invention are used in an advantageous manner. The preferred range of the above-mentioned mixture of the active compound and the fart is also applicable to This compound treatment plant is particularly emphasized by the use of the compounds of the invention as specifically set forth herein to (4) control pests, including, for example, harmful insects, biting insects and other parasitic pests, Pests for stockpiling pests, finished (four) materials, and sanitary pests, including parasites, are used in the field of veterinary medicine and can be used for their control, such as their elimination and extinction. Therefore, this includes methods for controlling harmful pests. Veterinary field 'that is in the field of veterinary medicine, the active compounds according to the invention can be active against animal parasites, in particular ectoparasites Endoparasites. Internal parasites - the term includes snails, such as worms, nematodes and trematodes, and protozoa such as coccidia. Extracorporeal parasites are usually and more preferably arthropods, especially insects such as the stalk (stinging and stepping), larvae of parasitic ropes, scorpions, hair lice, bird lice, fleas, etc.; or cockroaches, such as cockroaches, etc., such as hard cockroaches or soft mites or mites, such as scab, 螨, the bird's end, etc. These parasites include: From the order of the eye, such as the blood genus, the genus genus, the genus genus, the genus genus genus; the special examples are: canine, fox, sheep, Long cattle, foot, goat, horse, burdock, piglet, head wind, human body, Phylloera vastatrix, yin wind, small short nose wind. From the nectar and the Amblycerina and Ischnocerina suborders such as 74 201012812
Trime-nopon spp·、雞虱屬、Trinoton spp.' Bovicola spp·、 Werneckiellaspp.、Lepikentronspp.、Damalinaspp.、齒毛 虱屬、Felicolaspp.;特別實例是:牛鳥虱、綿羊虱、Bovicola limbata、Damalinabovis、犬食毛風、貓風、山羊毛虱、 Lepikentron ovis、Werneckiella equi。 從雙翅目及長角與Brachycerina亞目例如伊蚊屬、按 蚊屬、庫蚊屬、蚋屬、真蚋屬、白蛉屬、羅蛉屬、庫蠓屬 、斑it屬、瘤it屬、黃it屬、原虹:屬、麻虹:屬、Philipomyia spp.、Braula spp.、家蠅屬、齒股蠅屬、螫蠅屬、血蠅屬、 Morelliaspp.、廁繩屬、舌蠅屬、麗蜷屬、綠繩屬、金蠅屬 、Wohlfahrtiaspp.、麻蠅屬、狂蠅屬、皮蠅屬、胃蠅屬、虱 繩屬、Lipoptena spp.、碑繩屬、Rhinoestrus spp.、大蚊屬; 特別實例是:埃及斑蚊、白紋伊蚊、帶缘伊蚊、瘧蚊、日月 潭瘧蚊、琉璃蠅、麻翅虻、熱帶家蚊、淡色庫蚊、媒斑蚊、廁 蠅、肉蠅、廄螫蠅、沼澤大蚊、銅綠蠅、絲光綠蠅、爬蚋、静 食白蛉、長鬚白蛉、Odagmia ornata、Wilhelmia equina、 Boophthora erythrocephala、Tabanus bromius、Tabanus spodopterus、牛it、Tabanus sudeticus、Hybomitra ciurea、 Chrysops caecutiens ' 高原斑it、Haematopota pluvialis、 Haematopota italica、秋家绳、家繩、Haematobia irritans irritans、東方角繩、Haematobia stimulans、Hydrotaea irritans 、Hydrotaea albipuncta、Chrysomya chloropyga、虫且症金繩、 羊狂繩、牛皮繩、紋皮绳、Przhevalskiana silenus、人膚繩 、錦羊風蝇、Lipoptena capreoli、Lipoptena cervi、Hippobosca 75 201012812 variegata、Hippobosca equina、馬蠅、赤尾胃蠅、紅小胃蠅 、腸胃繩、黑角胃繩、黑腹胃繩、蜜蜂風。 從蚤目例如蚤屬、#頭蚤屬、客蚤屬、角葉蚤屬;特 別實例是:狗蚤、貓蚤、人蚤、穿皮潛蚤、印度鼠蚤。 從異翅目例如臭蟲屬、錐鼻屬、紅徵春屬、PanStr〇ngylUS spp.。 從蠊目例如蟑螂、美洲大蠊、德國小蠊、SupeiiaSpp.( 例如長鬚帶嫌)。 〇 從蜗亞綱(蜗蜱目)及後氣孔目與中胸氣孔目例如銳緣蜱 屬、鈍緣蜱屬、耳蜱屬、硬蜱屬、鈍眼蜱屬、牛蜱屬、革 蜱屬、血蜱屬、璃眼蜱屬、扇頭蜱屬、皮刺蟎屬、耳蟎屬、 肺刺蜗屬、Sternostoma spp.、"Varroa spp·、Acarapis spp.; 特別實例疋.波斯锐缘碑·、鹤銳緣碑、Ornithodorus moubata 、耳殘嗓碑、微小牛碑、消色牛碑、環狀牛碑、Rhipicephalus (Boophilus) calceratus、小玻璃眼蜱、埃及璃眼蜱、邊緣璃眼 蜱、Hyalommatransiens、Rhipicephalus evertsi、萬麻豆蝨、 Ο 六角形硬蜱、犬硬蜱、多毛硬蜱、淺紅硬蜱、黑脚硬蜱、全環¥ 硬碑、嗜群血碑、刻點血碑、Haemaphysalis cinnabarina、 Haemaphysalis otophila、犬血蜱、長角血蜱、邊緣壁蝨、網狀 矩頭壁兹、Dermacentor pictus、Dermacentor albipictus、 Dermacentor andersoni、Dermacentor variabilis、Hyalomma mauritanicum、褐犬蜱、Rhipicephalus bursa、扇頭壁蟲、 Rhipicephalus capensis、Rhipicephalus turanicus、Trime-nopon spp·, chicken genus, Trinoton spp. 'Bovicola spp·, Werneckiellaspp., Lepikentronspp., Damalinaspp., genus, Felicolaspp.; special examples are: cattle cockroach, sheep pheasant, Bovicola limbata, Damalinabovis, Dog hairy, cat wind, mountain wool, Lepikentron ovis, Werneckiella equi. From Diptera and Longhorn and Brachycerina suborders such as Aedes, Anopheles, Culex, genus, genus, genus, genus, genus, genus, genus, genus , genus, genus, genus, genus, genus, Philipomyia spp., Braula spp., housefly genus, genus, genus, genus, genus, morelliaspp., toilet genus, genus , genus, green genus, genus, genus Wohlfahrtiaspp., genus, genus, genus, genus, genus, genus, genus, genus, genus, genus, genus, genus, genus, genus, genus, genus, genus Special examples are: Aedes aegypti, Aedes albopictus, Aedes aegypti, Anopheles mosquito, Sun Moon Lake malaria, glabrium fly, Hemp winged hawksbill, tropical house mosquito, Culex pipiens pallens, vector mosquito, toilet fly, flies , ticks, swamps, tussah, sericulture, scorpion, white pheasant, white scorpion, Odagmia ornata, Wilhelmia equina, Boophthora erythrocephala, Tabanus bromius, Tabanus spodopterus, cattle it, Tabanus sudeticus, Hybomitra ciurea, Chrysops caecutiens ' plateau spot, Haematopota pluvialis, Haematopota i Talica, autumn rope, home rope, Haematobia irritans irritans, oriental horn rope, Haematobia stimulans, Hydroteaa irritans, Hydroteaa albipuncta, Chrysomya chloropyga, worm and golden rope, sheep mad rope, cowhide rope, leather rope, Przhevalskiana silenus, human Skin rope, Phyllostachys pubescens, Lipoptena capreoli, Lipoptena cervi, Hippobosca 75 201012812 variegata, Hippobosca equina, horsefly, red-tailed stomach fly, red small stomach fly, gastrointestinal rope, black horn stomach rope, black belly stomach rope, bee wind. From the order of the eye, such as the genus, the genus, the genus, the genus, the genus, the special examples are: shit, meerkat, human cockroach, skin squatting, Indian groin. From the order of the genus Heteroptera, such as the genus Bacillus, Cones genus, Rhododendron, PanStr〇ngylUS spp. From the eyes of the cockroaches, such as cockroaches, American cockroaches, German cockroaches, SupeiiaSpp. (for example, long hair is suspected). From the genus of the genus and the stomata and the stomata of the chest, such as the genus Quercus, the genus blunt, the genus of the genus, the genus, the genus, the genus, the genus , blood genus, genus, genus, genus, genus, genus, genus, genus Sternostoma spp., "Varroa spp·, Acarapis spp.; special case 波. Persian sharp Monument, He Ruiyuan, Ornithodorus moubata, ear wreck, tiny cattle monument, achromatic cattle monument, ring cattle monument, Rhipicephalus (Boophilus) calceratus, small glass eyelids, Egyptian glass eyelids, edge glass eyelids , Hyalommatransiens, Rhipicephalus evertsi, Wanma Cardamom, 六角 Hexagonal hard 蜱, canine hard 蜱, hairy hard 蜱, light red hard 蜱, black foot hard 蜱, full ring ¥ hard monument, bloody monument, engraved blood monument , Haemaphysalis cinnabarina, Haemaphysalis otophila, canine blood stasis, long-horned blood clam, marginal tick, reticular wall, Dermacentor pictus, Dermacentor albipictus, Dermacentor andersoni, Dermacentor variabilis, Hyalomma mauritanicum, brown dog, Rhipicephalus bursa, fan Insects, Rhipicephalus capensis, Rhipicephalus turanicus,
Rhipicephalus zambeziensis、孤星壁蟲、Amblyomma 76 201012812 variegatum、海灣蜱、Amblyommahebraeum、卡沿純眼蜱、 雞皮刺蜗、熱帶禽瞒、林禽刺蜗、蜜蜂蟹蜗。 從輻蟎目(前氣門亞目)及粉蟎目(無氣門亞目)例如蟎屬、 Cheyletiellaspp.、禽螯蜗屬、肉蜗屬、生挤蜗屬、螺蜗屬、恙蜗 屬、Listrophorusspp.、粉蜗屬、食酷瞒屬、Caloglyphusspp.、 Hypodectesspp.、Pterolichusspp.、庠瞒屬、皮蜗屬、耳蜗屬、挤 蜗屬、Notoedresspp.、Knemidocoptesspp.、Cytoditesspp.、雞離 蜗屬;特別實例是:恙蜗、Cheyletiella blakei、犬螺形瞒、 牛蠕形蟎、馬蠕形蟎、山羊蠕形蟎、倉鼠蠕形蟎、Demodex caballi、緒螺形、秋收恙蜗、Neotrombicula desaleri、 Neosch(5ngastiaxerothermobia、紅恙蜗、耳恙蟲、小穿孔挤癬 蟲、Sarcoptis canis、牛療蟎、羊挤瞒、Sarcoptes rupicaprae (=S. caprae)、馬疥蟎、豬疥蟎、羊癢蟎、耳疥癖蟲、馬痒蟎、牛济 癬、Psoergates ovis、Pneumonyssoidic mange、犬鼻济蟲、武 氏蜂盾蟎。 根據本發明之活性物質組合物也適於對抗攻擊動物之 節肢動物、蠕蟲及原蟲。動物包括農業家畜例如牛、綿羊 、山羊、馬、豬、驢、路騎、水牛、兔子、雞、火雞、鴨 子、鵝、養殖魚、蜜蜂。另外,動物包括家庭動物_也稱為 寵物-例如狗、貓、籠中鳥、水族箱中的魚,以及所謂的實 驗動物例如大田鼠、天竺鼠、大鼠與小鼠。 經由控制這些節肢動物、蠕蟲及/或原蟲,打算減少宿 主動物之死亡及改良表現(例如肉、奶、毛、獸皮、蛋、蜂 蜜等)與健康,所以經由使用根據本發明之活性化合物,可 201012812 以更經濟及更簡單地養殖動物。 例如,想要預防或阻止寄生蟲從宿主(當可行時)吸取血 液。而且,控制寄生蟲可以幫助預防感染介質之穿入。 「控制」一詞在本發明獸醫領域中使用時,係指該活性化合 物可有效地在感染寄生蟲之動物中將各寄生蟲之盛行率降低至 無害的程度。更確定地說,「控制」在本文使用時,係指該活性 化合物可以有效地殺死各寄生蟲、抑制其生長、或抑制其繁殖。 通常,當用於處理動物時,可以直接施加根據本發明 之活性化合物。其較宜以醫藥組成物使用,其中含有此項 技藝中已知之藥學上可接受的賦形劑及/或輔劑。 在獸醫領域及動物飼養方面’根據本發明之活性化合 物是以已知方法使用(=投藥),例如以片劑、膠囊劑、飲劑 、獸用頓服劑、顆粒劑、糊劑、大丸粒'餵食法及栓劑之 形式經由腸道用藥,經由非經腸道用藥例如經由注射(肌内 、皮下、靜脈内、腹膜内等)' 植入法、經由鼻子用藥、以 例如浸潰或洗澡、喷灑、沖淋及打點、清洗及灑粉形式經 由皮膚用藥’以及也可經由含活性化合物的塑造物品例如 頸圈、耳標、尾標、肢足繃帶、韁繩、印記物品等。該活 性化合物可以調製成洗髮精或作為合適的調製物供氣溶膠 或沒有加壓的喷霧劑使用,例如泵噴霧劑及喷霧器喷霧劑 〇 一用在豕畜、豕禽、寵物等時’根據本發明之活性化 合物可以作為調製物(例如粉劑、可溼化的粉劑[“WP”]、乳 液、可乳化的濃縮劑[“EC”]、流動性均勻的溶液及懸浮液 201012812 濃縮劑[“SC”])使用,其含有從1至80重量%的量之活性化合 物,不論是直接或稀釋後(例如100-10000倍稀釋),或其玎 以作為化學浴使用。 當在獸醫領域中使用時,根據本發明之活性化合物可 以結合合適的增效劑或其他活性化合物使用,例如殺蟎劑、 殺蟲劑、殺蠕蟲劑、殺原蟲劑。 還發現根據本發明之化合物對於破壞工業原料之昆蟲 也具有強烈的殺蟲作用。 下列昆蟲為可列舉但並不僅限於此之較佳實例: 曱轰類’例如:家天牛、Chlorophorus pilosis、家具竊蠹、 報死竊蠹、Ptilinus prcticornis、Dendrobium pertinex、粉竊 蠢、Priobiumcarpini、歐洲竹粉橐、非洲粉蠢、平頸粉蠹 、Lyctus linearis、Lyctus pubescens、Trogoxylon aequale、 Minthes rugicollis、Xyleboms spec·、Tryptodendron spec.、 Apate monachus、Bostrychus capucins、棕異翅長蠹、Sinoxylon spec.、竹長蠹; 膜翅類’例如.鋼月小樹蜂、大樹蜂、Urocerus gigas taignus > Urocerus augur ; 白蟻類,例如:木白蟻、麻頭堆砂白蟻、灰點鼻白蟻、黃胸 散白蟻、散白蟻、歐洲散白蟻、澳洲白蟻、z〇〇term〇psis nevadensis及台灣家白蟻; 蠹蟲類,例如··西洋衣魚。 在本發明的工業材料係指非不是活的物質,舉例來說 較宜為塑膠、黏著劑、膠水、紙及卡片、皮革、木材及木 201012812 材加工產品與塗料組成物。 如果合適時,即可使用的組成物可以另外含有其他殺 昆蟲劑’及如果合適時,其他一或多種殺真菌劑。 關於混合物中潛在的其他成份,可參考上述殺昆蟲劑 及殺真菌劑。 根據本發明之化合物也可以用於保護防止在物件上生 長’尤其是與海水或鹽水接觸之船殼、屏、網、建築物、 碼頭及訊號設備。 根據本發明之化合物,本身或結合其他活性化合物, 還可以作為抗海藻附著劑使用。 本活性化合物也適於在住宅、衛生及儲存產品之領域 中用於防治動物害蟲.,尤其是在密閉空間例如公寓、廠房 、辦公室、車艙等内部發現的昆蟲、蜘蛛綱節肢動物及蟎 類’其可獨自使用或結合在家庭殺蟲產品中用於防治這些 害蟲之其他活性物質及辅劑。其對於敏感與抗藥性物種及 全部發育階段具有活性。這些害蟲包括: 從長翅目例如螢光蠍。 從蜱蟎目例如波斯隱喙蜱、鴿壁虱、苔蟎、雞皮刺蟎、 住家食甜恙虫、Ornithodorus moubat、血紅扇頭碑、Trombicula alfreddugesi、Neutrombicula autumnalis、歐洲家刺皮蜗、美 洲家刺皮蟎。 從蛛形目例如Aviculariidae、鬼蛛。 從盲珠目例如擬嫩目螯缴、Pseudoscorpiones cheiridium、Opiliones phalangium ° 201012812 從等足目例如潮蟲、porcelli〇 scaber。 從倍足亞目例如 Blaniulus guttulatus、Polydesmus spp. ο 從唇足亞目例如Geophilus spp.。 從缕尾目例如Ctenolepisma spp.、西洋衣魚、盜火蟲。 從蟎蠊目例如東方蟎蠊、德國蟎蠊、佛羅里達張蟑螂、 馬得拉蝶蠊、角腹蠊、Parcoblatta spp.、澳洲大蠊、美洲大 ❹ 蠊、褐色大蠊、煙色大蠊、長鬚緋蠊。 從彈尾目例如家蟋蟀。 從革翅目例如歐洲球蟎。 從等翅目例如木白蟻、白蟻。 從唾蟲目例如Lepinatus spp.、家書風。 從稍翅目例如Anthrenus spp.、黑皮蠹、皮蠢、長頭谷 盜、郭公蟲、蛛甲、Rhizopertha dominica、谷象、米象、 玉米象、藥材盜谷。 ❹ 從雙翅目例如 Aedes spp.、Aedes albopictus、Aedes taeniorhynchus、斑按蚊、紅頭麗蠅、Chrysozonapluvialis 、五帶淡色庫蚊、尖音庫蚊、Culex tarsalis、果蠅、黃腹廄 繩、豕繩、Phlebotomus spp.、Sarcophaga carnaria、Simulium spp.、廄螫蠅、歐洲大蚊。 從鱗翅目例如小蠟螟、大蠟螟、印度谷螟、Tinea cloacella、網衣蛾、袋衣蛾。 從蚤目例如狗櫛頭蚤、貓櫛頭蚤、人蚤、穿皮潛蚤、 東方鼠蚤。 81 201012812 從膜翅目例如賓州大黑蟻、黑草蟻、普通黑蟻、Lasius umbratus、廚蟻、Paravespula spp.、鋪道蟻。 從風目例如頭風、人乱、陰風。 從異翅目例如熱帶臭蟲、臭蟲、長紅錐蝽、騷擾蝽。 在家用殺蟲劑領域中,其係獨自使用或結合其他合適 的活性化合物例如填酸酯類、胺基曱酸鹽類、合成除蟲菊 酯類、生長調節劑或從其他已知種類的殺蟲劑之活性化合 物。 使用時是以氣溶膠、未經加壓的喷霧例如泵及喷霧器 喷霧、喷霧器、霧化器、泡沫、膠、蒸發器產物及油纖維 素或塑膠製成之蒸發器片劑、液體蒸發器、膠及膜蒸發器、 螺旋槳操作之蒸發器、無動力或被動式蒸發器系統、蛾紙、 蛾小藥囊及蛾膠、顆粒或粉粒、用於散播的_或僻駐點之 形式進行。 【實施方式】 合成實例 L 4-[3·氯·5_(三氟甲基)苯基]_3_(曱基硫炫基) 吡唑-5-胺(化合物實例1-045從表1) u步聲7 (中間物6-034從表6): 在氬氣壓下,將2.28克(57毫莫耳)氫化鈉(6〇。/0在礦物油中) 先添加至10毫升無水甲苯中。在室溫下,緩慢逐滴加入5克(22 7 毫莫耳)的3-氯-5-三氟甲基苄腈及2.6克(34.2毫莫耳)的二硫化 碳在10毫升DMF中的混合物。隨後在用冰冷卻下,逐滴加入 8.08克(57毫莫耳)的曱基填。將混合物在室溫攪拌12小時後在 201012812 120°C加熱2小時。冷卻後’小心加入水,並將反應混合物用二 氯曱烷重複萃取。將合併的有機層經由硫酸鎮乾燥,過濾並在減 壓下濃縮。在矽膠上層析後得到6.7克(產量84.5%之理論值)的 2-[3-氯-5-(三氟曱基)苯基]-3,3-雙(甲基硫烷基)丙—2_稀赌。 1H-NMR (400 MHz, d^-DMSO), δ 7.87-7.86 (s+s, 2Η), 7.79 (s, 1H), 2.65 (s, 3H),2.38 (s,3H)。 lgP (HCOOH) = 4.40 1.2 #雜2 (中間物5-034從表5): 將6.7克(19.2毫莫耳)的2-[3-氯-5-(三氟甲基)苯基]_3,3_雙(甲 基硫烧基)丙-2-烯赌及1.93克(38.5毫莫耳)的胼水合物在迴流 下的50毫升乙醇中加熱12小時。將反應混合物在減壓下濃 縮,將殘留物溶解在水中並用二氯曱统重複萃取。將合併的有機 層經由硫酸鎂乾燥’過濾並在減壓下濃縮。如此得到5 8克(98〇/〇 的理論值)的化合物4-[3-氣-5-(三氟曱基)苯基]_3_(甲基硫烷 基)-111>比嗤-5-胺’其不再純化而可以在隨後的步驟3中反應。 1H-NMR (400 MHz,d6-DMSO),δ (NH 及 NH2 沒有偵測)7.72 (s, 1H), 7.70 (s,1H), 7.54 (s, 1H), 2·38 (s,3H)。 lgP (HCOOH) = 2.77 U步原^ (化合物實例1-045從表1) 將5克(16.25毫莫耳)的4_[3_氯_5_(三氟曱基)苯基]_3_(甲基 硫烷基HH-吡唑-5-胺溶解在10毫升DMF中,並加入〇.65克氣 化鈉(60%在礦物油中)。停止釋出氣體後,加入2 〇9克(17.9毫 莫耳)的2-氯嘧啶,並將反應混合物在10(^c攪拌12小時。冷 卻至室溫後,將混合物用30毫升的1 N氫氯酸及水稀釋。吸氣 201012812 將所得的沈澱物過濾並用正戊烷清洗。如此得到5.4克(63.8%的 理論值)的4_[3_氣-5-(三氟曱基)笨基]Μ曱基硫烷基)(嘧咬_2_ 基)-1Η-η比峻-5_胺。 iH-NMR (400 MHz, d6-DMSO), δ 8.88 (d, 2Η), 7.73 (s, 1H), 7.68 (s, 1H), 7.65 (s, 1H), 7.38 (t, 1H), 7.07 (% s, 2H, NH2), 2.53 (s, 3H) ° lgP(HCOOH)= 3.51 2. 4_[3-氣_5_(二氣曱基)本基]·*3-(曱基亞績酿基)-1-( 〇密咬-2-基)-1Η-σ比唾-5-胺(實例2-045從表2): 將2.3克(4.4毫莫耳)的4-[3-氣-5-(三氟曱基)苯基]-3-(曱基硫® 烷基)-1-(嘧啶-2-基)-1Η-吡唑-5-胺溶解在1〇毫升二氣甲烷中,並 在室溫下加入0.99克(4·4毫莫耳)的;氯過笨甲酸(77%強度)。 將反應混合物在室溫攪拌12小時後與飽和的碳酸氫納水溶液攪Rhipicephalus zambeziensis, Lone Star Wallworm, Amblyomma 76 201012812 variegatum, Gulf 蜱, Amblyommahebraeum, card along pure eyelids, chicken skin thorns, tropical birds, forest birds, snails, bees and crabs. From Radix (former genus) and genus (no genus) such as genus, Cheyletiellaspp., avian genus, genus, genus, genus, genus, Listrophorusspp ., genus, genus, Caloglyphusspp., Hypodectesspp., Pterolichusspp., genus, genus, cochlear, genus, genus Notoedresspp., Knemidocoptesspp., Cytoditesspp., genus Examples are: snail, Cheyletiella blakei, snail scorpion, snail scorpion, horse scorpion scorpion, goat scorpion, hamster, squirrel, Demodex caballi, snail, autumn snail, Neotrombicula desaleri, Neosch ( 5ngastiaxerothermobia, red worm, ear mites, small perforated mites, Sarcoptis canis, ox treatment, sheep squeezing, Sarcoptes rupicaprae (=S. caprae), horse owl, piglet, itch, deafness Aphids, horse mites, bovine mites, Psoergates ovis, Pneumonyssoidic mange, canine worms, W. striata. The active substance composition according to the invention is also suitable for combating arthropods, worms and originals of attacking animals. Worm Including agricultural livestock such as cattle, sheep, goats, horses, pigs, donkeys, road rides, buffalo, rabbits, chickens, turkeys, ducks, geese, farmed fish, bees. In addition, animals include family animals _ also known as pets - for example Dogs, cats, caged birds, fish in aquariums, and so-called experimental animals such as voles, guinea pigs, rats and mice. By controlling these arthropods, worms and/or protozoa, it is intended to reduce the death of host animals and Improved performance (eg meat, milk, wool, hides, eggs, honey, etc.) and health, so by using the active compound according to the invention, it is possible to farm animals more economically and simply in 201012812. For example, want to prevent or prevent The parasite draws blood from the host (when feasible). Moreover, controlling the parasite can help prevent penetration of the infectious agent. The term "control" as used in the veterinary art of the present invention means that the active compound is effective in infection. In parasitic animals, the prevalence of each parasite is reduced to a harmless degree. More specifically, "control" as used herein refers to the activity. The compound can effectively kill each parasite, inhibit its growth, or inhibit its reproduction. Generally, when used for treating animals, the active compound according to the present invention can be directly applied. It is preferably used as a pharmaceutical composition, which contains Pharmacologically acceptable excipients and/or adjuvants known in the art. In the veterinary field and in animal feeding, the active compounds according to the invention are used in known methods (= administration), for example in the form of tablets and capsules. Agent, drink, veterinary agent, granules, paste, large pellets in the form of 'feeding method and suppository, via enteral administration, via parenteral administration, for example via injection (intramuscular, subcutaneous, intravenous, intraperitoneal) Etc. 'implantation, administration via the nose, administration via the skin, for example, by dipping or bathing, spraying, showering, spotting, washing and powdering' and also via molded articles containing active compounds such as collars, ears Mark, tail mark, limb bandage, reins, imprinted items, etc. The active compound can be formulated into a shampoo or as a suitable preparation for aerosol or non-pressurized sprays, such as pump sprays and spray sprays, for use in scorpions, poultry, pets. Isochronous 'The active compound according to the invention can be used as a preparation (for example powder, wettable powder ["WP"], emulsion, emulsifiable concentrate ["EC"], homogeneous flow solution and suspension 201012812 A concentrate ["SC"]) is used which contains the active compound in an amount of from 1 to 80% by weight, either directly or after dilution (for example 100-10000 fold dilution), or it is used as a chemical bath. When used in the veterinary art, the active compounds according to the invention may be combined with suitable synergists or other active compounds, for example acaricides, insecticides, anthelmintics, bactericides. It has also been found that the compounds according to the invention also have a strong insecticidal action against insects which destroy industrial raw materials. The following insects are preferred but not limited to the following examples: 曱 类 ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' Bamboo whitefly, African powder stupid, Pleurotus ostreatus, Lyctus linearis, Lyctus pubescens, Trogoxylon aequale, Minthes rugicollis, Xyleboms spec, Tryptodendron spec., Apate monachus, Bostrychus capucins, brown winged scorpion, Sinoxylon spec., bamboo蠹 蠹; Membranes ', for example, steel moon bee, big tree bee, Urocerus gigas taignus > Urocerus augur; termites, such as: wood termites, hemp pile sand termites, gray point nose termites, yellow chest loose termites, scattered Termites, European termites, Australian termites, z〇〇term〇psis nevadensis, and Taiwanese termites; aphids, such as Western squid. The industrial material in the present invention refers to a material which is not a living material, for example, a plastic, an adhesive, a glue, a paper and a card, a leather, a wood and a wood 201012812. If appropriate, the ready-to-use compositions may additionally contain other insecticides' and, if appropriate, other one or more fungicides. For the other potential components in the mixture, reference may be made to the above-mentioned insecticides and fungicides. The compounds according to the invention can also be used to protect hulls, screens, nets, buildings, docks and signalling equipment that prevent growth on objects, especially in contact with sea water or salt water. The compounds according to the invention, by themselves or in combination with other active compounds, can also be used as anti-seaweed adhesion agents. The active compounds are also suitable for controlling animal pests in the field of residential, sanitary and storage products, especially insects, arachnids and mites found in confined spaces such as apartments, factories, offices, cabins, etc. 'It can be used alone or in combination with other active substances and adjuvants used in household insecticidal products for controlling these pests. It is active against sensitive and resistant species and all stages of development. These pests include: From the order of the pteridophyte, such as fluorescent mites. From eye-catching such as Persian concealment, pigeon tick, moss, chicken skin hedgehog, house-feeding sweet aphid, Ornithodorus moubat, blood red fanhead, Trombula alfreddugesi, Neutrombicula autumnalis, European home thorns, American home thorns Hey. From the arachnids such as Aviculariidae, ghost spiders. From the blind beaks such as Pseudoscorpiones cheiridium, Opiliones phalangium ° 201012812 from the order of the foot such as the worm, porcelli〇 scaber. From the suborders such as Blaniulus guttulatus, Polydesmus spp. ο from the lip-foot suborders such as Geophilus spp. From the appendix, such as Ctenolepisma spp., western piranha, and fire worm. From the order of the eye, such as Oriental 螨蠊, German 螨蠊, Florida Zhangye, Madhya 蠊, 角 蠊, Parcoblatta spp., Australian 蠊, American ❹ 蠊, brown 蠊, 烟 蠊, long Mustache. From the tail of the bullet, such as the family. From the genus Ganoderma, such as the European ball python. From the order of the isoptera, such as wood termites and termites. From the insects such as Lepinatus spp., the book style. From the genus Lepidoptera such as Anthrenus spp., black skin, stupid, long-headed stolen, cockroach, spider, Rhizopertha dominica, valley, rice, corn, medicinal material. ❹ From Diptera such as Aedes spp., Aedes albopictus, Aedes taeniorhynchus, Anopheles sinensis, Red-headed fly, Chrysozonapluvialis, Culex pipiens, Culex pipiens, Culex tarsalis, Drosophila, Yellow-bellied reins, reins , Phlebotomus spp., Sarcophaga carnaria, Simulium spp., ticks, European mosquitoes. From Lepidoptera such as small wax mites, large wax mites, Indian gluten, Tinea cloacella, nettle moth, and sacked moth. From the eyes of the eye, such as the dog's head, the cat's head, the man, the skin, and the oriental rat. 81 201012812 From Hymenoptera such as Penang black ant, black grass ant, common black ant, Lasius umbratus, kitchen ant, Paravespula spp., paving ant. From the wind, such as the head wind, people chaos, the wind. From the genus Heteroptera, such as tropical bed bugs, bed bugs, long red cones, and harassment. In the field of household insecticides, they are used alone or in combination with other suitable active compounds such as carboxylic acid esters, amino phthalates, synthetic pyrethroids, growth regulators or from other known species. Active compound of insecticide. Used in the form of aerosols, unpressurized sprays such as pumps and spray sprays, sprays, atomizers, foams, glues, evaporator products, and evaporator sheets made of oil cellulose or plastic. Agents, liquid evaporators, glue and membrane evaporators, propeller-operated evaporators, unpowered or passive evaporator systems, moth paper, moth sacs and moths, granules or powders, for spreading _ or secluded The form of the point is carried out. [Examples] Synthesis Example L 4-[3·Chloro-5-(trifluoromethyl)phenyl]_3_(mercaptothiol)pyrazole-5-amine (Compound Example 1-045 from Table 1) Acoustic 7 (Intermediate 6-034 from Table 6): 2.28 g (57 mmol) of sodium hydride (6 Torr. /0 in mineral oil) was first added to 10 mL of anhydrous toluene under argon. A mixture of 5 g (22 7 mmol) of 3-chloro-5-trifluoromethylbenzonitrile and 2.6 g (34.2 mmol) of carbon disulfide in 10 ml of DMF was slowly added dropwise at room temperature. Subsequently, 8.08 g (57 mmol) of hydrazine base was added dropwise with ice cooling. The mixture was stirred at room temperature for 12 hours and then heated at 201012812 120 °C for 2 hours. After cooling, water was carefully added, and the reaction mixture was repeatedly extracted with dichloromethane. The combined organic layers were dried over sulphuric acid, filtered and concentrated under reduced pressure. After chromatography on silica gel, 6.7 g (the theoretical value of 84.5% yield) of 2-[3-chloro-5-(trifluoromethyl)phenyl]-3,3-bis(methylsulfanyl)propane was obtained. —2_ Rare gambling. 1H-NMR (400 MHz, d^-DMSO), δ 7.87-7.86 (s+s, 2 Η), 7.79 (s, 1H), 2.65 (s, 3H), 2.38 (s, 3H). lgP (HCOOH) = 4.40 1.2 #杂2 (intermediate 5-034 from Table 5): 6.7 g (19.2 mmol) of 2-[3-chloro-5-(trifluoromethyl)phenyl]_3 , 3_bis(methylthioalkyl)prop-2-ene and 1.93 g (38.5 mmol) of hydrazine hydrate were heated in 50 ml of ethanol under reflux for 12 hours. The reaction mixture was concentrated under reduced pressure, and the residue was dissolved in water and extracted with dichloromethane. The combined organic layers were dried <RTI ID=0.0> Thus obtained 58 g (the theoretical value of 98 〇 / 〇) of the compound 4-[3- gas-5-(trifluoromethyl)phenyl]_3_(methylsulfanyl)-111> The amine, which is no longer purified, can be reacted in the subsequent step 3. 1H-NMR (400 MHz, d6-DMSO), δ (NH and NH2 not detected) 7.72 (s, 1H), 7.70 (s, 1H), 7.54 (s, 1H), 2·38 (s, 3H) . lgP (HCOOH) = 2.77 U step original ^ (Compound Example 1-045 from Table 1) 5 g (16.25 mmol) of 4_[3_chloro-5-(trifluoromethyl)phenyl]_3_(methyl The sulfanyl HH-pyrazole-5-amine was dissolved in 10 ml of DMF, and 〇.65 g of sodium hydride (60% in mineral oil) was added. After the gas evolution ceased, 2 〇 9 g (17.9 mM) was added. 2-chloropyrimidine, and the reaction mixture was stirred at 10 (c) for 12 hours. After cooling to room temperature, the mixture was diluted with 30 ml of 1 N hydrochloric acid and water. Inhalation 201012812 The solution was filtered and washed with n-pentane. This gave 5.4 g (63.8% of theory) of 4-[3_[sup]-5-(trifluoromethyl)phenyl]sulfenylalkyl). )-1Η-η比峻-5_amine. iH-NMR (400 MHz, d6-DMSO), δ 8.88 (d, 2Η), 7.73 (s, 1H), 7.68 (s, 1H), 7.65 (s, 1H), 7.38 (t, 1H), 7.07 (% s, 2H, NH2), 2.53 (s, 3H) ° lgP(HCOOH)= 3.51 2. 4_[3-gas_5_(dioxyl) group ]·*3-(曱基亚积酿基)-1-( 〇密咬-2-yl)-1Η-σ than salivary-5-amine (Example 2-045 from Table 2): 2.3 g (4.4 Methyl 4-[3- gas-5-(trifluoromethyl)phenyl]-3-(indolylthio® alkyl)-1-(pyrimidin-2-yl)- 1Η-pyrazole-5-amine was dissolved in 1 mL of di-methane, and 0.99 g (4·4 mmol) of chloroformic acid (77% strength) was added at room temperature. Stir at room temperature for 12 hours and stir with saturated aqueous solution of sodium bicarbonate
拌。將液層分離並用二氯甲烷逆萃取後,將合併的有機層經由 硫酸鎮乾燥,過濾並在減壓下濃縮。在矽膠上層析(溶劑:二氣甲 烧/曱醇=30:1)後得到0.92克(48.4%的理論值)的4-[3-氯-5-(三氟 甲基)苯基]_3_(甲基亞磺醢基)-1-(嘧啶-2-基)-1Η-吡唑-5-胺之無色 固體。 1H-NMR (400 MHz, d6-DMSO), δ 8.94 (d, 2Η), 7.89 (s, 2H), 7.72 (s, 1H), 7.52 (t, 1H),7.12 (broad s,2H,NH2),2.90 (s, 3H)。 lgP(HCOOH)= 2.21 3. 4-[3-乳-5_(二氣曱基)本基]_3-(曱基石黃酿基)_i_(鳴咬-2-基)-lH-吡唑-5-胺(實例3-045從表3): 將0.36 g (0.88毫莫耳)〇f 4_[3_氯_5_(三氟曱基)苯基]·3_(曱基 硫烷基)-1-(喊咬-2·基)-1Η·吡唑-5-胺溶解在5毫升二氯曱烷中, 84 201012812 並在室溫下加入0.39克(1·75毫莫耳)的界氯過苯甲酸(77%強 度)。將反應混合物在室溫擾拌12小時後與飽和的破酸氫納水溶 液攪拌。將液層分離並用二氯曱烷逆萃取後,將合併的有機層 經由硫酸鎂乾燥,過濾、並在減壓下濃縮。在發膠上層析(溶劑:二 亂甲燒/甲醇-30:1)後得到〇.〇8克(2〇·7%的理論值)的4_[3_氯 -5-(二氟曱基)苯基]_3_(曱基磺醯基)小(嘧咬_2_基)_1Η_吡唑_5_胺 之無色固體。mix. After separating the layers and back-extracting with dichloromethane, the combined organic layers were dried over EtOAc, filtered and evaporated. After chromatography on silica gel (solvent: two gas / decyl alcohol = 30:1), 0.92 g (48.4% of theory) of 4-[3-chloro-5-(trifluoromethyl)phenyl] _3_(Methylsulfinyl)-1-(pyrimidin-2-yl)-1Η-pyrazole-5-amine as a colorless solid. 1H-NMR (400 MHz, d6-DMSO), δ 8.94 (d, 2 Η), 7.89 (s, 2H), 7.72 (s, 1H), 7.52 (t, 1H), 7.12 (broad s, 2H, NH2) , 2.90 (s, 3H). lgP(HCOOH)= 2.21 3. 4-[3-milo-5_(dioxyl)-based]_3-(sulfenyl-branched)_i_(bine-2-yl)-lH-pyrazole-5 -Amine (Example 3-045 from Table 3): 0.36 g (0.88 mmol) 〇f 4_[3_chloro-5-(trifluoromethyl)phenyl]·3_(mercaptosulfanyl)-1 - (Snack bite - 2 · base) -1 Η pyrazole-5-amine dissolved in 5 ml of dichloromethane, 84 201012812 and added 0.39 g (1·75 mmol) of bound chlorine at room temperature Benzoic acid (77% strength). The reaction mixture was stirred at room temperature for 12 hours and then stirred with a saturated aqueous solution of sodium hydrogencarbonate. After the liquid layer was separated and extracted with dichloromethane, the combined organic layer was dried over magnesium sulfate, filtered and evaporated. After electrophoresis on a hair gel (solvent: turpentine/methanol-30:1), _.〇8 g (2 〇·7% of theoretical value) of 4_[3_chloro-5-(difluorofluorenyl) was obtained. a colorless solid of phenyl]_3_(mercaptosulfonyl) small (pyrimidine-2-yl)_1Η_pyrazole-5-amine.
1H-NMR (400 MHz, d6-DMSO), δ 8.96 (d, 2Η), 7.79 (s, 1H), 7.77 (s, 1H), 7.74 (s, 1H), 7.55 (t, 1H), 7.09 (broad s, 2H, NH2) 3 27 (s 3H). ? lgP(HC00H)= 2.53 ♦p-氯-5-(三氟甲基)苯基]_3_(乙基硫烷基M(喷咬·2_ 基)-1Η-吡唑-5-S}-N,N-二甲基亞醯胺基甲醯胺(實例4_〇〇4從表 4)1H-NMR (400 MHz, d6-DMSO), δ 8.96 (d, 2 Η), 7.79 (s, 1H), 7.77 (s, 1H), 7.74 (s, 1H), 7.55 (t, 1H), 7.09 ( Broad s, 2H, NH2) 3 27 (s 3H). ? lgP(HC00H)= 2.53 ♦p-chloro-5-(trifluoromethyl)phenyl]_3_(ethylsulfanyl M (injection bite·2_ Base)-1Η-pyrazole-5-S}-N,N-dimethylimidazolylamine (Example 4_〇〇4 from Table 4)
將0.11克(0.9毫莫耳;0J2毫升)的二曱基甲醯胺二甲基乙 醛(DMF-DMA)添加至在5毫升曱苯中的03克(〇 75毫莫耳)的 4_[3_氯_5_(三氟甲基)苯基]_3_(乙基硫烷基)小(喷喷1基)_迅吼 吐-5-胺中’並將混合物在迴流下鮮12 *時。錢^下將= 蒸顧去除’得到留下的無色固體沖-{413-氯_5-(三氣甲基)苯 基]_3_(乙基硫烧基)-l-(p嘧咬_2·基)-1Η·吡唑-5_基二甲美 亞醯胺基甲醯胺,產量0·31克(91.4%的理論值)。 土 1H-NMR (400 MHz. d6-DMS0). δ 8.86 (d. 2Η). 7.91 (m 2Η) (s. 1H)· 7.47 (t. 1H). 3.08 (q. 2H). 2.88 (s. 3H). 1.31 (t 3ίΙ) lgP (HCOOH) = 3.48 · .7.60 85 201012812 表10.11 g (0.9 mmol; 0 J2 ml) of dimercaptocarhamamine dimethylacetaldehyde (DMF-DMA) was added to 03 g (〇75 mmol) in 5 ml of toluene. 3_Chloro_5_(trifluoromethyl)phenyl]_3_(ethylsulfanyl) is small (jet 1 base) _ 吼 吼 -5 -5 - amine - and the mixture is fresh under reflux for 12 *. Money ^ will be = steamed to remove 'obtained colorless solids - {413-chloro-5-(trimethylmethyl)phenyl]_3_(ethylthioalkyl)-l-(p-pyridine_2 • Base)-1Η·pyrazole-5-yldimethylmethaneamine carbenamide, yield 0. 31 g (91.4% of theory). Soil 1H-NMR (400 MHz. d6-DMS0). δ 8.86 (d. 2Η). 7.91 (m 2Η) (s. 1H)· 7.47 (t. 1H). 3.08 (q. 2H). 2.88 (s. 3H). 1.31 (t 3ίΙ) lgP (HCOOH) = 3.48 · .7.60 85 201012812 Table 1
R1 = R2 = H n = 0 or 1 x= g2 G1 實例編號 A1 A2 R3 B G1 G2 G3 數據:b-NMR 特徵訊號(400 MHz, d6-DMSO), δ 1-001 N CH H ch3 2-C1 H H (CD3CN),8.76 (d, 2H)5 7.24 (t5 1H) 1-002 N CH H CH2CH3 2-C1 H H 1-003 N CH H ch(ch3)2 2-C1 H H 1-004 N CH 5-F ch3 2-C1 H H 1-005 N CH H ch3 2*F 6-F H (CD3CN),8.76 (d, 2H),7.24 (t,1H) 1-006 N CH H ch2ch3 2-F 6-F H 1-007 N CH H CH(CH3)2 2-F 6-F H 1-008 N CH 5-F ch3 2-F 6-F H 1-009 N CH H ch3 3-C1 H H 8.85 (d, 2H) 1-010 N CH H ch2ch3 3-C1 H H 1-011 N CH H CH(CH3)2 3-Cl H H 1-012 N CH 5-F ch3 3-C1 H H 1-013 N CH H ch3 3-CFj H H 8.86 (d, 2H), 7.38 86 201012812R1 = R2 = H n = 0 or 1 x= g2 G1 Example number A1 A2 R3 B G1 G2 G3 Data: b-NMR characteristic signal (400 MHz, d6-DMSO), δ 1-001 N CH H ch3 2-C1 HH (CD3CN), 8.76 (d, 2H)5 7.24 (t5 1H) 1-002 N CH H CH2CH3 2-C1 HH 1-003 N CH H ch(ch3)2 2-C1 HH 1-004 N CH 5- F ch3 2-C1 HH 1-005 N CH H ch3 2*F 6-FH (CD3CN), 8.76 (d, 2H), 7.24 (t,1H) 1-006 N CH H ch2ch3 2-F 6-FH 1 -007 N CH H CH(CH3)2 2-F 6-FH 1-008 N CH 5-F ch3 2-F 6-FH 1-009 N CH H ch3 3-C1 HH 8.85 (d, 2H) 1- 010 N CH H ch2ch3 3-C1 HH 1-011 N CH H CH(CH3)2 3-Cl HH 1-012 N CH 5-F ch3 3-C1 HH 1-013 N CH H ch3 3-CFj HH 8.86 ( d, 2H), 7.38 86 201012812
實例編號 A1 A2 R3 B G1 G2 G3 數據:W-NMR 特徵訊號(400 MHz, d6-DMSO), δ 1-014 N CH H CH2CH3 3-CF3 H H 1-015 N CH H CH(CH3)2 3-CF3 H H 1-016 N CH 5-F ch3 3-CF3 H H 1-017 N CH H ch3 4-C1 H H 8.84 (d, 2H), 7.35 1-018 N CH H ch2ch3 4-C1 H H 1-019 N CH H ch(ch3)2 4-C1 H H 1-020 N CH 5-F ch3 4-C1 H H 1-021 N CH H ch3 4-Br H H 8.84 (d,2H) 1-022 N CH H ch2ch3 4-Br H H 1-023 N CH H ch(ch3)2 4-Br H H 1-024 N CH 5-F ch3 4-Br H H 1-025 N CH H ch3 4-1 H H 8.84 (d,2H),7.35 1-026 N CH H ch2ch3 4-1 H H 1-027 N CH H ch(ch3)2 4-1 H H 1-028 N CH 5-F ch3 4-1 H H 1-029 N CH H ch3 3-Cl 4-C1 H (CD3CN), 8.76 (d, 2H), 7.24 (t, 1H) 1-030 N CH H ch2ch3 3-C1 4-Cl H 1-031 N CH H CH(CH3)2 3-Cl 4-C1 H 87 201012812 實例編號 A1 A2 R3 B G1 G2 G3 數據:iH-NMR 特徵訊號(400 MHz, d6-DMSO), δ 1-032 N CH 5-F ch3 3-C1 4-Cl H 8.91 (s, 2H) 1-033 N CH H ch3 3-CF3 4-C1 H 8.85 (d, 2H), 7.38 1-034 N CH H ch2ch3 3-CF3 4-Cl H 1-035 N CH H CH(CH3)2 3-CF3 4-Cl H 1-036 N CH 5-F ch3 3-CF3 4-Cl H (CD3CN), 8.68 (s? 2H) 1-037 N CH H ch3 3-C1 5-C1 H 8.86 (d, 2H) 1-038 N CH H CH2CH3 3-C1 5-Cl H 8.86 (d,2H), 1.31 (t,3H) 1-039 N CH H ch(ch3)2 3-C1 5-C1 H 8.86 (d, 2H)? 1.33 (d,6H) 1-040 N CH 5-F ch3 3-C1 5-Cl H 1-041 N CH H ch3 3-CF3 5-F H (CD3CN), 8.76 (d, 2H), 7.23 (t, 1H) 1-042 N CH H ch2ch3 3-CF3 5-F H 1-043 N CH H ch(ch3)2 3-CFs 5-F H 1-044 N CH 5-F ch3 3-CF3 5-F H 1-045 N CH H ch3 3-CF3 5-Cl H 8.86 (d, 2H), 7.38 (t,lH) 1-046 N CH H CH2CH3 3-CF3 5-Cl H 8.86 (d, 2H), 7.39 (t,lH) 1-047 N CH H ch(ch3)2 3-CFs 5-Cl H 8.87 (d, 2H), 7.40 (t,lH) 1-048 N CH 5-F ch3 3-CF3 5-Cl H 8.92 (s, 2H) 88 201012812Example No. A1 A2 R3 B G1 G2 G3 Data: W-NMR Characteristic Signal (400 MHz, d6-DMSO), δ 1-014 N CH H CH2CH3 3-CF3 HH 1-015 N CH H CH(CH3)2 3- CF3 HH 1-016 N CH 5-F ch3 3-CF3 HH 1-017 N CH H ch3 4-C1 HH 8.84 (d, 2H), 7.35 1-018 N CH H ch2ch3 4-C1 HH 1-019 N CH H ch(ch3)2 4-C1 HH 1-020 N CH 5-F ch3 4-C1 HH 1-021 N CH H ch3 4-Br HH 8.84 (d,2H) 1-022 N CH H ch2ch3 4-Br HH 1-023 N CH H ch(ch3)2 4-Br HH 1-024 N CH 5-F ch3 4-Br HH 1-025 N CH H ch3 4-1 HH 8.84 (d,2H),7.35 1- 026 N CH H ch2ch3 4-1 HH 1-027 N CH H ch(ch3)2 4-1 HH 1-028 N CH 5-F ch3 4-1 HH 1-029 N CH H ch3 3-Cl 4-C1 H (CD3CN), 8.76 (d, 2H), 7.24 (t, 1H) 1-030 N CH H ch2ch3 3-C1 4-Cl H 1-031 N CH H CH(CH3)2 3-Cl 4-C1 H 87 201012812 Example No. A1 A2 R3 B G1 G2 G3 Data: iH-NMR characteristic signal (400 MHz, d6-DMSO), δ 1-032 N CH 5-F ch3 3-C1 4-Cl H 8.91 (s, 2H) 1-033 N CH H ch3 3-CF3 4-C1 H 8.85 (d, 2H), 7.38 1-034 N CH H ch2ch3 3-CF3 4-Cl H 1-035 N CH H CH(CH3)2 3-CF3 4-Cl H 1-036 N CH 5-F ch3 3-CF3 4-Cl H (CD3CN), 8.68 (s? 2H) 1-037 N CH H ch3 3-C1 5-C1 H 8.86 (d, 2H) 1-038 N CH H CH2CH3 3 -C1 5-Cl H 8.86 (d,2H), 1.31 (t,3H) 1-039 N CH H ch(ch3)2 3-C1 5-C1 H 8.86 (d, 2H)? 1.33 (d,6H) 1-040 N CH 5-F ch3 3-C1 5-Cl H 1-041 N CH H ch3 3-CF3 5-FH (CD3CN), 8.76 (d, 2H), 7.23 (t, 1H) 1-042 N CH H ch2ch3 3-CF3 5-FH 1-043 N CH H ch(ch3)2 3-CFs 5-FH 1-044 N CH 5-F ch3 3-CF3 5-FH 1-045 N CH H ch3 3- CF3 5-Cl H 8.86 (d, 2H), 7.38 (t,lH) 1-046 N CH H CH2CH3 3-CF3 5-Cl H 8.86 (d, 2H), 7.39 (t,lH) 1-047 N CH H ch(ch3)2 3-CFs 5-Cl H 8.87 (d, 2H), 7.40 (t,lH) 1-048 N CH 5-F ch3 3-CF3 5-Cl H 8.92 (s, 2H) 88 201012812
實例編號 A1 A2 R3 B G1 G2 G3 數據:々-NMR 特徵訊號(400 MHz, d6-DMSO), δ 1-049 N CH H ch2ch2ch3 3-CF3 5-C1 H 8.86 (d, 2H), 7.39 (t,lH), 0.96 (t, 3H) 1-050 N CH H ch2ch2ch2c h3 3-CF3 5-C1 H 8.86 (d, 2H), 7.39 1-051 N CH H ch2cf3 3-CF3 5-C1 H 1-052 N CH H 苯基 3-CF3 5-C1 H 1-053 N CH H CH2-苯基 3-CF3 5-C1 H 8.89 (d, 2H), 4.32 (s, 2H) 1-054 N CH H CH2-2-吡啶 基 3-CF3 5-C1 H 1-055 N CH H ch2ch=ch2 3-CF3 5-C1 H 1-056 N CH H ch2cch 3-CF3 5-C1 H 1-057 N CH H ch2ch2och3 3-CF3 5-C1 H 8.86 (d, 2H), 7.39 (t, 1H), 3.61 (t, 2H) 1-058 N CH H ch2ch2cf3 3-CF3 5-C1 H 8.87 (d, 2H), 7.40 (t, 1H), 3.27 (dd, 2H) 1-059 N CH H ch2co2ch3 3-CF3 5-C1 H 1-060 N CH H ch3 3-CF3 5-CF3 H (CD3CN), 8.78 (d, 2H), 7.26 (t, 1H) 1-061 N CH H ch2ch3 3-CF3 5-CF3 H 8.87 (d, 2H), 7.40 (t, 1H) 1-062 N CH H CH(CH3)2 3-CF3 5-CF3 H 8.88 (d, 2H), 7.41 (t, 1H), 1.32 (d, 6H) 1-063 N CH 5-F ch3 3-CF3 5-CF3 H 89 201012812 實例编號 A1 A2 R3 B G1 G2 G3 數據:々-NMR 特徵訊號(400 MHz, d6-DMSO), δ 1-064 N CH H ch2ch2ch3 3-CF3 5-CF3 H 8.87 (d, 2H), 7.40 (UH) 1-065 N CH H ch2ch2ch2ch3 3-CF3 5-CF3 H 8.87 (d, 2H), 7.40 (t, 1H) 1-066 N CH H ch2cf3 3-CF3 5-CF3 H 1-067 N CH H 苯基 3-CF3 5-CF3 H 1-068 N CH H CH2-苯基 3-CF3 5-CFs H 1-069 N CH H CH2-2-°lt ^ 基 3-CF3 5-CF3 H 1-070 N CH H CH2CH=CH2 3-CF3 5-CF3 H 1-071 N CH H ch2cch 3-CF3 5-CF3 H 1-072 N CH H ch2ch2och3 3-CF3 5-CF3 H 1-073 N CH H CH2CH2CF3 3-CF3 5-CF3 H 1-074 N CH H ch3 3-C1 4-C1 5-CF3 1-075 N CH H CH2CH3 3-C1 4-C1 5-CF3 1-076 N CH H ch3 3-Cl 4-C1 5-C1 1-077 N CH H ch2ch3 3-C1 4-C1 5-C1 1-078 N CH H ch3 3-F 4-F 5-F 1-079 N CH H ch2ch3 3-F 4-F 5-F 1-080 N CH H ch3 3-Cl 4-OC h3 5-C1 1-081 N CH H ch2ch3 3-Cl 4-OC h3 5-Cl 90 201012812Example No. A1 A2 R3 B G1 G2 G3 Data: 々-NMR characteristic signal (400 MHz, d6-DMSO), δ 1-049 N CH H ch2ch2ch3 3-CF3 5-C1 H 8.86 (d, 2H), 7.39 (t ,lH), 0.96 (t, 3H) 1-050 N CH H ch2ch2ch2c h3 3-CF3 5-C1 H 8.86 (d, 2H), 7.39 1-051 N CH H ch2cf3 3-CF3 5-C1 H 1-052 N CH H Phenyl 3-CF3 5-C1 H 1-053 N CH H CH2-phenyl 3-CF3 5-C1 H 8.89 (d, 2H), 4.32 (s, 2H) 1-054 N CH H CH2- 2-pyridyl 3-CF3 5-C1 H 1-055 N CH H ch2ch=ch2 3-CF3 5-C1 H 1-056 N CH H ch2cch 3-CF3 5-C1 H 1-057 N CH H ch2ch2och3 3- CF3 5-C1 H 8.86 (d, 2H), 7.39 (t, 1H), 3.61 (t, 2H) 1-058 N CH H ch2ch2cf3 3-CF3 5-C1 H 8.87 (d, 2H), 7.40 (t, 1H), 3.27 (dd, 2H) 1-059 N CH H ch2co2ch3 3-CF3 5-C1 H 1-060 N CH H ch3 3-CF3 5-CF3 H (CD3CN), 8.78 (d, 2H), 7.26 ( t, 1H) 1-061 N CH H ch2ch3 3-CF3 5-CF3 H 8.87 (d, 2H), 7.40 (t, 1H) 1-062 N CH H CH(CH3)2 3-CF3 5-CF3 H 8.88 (d, 2H), 7.41 (t, 1H), 1.32 (d, 6H) 1-063 N CH 5-F ch3 3-CF3 5-CF3 H 89 201012812 Example No. A1 A2 R3 B G1 G2 G3 Data: 々 -NMR characteristic signal (400 MHz, d6 -DMSO), δ 1-064 N CH H ch2ch2ch3 3-CF3 5-CF3 H 8.87 (d, 2H), 7.40 (UH) 1-065 N CH H ch2ch2ch2ch3 3-CF3 5-CF3 H 8.87 (d, 2H) , 7.40 (t, 1H) 1-066 N CH H ch2cf3 3-CF3 5-CF3 H 1-067 N CH H Phenyl 3-CF3 5-CF3 H 1-068 N CH H CH2-phenyl 3-CF3 5 -CFs H 1-069 N CH H CH2-2-°lt ^ group 3-CF3 5-CF3 H 1-070 N CH H CH2CH=CH2 3-CF3 5-CF3 H 1-071 N CH H ch2cch 3-CF3 5-CF3 H 1-072 N CH H ch2ch2och3 3-CF3 5-CF3 H 1-073 N CH H CH2CH2CF3 3-CF3 5-CF3 H 1-074 N CH H ch3 3-C1 4-C1 5-CF3 1- 075 N CH H CH2CH3 3-C1 4-C1 5-CF3 1-076 N CH H ch3 3-Cl 4-C1 5-C1 1-077 N CH H ch2ch3 3-C1 4-C1 5-C1 1-078 N CH H ch3 3-F 4-F 5-F 1-079 N CH H ch2ch3 3-F 4-F 5-F 1-080 N CH H ch3 3-Cl 4-OC h3 5-C1 1-081 N CH H ch2ch3 3-Cl 4-OC h3 5-Cl 90 201012812
實例編號 A1 A2 R3 B G1 G2 G3 數據:々-NMR 特徵訊號(400 MHz, d6-DMSO), δ 1-082 N CH H ch3 3-C1 (4)-OC H20-(5) (CDClj) 8.76 (d, 2H), 7.14 (t, 1H), 6.08 (s, 2H) 1-083 N CH H ch2ch3 3-C1 (4)-OCH20-(5) 8.84 (d, 2H), 7.35 (t, 1H), 6.13 (s, 2H) 1-084 N CH H ch3 3-C1 4-F 5-Cl 1-085 N CH H CH2CH3 3-C1 4-F 5-Cl 1-086 N CH H ch3 3-OCH3 5^CF3 H 1-087 N CH H ch2ch3 3-OCH3 5-CF3 H 1-088 C- R3 N 3-OC h3 ch2ch3 3-CF3 5-C1 H (CDCI3), 8.12 (d, 1H), 8.02 (d, 1H), 1.40 (t,3H) 1-089 N CH H CH2-4-Cl-苯基 3-CF3 5-Cl H 8.89 (d, 2H), 4.31 (s, 2H) 1-090 N CH H CH2-4-OCH3- 苯基 3-CF3 5-C1 H 8.89 (d, 2H), 7.41 (t, 1H), 4.27 (s, 2H) 1-091 N CH H CH2-CH=CC12 3-CF3 5-Cl H 8.88 (d, 2H), 7.41 (t,lH), 6.32(1, 1H) 1-092 N CH H CH(CH3)CH2C h3 3-CF3 5-Cl H 8.89 (d, 1H), 7.40 (t, 1 H), 3.52 (m, 1H) 1-093 N CH H ch2chf2 3-CF3 5-Cl H 8.88 (d, 2H), 7.41 (t, 1H), 6.46-6.16(tt,CHF2) 1-094 N CH H cf3 3-C1 5-Cl H 8.93 (d, 2H), 7.53 - 7.50 (m, 2H), 7.45 (s, 1H), 7.44 (s, 1H) 91 201012812 實例編號 A1 A2 R3 B G1 G2 G3 數據:iH-NMR 特徵訊號(400 MHz, d6-DMSO), δ 1-095 N CH H ch2ch3 3-C1 4-OC h3 5-OC h3 8.87 (d, 2H), 7.39 (t,lH), 3.87(s, 3H), 3.78 (s, 3H) 1-096 N CH H CH2CH2Si(CH3)3 3-CF3 5-Cl H 8.86 (d, 2H), 7.39 (1,1H), 0.96 (dd, 2H) 1-097 N CH H CH(CH3)2 3-C1 (4)-OC] H20-(5) 8.84 (d, 2H), 7.36 (t, 1H), 6.13 (s, 2H) 1-098 N CH H ch3 3-C1 (4)-OCH2CH2-(5) 8.85 (d, 2H), 7.38 (t, 1H), 4.64 (t, 2H) 1-099 N CH H ch2ch3 3-Cl (4)-OCH2CH2-(5) 8.83 (d, 2H), 7.35 (t, 1H), 4.64 (t, 2H) 1-100 N CH H CH(CH3)2 3-C1 (4)-OCH2CH2-(5) 8.84, (d, 2H), 7.35 (t, 1H), 4.64 (t, 2H) 表2Example No. A1 A2 R3 B G1 G2 G3 Data: 々-NMR characteristic signal (400 MHz, d6-DMSO), δ 1-082 N CH H ch3 3-C1 (4)-OC H20-(5) (CDClj) 8.76 (d, 2H), 7.14 (t, 1H), 6.08 (s, 2H) 1-083 N CH H ch2ch3 3-C1 (4)-OCH20-(5) 8.84 (d, 2H), 7.35 (t, 1H ), 6.13 (s, 2H) 1-084 N CH H ch3 3-C1 4-F 5-Cl 1-085 N CH H CH2CH3 3-C1 4-F 5-Cl 1-086 N CH H ch3 3-OCH3 5^CF3 H 1-087 N CH H ch2ch3 3-OCH3 5-CF3 H 1-088 C- R3 N 3-OC h3 ch2ch3 3-CF3 5-C1 H (CDCI3), 8.12 (d, 1H), 8.02 ( d, 1H), 1.40 (t,3H) 1-089 N CH H CH2-4-Cl-phenyl 3-CF3 5-Cl H 8.89 (d, 2H), 4.31 (s, 2H) 1-090 N CH H CH2-4-OCH3-phenyl 3-CF3 5-C1 H 8.89 (d, 2H), 7.41 (t, 1H), 4.27 (s, 2H) 1-091 N CH H CH2-CH=CC12 3-CF3 5-Cl H 8.88 (d, 2H), 7.41 (t,lH), 6.32(1, 1H) 1-092 N CH H CH(CH3)CH2C h3 3-CF3 5-Cl H 8.89 (d, 1H), 7.40 (t, 1 H), 3.52 (m, 1H) 1-093 N CH H ch2chf2 3-CF3 5-Cl H 8.88 (d, 2H), 7.41 (t, 1H), 6.46-6.16(tt,CHF2) 1-094 N CH H cf3 3-C1 5-Cl H 8.93 (d, 2H), 7.53 - 7.50 (m, 2H), 7.45 (s, 1H), 7.44 (s, 1H) 91 201012812 No. A1 A2 R3 B G1 G2 G3 Data: iH-NMR characteristic signal (400 MHz, d6-DMSO), δ 1-095 N CH H ch2ch3 3-C1 4-OC h3 5-OC h3 8.87 (d, 2H), 7.39 (t,lH), 3.87(s, 3H), 3.78 (s, 3H) 1-096 N CH H CH2CH2Si(CH3)3 3-CF3 5-Cl H 8.86 (d, 2H), 7.39 (1,1H ), 0.96 (dd, 2H) 1-097 N CH H CH(CH3)2 3-C1 (4)-OC] H20-(5) 8.84 (d, 2H), 7.36 (t, 1H), 6.13 (s , 2H) 1-098 N CH H ch3 3-C1 (4)-OCH2CH2-(5) 8.85 (d, 2H), 7.38 (t, 1H), 4.64 (t, 2H) 1-099 N CH H ch2ch3 3 -Cl (4)-OCH2CH2-(5) 8.83 (d, 2H), 7.35 (t, 1H), 4.64 (t, 2H) 1-100 N CH H CH(CH3)2 3-C1 (4)-OCH2CH2 -(5) 8.84, (d, 2H), 7.35 (t, 1H), 4.64 (t, 2H) Table 2
R1 = R2 = Η η = 0 or 1R1 = R2 = Η η = 0 or 1
實例編 號 A1 A2 R3 B G1 G2 G3 數據:々-NMR特 徵訊號(400 MHz, d6-DMSO),δ 92 201012812Example No. A1 A2 R3 B G1 G2 G3 Data: 々-NMR characteristic signal (400 MHz, d6-DMSO), δ 92 201012812
實例編 號 A* A2 R3 B G1 G2 G3 數據:^-NMR特 徵訊號(400 MHz^ d6-DMSO),δ 2-001 N CH H ch3 2-C1 H H 2-002 N CH H ch2ch3 2-C1 H H 2-003 N CH H ch(ch3)2 2-C1 H H 2-004 N CH 5-F ch3 2-C1 H H 2-005 N CH H ch3 2-F 6-F H (CD3CN), 8.84 (d, 2H), 7.37 (t, 1H) 2-006 N CH H CH2CH3 2-F 6-F H 2-007 N CH H CH(CH3)2 2-F 6-F H 2-008 N CH 5-F ch3 2-F 6-F H 2-009 N CH H ch3 3-C1 H H 8.94 (d, 2H) 2-010 N CH H CH2CH3 3-C1 H H 2-011 N CH H CH(CH3)2 3-C1 H H 2-012 N CH 5-F ch3 3-C1 H H 2-013 N CH H ch3 3-CF3 H H 8.94 (d, 2H), 7.51 2-014 N CH H CH2CH3 3-CF3 H H 2-015 N CH H ch(ch3)2 3-CFs H H 2-016 N CH 5-F ch3 3-CF3 H H 2-017 N CH H ch3 4-C1 H H 8.93 (d5 2H) 2-018 N CH H CH2CH3 4-Cl H H 2-019 N CH H CH(CH3)2 4-C1 H H 93 201012812 實例編 號 A1 A2 R3 B G1 G2 G3 數據:々-NMR特 徵訊號(400 MHz, d6-DMSO), δ 2-020 N CH 5-F ch3 4-C1 H H 2-021 N CH H ch3 4-Br H H 8.93 (d, 2H) 2-022 N CH H ch2ch3 4-Br H H 2-023 N CH H ch(ch3)2 4-Br H H 2-024 N CH 5-F ch3 4-Br H H 2-025 N CH H ch3 4-1 H H 8.93 (d, 2H), 7.50 2-026 N CH H CH2CH3 4-1 H H 2-027 N CH H ch(ch3)2 4-1 H H 2-028 N CH 5-F ch3 4-1 H H 2-029 N CH H ch3 3-C1 4-Cl H (CD3CN), 8.84 (d5 2H), 7.50 (t, 1H) 2-030 N CH H CH2CH3 3-C1 4-C1 H 2-031 N CH H CH(CH3)2 3-Cl 4-Cl H 2-032 N CH 5-F ch3 3-C1 4-Cl H (DMF),9.09 (s,2H) 2-033 N CH H ch3 3-CF3 4-Cl H (CD3CN), 8.83 (d, 2H), 7.36 (t, 1H) 2-034 N CH H CH2CH3 3-CF3 4-Cl H 2-035 N CH H ch(ch3)2 3-CF3 4-Cl H 2-036 N CH 5-F ch3 3-CF3 4-Cl H (CD3CN),8·77 (s, 2H) 2-037 N CH H ch3 3-Cl 5-C1 H (CD3CN),8.85 (d, 2H),7.43 (t,1H) 94 201012812Example No. A* A2 R3 B G1 G2 G3 Data: ^-NMR characteristic signal (400 MHz^d6-DMSO), δ 2-001 N CH H ch3 2-C1 HH 2-002 N CH H ch2ch3 2-C1 HH 2 -003 N CH H ch(ch3)2 2-C1 HH 2-004 N CH 5-F ch3 2-C1 HH 2-005 N CH H ch3 2-F 6-FH (CD3CN), 8.84 (d, 2H) , 7.37 (t, 1H) 2-006 N CH H CH2CH3 2-F 6-FH 2-007 N CH H CH(CH3)2 2-F 6-FH 2-008 N CH 5-F ch3 2-F 6 -FH 2-009 N CH H ch3 3-C1 HH 8.94 (d, 2H) 2-010 N CH H CH2CH3 3-C1 HH 2-011 N CH H CH(CH3)2 3-C1 HH 2-012 N CH 5-F ch3 3-C1 HH 2-013 N CH H ch3 3-CF3 HH 8.94 (d, 2H), 7.51 2-014 N CH H CH2CH3 3-CF3 HH 2-015 N CH H ch(ch3)2 3 -CFs HH 2-016 N CH 5-F ch3 3-CF3 HH 2-017 N CH H ch3 4-C1 HH 8.93 (d5 2H) 2-018 N CH H CH2CH3 4-Cl HH 2-019 N CH H CH (CH3)2 4-C1 HH 93 201012812 Example No. A1 A2 R3 B G1 G2 G3 Data: 々-NMR characteristic signal (400 MHz, d6-DMSO), δ 2-020 N CH 5-F ch3 4-C1 HH 2 -021 N CH H ch3 4-Br HH 8.93 (d, 2H) 2-022 N CH H ch2ch3 4-Br HH 2-023 N CH H ch(ch3)2 4-Br HH 2-024 N CH 5-FCh3 4-Br HH 2-025 N CH H ch3 4-1 HH 8.93 (d, 2H), 7.50 2-026 N CH H CH2CH3 4-1 HH 2-027 N CH H ch(ch3)2 4-1 HH 2-028 N CH 5-F ch3 4-1 HH 2-029 N CH H ch3 3-C1 4-Cl H (CD3CN), 8.84 (d5 2H), 7.50 (t, 1H) 2-030 N CH H CH2CH3 3-C1 4-C1 H 2-031 N CH H CH(CH3)2 3-Cl 4-Cl H 2-032 N CH 5-F ch3 3-C1 4-Cl H (DMF), 9.09 (s, 2H 2-033 N CH H ch3 3-CF3 4-Cl H (CD3CN), 8.83 (d, 2H), 7.36 (t, 1H) 2-034 N CH H CH2CH3 3-CF3 4-Cl H 2-035 N CH H ch(ch3)2 3-CF3 4-Cl H 2-036 N CH 5-F ch3 3-CF3 4-Cl H (CD3CN),8·77 (s, 2H) 2-037 N CH H ch3 3 -Cl 5-C1 H (CD3CN), 8.85 (d, 2H), 7.43 (t, 1H) 94 201012812
實例編 號 A1 A2 R3 B G1 G2 G3 數據:’H-NMR特 徵訊號(400 MHz, d6-DMSO), δ 2-038 N CH H CH2CH3 3-C1 5-C1 H 2-039 N CH H ch(ch3)2 3-C1 5-C1 H 8.93 (d, 2H), 7.51 2-040 N CH 5-F ch3 3-C1 5-Cl H 9.05 (s, 2H) 2-041 N CH H ch3 3-CF3 5-F H (CD3CN),8.84 (d, 2H), 2·84 (s, 3H) 2-042 N CH H CH2CH3 3-CF3 5-F H 2-043 N CH H ch(ch3)2 3-CF3 5-F H 2-044 N CH 5-F ch3 3-CF3 5-F H 2-045 N CH H ch3 3-CF3 5-Cl H 8.94 (d,2H),7.52 2-046 N CH H ch2ch3 3-CF3 5-Cl H 8·94 (d,2H),7.52 (t,1H),U5 (t,3H) 2-047 N CH H CH(CH3)2 3-CF3 5-CI H 8.93 (d, 2H), 7.51 2-048 N CH 5-F ch3 3-CF3 5-Cl H 9.00 (s, 2H) 2-049 N CH H ch2ch2ch3 3-CF3 5-Cl H 8.94 (d, 2H), 7.52 (t, 1H), 0.96 (t, 3H) 2-050 N CH H ch2ch2ch2ch3 3-CF3 5-Cl H 8.94 (d, 2H), 7.52 2-051 N CH H ch2cf3 3-CF3 5-Cl H 2-052 N CH H 苯基 3-CF3 5-Cl H 2-053 N CH H ch2-苯基 3-CF3 5-Cl H 8.95 (d, 2H), 7.66 (t, 1H), 4.46 (q, 2H) 2-054 N CH H CH2-2-吡啶基 3-CF3 5-Cl H 2-055 N CH H ch2ch=ch2 3-CF3 5-Cl H 95 201012812Example No. A1 A2 R3 B G1 G2 G3 Data: 'H-NMR characteristic signal (400 MHz, d6-DMSO), δ 2-038 N CH H CH2CH3 3-C1 5-C1 H 2-039 N CH H ch(ch3 ) 2 3-C1 5-C1 H 8.93 (d, 2H), 7.51 2-040 N CH 5-F ch3 3-C1 5-Cl H 9.05 (s, 2H) 2-041 N CH H ch3 3-CF3 5 -FH (CD3CN), 8.84 (d, 2H), 2·84 (s, 3H) 2-042 N CH H CH2CH3 3-CF3 5-FH 2-043 N CH H ch(ch3)2 3-CF3 5- FH 2-044 N CH 5-F ch3 3-CF3 5-FH 2-045 N CH H ch3 3-CF3 5-Cl H 8.94 (d,2H),7.52 2-046 N CH H ch2ch3 3-CF3 5- Cl H 8·94 (d,2H), 7.52 (t,1H), U5 (t,3H) 2-047 N CH H CH(CH3)2 3-CF3 5-CI H 8.93 (d, 2H), 7.51 2-048 N CH 5-F ch3 3-CF3 5-Cl H 9.00 (s, 2H) 2-049 N CH H ch2ch2ch3 3-CF3 5-Cl H 8.94 (d, 2H), 7.52 (t, 1H), 0.96 (t, 3H) 2-050 N CH H ch2ch2ch2ch3 3-CF3 5-Cl H 8.94 (d, 2H), 7.52 2-051 N CH H ch2cf3 3-CF3 5-Cl H 2-052 N CH H Phenyl 3-CF3 5-Cl H 2-053 N CH H ch2-phenyl 3-CF3 5-Cl H 8.95 (d, 2H), 7.66 (t, 1H), 4.46 (q, 2H) 2-054 N CH H CH2-2-pyridyl 3-CF3 5-Cl H 2-055 N CH H ch2ch=ch2 3-CF3 5-Cl H 95 2010128 12
實例編 號 A1 A2 R3 B G1 G2 G3 數據:々-NMR特 徵訊號(400 MHz, d6-DMSO), δ 2-056 N CH H ch2cch 3-CF3 5-C1 H 2-057 N CH H ch2ch2och3 3-CF3 5-C1 H 8·94 (d,2H),7.52 (t,1H),3·24 (s,3H) 2-058 N CH H ch2ch2cf3 3-CF3 5-C1 H 8.95 (d, 2H), 7.53 2-059 N CH H ch2co2ch3 3-CF3 5-C1 H 2-060 N CH H ch3 3-CF3 5-CF3 H (CD3CN),8.86 (d, 2H),7.40 (t,1H) 2-061 N CH H ch2ch3 3-CF3 5-CF3 H 8.94 (d, 2H), 7.52 (t,lH),1.15(t,3H) 2-062 N CH H ch(ch3)2 3-CF3 5-CF3 H 8.94 (d,2H),7.52 2-063 N CH 5-F ch3 3-CF3 5-CF3 H 2-064 N CH H CH2CH2CH3 3-CF3 5-CF3 H 8.94 (d, 2H), 7.52 (t,1H),0.96 (t,3H) 2-065 N CH H ch2ch2ch2ch3 3-CF3 5-CF3 H 8.94 (d? 2H), 7.52 (t,1H) 2-066 N CH H CH2CF3 3-CF3 5-CF3 H 2-067 N CH H 苯基 3-CF3 5-CF3 H 2-068 N CH H CHr苯基 3-CF3 5-CF3 H 2-069 N CH H CHr2-吡啶基 3-CF3 5-CF3 H 2-070 N CH H ch2ch=ch2 3-CF3 5-CF3 H 2-071 N CH H ch2cch 3-CF3 5-CF3 H 2-072 N CH H ch2ch2och3 3-CF3 5-CF3 H 2-073 N CH H ch2ch2cf3 3-CF3 5-CF3 HExample No. A1 A2 R3 B G1 G2 G3 Data: 々-NMR characteristic signal (400 MHz, d6-DMSO), δ 2-056 N CH H ch2cch 3-CF3 5-C1 H 2-057 N CH H ch2ch2och3 3-CF3 5-C1 H 8·94 (d,2H), 7.52 (t,1H),3·24 (s,3H) 2-058 N CH H ch2ch2cf3 3-CF3 5-C1 H 8.95 (d, 2H), 7.53 2-059 N CH H ch2co2ch3 3-CF3 5-C1 H 2-060 N CH H ch3 3-CF3 5-CF3 H (CD3CN), 8.86 (d, 2H), 7.40 (t,1H) 2-061 N CH H ch2ch3 3-CF3 5-CF3 H 8.94 (d, 2H), 7.52 (t,lH), 1.15(t,3H) 2-062 N CH H ch(ch3)2 3-CF3 5-CF3 H 8.94 (d ,2H),7.52 2-063 N CH 5-F ch3 3-CF3 5-CF3 H 2-064 N CH H CH2CH2CH3 3-CF3 5-CF3 H 8.94 (d, 2H), 7.52 (t,1H),0.96 (t,3H) 2-065 N CH H ch2ch2ch2ch3 3-CF3 5-CF3 H 8.94 (d? 2H), 7.52 (t,1H) 2-066 N CH H CH2CF3 3-CF3 5-CF3 H 2-067 N CH H Phenyl 3-CF3 5-CF3 H 2-068 N CH H CHr Phenyl 3-CF3 5-CF3 H 2-069 N CH H CHr2-pyridyl 3-CF3 5-CF3 H 2-070 N CH H Ch2ch=ch2 3-CF3 5-CF3 H 2-071 N CH H ch2cch 3-CF3 5-CF3 H 2-072 N CH H ch2ch2och3 3-CF3 5-CF3 H 2-073 N CH H ch2ch2cf3 3-CF3 5- CF3 H
96 20101281296 201012812
實例編 號 A1 A2 R3 B G1 G2 G3 數據:】H-NMR特 徵訊號(400 Μ# d6-DMSO),δ 2-074 N CH H ch3 3-C1 4-C1 5-CFs 2-075 N CH H ch2ch3 3-C1 4-C1 5-CF3 2-076 N CH H ch3 3-C1 4-C1 5-Cl 2-077 N CH H ch2ch3 3-Cl 4-C1 5-Cl 2-078 N CH H ch3 3-F 4-F 5-F 2-079 N CH H ch2ch3 3-F 4-F 5-F 2-080 N CH H ch3 3-Cl 4-OCH3 5-Cl 2-081 N CH H CH2CH3 3-Cl 4-OCH3 5-Cl 2-082 N CH H ch3 3-Cl (4)-0CH20-(5) 8.93 (d, 2H), 7.49 (t, 1H), 6.16 (s, 2H) 2-083 N CH H CH2CH3 3-Cl (4)-0CH20_(5) 8.92 (d, 2H), 7.49 (t, 1H), 6.15 (s, 2H) 2-084 N CH H ch3 3-Cl 4-F 5-Cl 2-085 N CH H ch2ch3 3-Cl 4-F 5-Cl 2-086 N CH H ch3 3-OCH3 5-CF3 H 2-087 N CH H CH2CH3 3-0CH3 5-CF3 H 2-088 C-R3 N 3-〇ch3 CH2CH3 3-CF3 5-Cl H 2-089 N CH H CH2-4-Cl-苯基 3-CF3 5-CI H 8.96 (d, 2H), 7.66 (t, 1H), 4.48 (q, 2H) 2-090 N CH H 〇12-4-0〇13-苯 基 3-CF3 5-Cl H 8.95 (d, 2H), 7.53 (t, 1H), 4.44-4.32 (dd, 2H) 2-091 N CH H CH2-CH=CC12 3-CF3 5-Cl H 97 201012812 實例編 號 A* A2 R3 B G1 G2 G3 數據··々-ΝΜΚ特 徵訊號(400 d6-DMSO),δ 2^092 N CH H CH(CH3)CH2CH3 3-CF3 5-C1 H 8.95 (2d,非對掌 異構物之混合物, 2+2Η), 7.51 (21, 非對掌異構物之混 合物,1+1 H) 2-093 N CH H ch2chf2 3-CF3 5-C1 H 8.97 (d, 2H), 7.56 (t, 1H), 6.63 - 6.34 (tt, CHF2) 2顧 N CH H cf3 3-C1 5-Cl H lgP = 3.26 2-095 N CH H CH2CH3 3-C1 4-OCH3 5-OCH3 8.83 (d, 2H), 7.50 (t, 1H), 3.87 (s, 3H), 3.81 (s, 3H) 2-096 N CH H CH2CH2Si(CH3)3 3-CF3 5-Cl H 9.02 (d, 2H), 7.60 (t, 1H) 2-097 N CH H CH(CH3)2 3-C1 (4)-0CH20-(5) 8.93 (d, 2H), 7.49 (t, 1H), 6.15 (s, 2H) 2*098 N CH H ch3 3-C1 (4)-OCH2CH2-(5) 8.92 (d, 2H), 7.49 (t, 1H), 4,67 (t, 2H) 2-099 N CH H CH2CH3 3-C1 (4)-OCH2CH2-(5) 8.92 (d, 2H), 7.49 (t, 1H), 4.66 (t, 2H) 2-100 N CH H CH(CH3)2 3-C1 (4)-OCH2CH2-(5)Example No. A1 A2 R3 B G1 G2 G3 Data:] H-NMR characteristic signal (400 Μ# d6-DMSO), δ 2-074 N CH H ch3 3-C1 4-C1 5-CFs 2-075 N CH H ch2ch3 3-C1 4-C1 5-CF3 2-076 N CH H ch3 3-C1 4-C1 5-Cl 2-077 N CH H ch2ch3 3-Cl 4-C1 5-Cl 2-078 N CH H ch3 3- F 4-F 5-F 2-079 N CH H ch2ch3 3-F 4-F 5-F 2-080 N CH H ch3 3-Cl 4-OCH3 5-Cl 2-081 N CH H CH2CH3 3-Cl 4 -OCH3 5-Cl 2-082 N CH H ch3 3-Cl (4)-0CH20-(5) 8.93 (d, 2H), 7.49 (t, 1H), 6.16 (s, 2H) 2-083 N CH H CH2CH3 3-Cl (4)-0CH20_(5) 8.92 (d, 2H), 7.49 (t, 1H), 6.15 (s, 2H) 2-084 N CH H ch3 3-Cl 4-F 5-Cl 2- 085 N CH H ch2ch3 3-Cl 4-F 5-Cl 2-086 N CH H ch3 3-OCH3 5-CF3 H 2-087 N CH H CH2CH3 3-0CH3 5-CF3 H 2-088 C-R3 N 3 -〇ch3 CH2CH3 3-CF3 5-Cl H 2-089 N CH H CH2-4-Cl-phenyl 3-CF3 5-CI H 8.96 (d, 2H), 7.66 (t, 1H), 4.48 (q, 2H) 2-090 N CH H 〇12-4-0〇13-phenyl 3-CF3 5-Cl H 8.95 (d, 2H), 7.53 (t, 1H), 4.44-4.32 (dd, 2H) 2- 091 N CH H CH2-CH=CC12 3-CF3 5-Cl H 97 201012812 Example No. A* A2 R3 B G1 G2 G3 Data··々-ΝΜ Characteristic signal (400 d6-DMSO), δ 2^092 N CH H CH(CH3)CH2CH3 3-CF3 5-C1 H 8.95 (2d, a mixture of non-palphaliomers, 2+2Η), 7.51 (21, a mixture of non-palphaliomers, 1+1 H) 2-093 N CH H ch2chf2 3-CF3 5-C1 H 8.97 (d, 2H), 7.56 (t, 1H), 6.63 - 6.34 (tt, CHF2) 2顾N CH H cf3 3-C1 5-Cl H lgP = 3.26 2-095 N CH H CH2CH3 3-C1 4-OCH3 5-OCH3 8.83 (d, 2H), 7.50 (t, 1H), 3.87 (s, 3H), 3.81 (s, 3H) 2-096 N CH H CH2CH2Si(CH3)3 3-CF3 5-Cl H 9.02 (d, 2H), 7.60 (t, 1H) 2-097 N CH H CH(CH3) 2 3-C1 (4)-0CH20-(5) 8.93 (d, 2H), 7.49 (t, 1H), 6.15 (s, 2H) 2*098 N CH H ch3 3-C1 (4)-OCH2CH2-( 5) 8.92 (d, 2H), 7.49 (t, 1H), 4,67 (t, 2H) 2-099 N CH H CH2CH3 3-C1 (4)-OCH2CH2-(5) 8.92 (d, 2H), 7.49 (t, 1H), 4.66 (t, 2H) 2-100 N CH H CH(CH3)2 3-C1 (4)-OCH2CH2-(5)
表3table 3
η = 0 or 1η = 0 or 1
98 20101281298 201012812
實例編 號 A1 A2 R3 B G1 G2 G3 數據:^-NMR 特徵訊號(400 MHz, d6-DMSO), δ 3-001 N CH H ch3 2-C1 H H (CD3CN), 8.86 (d, 2H) 3-002 N CH H ch2ch3 2-C1 H H 3-003 N CH H CH(CH3)2 2-C1 H H 3-004 N CH 5-F ch3 2-C1 H H 3-005 N CH H ch3 2-F 6-F H (CD3CN), 8.86 (d, 2H) 3-006 N CH H ch2ch3 2-F 6-F H 3-007 N CH H ch(ch3)2 2-F 6-F H 3-008 N CH 5-F ch3 2-F 6-F H 3-009 N CH H ch3 3-C1 H H 8.96 (d, 2H) 3-010 N CH H ch2ch3 3-C1 H H 3-011 N CH H CH(CH3)2 3-C1 H H 3-012 N CH 5-F ch3 3-Cl H H 3-013 N CH H ch3 3-CFs H H 8.96 (d, 2H), 7.54 3-014 N CH H CH2CH3 3-CF3 H H 3-015 N CH H ch(ch3)2 3-CFs H H 3-016 N CH 5-F ch3 3-CF3 H H 3-017 N CH H ch3 4-C1 H H 8.94 (d, 2H), 7.53 3-018 N CH H ch2ch3 4-C1 H H 99 201012812 實例編 號 A1 A2 R3 B G1 G2 G3 數據:々-NMR 特徵訊號(400 MHz, d6-DMSO), δ 3-019 N CH H ch(ch3)2 4-C1 H H 3-020 N CH 5-F ch3 4-C1 H H 3-021 N CH H ch3 4-Br H H 8.94 (d, 2H), 3.22 (s, 3H) 3-022 N CH H CH2CH3 4-Br H H 3-023 N CH H CH(CH3)2 4-Br H H 3-024 N CH 5-F ch3 4-Br H H 3-025 N CH H ch3 4-1 H H 8.94 (d, 2H), 7.53 (t, 1H) 3-026 N CH H ch2ch3 4-1 H H 3-027 N CH H CH(CH3)2 4-1 H H 3-028 N CH 5-F ch3 4-1 H H 3-029 N CH H ch3 3-C1 4-C1 H (CD3CN),8.86 (d, 2H),3.13(s,3H) 3-030 N CH H ch2ch3 3-Cl 4-Cl H 3-031 N CH H CH(CH3)2 3-C1 4-C1 H 3-032 N CH 5-F ch3 3-Cl 4-Cl H (CD3CN), 8.78 (s? 2H) 3-033 N CH H ch3 3-CF3 4-Cl H (CD3CN), 8.85 (d, 2H), 7.40 (t, 1H) 3-034 N CH H ch2ch3 3-CFs 4-Cl H 3-035 N CH H ch(ch3)2 3-CF3 4-Cl H 3-036 N CH 5-F ch3 3-CF3 4-Cl H (CD3CN), 8.76 (s, 2H) 100 201012812Example No. A1 A2 R3 B G1 G2 G3 Data: ^-NMR Characteristic Signal (400 MHz, d6-DMSO), δ 3-001 N CH H ch3 2-C1 HH (CD3CN), 8.86 (d, 2H) 3-002 N CH H ch2ch3 2-C1 HH 3-003 N CH H CH(CH3)2 2-C1 HH 3-004 N CH 5-F ch3 2-C1 HH 3-005 N CH H ch3 2-F 6-FH ( CD3CN), 8.86 (d, 2H) 3-006 N CH H ch2ch3 2-F 6-FH 3-007 N CH H ch(ch3)2 2-F 6-FH 3-008 N CH 5-F ch3 2- F 6-FH 3-009 N CH H ch3 3-C1 HH 8.96 (d, 2H) 3-010 N CH H ch2ch3 3-C1 HH 3-011 N CH H CH(CH3)2 3-C1 HH 3-012 N CH 5-F ch3 3-Cl HH 3-013 N CH H ch3 3-CFs HH 8.96 (d, 2H), 7.54 3-014 N CH H CH2CH3 3-CF3 HH 3-015 N CH H ch(ch3) 2 3-CFs HH 3-016 N CH 5-F ch3 3-CF3 HH 3-017 N CH H ch3 4-C1 HH 8.94 (d, 2H), 7.53 3-018 N CH H ch2ch3 4-C1 HH 99 201012812 Example No. A1 A2 R3 B G1 G2 G3 Data: 々-NMR characteristic signal (400 MHz, d6-DMSO), δ 3-019 N CH H ch(ch3)2 4-C1 HH 3-020 N CH 5-F ch3 4-C1 HH 3-021 N CH H ch3 4-Br HH 8.94 (d, 2H), 3.22 (s, 3H) 3-022 N CH H CH2CH3 4-Br HH 3-023 N CH H CH(CH3)24-Br HH 3-024 N CH 5-F ch3 4-Br HH 3-025 N CH H ch3 4-1 HH 8.94 (d, 2H), 7.53 (t, 1H) 3-026 N CH H ch2ch3 4- 1 HH 3-027 N CH H CH(CH3)2 4-1 HH 3-028 N CH 5-F ch3 4-1 HH 3-029 N CH H ch3 3-C1 4-C1 H (CD3CN), 8.86 ( d, 2H), 3.13(s,3H) 3-030 N CH H ch2ch3 3-Cl 4-Cl H 3-031 N CH H CH(CH3)2 3-C1 4-C1 H 3-032 N CH 5- F ch3 3-Cl 4-Cl H (CD3CN), 8.78 (s? 2H) 3-033 N CH H ch3 3-CF3 4-Cl H (CD3CN), 8.85 (d, 2H), 7.40 (t, 1H) 3-034 N CH H ch2ch3 3-CFs 4-Cl H 3-035 N CH H ch(ch3)2 3-CF3 4-Cl H 3-036 N CH 5-F ch3 3-CF3 4-Cl H (CD3CN ), 8.76 (s, 2H) 100 201012812
實例編 號 A1 A2 R3 B G1 G2 G3 數據:W-NMR 特徵訊號(400 MHz, d6-DMSO), δ 3-037 N CH H ch3 3-C1 5-C1 H (CD3CN), 8.86 (d, 2H), 7.42 (t, 1H) 3-038 N CH H ch2ch3 3-C1 5-C1 H 3-039 N CH H ch(ch3)2 3-C1 5-C1 H 8.85 (d, 2H), 1.25 (d, 6H) 3-040 N CH 5-F ch3 3-C1 5-C1 H (CD3CN), 8.78 (s, 2H) 3-041 N CH H ch3 3-CF3 5-F H (CD3CN), 8.86 (d, 2H) 3-042 N CH H CH2CH3 3-CF3 5-F H 3-043 N CH H ch(ch3)2 3-CF3 5-F H 3-044 N CH 5-F ch3 3-CF3 5-F H 3-045 N CH H ch3 3-CF3 5-C1 H 8.96 (d, 2H), 7.55 (t,lH) 3-046 N CH H ch2ch3 3-CF3 5-Cl H 8.96 (d, 2H), 7.55 (t, 1H), 1.24 (t, 3H) 3-047 N CH H ch(ch3)2 3-CF3 5-C1 H 8.96 (d, 2H), 7.55 3-048 N CH 5-F ch3 3-CF3 5-Cl H 9.02 (s, 2H) 3-049 N CH H ch2ch2ch3 3-CF3 5-Cl H 8.96 (d, 2H), 7.55 (t, 1H), 0.96 (t, 3H) 3-050 N CH H ch2ch2ch2ch3 3-CF3 5-Cl H 8.95 (d, 2H), 7.54 0,1H) 3-051 N CH H ch2cf3 3-CF3 5-Cl H 3-052 N CH H 苯基 3-CF3 5-Cl H 101 201012812Example No. A1 A2 R3 B G1 G2 G3 Data: W-NMR Characteristic Signal (400 MHz, d6-DMSO), δ 3-037 N CH H ch3 3-C1 5-C1 H (CD3CN), 8.86 (d, 2H) , 7.42 (t, 1H) 3-038 N CH H ch2ch3 3-C1 5-C1 H 3-039 N CH H ch(ch3)2 3-C1 5-C1 H 8.85 (d, 2H), 1.25 (d, 6H) 3-040 N CH 5-F ch3 3-C1 5-C1 H (CD3CN), 8.78 (s, 2H) 3-041 N CH H ch3 3-CF3 5-FH (CD3CN), 8.86 (d, 2H 3-042 N CH H CH2CH3 3-CF3 5-FH 3-043 N CH H ch(ch3)2 3-CF3 5-FH 3-044 N CH 5-F ch3 3-CF3 5-FH 3-045 N CH H ch3 3-CF3 5-C1 H 8.96 (d, 2H), 7.55 (t,lH) 3-046 N CH H ch2ch3 3-CF3 5-Cl H 8.96 (d, 2H), 7.55 (t, 1H) , 1.24 (t, 3H) 3-047 N CH H ch(ch3)2 3-CF3 5-C1 H 8.96 (d, 2H), 7.55 3-048 N CH 5-F ch3 3-CF3 5-Cl H 9.02 (s, 2H) 3-049 N CH H ch2ch2ch3 3-CF3 5-Cl H 8.96 (d, 2H), 7.55 (t, 1H), 0.96 (t, 3H) 3-050 N CH H ch2ch2ch2ch3 3-CF3 5 -Cl H 8.95 (d, 2H), 7.54 0,1H) 3-051 N CH H ch2cf3 3-CF3 5-Cl H 3-052 N CH H Phenyl 3-CF3 5-Cl H 101 201012812
實例編 號 A1 A2 R3 B G1 G2 G3 數據:'H-NMR 特徵訊號(400 MHz, d6-DMSO), δ 3-053 N CH H CHr苯基 3-CF3 5-C1 H 8.98 (d, 2H), 4.67 (s, 2H) 3-054 N CH H CH2-2-吡啶基 3-CF3 5-C1 H 3-055 N CH H ch2ch=ch2 3-CF3 5-C1 H 3-056 N CH H ch2cch 3-CF3 5-Cl H 3-057 N CH H ch2ch2och3 3-CF3 5-C] H 8.96 (d, 2H), 7.55 (t,lH),3.75-3.61 (2xdd, 4H) 3-058 N CH H CH2CH2CF3 3-CF3 5-G1 H 8.96 (d,2H),7·56 (t,1H), 2·65 — 2.61 (dd, 2H) 3-059 N CH H CH2C02CH3 3-CF3 5-Cl H 3-060 N CH H ch3 3-CF3 5-CF3 H (CD3CN), 8.87 (d, 2H), 7.43 (t, 1H) 3-061 N CH H ch2ch3 3-CF3 5-CF3 H 8.96 (d, 2H)5 7.56 (1,1^1.24 (t5 3H) 3-062 N CH H ch(ch3)2 3-CF3 5-CF3 H 8.96 (d, 2H), 7.56 (t, 1H), 1.24 (d, 2H) 3-063 N CH 5-F ch3 3-CF3 5-CF3 H 3-064 N CH H ch2ch2ch3 3-CF3 5-CF3 H 8.96 (d, 2H), 7.56 (t, 1H), 0.96 (t, 3H) 3-065 N CH H ch2ch2ch2ch3 3-CF3 5-CF3 H 8.96 (d, 2H), 7.55 3-066 N CH H CH2CF3 3-CF3 5-CF3 H 3-067 N CH H 苯基 3-CF3 5-CF3 H 102 201012812Example No. A1 A2 R3 B G1 G2 G3 Data: 'H-NMR characteristic signal (400 MHz, d6-DMSO), δ 3-053 N CH H CHrphenyl 3-CF3 5-C1 H 8.98 (d, 2H), 4.67 (s, 2H) 3-054 N CH H CH2-2-pyridyl 3-CF3 5-C1 H 3-055 N CH H ch2ch=ch2 3-CF3 5-C1 H 3-056 N CH H ch2cch 3- CF3 5-Cl H 3-057 N CH H ch2ch2och3 3-CF3 5-C] H 8.96 (d, 2H), 7.55 (t,lH), 3.75-3.61 (2xdd, 4H) 3-058 N CH H CH2CH2CF3 3 -CF3 5-G1 H 8.96 (d,2H),7·56 (t,1H), 2·65 — 2.61 (dd, 2H) 3-059 N CH H CH2C02CH3 3-CF3 5-Cl H 3-060 N CH H ch3 3-CF3 5-CF3 H (CD3CN), 8.87 (d, 2H), 7.43 (t, 1H) 3-061 N CH H ch2ch3 3-CF3 5-CF3 H 8.96 (d, 2H)5 7.56 ( 1,1^1.24 (t5 3H) 3-062 N CH H ch(ch3)2 3-CF3 5-CF3 H 8.96 (d, 2H), 7.56 (t, 1H), 1.24 (d, 2H) 3-063 N CH 5-F ch3 3-CF3 5-CF3 H 3-064 N CH H ch2ch2ch3 3-CF3 5-CF3 H 8.96 (d, 2H), 7.56 (t, 1H), 0.96 (t, 3H) 3-065 N CH H ch2ch2ch2ch3 3-CF3 5-CF3 H 8.96 (d, 2H), 7.55 3-066 N CH H CH2CF3 3-CF3 5-CF3 H 3-067 N CH H Phenyl 3-CF3 5-CF3 H 102 201012812
實例編 號 A1 A2 R3 B G1 G2 G3 數據:】H-NMR 特徵訊號(400 MHz, d6-DMSO), δ 3-068 N CH H CH2-苯基 3-CF3 5-CF3 H 3-069 N CH H CHr2-吡啶基 3-CF3 5-CF3 H 3-070 N CH H ch2ch=ch2 3-CF3 5-CF3 H 3-071 N CH H ch2cch 3-CF3 5-CF3 H 3-072 N CH H ch2ch2och3 3-CF3 5-CF3 H 3-073 N CH H CH2CH2CF3 3-CF3 5-CF3 H 3-074 N CH H ch2co2ch3 3-CF3 5-C1 H 3-075 N CH H ch3 3-C1 4-CI 5-CF3 3-076 N CH H CH2CH3 3-C1 4-Cl 5-CF3 3-077 N CH H ch3 3-C1 4-CI 5-Cl 3-078 N CH H CH2CH3 3-C1 4-Cl 5-C1 3-079 N CH H ch3 3-F 4-F 5-F 3-080 N CH H CH2CH3 3-F 4-F 5-F 3-081 N CH H ch3 3-Cl 4-OCH3 5-Cl 3-082 N CH H CH2CH3 3-C1 4-OCH3 5-Cl 3-083 N CH H ch3 3-Cl (4)-0CH20-(5) 8.94 (d, 2H), 7.53 (t, 1H), 6.16 (s, 2H) 3-084 N CH H CH2CH3 3-CI (4)-0CH20-(5) 8,94 (d, 2H), 7.53 (t, 1H), 6.16 (s, 2H) 3-085 N CH H ch3 3-Cl 4-F 5-Cl 103 201012812 實例編 號 A1 A2 R3 B G1 G2 G3 數據:々-ΝΜΚ 特徵訊號(400 MHz, d6-DMSO), δ 3-086 N CH H CH2CH3 3-C1 4-F 5-Cl 3-087 N CH H ch3 3-OCH3 5-CF3 H 3-088 N CH H ch2ch3 3-OCH3 5-CF3 H 3-089 C-RJ N 3-〇ch3 CH2CH3 3-CF3 5-Cl H 3-090 N CH H CH2-4-Cl-苯基 3-CFa 5-C1 H 8.98 (d, 2H), 4.71 (s, 2H) 3-091 N CH H CH2-4-OCH3-苯 基 3-CF3 5-Cl H 8.98 (d, 2H), 7.57 (t, 1H), 4.59 (s, 2H) 3-092 N CH H CHrCH=CCl2 3-CF3 5-Cl H 3-093 N CH H CH(CH3)CH2CH3 3-CFs 5-Cl H 8.95 (d, 2H), 7.55 (t,lH) 3-094 N CH H CH2CHF2 3-CFs 5-Cl H 8.97 (d, 2H)? 7.58 (t, 1H), 6.59-6.30 (tt? CHF2) 3-095 N CH H CH2CH3 3-C1 4-OCH3 5-0CH3 8.95 (d3 2H), 7.53 (t,lH),3_86(s, 3H),3.82(s,3H) 3-096 N CH H CH2CH2Si(CH3)3 3-CF3 5-Cl H 8.97 (d, 2H), 7.57 (t, 1H), 0.89 -0.85 (dd, 2H) 3-097 N CH H ch(ch3)2 3-C1 (4)-0CH20-(5) 8.94 (d, 2H), 7.53 (t, 1H), 6.16 (s, 2H) 3-098 N CH H ch3 3-C1 (4)-OCH2CH2-(5) 8.94 (d, 2H), 7.52 (t, 1H), 4.67 (t, 2H) 3-099 N CH H ch2ch3 3-Cl (4)-OCH2CH2-(5) 8.95 (d, 2H), 7.52 (t, 1H), 4,67 (t, 2H) 104 201012812 實例編 號 A1 A2 R3 B G1 G2 G3 數據:々-ΝΜΚ 特徵訊號(400 MHz, d6-DMSO), δ 3-100 N CH H CH(CH3)2 3-C1 (4)-OCH2CH2-(5) 表4Example No. A1 A2 R3 B G1 G2 G3 Data: ] H-NMR Characteristic Signal (400 MHz, d6-DMSO), δ 3-068 N CH H CH2-Phenyl 3-CF3 5-CF3 H 3-069 N CH H CHr2-pyridyl 3-CF3 5-CF3 H 3-070 N CH H ch2ch=ch2 3-CF3 5-CF3 H 3-071 N CH H ch2cch 3-CF3 5-CF3 H 3-072 N CH H ch2ch2och3 3- CF3 5-CF3 H 3-073 N CH H CH2CH2CF3 3-CF3 5-CF3 H 3-074 N CH H ch2co2ch3 3-CF3 5-C1 H 3-075 N CH H ch3 3-C1 4-CI 5-CF3 3 -076 N CH H CH2CH3 3-C1 4-Cl 5-CF3 3-077 N CH H ch3 3-C1 4-CI 5-Cl 3-078 N CH H CH2CH3 3-C1 4-Cl 5-C1 3-079 N CH H ch3 3-F 4-F 5-F 3-080 N CH H CH2CH3 3-F 4-F 5-F 3-081 N CH H ch3 3-Cl 4-OCH3 5-Cl 3-082 N CH H CH2CH3 3-C1 4-OCH3 5-Cl 3-083 N CH H ch3 3-Cl (4)-0CH20-(5) 8.94 (d, 2H), 7.53 (t, 1H), 6.16 (s, 2H) 3-084 N CH H CH2CH3 3-CI (4)-0CH20-(5) 8,94 (d, 2H), 7.53 (t, 1H), 6.16 (s, 2H) 3-085 N CH H ch3 3- Cl 4-F 5-Cl 103 201012812 Example No. A1 A2 R3 B G1 G2 G3 Data: 々-ΝΜΚ Characteristic signal (400 MHz, d6-DMSO), δ 3-086 N CH H CH2CH3 3-C1 4-F 5- Cl 3-087 N CH H ch3 3-OCH 3 5-CF3 H 3-088 N CH H ch2ch3 3-OCH3 5-CF3 H 3-089 C-RJ N 3-〇ch3 CH2CH3 3-CF3 5-Cl H 3-090 N CH H CH2-4-Cl- Phenyl 3-CFa 5-C1 H 8.98 (d, 2H), 4.71 (s, 2H) 3-091 N CH H CH2-4-OCH3-phenyl 3-CF3 5-Cl H 8.98 (d, 2H), 7.57 (t, 1H), 4.59 (s, 2H) 3-092 N CH H CHrCH=CCl2 3-CF3 5-Cl H 3-093 N CH H CH(CH3)CH2CH3 3-CFs 5-Cl H 8.95 (d , 2H), 7.55 (t,lH) 3-094 N CH H CH2CHF2 3-CFs 5-Cl H 8.97 (d, 2H)? 7.58 (t, 1H), 6.59-6.30 (tt? CHF2) 3-095 N CH H CH2CH3 3-C1 4-OCH3 5-0CH3 8.95 (d3 2H), 7.53 (t,lH),3_86(s, 3H),3.82(s,3H) 3-096 N CH H CH2CH2Si(CH3)3 3 -CF3 5-Cl H 8.97 (d, 2H), 7.57 (t, 1H), 0.89 -0.85 (dd, 2H) 3-097 N CH H ch(ch3)2 3-C1 (4)-0CH20-(5 8.94 (d, 2H), 7.53 (t, 1H), 6.16 (s, 2H) 3-098 N CH H ch3 3-C1 (4)-OCH2CH2-(5) 8.94 (d, 2H), 7.52 (t , 1H), 4.67 (t, 2H) 3-099 N CH H ch2ch3 3-Cl (4)-OCH2CH2-(5) 8.95 (d, 2H), 7.52 (t, 1H), 4,67 (t, 2H 104 201012812 Example No. A1 A2 R3 B G1 G2 G3 Data: 々-ΝΜΚ Characteristic signal (400 MHz, d6-DMSO), δ 3-100 N CH H CH(CH3)2 3-C1 (4)-OCH2CH2-(5) Table 4
\ B (I-J) R4 = R5 = CH3 X =\ B (I-J) R4 = R5 = CH3 X =
η = 0 or 1η = 0 or 1
實例編 號 A1 A2 R3 Y B G1 G2 G3 數據:IH-NMR特徵 訊號(400 MHz, d6-DMSO), δ 4-001 N CH H s ch3 3-C1 5-C1 H 4-002 N CH H -s(o)_ ch3 3-C1 5-Cl H 4-003 N CH H S〇2 ch3 3-C1 5-C1 H 4-004 N CH H s CH2CH3 3-C1 5-Cl H 4-005 N CH H -s(o)_ ch2ch3 3-C1 5-Cl H 4-006 N CH H S〇2 ch2ch3 3-C1 5-Cl H 4-007 N CH H s ch3 3-C1 5-CF3 H 4-008 N CH H -s(o)_ ch3 3-C1 5-CF3 H 4-009 N CH H S〇2 ch3 3-C1 5-CF3 H 105 201012812Example No. A1 A2 R3 YB G1 G2 G3 Data: IH-NMR characteristic signal (400 MHz, d6-DMSO), δ 4-001 N CH H s ch3 3-C1 5-C1 H 4-002 N CH H -s( o)_ch3 3-C1 5-Cl H 4-003 N CH HS〇2 ch3 3-C1 5-C1 H 4-004 N CH H s CH2CH3 3-C1 5-Cl H 4-005 N CH H -s (o)_ch2ch3 3-C1 5-Cl H 4-006 N CH HS〇2 ch2ch3 3-C1 5-Cl H 4-007 N CH H s ch3 3-C1 5-CF3 H 4-008 N CH H - s(o)_ ch3 3-C1 5-CF3 H 4-009 N CH HS〇2 ch3 3-C1 5-CF3 H 105 201012812
實例編 號 A1 A2 R3 Υ B G1 G2 G3 數據:^-NMR特徵 訊號(400 d6-DMSO), δ 4-010 N CH Η S ch2ch3 3-C1 5-CF3 H 8.86 (d, 2H), 7.47 (t, 1H) 4-011 N CH Η -S(O)- ch2ch3 3-C1 5-CF3 H 8.94 (d, 2H), 7.59 (t, 1H) 4-012 N CH Η S02 ch2ch3 3-C1 5-CF3 H 8.99 (d, 2H), 7.67 (t, 1H) 4-013 N CH Η S ch3 3-CF3 5-CF3 H 4-014 N CH Η -S(O)- ch3 3-CF3 5-CF3 H 4-015 N CH Η S02 ch3 3-CF3 5-CF3 H 4-016 N CH Η S ch2ch3 3-CF3 5-CF3 H 4-017 N CH Η -S(O)- CH2CH3 3-CF3 5-CF3 H 4-018 N CH Η S〇2 ch2ch3 3-CF3 5-CF3 HExample No. A1 A2 R3 Υ B G1 G2 G3 Data: ^-NMR characteristic signal (400 d6-DMSO), δ 4-010 N CH Η S ch2ch3 3-C1 5-CF3 H 8.86 (d, 2H), 7.47 (t , 1H) 4-011 N CH Η -S(O)- ch2ch3 3-C1 5-CF3 H 8.94 (d, 2H), 7.59 (t, 1H) 4-012 N CH Η S02 ch2ch3 3-C1 5-CF3 H 8.99 (d, 2H), 7.67 (t, 1H) 4-013 N CH Η S ch3 3-CF3 5-CF3 H 4-014 N CH Η -S(O)- ch3 3-CF3 5-CF3 H 4 -015 N CH Η S02 ch3 3-CF3 5-CF3 H 4-016 N CH Η S ch2ch3 3-CF3 5-CF3 H 4-017 N CH Η -S(O)- CH2CH3 3-CF3 5-CF3 H 4 -018 N CH Η S〇2 ch2ch3 3-CF3 5-CF3 H
表5-中間物Table 5 - Intermediates
實例編 號 B G1 G2 G3 數據:1H-NMR特徵訊號 (400 MHz, d6-DMSO), δ 5-001 ch3 2-C1 H H (CD3CN), 7.51-7.48 (m, 1H) 5-002 ch2ch3 2-C1 H H 106 201012812Example No. B G1 G2 G3 Data: 1H-NMR characteristic signal (400 MHz, d6-DMSO), δ 5-001 ch3 2-C1 HH (CD3CN), 7.51-7.48 (m, 1H) 5-002 ch2ch3 2-C1 HH 106 201012812
實例編 號 B G1 G2 G3 數據:1H-NMR特徵訊號 (400 MHz,d6-DMSO), δ 5-003 ch(ch3)2 2-C1 H H 5-004 ch3 2-F 6-F H (CD3CN), 2.32 (s, 3H) 5-005 CH2CH3 2-F 6-F H 5-006 ch(ch3)2 2-F 6-F H 5-007 ch3 3-CI H H 2.35 (s, 3H) 5-008 ch2ch3 3-C1 H H 5-009 ch(ch3)2 3-CI H H 5-010 ch3 3-CF3 H H 2.36 (s,3H) 5-011 CH2CH3 3-CF3 H H 5-012 ch(ch3)2 3-CF3 H H 5-013 ch3 4-Cl H H 2.33 (s, 3H) 5-014 CH2CH3 4-C1 H H 5-015 ch(ch3)2 4-Cl H H 5-016 ch3 4-Br H H 2.34 (s,3H) 5-017 CH2CH3 4-Br H H 5-018 CH(CH3)2 4-Br H H 5-019 ch3 4-1 H H 2.33 (s, 3H) 5-020 CH2CH3 4-1 H H 5-021 CH(CH3)2 4-1 H H 5-022 ch3 3-CI 4-Cl H (CD3CN), 7.63 (s, 1H), 7.51 (d, 1H), 7.39 (d, 1H) 107 201012812 實例編 號 B G1 G2 G3 數據:IH-NMR特徵訊號 (400 MHz, d6-DMSO), δ 5-023 ch2ch3 3-C1 4-C1 H 5-024 CH(CH3)2 3-C1 4-C1 H 5-025 ch3 3-CF3 4-C1 H (CD3CN), 7.87 (s, 1H), 7.66 (d, 1H), 7.6 l(d, 1H) 5-026 CH2CH3 3-CF3 4-C1 H 5-027 ch(ch3)2 3-CF3 4-C1 H 5-028 ch3 3-C1 5-C1 H (CD3CN), 7.42 (s, 2H), 7.30 (s, 1H), 2.39 (s, 3H) 5-029 CH2CH3 3-C1 5-C1 H 7.41 (寬訊號,2H),7.31 (寬訊號,1H) 5-030 CH(CH3)2 3-C1 5-Cl H 7.46 (寬訊號,2H), 7.45 (寬訊號,1H) 5-031 ch3 3-F 5-CF3 H 5-032 CH2CH3 3-F 5-CF3 H 5-033 ch(ch3)2 3-F 5-CF3 H 5-034 ch3 3-CI 5-CF3 H (CD3CN)5 2.32 (s, 3H) 5-035 CH2CH3 3-C1 5-CF3 H 2.84(寬訊號,2H), 1.18 (寬訊號,3H) 5-036 ch(ch3)2 J-Cl 5-CF3 H 7.78(寬訊號,2H), 7.56 (寬訊號,1H) 5-037 ch2ch2ch3 3-CI 5-CF3 H 7.74(寬訊號,2H),7.55 (寬訊號,1H) 5-038 ch2ch2ch2ch3 3-CI 5-CF3 H 7.74 (寬訊號,2H), 7.55 (寬訊號,1H) 5-039 ch2cf3 3-CI 5-CF3 H 7.61 (寬訊號,1H), 7.65 (寬訊號,1H),7_58 (寬訊 號,1H) 108 201012812Example No. B G1 G2 G3 Data: 1H-NMR characteristic signal (400 MHz, d6-DMSO), δ 5-003 ch(ch3)2 2-C1 HH 5-004 ch3 2-F 6-FH (CD3CN), 2.32 (s, 3H) 5-005 CH2CH3 2-F 6-FH 5-006 ch(ch3)2 2-F 6-FH 5-007 ch3 3-CI HH 2.35 (s, 3H) 5-008 ch2ch3 3-C1 HH 5-009 ch(ch3)2 3-CI HH 5-010 ch3 3-CF3 HH 2.36 (s,3H) 5-011 CH2CH3 3-CF3 HH 5-012 ch(ch3)2 3-CF3 HH 5-013 Ch3 4-Cl HH 2.33 (s, 3H) 5-014 CH2CH3 4-C1 HH 5-015 ch(ch3)2 4-Cl HH 5-016 ch3 4-Br HH 2.34 (s,3H) 5-017 CH2CH3 4 -Br HH 5-018 CH(CH3)2 4-Br HH 5-019 ch3 4-1 HH 2.33 (s, 3H) 5-020 CH2CH3 4-1 HH 5-021 CH(CH3)2 4-1 HH 5 -022 ch3 3-CI 4-Cl H (CD3CN), 7.63 (s, 1H), 7.51 (d, 1H), 7.39 (d, 1H) 107 201012812 Example No. B G1 G2 G3 Data: IH-NMR characteristic signal ( 400 MHz, d6-DMSO), δ 5-023 ch2ch3 3-C1 4-C1 H 5-024 CH(CH3)2 3-C1 4-C1 H 5-025 ch3 3-CF3 4-C1 H (CD3CN), 7.87 (s, 1H), 7.66 (d, 1H), 7.6 l(d, 1H) 5-026 CH2CH3 3-CF3 4-C1 H 5-027 ch(ch3)2 3-CF3 4-C1 H 5-028 Ch3 3-C1 5-C1 H (CD3CN), 7. 42 (s, 2H), 7.30 (s, 1H), 2.39 (s, 3H) 5-029 CH2CH3 3-C1 5-C1 H 7.41 (Wide signal, 2H), 7.31 (Wide signal, 1H) 5-030 CH (CH3)2 3-C1 5-Cl H 7.46 (Wide signal, 2H), 7.45 (Wide signal, 1H) 5-031 ch3 3-F 5-CF3 H 5-032 CH2CH3 3-F 5-CF3 H 5- 033 ch(ch3)2 3-F 5-CF3 H 5-034 ch3 3-CI 5-CF3 H (CD3CN)5 2.32 (s, 3H) 5-035 CH2CH3 3-C1 5-CF3 H 2.84 (Wide signal, 2H), 1.18 (Wide signal, 3H) 5-036 ch(ch3)2 J-Cl 5-CF3 H 7.78 (Wide signal, 2H), 7.56 (Wide signal, 1H) 5-037 ch2ch2ch3 3-CI 5-CF3 H 7.74 (Wide signal, 2H), 7.55 (Wide signal, 1H) 5-038 ch2ch2ch2ch3 3-CI 5-CF3 H 7.74 (Wide signal, 2H), 7.55 (Wide signal, 1H) 5-039 ch2cf3 3-CI 5 -CF3 H 7.61 (Wide signal, 1H), 7.65 (Wide signal, 1H), 7_58 (Wide signal, 1H) 108 201012812
實例編 號 B G1 G2 G3 數據:W-NMR特徵訊號 (400 MHz, d6-DMSO), δ 5-040 苯基 3-C1 5-CF3 H 5-041 CHr苯基 3-C1 5-CF3 H 4.05(寬訊號,2H) 5-042 CH2-2-吡啶基 3-C1 5-CF3 H 5-043 ch2ch=ch2 3-C1 5-CF3 H 5-044 ch2cch 3-C1 5-CF3 H 5-045 ch2ch2och3 3-C1 5-CF3 H 7.73 (寬訊號,2H),7_55 (寬訊號,1H) 5-046 ch2ch2cf3 3-Cl 5-CF3 H 7.69 (s5 1H), 7.66 (s51H), 7.56 (s,1H) 5-047 ch2co2ch3 3-C1 5-CF3 H 5-048 ch3 3-CF3 5-CF3 H (CD3CN), 2.37 (s, 3H) 5-049 ch2ch3 3-CF3 5-CF3 H 2.84(寬訊號,2H),1.16 (寬訊號,3H) 5-050 CH(CH3)2 3-CF3 5-CF3 H 8.10(寬8,211),7.79(寬3, 1H) 5-051 ch2ch2ch3 3-CF3 5-CF3 H 8.03(寬3,211),7.79(寬5, 1H) 5-052 CH2CH2CH2CH3 3-CF3 5-CF3 H 8.06(寬3,211),7.79(寬3, 1H) 5-053 ch2cf3 3-CF3 5-CF3 H 5-054 苯基 3-CFb 5-CF3 H 5-055 CH2-苯基 3-CFs 5-CF3 H 5-056 CH2-2-吡啶基 3-CFs 5-CF3 H 5-057 ch2ch=ch2 3-CF3 5-CF3 H 109 201012812 實例編 號 B G1 G2 G3 數據:1H-NMR特徵訊號 (400 MHz, d6-DMSO), δ 5-058 ch2cch 3-CF3 5-CF3 H 5-059 ch2ch2och3 3-CF3 5-CF3 H 5-060 ch2ch2cf3 3-CF3 5-CF3 H 5-061 CH2C02CH3 3-CF3 5-CF3 H 5-062 ch3 3-C1 4-Cl 5-CF3 5-063 ch2ch3 3-C1 4-C1 5-CF3 5-064 ch3 3-C1 4-Cl 5-C1 5-065 CH2CH3 3-Cl 4-Cl 5-Cl 5-066 ch3 3-F 4-F 5-F 5-067 CH2CH3 3-F 4-F 5-F 5-068 ch3 3-Cl 4-OCH3 5-Cl 5-069 CH2CH3 3-Cl 4-OCH3 5-Cl 5-070 ch3 3-Cl (4)-0CH20-(5) 6.89(寬訊號,211),6.12(3, 2H) 5-071 CH2CH3 3-Cl (4)-0CH20-(5) 6·90 (寬訊號,2H),6.10 (s, 2H) 5-072 ch3 3-Cl 4-F 5-Cl 5-073 CH2CH3 3-Cl 4-F 5-Cl 5-074 ch3 3-OCH3 5-CF3 H 5-075 ch2ch3 3-OCH3 5-CF3 H 5-076 CHr4-Cl-苯基 3-Cl 5-CF3 H 4.03 (寬訊號,2H) 110 201012812 實例編 號 B G1 G2 G3 數據:b-NMR特徵訊號 (400 MHz, d6-DMSO),δ 5-077 CH2-4-OCHr 苯基 3-C1 5-cf3 H 4.03 (寬訊號,2H) 5-078 CH2C=CC12 3-C1 5-CF3 H lgP = 3.73 5-079 cf3 3-C1 5-CF3 H 12.42 (s,NH), 7.40(寬 s, 1H),7_39 (寬 s, 2H) 5-080 CH(CH3)CH2CH3 3-C1 5-CF3 H 7.77 (寬訊號,2H),7.56 (寬訊號,1 Η) 5-081 ch2chf2 3-Cl 5-CF3 H 6.14 (寬 t,CHF2) 5-082 ch2ch3 3-C1 4-OCH3 5-OCH3 3.85 (s, 3H), 3.77 (s, 3H) 5-083 CH2CH2Si(CH3)3 3-CF3 5-Cl H 7.80(寬訊號,2H),7.62 (寬訊號,1H) 5-084 CH(CH3)2 3-Cl (4)-0CH20-(5) 6.92(寬訊號,2玢,6.10(5, 2H) 5-085 ch3 3-Cl (4)-OCH2CH2-(5) 7.18(s,lH),7.12(s,1H), 4.61 (t5 2H) 5-086 ch2ch3 3-Cl (4)-OCH2CH2-(5) 7.19(寬3,111),7.14(寬8, 1H),4.62 (t,2H) 5-087 ch(ch3)2 3-Cl (4)-OCH2CH2-(5) 7.20(寬 s,1H),7.16(寬 s, 1H), 4.62 (t, 2H) 表6-中間物 CN /G3 VS'B X: -β (iv) S、B G1 實例編 號 B G1 G2 G3 數據:W-NMR特徵訊號 (400 MHz,d6-DMSO),δ 111 201012812Example No. B G1 G2 G3 Data: W-NMR characteristic signal (400 MHz, d6-DMSO), δ 5-040 phenyl 3-C1 5-CF3 H 5-041 CHr phenyl 3-C1 5-CF3 H 4.05 ( Wide signal, 2H) 5-042 CH2-2-pyridyl 3-C1 5-CF3 H 5-043 ch2ch=ch2 3-C1 5-CF3 H 5-044 ch2cch 3-C1 5-CF3 H 5-045 ch2ch2och3 3 -C1 5-CF3 H 7.73 (Wide signal, 2H), 7_55 (Wide signal, 1H) 5-046 ch2ch2cf3 3-Cl 5-CF3 H 7.69 (s5 1H), 7.66 (s51H), 7.56 (s, 1H) 5 -047 ch2co2ch3 3-C1 5-CF3 H 5-048 ch3 3-CF3 5-CF3 H (CD3CN), 2.37 (s, 3H) 5-049 ch2ch3 3-CF3 5-CF3 H 2.84 (Wide Signal, 2H), 1.16 (Wide signal, 3H) 5-050 CH(CH3)2 3-CF3 5-CF3 H 8.10 (width 8,211), 7.79 (width 3, 1H) 5-051 ch2ch2ch3 3-CF3 5-CF3 H 8.03 (width 3,211 ), 7.79 (width 5, 1H) 5-052 CH2CH2CH2CH3 3-CF3 5-CF3 H 8.06 (width 3,211), 7.79 (width 3, 1H) 5-053 ch2cf3 3-CF3 5-CF3 H 5-054 Phenyl 3 -CFb 5-CF3 H 5-055 CH2-phenyl 3-CFs 5-CF3 H 5-056 CH2-2-pyridyl 3-CFs 5-CF3 H 5-057 ch2ch=ch2 3-CF3 5-CF3 H 109 201012812 Example No. B G1 G2 G3 Data: 1H-NMR characteristic signal (400 MHz, d6-DMSO), δ 5-058 ch2cc h 3-CF3 5-CF3 H 5-059 ch2ch2och3 3-CF3 5-CF3 H 5-060 ch2ch2cf3 3-CF3 5-CF3 H 5-061 CH2C02CH3 3-CF3 5-CF3 H 5-062 ch3 3-C1 4- Cl 5-CF3 5-063 ch2ch3 3-C1 4-C1 5-CF3 5-064 ch3 3-C1 4-Cl 5-C1 5-065 CH2CH3 3-Cl 4-Cl 5-Cl 5-066 ch3 3-F 4-F 5-F 5-067 CH2CH3 3-F 4-F 5-F 5-068 ch3 3-Cl 4-OCH3 5-Cl 5-069 CH2CH3 3-Cl 4-OCH3 5-Cl 5-070 ch3 3 -Cl (4)-0CH20-(5) 6.89 (Wide Signal, 211), 6.12 (3, 2H) 5-071 CH2CH3 3-Cl (4)-0CH20-(5) 6·90 (Wide Signal, 2H) ,6.10 (s, 2H) 5-072 ch3 3-Cl 4-F 5-Cl 5-073 CH2CH3 3-Cl 4-F 5-Cl 5-074 ch3 3-OCH3 5-CF3 H 5-075 ch2ch3 3- OCH3 5-CF3 H 5-076 CHr4-Cl-phenyl 3-Cl 5-CF3 H 4.03 (Wide signal, 2H) 110 201012812 Example No. B G1 G2 G3 Data: b-NMR characteristic signal (400 MHz, d6-DMSO) ), δ 5-077 CH2-4-OCHr Phenyl 3-C1 5-cf3 H 4.03 (Wide signal, 2H) 5-078 CH2C=CC12 3-C1 5-CF3 H lgP = 3.73 5-079 cf3 3-C1 5-CF3 H 12.42 (s, NH), 7.40 (width s, 1H), 7_39 (width s, 2H) 5-080 CH(CH3)CH2CH3 3-C1 5-CF3 H 7.77 (Wide signal, 2H), 7.56 (Wide signal, 1 Η) 5 -081 ch2chf2 3-Cl 5-CF3 H 6.14 (width t, CHF2) 5-082 ch2ch3 3-C1 4-OCH3 5-OCH3 3.85 (s, 3H), 3.77 (s, 3H) 5-083 CH2CH2Si(CH3) 3 3-CF3 5-Cl H 7.80 (Wide Signal, 2H), 7.62 (Wide Signal, 1H) 5-084 CH(CH3)2 3-Cl (4)-0CH20-(5) 6.92 (Wide Signal, 2玢) ,6.10(5, 2H) 5-085 ch3 3-Cl (4)-OCH2CH2-(5) 7.18(s,lH),7.12(s,1H), 4.61 (t5 2H) 5-086 ch2ch3 3-Cl ( 4) -OCH2CH2-(5) 7.19 (width 3,111), 7.14 (width 8, 1H), 4.62 (t, 2H) 5-087 ch(ch3)2 3-Cl (4)-OCH2CH2-(5) 7.20 (width s, 1H), 7.16 (width s, 1H), 4.62 (t, 2H) Table 6 - Intermediate CN / G3 VS 'B X: -β (iv) S, B G1 Example number B G1 G2 G3 Data: W-NMR characteristic signal (400 MHz, d6-DMSO), δ 111 201012812
實例編 號 B G1 G2 G3 數據:^H-NMR特徵訊號 (400 MHz, d6-DMSO), δ 6-001 ch3 2-C1 H H 6-002 CH2CH3 2-C1 H H 6-003 ch(ch3)2 2-C1 H H 6-004 ch3 2-F 6-F H (CD3CN), 2.63 (s,3H), 2.36 (s3 3H) 6-005 CH2CH3 2-F 6-F H 6-006 ch(ch3)2 2-F 6-F H 6-007 ch3 3-Cl H H 2.62 (s, 3H), 2.34 (s, 3H) 6-008 CH2CH3 3-C1 H H 6-009 ch(ch3)2 3-Cl H H 6-010 ch3 3-CF3 H H 2.64 (s, 3H), 2.35 (s, 3H) 6-011 CH2CH3 3-CF3 H H 6-012 ch(ch3)2 3-CF3 H H 6-013 ch3 4-C1 H H 2.61 (s, 3H), 2.34 (s, 3H) 6-014 ch2ch3 4-Cl H H 6-015 ch(ch3)2 4-C1 H H 6-016 ch3 4-Br H H 7.65 (d, 2H), 7.43 (d, 2H) 6-017 ch2ch3 4-Br H H 6-018 ch(ch3)2 4-Br H H 6-019 ch3 4-1 H H 7.83 (d, 2H), 7.28 (d, 2H) 6-020 ch2ch3 4-1 H H 112 201012812 實例編 號 B G1 G2 G3 數據:1H-NMR特徵訊號 (400 MHz, d6-DMSO), δ 6-021 CH(CH3)2 4-1 H H 6-022 ch3 3-C1 4-C1 H (CD3CN),2.60 (s,3H), 2.33 (s,3H) 6-023 ch2ch3 3-C1 4-Cl H 6-024 ch(ch3)2 3-C1 4-C1 H 6-025 ch3 3-CF3 4-CI H (CD3CN),2.62 (s,3H), 2.33 (s,3H) 6-026 CH2CH3 3-CF3 4-CI H 6-027 ch(ch3)2 3-CF3 4-Cl H 6-028 ch3 3-C1 5-C1 H (CD3CN),2.61 (s,3H), 2.34 (s,3H) 6-029 CH2CH3 3-CI 5-C1 H 6-030 CH(CH3)2 3-C1 5-C1 H 6-031 ch3 3-F 5-CF3 H 6-032 CH2CH3 3-F 5-CF3 H 6-033 ch(ch3)2 3-F 5-CF3 H 6-034 ch3 3-Cl 5-CF3 H (CD3CN),7.93 (s,1H), 7.75-7.72 (s +s5 2H) 6-035 ch2ch3 3-CI 5-CF3 H 7.96 (s,1H),7.91 (s,1H), 7·83 (s,1H) 6-036 ch(ch3)2 3-Cl 5-CF3 H 7.88 (s,1H),7.85 (s,1H), 7.78 (s, 1H) 6-037 ch2ch2ch3 3-Cl 5-CF3 H 7.87 (s,1H),7.86 (s,1H), 7.79 (s? 1H) 6-038 ch2ch2ch2ch3 3-Cl 5-CF3 H 7.87 (s, 1H), 7.86 (s, 1H), 7.78 (s, 1H) 113 201012812Example No. B G1 G2 G3 Data: ^H-NMR characteristic signal (400 MHz, d6-DMSO), δ 6-001 ch3 2-C1 HH 6-002 CH2CH3 2-C1 HH 6-003 ch(ch3)2 2- C1 HH 6-004 ch3 2-F 6-FH (CD3CN), 2.63 (s, 3H), 2.36 (s3 3H) 6-005 CH2CH3 2-F 6-FH 6-006 ch(ch3)2 2-F 6 -FH 6-007 ch3 3-Cl HH 2.62 (s, 3H), 2.34 (s, 3H) 6-008 CH2CH3 3-C1 HH 6-009 ch(ch3)2 3-Cl HH 6-010 ch3 3-CF3 HH 2.64 (s, 3H), 2.35 (s, 3H) 6-011 CH2CH3 3-CF3 HH 6-012 ch(ch3)2 3-CF3 HH 6-013 ch3 4-C1 HH 2.61 (s, 3H), 2.34 (s, 3H) 6-014 ch2ch3 4-Cl HH 6-015 ch(ch3)2 4-C1 HH 6-016 ch3 4-Br HH 7.65 (d, 2H), 7.43 (d, 2H) 6-017 ch2ch3 4-Br HH 6-018 ch(ch3)2 4-Br HH 6-019 ch3 4-1 HH 7.83 (d, 2H), 7.28 (d, 2H) 6-020 ch2ch3 4-1 HH 112 201012812 Example No. B G1 G2 G3 data: 1H-NMR characteristic signal (400 MHz, d6-DMSO), δ 6-021 CH(CH3)2 4-1 HH 6-022 ch3 3-C1 4-C1 H (CD3CN), 2.60 (s ,3H), 2.33 (s,3H) 6-023 ch2ch3 3-C1 4-Cl H 6-024 ch(ch3)2 3-C1 4-C1 H 6-025 ch3 3-CF3 4-CI H (CD3CN) , 2.62 (s, 3H) 2.33 (s,3H) 6-026 CH2CH3 3-CF3 4-CI H 6-027 ch(ch3)2 3-CF3 4-Cl H 6-028 ch3 3-C1 5-C1 H (CD3CN), 2.61 (s ,3H), 2.34 (s,3H) 6-029 CH2CH3 3-CI 5-C1 H 6-030 CH(CH3)2 3-C1 5-C1 H 6-031 ch3 3-F 5-CF3 H 6-032 CH2CH3 3-F 5-CF3 H 6-033 ch(ch3)2 3-F 5-CF3 H 6-034 ch3 3-Cl 5-CF3 H (CD3CN), 7.93 (s,1H), 7.75-7.72 (s +s5 2H) 6-035 ch2ch3 3-CI 5-CF3 H 7.96 (s,1H), 7.91 (s,1H), 7·83 (s,1H) 6-036 ch(ch3)2 3-Cl 5- CF3 H 7.88 (s,1H), 7.85 (s,1H), 7.78 (s, 1H) 6-037 ch2ch2ch3 3-Cl 5-CF3 H 7.87 (s,1H),7.86 (s,1H), 7.79 (s 1H) 6-038 ch2ch2ch2ch3 3-Cl 5-CF3 H 7.87 (s, 1H), 7.86 (s, 1H), 7.78 (s, 1H) 113 201012812
實例編 號 B G1 G2 G3 數據:b-NMR特徵訊號 (400 MHz, d6-DMSO), 5 6-039 ch2cf3 3-C1 5-CF3 H 6-040 ch2-苯基 3-C1 5-CF3 H 4.41 (s,2H), 4.14 (s, 2H) 6-041 CH2-2-吡啶基 3-C1 5-CF3 H 6-042 ch2ch=ch2 3-C1 5-CF3 H 6-044 ch2cch 3-CI 5-CF3 H 6-045 ch2ch2och3 3-C1 5-CF3 H 7.94 (s, 2H), 7.88 (s, 1 H) 6-046 CH2CH2CF3 3-CI 5-CF3 H 7.93 (s5 1H), 7.89 (s5 1H)? 7_86 (s,1H) 6-047 CH2C02CH3 3-CI 5-CF3 H 6-048 ch3 3-CF3 5-CF3 H (CD3CN), 8.04 (s,2H), 7.98 (s,1H) 6-049 CH2CH3 3-CF3 5-CF3 H 8.16 (s,2H),8.1 l(s,lH) 6-050 ch(ch3)2 3-CF3 5-CF3 H 8.16 (s, 2H), 8.11 (s, 1H) 6-051 CH2CH2CH3 3-CF3 5-CF3 H 8.16(s,2H),8.10(s,1H) 6-052 ch2ch2ch2ch3 3-CFs 5-CF3 H 8.15(s,2H),8.11(s,lH) 6-053 CH2CF3 3-CF3 5-CF3 H 6-055 CH2-苯基 3-CF3 5-CF3 H 6-056 CH2-2-吡啶基 3-CF3 5-CF3 H 6-057 ch2ch=ch2 3-CF3 5-CF3 H 6-058 ch2cch 3-CF3 5-CF3 H 6-059 CH2CH20CH3 3-CF3 5-CF3 H 114 201012812Example No. B G1 G2 G3 Data: b-NMR characteristic signal (400 MHz, d6-DMSO), 5 6-039 ch2cf3 3-C1 5-CF3 H 6-040 ch2-phenyl 3-C1 5-CF3 H 4.41 ( s,2H), 4.14 (s, 2H) 6-041 CH2-2-pyridyl 3-C1 5-CF3 H 6-042 ch2ch=ch2 3-C1 5-CF3 H 6-044 ch2cch 3-CI 5-CF3 H 6-045 ch2ch2och3 3-C1 5-CF3 H 7.94 (s, 2H), 7.88 (s, 1 H) 6-046 CH2CH2CF3 3-CI 5-CF3 H 7.93 (s5 1H), 7.89 (s5 1H)? 7_86 (s,1H) 6-047 CH2C02CH3 3-CI 5-CF3 H 6-048 ch3 3-CF3 5-CF3 H (CD3CN), 8.04 (s,2H), 7.98 (s,1H) 6-049 CH2CH3 3- CF3 5-CF3 H 8.16 (s,2H),8.1 l(s,lH) 6-050 ch(ch3)2 3-CF3 5-CF3 H 8.16 (s, 2H), 8.11 (s, 1H) 6-051 CH2CH2CH3 3-CF3 5-CF3 H 8.16(s,2H),8.10(s,1H) 6-052 ch2ch2ch2ch3 3-CFs 5-CF3 H 8.15(s,2H),8.11(s,lH) 6-053 CH2CF3 3 -CF3 5-CF3 H 6-055 CH2-phenyl 3-CF3 5-CF3 H 6-056 CH2-2-pyridyl 3-CF3 5-CF3 H 6-057 ch2ch=ch2 3-CF3 5-CF3 H 6 -058 ch2cch 3-CF3 5-CF3 H 6-059 CH2CH20CH3 3-CF3 5-CF3 H 114 201012812
實例編 號 B G1 G2 G3 數據·· 'H-NMR特徵訊號 (400 MHz, d6-DMSO), δ 6-060 ch2ch2cf3 3-CF3 5-CF3 H 6-061 ch2co2ch3 3-CF3 5-CF3 H 6-062 ch3 3-C1 4-C1 5-CF3 6-063 ch2ch3 3-C1 4-C1 5-CF3 6-064 ch3 3-CI 4-C1 5-Cl 6-065 ch2ch3 3-C1 4-CI 5-C1 6-066 ch3 3-F 4-F 5-F 6-067 CH2CH3 3-F 4-F 5-F 6-068 ch3 3-CI 4-OCHs 5-Cl 6-069 ch2ch3 3-CI 4-OCH3 5-Cl 6-070 ch3 3-CI (4)-0CH20-(5) 6.99 (s, 2H), 6.18 (s, 2H) 6-071 ch2ch3 3-CI (4)-0CH20-(5) 6.99 (s, 2H), 6.18 (s, 2H) 6-072 ch3 3-CI 4-F 5-Cl 6-073 CH2CH3 3-CI 4-F 5-Cl 6-074 ch3 3-OCH3 5-CF3 H 6-075 CH2CH3 3-OCH3 5-CF3 H 6-076 CH2-4-Cl-苯基 3-CI 5-CF3 H 4.40 (s, 2H), 4.16 (s, 2H) 6-077 CH2-CH=C12 3-CI 5-CF3 H 6.39 (t, 1H), 6.19 (t, 1H) 6-078 CH(CH3)CH2CH3 3-CI 5-CF3 H 7.88 (s, 1H), 7.85 (s, 1H), 7.76 (s, 1H) 6-079 ch2ch2cf3 3-Cl 5-CF3 H 7.93 (s, 1H), 7.89 (s, 1H), 115 201012812 實例編 號 B G1 G2 G3 數據:^H-NMR特徵訊號 (400 MHz, d6-DMSO), δ (=6-046) 7.86 (s, 1H) 6-080 CHr4-OCHr 苯基 3-C1 5-CF3 H 4.41 (s, 2H),4.13(s, 2H) 6-081 ch2chf2 3-C1 5-CF3 H 6.46-6.02 (2xtt,CHF2) 6-082 ch2ch3 3-C1 4-OCH3 5-OCH3 3.84 (s,3H), 3.81 (s,3H) 6-083 CH2CH2Si(CH3)3 3-CF3 5-C1 H 7.93 (s, 2H), 7.86 (s, 1H) 6-084 ch(ch3)2 3-C1 (4)-0CH20-(5) 7.00 (s, 2H), 6.21 (s, 1H) 6-085 ch3 3-C1 (4)-OCH2CH2-(5) 7.27 (s, 1H), 7.25 (s, 1H), 4.68 (t, 2H) 6-086 CH2CH3 3-C1 (4)-OCH2CH2-(5) 7.27 (s5 1H), 7.25 (s, 1H), 4.68 (t, 2H) 6-087 ch(ch3)2 3-Cl (4)-OCH2CHr(5) 7.25 (s, 1H)S 7.23 (s, 1H)? 4.68 (t,1H)Example No. B G1 G2 G3 Data·· 'H-NMR characteristic signal (400 MHz, d6-DMSO), δ 6-060 ch2ch2cf3 3-CF3 5-CF3 H 6-061 ch2co2ch3 3-CF3 5-CF3 H 6-062 Ch3 3-C1 4-C1 5-CF3 6-063 ch2ch3 3-C1 4-C1 5-CF3 6-064 ch3 3-CI 4-C1 5-Cl 6-065 ch2ch3 3-C1 4-CI 5-C1 6 -066 ch3 3-F 4-F 5-F 6-067 CH2CH3 3-F 4-F 5-F 6-068 ch3 3-CI 4-OCHs 5-Cl 6-069 ch2ch3 3-CI 4-OCH3 5- Cl 6-070 ch3 3-CI (4)-0CH20-(5) 6.99 (s, 2H), 6.18 (s, 2H) 6-071 ch2ch3 3-CI (4)-0CH20-(5) 6.99 (s, 2H), 6.18 (s, 2H) 6-072 ch3 3-CI 4-F 5-Cl 6-073 CH2CH3 3-CI 4-F 5-Cl 6-074 ch3 3-OCH3 5-CF3 H 6-075 CH2CH3 3-OCH3 5-CF3 H 6-076 CH2-4-Cl-phenyl 3-CI 5-CF3 H 4.40 (s, 2H), 4.16 (s, 2H) 6-077 CH2-CH=C12 3-CI 5 -CF3 H 6.39 (t, 1H), 6.19 (t, 1H) 6-078 CH(CH3)CH2CH3 3-CI 5-CF3 H 7.88 (s, 1H), 7.85 (s, 1H), 7.76 (s, 1H 6-079 ch2ch2cf3 3-Cl 5-CF3 H 7.93 (s, 1H), 7.89 (s, 1H), 115 201012812 Example No. B G1 G2 G3 Data: ^H-NMR characteristic signal (400 MHz, d6-DMSO) , δ (=6-046) 7.86 (s, 1H) 6-080 CHr4-OCHr Phenyl 3-C1 5 -CF3 H 4.41 (s, 2H), 4.13(s, 2H) 6-081 ch2chf2 3-C1 5-CF3 H 6.46-6.02 (2xtt,CHF2) 6-082 ch2ch3 3-C1 4-OCH3 5-OCH3 3.84 ( s,3H), 3.81 (s,3H) 6-083 CH2CH2Si(CH3)3 3-CF3 5-C1 H 7.93 (s, 2H), 7.86 (s, 1H) 6-084 ch(ch3)2 3-C1 (4)---------- ), 4.68 (t, 2H) 6-086 CH2CH3 3-C1 (4)-OCH2CH2-(5) 7.27 (s5 1H), 7.25 (s, 1H), 4.68 (t, 2H) 6-087 ch(ch3) 2 3-Cl (4)-OCH2CHr(5) 7.25 (s, 1H)S 7.23 (s, 1H)? 4.68 (t,1H)
表7-中間物Table 7 - Intermediates
實例編 號 B G1 G2 G3 數據:b-NMR特徵訊號(400 MHz, d6-DMSO), δ 7-001 ch2cf3 3-CF3 5-Cl H 飛對掌異構物之混合物:主要 4.10 - 4.02 (q, 2Η) + 次要3.98-3.90 (q, 2H) 7-002 CH2CH3 3-CF3 5-CF3 H 表8 116 201012812Example No. B G1 G2 G3 Data: b-NMR characteristic signal (400 MHz, d6-DMSO), δ 7-001 ch2cf3 3-CF3 5-Cl H Mix of fly-to-palm isomers: mainly 4.10 - 4.02 (q, 2Η) + Minor 3.98-3.90 (q, 2H) 7-002 CH2CH3 3-CF3 5-CF3 H Table 8 116 201012812
R1 = R2 = Η η = 0 or 1R1 = R2 = Η η = 0 or 1
實例編 號 A1 A2 R3 Β G1 G2 G3 數據:W-NMR特徵訊 號(400 ΜΗζ> d6-DMSO), δ 8-001 N CH Η ch3 3-C1 5-CI H (CD3CN),8.88 (d,2H), 7.44 (t, 1H) 表9-中間物Example No. A1 A2 R3 Β G1 G2 G3 Data: W-NMR characteristic signal (400 ΜΗζ> d6-DMSO), δ 8-001 N CH Η ch3 3-C1 5-CI H (CD3CN), 8.88 (d, 2H) , 7.44 (t, 1H) Table 9 - Intermediates
實例編 號 G1 G2 G3 數據:々-NMR特徵訊號 (400 MHz, d6-DMSO),δ 9-001 3-Cl 5-Cl H 9-002 3-C1 4-CF3 H 9-003 3-CF3 4-C1 H 9-004 3-Cl 4-Cl H 9-005 3-Cl 5-CF3 H 9-006 3-cf3 5-CF3 H 117 201012812 實例編 號 G1 G2 G3 數據:1H-NMR特徵訊號 (400 MHz, d6-DMSO), δ 9-007 3-C1 (4)-OCH20-(5) 9-008 3-C1 (4)-OCH2CH2-(5)Example No. G1 G2 G3 Data: 々-NMR characteristic signal (400 MHz, d6-DMSO), δ 9-001 3-Cl 5-Cl H 9-002 3-C1 4-CF3 H 9-003 3-CF3 4- C1 H 9-004 3-Cl 4-Cl H 9-005 3-Cl 5-CF3 H 9-006 3-cf3 5-CF3 H 117 201012812 Example No. G1 G2 G3 Data: 1H-NMR characteristic signal (400 MHz, D6-DMSO), δ 9-007 3-C1 (4)-OCH20-(5) 9-008 3-C1 (4)-OCH2CH2-(5)
118 201012812 生物數摟 實例編號1 猿葉蟲測試 溶劑:78.0資量組份丙酮 j 5爹量組份二甲基甲醯胺 乳化劑:0.5重量組份烷基芳基多元醇醚 為了製造活性化合物之合適製劑,將1重量組份之活 性化合物與所示量之溶劑與乳化劑混合,並將濃縮物用含 乳化劑之水稀釋至所要的濃度。 將大白菜⑺^3^57·^ 的葉盤嘴灌所要濃度的 活性化合物製劑,乾燥後,植入猿葉蟲幼蟲 cochleariae)。 經7天後,測定活性之%。在此,100%係指殺死全部 的猿葉蟲幼蟲;〇%係指沒有猿葉蟲幼蟲被殺死。 在此測試中,例如下面的製備實例之化合物在500克/ 公頃之使用率下顯現2 80%之活性: 實例編號:1-009、1-013、1-017、1-021、1-025、1-029、 1-033、1-036、1-037、1-038、卜〇39、1-041、1-045、1-046、 1-047、1-048、1-049、1-050、卜〇53、1-057、1-058、1-060、 1_061、1-062、1-064、1-065、1-082、1-083、1-089、1-091、 1- 092、1-093、1-094、1-095、卜097、1-098、1-099、1-100、 2- 013、2-017、2-021、2-025、2-029、2-033、2-037、2-039、 2-040、2-041、2-045、2-046、2-047、2-048、2-049、2-050、 2-053、2-058、2-060、2-061、2-062、2-064、2-065、2-082、 119 201012812 2- 083、2-089、2-092、2-094、2-096、2-097、2-099、3-009、 3- 013、3-017、3-02卜 3-025、3-029、3-033、3-036、3-037、 3-039、3-040、3-045、3-046、3-048、3-049、3-050、3-053、 3-057、3-058、3-060、3-061、3-062、3-064、3-065、3-083、 3-084、3-089、3-091、3-093、3·〇95、3-099、4-010、4-012、 7-001 實例編號2 秋行軍蟲測試(喷灑處理) 溶劑:78.0重量組份丙酮 1.5重量組份二甲基甲醯胺 乳化劑:〇·5重量組份烷基芳基多元醇醚 為了製造活性化合物之合適製劑,將1重量組份之活 性化合物與所示量之溶劑與乳化劑混合,並將濃縮物用含 乳化劑之水稀釋至所要的濃度。118 201012812 Biological number 搂 Example No. 1 Trichophyton test solvent: 78.0 Amount of acetone A 5 Amount of dimethylformamide Emulsifier: 0.5 part by weight of alkyl aryl polyol ether for the preparation of active compounds For a suitable formulation, one part by weight of the active compound is mixed with the indicated amount of solvent and emulsifier, and the concentrate is diluted with the emulsifier-containing water to the desired concentration. The active compound preparation of the desired concentration of the cabbage leaf of Chinese cabbage (7)^3^57·^ was dried and then implanted into the cochleariae larvae. After 7 days, the % activity was determined. Here, 100% means killing all of the locust larvae; 〇% means that no locust larvae are killed. In this test, for example, the compounds of the following preparation examples showed an activity of 280% at a usage rate of 500 g/ha: Example No.: 1-009, 1-013, 1-017, 1-021, 1-025 , 1-029, 1-033, 1-036, 1-037, 1-038, divination 39, 1-041, 1-045, 1-046, 1-047, 1-048, 1-049, 1 -050, dip 53, 1-057, 1-058, 1-060, 1_061, 1-062, 1-064, 1-065, 1-082, 1-083, 1-089, 1-091, 1 - 092, 1-093, 1-094, 1-095, 097, 1-098, 1-099, 1-100, 2-013, 2-017, 2-021, 2-025, 2-029, 2-033, 2-037, 2-039, 2-040, 2-041, 2-045, 2-046, 2-047, 2-048, 2-049, 2-050, 2-053, 2- 058, 2-060, 2-061, 2-062, 2-064, 2-065, 2-082, 119 201012812 2- 083, 2-089, 2-092, 2-094, 2-096, 2- 097, 2-099, 3-009, 3-013, 3-017, 3-02, 3-025, 3-029, 3-033, 3-036, 3-037, 3-039, 3-040, 3-045, 3-046, 3-048, 3-049, 3-050, 3-053, 3-057, 3-058, 3-060, 3-061, 3-062, 3-064, 3- 065, 3-083, 3-084, 3-089, 3-091, 3-093, 3·〇95, 3-099, 4-010, 4-012, 7-001 No. 2 Autumn army insect test (spray treatment) Solvent: 78.0 parts by weight acetone 1.5 parts by weight dimethylformamide emulsifier: 〇·5 parts by weight of alkyl aryl polyol ether suitable for the manufacture of active compounds For the formulation, 1 part by weight of the active compound is mixed with the indicated amount of solvent and emulsifier, and the concentrate is diluted with the emulsifier-containing water to the desired concentration.
將玉蜀黍(Zea所吵·?)的葉盤喷灑所要濃度的活性化合 物製劑’乾燥後’植入秋行軍蟲之 毛蟲。 經7天後’測定活性之%。在此,100%係指殺死全部 的毛蟲;0%係指沒有毛蟲被殺死。 在此測試中,例如下面的製備實例之化合物在500克/ 公頃之使用率下顯現2 80%之活性: 實例編號:1-038、1-039、1-045、1-046、1-049、1-050、 1-058 ' 1-061 > 1-062 > 1-064 ' 1-065 ' 1-082 ' 1-083 > 1-091 -1-092、1-094、1-095、1-097、1-099、1-100、2-025、2-032、 120 201012812 2-033、2-036、2-039、2-045、2-046、2-049、2-050、2-058、 2-060、2-06卜 2-062、2-064、2-065、2-083、2-092、2-093、 2- 094、2-097、2-099、3-025、3-029、3-033、3_036、3-037、 3- 039、3-041、3-045、3-046、3-048、3-049、3_050、3-058、 3- 060、3-061、3-062、3-064、3-065、3-083、3-095、3-099、 4- 012 在此測試中,例如下面的製備實例之化合物在100克/ 公頃之使用率下顯現2 80%之活性: 實例編號:1-047、1_049, 2-047、3-057 實例編號3The leaves of the maize (Zea's noisy?) are sprayed with the active compound preparation of the desired concentration, and then dried, and then implanted into the caterpillar of the autumn army insect. The % activity was measured after 7 days. Here, 100% means that all caterpillars are killed; 0% means that no caterpillars are killed. In this test, for example, the compounds of the following preparation examples showed an activity of 280% at a usage rate of 500 g/ha: Example No.: 1-038, 1-039, 1-045, 1-046, 1-049 1-050, 1-058 ' 1-061 > 1-062 > 1-064 ' 1-065 ' 1-082 ' 1-083 > 1-091 -1-092, 1-094, 1- 095, 1-097, 1-099, 1-100, 2-025, 2-032, 120 201012812 2-033, 2-036, 2-039, 2-045, 2-046, 2-049, 2- 050, 2-058, 2-060, 2-06 Bu 2-062, 2-064, 2-065, 2-083, 2-092, 2-093, 2-094, 2-097, 2-099, 3-025, 3-029, 3-033, 3_036, 3-037, 3-039, 3-041, 3-045, 3-046, 3-048, 3-049, 3_050, 3-058, 3- 060, 3-061, 3-062, 3-064, 3-065, 3-083, 3-095, 3-099, 4-012 In this test, for example, the compound of the following preparation example is at 100 g/ha The activity shows 2 80% activity: Example No.: 1-047, 1_049, 2-047, 3-057 Example No. 3
Tetranychus test, OP-resistant (TETRUR 喷麗處理) 溶劑:78.0重量組份丙酮 1.5重量組份二甲基甲醢胺 乳化劑:0.5重量組份烷基芳基多元醇醚 為了製造活性化合物之合適製劑,將1重量組份之活 性化合物與所示量之溶劑與乳化劑混合,並將濃縮物用含 乳化劑之水稀釋至所要的濃度。 在感染全部發月階段的溫室棉紅缺1蛛蠕 wrNcae)之白腎豆vw/gaA)的葉盤喷灑所要濃度 的活性化合物製劑。 經6天後,測定活性之%。在此,100%係指殺死全部 的虫知蛛蟎;0%係指沒有蜘蛛蟎被殺死。 在此測試中,例如下面的製備實例之化合物在500克/ 公頃之使用率下顯現> 80%之活性: 121 201012812 實例編號:1-053、1-082、1-083、1-093、1-097、2-039、 2- 046、2-053、2-094、2-097、2-099、3-029、3-033、3-037、 3- 046、3-093、6-010、6-045 實例編號4Tetranychus test, OP-resistant (TETRUR treatment) Solvent: 78.0 parts by weight acetone 1.5 parts by weight dimethylformamide emulsifier: 0.5 parts by weight of alkyl aryl polyol ethers Suitable formulations for the preparation of active compounds 1 part by weight of the active compound is mixed with the indicated amount of solvent and emulsifier, and the concentrate is diluted with the emulsifier-containing water to the desired concentration. The active compound preparation of the desired concentration is sprayed on the leaf disc of the white kidney bean vw/gaA) of the greenhouse cotton red wrought wrNcae). After 6 days, the % activity was determined. Here, 100% means killing all of the insects; 0% means that no spider mites are killed. In this test, for example, the compound of the following preparation example showed > 80% activity at a usage rate of 500 g/ha: 121 201012812 Example number: 1-053, 1-082, 1-083, 1-093, 1-097, 2-039, 2-046, 2-053, 2-094, 2-097, 2-099, 3-029, 3-033, 3-037, 3-046, 3-093, 6- 010, 6-045 Instance number 4
Myzus測試(MYZUPE喷灑處理) 溶劑:78.0重量組份丙酮 1.5重量組份二甲基甲醯胺 乳化劑:〇·5重量組份烷基芳基多元醇醚 為了製造活性化合物之合適製劑,將1重量組份之活 性化合物與所示量之溶劑與乳化劑混合,並將濃縮物用含 乳化劑之水稀釋至所要的濃度。 在感染全部發育階段的綠桃辑之大白 菜的葉盤喷麗所要濃度的活性化合物 製劑。 經6天後,測定活性之%。在此,100%係指殺死全部 的桃蚜;0%係指沒有桃蚜被殺死。 在此測試中,例如下面的製備實例之化合物在500克/ 公頃之使用率下顯現2 80%之活性: 實例編號:1-046、1_06卜 1-082、2-013、2-041、2-045、 2-046、2-058、2-083、2-094、2-097、3-033、3-045、3-046 實例編號5 根瘤線蟲測試(MELGIN喷灑處理) 溶劑:80重量組份丙酮 為了製造活性化合物之合適製劑,將1重量組份之活 122 201012812 並將/辰縮物用水稀釋至所 性化合物與所示量之溶劑混合, 要的濃度。 將容器填入沙子、活性化合物之溶液、黃瓜根瘤線蟲 卵/幼蟲懸浮液及萵苣籽。萵苣籽發芽且植物發育。在根部 形成瘤。 ° 經14天後’經由瘤形成測定殺線蟲效應之%。在此,Myzus test (MYZUPE spray treatment) Solvent: 78.0 parts by weight acetone 1.5 parts by weight dimethylformamide emulsifier: 〇·5 parts by weight of alkyl aryl polyol ether For the preparation of suitable formulations of active compounds, The active compound of 1 part by weight is mixed with the indicated amount of solvent and emulsifier, and the concentrate is diluted with the emulsifier-containing water to the desired concentration. The active compound preparation at the desired concentration of the leaves of the Chinese cabbage in the whole development stage of the infection. After 6 days, the % activity was determined. Here, 100% means killing all peach aphids; 0% means that no peach aphids are killed. In this test, for example, the compounds of the following preparation examples showed an activity of 280% at a usage rate of 500 g/ha: Example No.: 1-046, 1_06, 1-082, 2-013, 2-041, 2 -045, 2-046, 2-058, 2-083, 2-094, 2-097, 3-033, 3-045, 3-046 Example No. 5 Nodule nematode test (MELGIN spray treatment) Solvent: 80 weight Component Acetone For the preparation of a suitable formulation of the active compound, 1 part by weight of the active 122 201012812 and the diluted product are diluted with water to the desired concentration of the compound mixed with the indicated amount of solvent. The container is filled with sand, a solution of the active compound, a cucumber root nodule egg/larva suspension and lettuce seeds. Lettuce seeds germinate and plants develop. A tumor is formed at the root. ° % of the nematicidal effect was determined via tumor formation after 14 days. here,
❹ 10 〇 %係指沒有發現瘤;〇 %係指在經處理的植物之瘤數量相 當於未經處理的植物。 在此測試中’例如下面的製備實例之化合物在2〇ppm 之使用率下顯現2 80%之活性: 實例編號3-029、3-033 實例編號6 微小牛蜱測試(BOOPMI注射) 溶劑:二曱亞石風 為了製造活性化合物之合適製劑’將1重量組份之活 性化合物與所示量之溶劑混合,並將濃縮物用水稀釋至所 要的濃度。 將活性化合物之溶液注射至腹部(微小牛蜱)内,將動物 移至盤内並儲存在溫控室内。經由有繁殖力的卵評估活性。 經7天後’測定活性之%。在此,100%係指沒有碑產 下有繁殖力的卵。 在此測試中’例如下面的製備實例之化合物在20微克 /動物之使用率下顯現2 80%之活性·· 實例編號:1-021、1-025、1-029、卜〇33、1-046、1_〇61、 123 201012812 1-062、1-064、1-065、2-025、2-029、2-062、3-025、3-046、 3-061 、 3-062 、 3-065 、 4-010 、 4-012 實例編號7 貓蚤;口側(CTECFE) 溶劑:1重量組份二曱亞砜 為了製造活性化合物之合適製劑,將2重量組份之活 性化合物與所示量之溶劑混合。將依部份的濃縮物用檸檬 酸化的牛血稀釋,並製備所要的濃度。 0 將20隻未餵食的成年蚤(貓蚤)放入頂端及底部用紗布 密封的腔體内。將底部用石蠟密封的金屬圓柱體放在腔體 上。該圓柱體含有血液/活性化合物製劑,其可以被蚤經由 石蠟膜攝取。 經2天後,測定殺死之%。在此,100%係指殺死全部 的蚤;0%係指沒有蚤被殺死。 在此測試中,例如下面的製備實例之化合物在100 ppm 之使用率下顯現2 80%之活性: 〇 實例編號:1-046、1-06卜 1-062、1-064、1-065、2-045、 2-046、2-060、2-06卜 2-062、2-064、2-065、3-04卜 3-045、 3-046、3-060、3-061、3-062、3-065、4-010、4-012 實例編號8 赤銅綠蠅測試(LUCICU) 溶劑:二曱亞艰 為了製造活性化合物之合適製劑,將1重量組份之活 性化合物與所示量之溶劑混合,並將濃縮物用水稀釋至所 124 201012812 要的濃度。 在含有用所要濃度的活性化合物製劑處理的馬肉之容 器内植入赤銅綠蠅幼蟲。 經2天後,測定殺死之%。在此,100%係指殺死全部 的幼蟲;0%係指沒有幼蟲被殺死。 在此測試中,例如下面的製備實例之化合物在100 ppm 之使用率下顯現2 80%之活性: 實例編號:1-02卜 1-025、1-029、1-033、1-037、1-041、 1- 045、1-046、1-060、1-06 卜 1-062、1-064、1-065、2-013、 2- 017、2-02卜 2-025、2-029、2-033、2-045、2-046、2-060、 2- 06卜 2-062、2-064、2-065、3-017、3-025、3-029、3-036、 3- 041、3-045、3-046、3-060、3-06卜 3-062、3-065、4-010、 4- 012 實例編號9 家蠅測試(MUSCDO) 溶劑:二曱亞颯 為了製造活性化合物之合適製劑,將1重量組份之活 性化合物與所示量之溶劑,並將濃縮物用含水稀釋至所要 的濃度。 在含有用所要濃度的活性化合物製劑處理的海綿之容 器内植入成年家蠅。 經2天後,測定殺死之%。在此,100%係指殺死全部 的家蠅;0%係指沒有家蠅被殺死。 在此測試中,例如下面的製備實例之化合物在1〇〇 ppm 125 201012812 之使用率下顯現2 80%之活性: 實例編號:1-025、1-029、1-046、1-062、2-025、2-046、 2- 060、2-06卜 2-062、2-065、3-04卜 3-045、3-046、3-061、 3- 062 .% 在此測試中,例如下面的製備實例之化合物在20 ppm 之使用率下顯現2 80%之活性: 實例編號:2-029❹ 10 〇 % means no tumor was found; 〇 % means that the number of tumors in the treated plants is equivalent to untreated plants. In this test, for example, the compound of the following preparation example showed an activity of 2 80% at a usage rate of 2 〇 ppm: Example No. 3-029, 3-033 Example No. 6 Microburd test (BOOPMI injection) Solvent: two In order to produce a suitable formulation of the active compound, one part by weight of the active compound is mixed with the indicated amount of solvent and the concentrate is diluted with water to the desired concentration. A solution of the active compound is injected into the abdomen (micro burdock), the animal is transferred to a tray and stored in a temperature controlled chamber. Activity was assessed via fertile eggs. The % activity was measured after 7 days. Here, 100% means an egg that has no fertility under the monument. In this test, for example, the compound of the following preparation example showed 280% activity at a usage rate of 20 μg/animal. Example number: 1-021, 1-025, 1-029, dip 33, 1- 046, 1_〇61, 123 201012812 1-062, 1-064, 1-065, 2-025, 2-029, 2-062, 3-025, 3-046, 3-061, 3-062, 3 -065, 4-010, 4-012 Example No. 7 Meerkat; mouth side (CTECFE) Solvent: 1 part by weight of disulfoxide, in order to prepare a suitable formulation of the active compound, 2 parts by weight of the active compound are shown The amount of solvent is mixed. A portion of the concentrate is diluted with lemon acidified bovine blood and the desired concentration is prepared. 0 Place 20 unfed adult ticks (cat mites) into the cavity sealed at the top and bottom with gauze. A metal cylinder with a paraffin seal at the bottom is placed on the cavity. The cylinder contains a blood/active compound formulation that can be taken up by the sputum via the parafilm. After 2 days, the % killed was determined. Here, 100% means that all cockroaches are killed; 0% means that no cockroaches are killed. In this test, for example, the compound of the following preparation example showed 280% activity at a usage rate of 100 ppm: 〇Example No.: 1-046, 1-06 Bu 1-062, 1-064, 1-065, 2-045, 2-046, 2-060, 2-06 Bu 2-062, 2-064, 2-065, 3-04 Bu 3-045, 3-046, 3-060, 3-061, 3- 062, 3-065, 4-010, 4-012 Example No. 8 Red Copper Fly Test (LUCICU) Solvent: Dimethoate To prepare a suitable formulation of the active compound, 1 part by weight of active compound and the indicated amount The solvent is mixed and the concentrate is diluted with water to the desired concentration of 124 201012812. The larvae of the green fly fly are implanted in a container containing horse meat treated with the active compound preparation of the desired concentration. After 2 days, the % killed was determined. Here, 100% means killing all larvae; 0% means that no larvae are killed. In this test, for example, the compounds of the following preparation examples showed an activity of 280% at a usage rate of 100 ppm: Example No.: 1-02b 1-025, 1-029, 1-033, 1-037, 1 -041, 1-045, 1-046, 1-060, 1-06 Bu 1-062, 1-064, 1-065, 2-013, 2-017, 2-02 Bu 2-025, 2-029 , 2-033, 2-045, 2-046, 2-060, 2- 06- 2-062, 2-064, 2-065, 3-017, 3-025, 3-029, 3-036, 3 - 041, 3-045, 3-046, 3-060, 3-06, 3-062, 3-065, 4-010, 4-012 Example No. 9 Housefly test (MUSCDO) Solvent: Dijon Aachen For the preparation of the active compound, 1 part by weight of the active compound is added to the indicated amount of the solvent, and the concentrate is diluted with water to the desired concentration. Adult housefly is implanted in a container containing a sponge treated with the active compound preparation of the desired concentration. After 2 days, the % killed was determined. Here, 100% means killing all house flies; 0% means that no house flies are killed. In this test, for example, the compounds of the following preparation examples showed an activity of 2 80% at a usage rate of 1 〇〇 ppm 125 201012812: Example No.: 1-025, 1-029, 1-046, 1-062, 2 -025, 2-046, 2-060, 2-06 Bu 2-062, 2-065, 3-04 Bu 3-045, 3-046, 3-061, 3- 062 .% In this test, for example The compounds of the following preparation examples showed 280% activity at 20 ppm usage: Example No.: 2-029
126 201012812 【圖式簡單說明】 ¥ 【主要元件符號說明】126 201012812 [Simple diagram description] ¥ [Main component symbol description]
127127
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08159069 | 2008-06-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201012812A true TW201012812A (en) | 2010-04-01 |
Family
ID=40039731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW98121287A TW201012812A (en) | 2008-06-26 | 2009-06-25 | Insecticidal sulphur-derivatized 1-azinylpyrazoles |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR072673A1 (en) |
TW (1) | TW201012812A (en) |
WO (1) | WO2009156090A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102499218A (en) * | 2011-10-21 | 2012-06-20 | 福建农林大学 | Pretreatment device and method for toxicological experiments of pesticides |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2266973A1 (en) * | 2009-05-29 | 2010-12-29 | Bayer CropScience AG | Pyrazinylpyrazole |
KR20140100474A (en) | 2011-11-21 | 2014-08-14 | 바스프 에스이 | Process for preparing n-substituted 1h-pyrazole-5-carboxylate compounds and derivatives thereof |
WO2013164295A1 (en) | 2012-05-04 | 2013-11-07 | Basf Se | Substituted pyrazole-containing compounds and their use as pesticides |
EP4097087A1 (en) * | 2020-01-31 | 2022-12-07 | Bayer Aktiengesellschaft | [(1,4,5-trisubstituted-1h-pyrazol-3-yl)sulfanyl]acetic acid derivatives, salts thereof, and use thereof as herbicidal ingredients |
WO2024121261A1 (en) | 2022-12-09 | 2024-06-13 | Syngenta Crop Protection Ag | Insecticidal compound based on pyrazole derivatives |
WO2024121264A1 (en) | 2022-12-09 | 2024-06-13 | Syngenta Crop Protection Ag | Insecticidal compound based on pyrazole derivatives |
WO2024121262A1 (en) | 2022-12-09 | 2024-06-13 | Syngenta Crop Protection Ag | Insecticidal compound based on pyrazole derivatives |
WO2024121263A1 (en) | 2022-12-09 | 2024-06-13 | Syngenta Crop Protection Ag | Insecticidal compound based on pyrazole derivatives |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2015566B3 (en) * | 1986-02-19 | 1990-09-01 | Duphar Int Res B V | NEW UNCLE COMPOUNDS THAT HAVE FUNGICIDE ACTIVITY. |
DE4405207A1 (en) * | 1994-02-18 | 1995-08-24 | Bayer Ag | N-pyrazolylanilines and N-pyrazolylaminopyridines |
JPH08208620A (en) * | 1995-02-03 | 1996-08-13 | Takeda Chem Ind Ltd | Aminopyrazole derivative, its production and use |
AU6116800A (en) * | 1999-07-22 | 2001-02-13 | 3-Dimensional Pharmaceuticals, Inc. | 1-aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticides |
-
2009
- 2009-06-18 WO PCT/EP2009/004391 patent/WO2009156090A2/en active Application Filing
- 2009-06-25 TW TW98121287A patent/TW201012812A/en unknown
- 2009-06-26 AR ARP090102376 patent/AR072673A1/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102499218A (en) * | 2011-10-21 | 2012-06-20 | 福建农林大学 | Pretreatment device and method for toxicological experiments of pesticides |
Also Published As
Publication number | Publication date |
---|---|
AR072673A1 (en) | 2010-09-15 |
WO2009156090A3 (en) | 2010-04-08 |
WO2009156090A2 (en) | 2009-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6840802B2 (en) | New compounds for controlling arthropods | |
EP3089972B1 (en) | Novel pyrazole heteroarylamides as pesticides | |
ES2759902T3 (en) | New compounds to combat arthropods | |
CN103502221B (en) | N-(3-Carbamoylphenyl)-1H-pyrazoles-5-carboxamides derivatives and the purposes for preventing and treating animal pest thereof | |
CN102844299B (en) | Desinsection aryl-pyrrolidine alkane | |
TW201012812A (en) | Insecticidal sulphur-derivatized 1-azinylpyrazoles | |
JP2012527414A (en) | Insecticidal arylpyrroline | |
TW201127290A (en) | Novel amides and thioamides as pesticides | |
TW201236565A (en) | Insecticidal compounds | |
TW201518280A (en) | Novel halogen-substituted compounds | |
CN103502216B (en) | As pesticide and acaricidal indole carboxamides and benzimidazole-carboxamide | |
JP5834067B2 (en) | Triazole substituted anthranilamides as pest control agents | |
TW201127292A (en) | Pesticidal heterocyclic compounds | |
JP2013530197A (en) | Anthranilamide derivatives as pesticides | |
CN104011026B (en) | Parasite killing virtue amide | |
CN101175729B (en) | 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof | |
TW201108939A (en) | Substituted enaminocarbonyl compounds | |
JP2020518635A (en) | New heterocyclic compounds as insecticides | |
TW200823221A (en) | Avermectin derivatives |